




Integrating a longitudinal ward placement into the 
hospital pharmacist pre-registration year:                                             
a design-based research approach  
 
 
Hannah Kathleen Kinsey 
 
 
Submitted for the degree of Doctor of Philosophy 
University of East Anglia 
School of Pharmacy 
Submitted August 2020 
 
This copy of the thesis has been supplied on condition that anyone who consults it 
is understood to recognise that its copyright rests with the author and that use of 
any information derived therefrom must be in accordance with current UK Copyright 





Qualifying as a pharmacist in the United Kingdom typically comprises a 
four-year degree and one year of pre-registration training in the workplace, 
followed by a registration assessment. Within the hospital setting, the 
pre-registration year usually consists of short block rotations (1-3 weeks) 
through different areas. In medical education, longitudinal placements 
(minimum of 13-weeks), have demonstrated benefits over short block 
rotations. Longitudinal placements afford students more time, which 
communities of practice theory emphasises as important, for building positive 
working relationships that enable learning opportunities. 
The aim of this research was to develop an alternative model for hospital 
pre-registration pharmacist training.  
Methods 
The design-based research approach underpinned this research, using 
learning theories and stakeholder engagement to inform the process.  
Four iterative studies were undertaken: analysis and exploration of 
stakeholder views on current and proposed training models, design and 
construction of a ward placement, evaluating a prototype placement using 
alpha testing and evaluating a longitudinal placement using beta testing.  
Results 
The registration assessment was a barrier to exploring alternative 
pre-registration training models, such as a ward placement. Multi-disciplinary 
stakeholder engagement overcame this barrier and a longitudinal 13-week 
ward placement was constructed. A prototype placement revealed the design 
was suitable for pre-registration pharmacist training. 
The longitudinal placement identified that pre-registration pharmacists 
became part of the ward team, which enriched their learning experience, 
supported their development and improved the ward pharmacy service. 
Recommendations for incorporating longitudinal placements into hospital 
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pre-registration training included identifying ward teams that had a positive 
learning culture and ward pharmacists who were passionate about 
developing people. 
Conclusion 
Longitudinal placements as part of hospital pre-registration pharmacist 
training present an alternative training model, which have additional benefits 
for pre-registration pharmacists, staff teams and patients. Further research 
into 13-week longitudinal placements is warranted to determine their 
effectiveness and impact on pre-registration/foundation pharmacist training. 
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Let us run with perseverance the race marked out for us, fixing our eyes on 
Jesus, the pioneer and perfecter of faith.  









“…as a pre-reg…it’s part of the job description to be in the way…cos 
obviously nobody knows who we are and…we don’t really know what’s going 
on…the first time we went onto the wards, we were just shadowing 
pharmacists…and when you’re shadowing, you’re inevitably in the way. 
Someone wants to get to the computer, someone wants to get to the notes 
and you’re just stood there watching everything go on around you…but I 
didn’t feel like I was in the way on [placement ward] which was quite 
nice…cos they [ward staff] all knew who I was and they knew why I was 
there and I was always around so…I felt like I had a place on the ward and I 
fitted into the team...” 



















This chapter provides an overview of the pharmacy profession, hospital 
pharmacy pre-registration training and the use of longitudinal placements to 
support learning in healthcare settings. 
1.2 The pharmacy landscape 
In the early 20th century, the role of the pharmacist centred on medicines 
supply, with most hospital pharmacists working within dispensaries. Hospital 
pharmacists in the United Kingdom (UK) first started assuming 
responsibilities for medicines-related activities on wards in the 1970s (Hall, 
1970). The hospital pharmacy service gradually evolved to become more 
patient-facing over the next two decades, as ward pharmacy services were 
introduced. Pharmacists gradually transitioned from the dispensary onto 
hospital wards to order medicines and review prescriptions. The transition 
from a product-orientated to a patient-orientated service was formalised in 
the 1986 Nuffield Report as ‘Clinical Pharmacy’ which signalled the change 
in perception of the hospital pharmacists’ role (Nuffield Foundation, 1986). 
Clinical pharmacy enabled pharmacists to become more involved with 
providing direct patient care such as advice at the point of prescribing, 
therapeutic drug monitoring, patient education and counselling (Cotter, 
Barber and McKee, 1994). 
In 2014, the secretary of state for the UK Government commissioned a 
report to investigate how National Health Service (NHS) hospitals in England 
could become more efficient, reducing costs and variability between 
hospitals (Lord Carter of Coles, 2016). The report emphasises the need for 
hospitals to utilise their most valuable resource – their staff – in order to 
achieve this. Pharmacists were identified as an underutilised clinical 
resource for patients and as a result, it was recommended that hospital 




1.2.1 Patient Safety 
The failure of certain hospitals to provide safe and effective care for their 
patients has been highlighted through reports outlining how patient safety 
was not upheld, leading to loss of life (Francis, 2013; Gosport Independent 
Panel, 2018). 
At Mid Staffordshire NHS Foundation Trust, a negative culture towards 
patient care was cultivated by understaffing and a tolerance of poor practice, 
that eventually led to inadequate service provision (Francis, 2013). Patients 
died as a result of medication errors or omitted medicines, yet the report did 
not comment on the activities of the ward pharmacist or the pharmacy 
department. The General Pharmaceutical Council (GPhC) (the regulatory 
body for the pharmacy profession) were not called to account for the actions 
of any pharmacists and there were no fitness-to-practise cases brought 
forward (Colquhoun, 2013; Francis, 2013). The Royal Pharmaceutical 
Society (RPS) (the professional body for pharmacists), published 
recommendations for the pharmacy profession which included: checking that 
patients receive the correct medicines, providing a proactive medicines 
discharge service and documenting details of any changes to medicines in 
the discharge letter (Colquhoun, 2013; Royal Pharmaceutical Society, 2017). 
At The Gosport War Memorial Hospital (a community hospital), 456 patients 
died (with a further 200 potential deaths) from opioid administration over a 
twelve year period (Gosport Independent Panel, 2018). The dose range 
prescribed for the opioids was wide and did not follow national guidance, the 
British National Formulary or local guidelines. Ultimately, the report found no 
clinical justification for prescribing, supplying and administering these 
opioids.  
Unlike the Francis report, which was silent on the role of the ward pharmacist 
and pharmacy department, the Gosport report (published five years after the 
Francis report) provided information on the activities of the ward pharmacist 
and pharmacy department. Medicines were supplied directly to the wards; 
the pharmacist visited the hospital twice a week to check the ward stock and 
examine patients’ drug charts, but no evidence was found that prescribing 
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decisions were ever challenged by the pharmacist (Gosport Independent 
Panel, 2018). It is possible that patients’ notes may have been locked away 
and a culture of practice existed that meant the pharmacist did not get 
directly involved in the patients’ care (Andalo, 2018). Notwithstanding, this 
practice highlights the lack of time the pharmacist spent in a patient-facing 
role and the lack of medication safety audits, which are now becoming a part 
of routine practice in all hospitals (Andalo, 2018; Godlee, 2018; Gosport 
Independent Panel, 2018).  
The recently published NHS long-term plan affirms that pharmacy has a 
central role to play in the evolving NHS, particularly the expansion of the 
profession into General Practice and the establishment of multi-disciplinary 
teams to deliver integrated community-based healthcare (NHS England, 
2019). Increasingly, the need to better utilise pharmacists in patient-centred 
roles, as members of the wider multi-disciplinary teams, is being recognised 
(NHS England et al., 2014; NHS England, 2019).  
1.2.2 The changing role of the hospital pharmacist 
Whilst the opportunities for pharmacists to become more patient-facing and 
work as members of multi-disciplinary teams in both primary and secondary 
care, brings about exciting opportunities for the profession, they also bring a 
new set of challenges (The Pharmaceutical Journal, 2017). The rise of 
automated systems, such as robot dispensing, bar code medication 
administration technology and electronic prescribing, threaten ‘traditional 
pharmacy territory’ such as the supply of medicines (Altman, 2017). 
However, automation also provides an avenue for pharmacists to spend 
more time carrying out patient-facing activities, increasing their clinical 
autonomy, improving patient safety and reducing costs (Cotter, Barber and 
McKee, 1994; Green and Hughes, 2011; Macgregor, 2015; Wickware, 2019).  
Whilst the Carter report advocated for hospital pharmacists spending more 
time in patient-facing roles, it did not recognise or address the additional 
training and education needs for pharmacists, pharmacy technicians and 
pharmacy assistants to take on these roles (Lord Carter of Coles, 2016). The 
Carter report made no explicit mention of the time or monies to be set aside 
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for training to support the pharmacy team to deliver a more patient-facing 
service.  
1.2.3 Integrating pharmacists into ward teams 
In an attempt to deliver a more patient-facing service, one hospital created a 
new role for pharmacists; the ‘Integrated Care Pharmacist’ (ICP). The ICP 
role combined the responsibilities of a ward nurse and a ward pharmacist 
into one. This dual role was intended to enable hospital pharmacists to work 
more closely with patients as a member of the ward team. The ICPs worked 
12-hour shifts on alternate days on the same ward and undertook tasks such 
as; medicines administration, health observations and providing general care 
for their patients (Hung et al., 2017).  
These responsibilities were in addition to the ‘traditional’ role of the hospital 
ward pharmacist; performing medicines reconciliations, ordering medicines 
and counselling patients. Patient benefits attributed to the ICP included: 
reduced length of patient stay, reduced readmission rates and nurses’ 
access to a pharmacist’s knowledge when administering medicines. 
However, the ICPs were paid a band 6 salary from the nursing budget (one 
band higher than nurses receive) and this, coupled with the extensive 
induction the ICPs needed to acquire essential nursing skills for their 
extended roles, created friction between the nursing staff and the ICPs 
(Hung et al., 2017).  
This did not foster a healthy environment for promoting interprofessional 
working and all four ICPs resigned within twelve months of commencing their 
post. In spite of this, the patient benefits attributed to the increased pharmacy 
presence on the ward, must be acknowledged. The study went on to 
recommend that more ward-based training should be incorporated as part of 
pre-registration pharmacist training (Hung et al., 2017). Receiving enhanced 
ward-based training earlier on in their career would have better equipped 
these pharmacists to carry out their ward-based activities in their ICP role. 
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1.3 Pharmacy education 
Qualifying as a pharmacist in the UK takes five years; four years to complete 
a pharmacy degree and one year to complete a work-based pre-registration 
training programme. Both the degree course and pre-registration training 
programme must be accredited by the GPhC (General Pharmaceutical 
Council, 2019d). During the pre-registration year, the pre-registration 
pharmacist must produce a portfolio of evidence in support of having met the 
GPhC’s 76 performance standards and pass the GPhC registration 
assessment.  
During the pre-registration year, the pre-registration pharmacist (also 
referred to as a trainee) is supported by a pre-registration tutor, who mentors 
the trainee, facilitates the training programme and assesses their readiness 
to be a ‘fit to practise’ pharmacist (General Pharmaceutical Council, 2019c). 
This final ‘sign-off’ from the pre-registration tutor as ‘fit to practise’ enables 
the trainee to register with the GPhC, provided they are also successful at 
the GPhC registration assessment (General Pharmaceutical Council, 2019d).   
This assessment consists of a summative written examination which includes 
topics such as clinical therapeutics, calculations and law (General 
Pharmaceutical Council, 2011). In 2019, the national average pass rate was 
72%. University College London graduates achieved an average pass rate of 
93% and Central Lancashire graduates achieved an average pass rate of 
47% (Andalo, 2019).Hence, the pass rates for the assessment vary widely. 
Some of the reasons why pass rates vary so widely may include: the 
university the candidate attended, the sector the training programme was 
completed in and the A-level grades achieved.  
Passing the registration assessment enables a pharmacist to practise in any 
sector: community, hospital, industry, primary care, irrespective of whether 
the pharmacist has any previous experience working in that sector (Jee, 
Schafheutle and Noyce, 2019). Pre-registration training is, in the majority of 
cases, a single-sector training programme; hence a pharmacist could 
complete their pre-registration training in community pharmacy and proceed 
to work as a hospital pharmacist (Jee, Schafheutle and Noyce, 2016). As 
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such, the performance standards which pre-registration pharmacists need 
produce evidence in support of having met during their training year are 












Figure 1: Summary of pharmacy education in the UK 
1.3.1 MPharm (4 years)  
Thirty-one universities in the UK offer an accredited four-year pharmacy 
degree (MPharm), with a further university holding provisional registration 
(General Pharmaceutical Council, 2020a). The MPharm curriculum often 
follows a spiral design with content, both scientific and practice-related, 
introduced in the early years and revisited in increasing complexity in the 
later years (Harden and Stamper, 1999; General Pharmaceutical Council, 
2011). The course remains largely theory-based and incorporates little 
practice-based teaching or assessment (Taylor and Harding, 2007; Jee, 
Schafheutle and Noyce, 2016). However, more practice-based training is 
being incorporated, as experiential placements are now a mandatory 
component of the MPharm (General Pharmaceutical Council, 2011). 
Experiential placements are set hours/days where students attend a 
Pharmacy Degree at a GPhC accredited school of pharmacy 
(4 years) 
Pre-registration training (1 year) 






Candidates take the pre-registration exam 
Candidates who pass can work in any sector as a pharmacist 
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workplace (often related to the relevant field of practice) in order to learn 
from their experiences. The GPhC does not provide any guidance or 
regulation on the amount of hours students should spend undertaking 
experiential placements within the MPharm. Hence, there is significant 
variability in quantity of experiential placements between universities; ranging 
from 54 to 496 total hours per student across the four years (Jacob and 
Boyter, 2020). In addition, whether universities choose to incorporate 
experiential placements as part of a module with credits attached is 
determined by each individual university. Similarly, whether placement sites 
are paid and the sector(s) placements are held in, also varies between 
universities (Jacob and Boyter, 2020). These experiential placements, whilst 
recognised as a valuable learning experience, do not better prepare students 
for pre-registration training as the opportunities to interact with healthcare 
professionals and work as part of a team in this time period is very limited 
(Taylor and Harding, 2007; Guile and Ahamed, 2011; Bullen, Davison and 
Hardisty, 2019).  
1.3.2 MPharm (5 years) 
Two universities in England offer five-year pharmacy degrees that 
incorporate pre-registration training as two 6-month placements and a further 
four are provisionally accredited (General Pharmaceutical Council, 2020a). 
These universities secure the 6-month placements for their students and are 
held jointly responsible with the pre-registration training provider for trainee 
‘sign-off’ prior to sitting the registration assessment (Bullen, Davison and 
Hardisty, 2019). One university also offers a five-year degree that involves 
the students intercalating, hence the university does not share responsibility 
with the training provider for final sign-off (General Pharmaceutical Council, 
2020a). 
In addition to accrediting these programmes, the GPhC determines the 
education standards that all universities offering an MPharm degree and all 
pre-registration training providers must adhere to (General Pharmaceutical 
Council, 2011). The GPhC does not stipulate how these standards may be 
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met; each school of pharmacy and each pre-registration training provider 
determines this individually.  
In January 2019, the GPhC launched a consultation to explore aligning the 
education standards for the 4-year MPharm degree plus the 12-month 
pre-registration training. This combined approach for the initial education of 
pharmacists aims to create an education pathway which better links 
academic study to practical experience (General Pharmaceutical Council, 
2019b). It has been reported that students’ lack of practice-based experience 
may affect their ability to apply knowledge in their professional practice 
(Taylor and Harding, 2007; Husband, Todd and Fulton, 2014; Thomas, 
2017). Hence, it is important that academic study and practical experience 
are linked. The GPhC does not intend to instruct universities and workplace 
training providers how these education standards need to be met, or how 
academic and practical experience should be linked; this will continue to be 
determined by individual organisations (General Pharmaceutical Council, 
2019b).  
The GPhC have considered that a five-year degree, inclusive of workplace 
training, will enable more consistency and accountability with respect to the 
quality of workplace training provided (General Pharmaceutical Council, 
2019b). This will move the pharmacy degree in line with other healthcare 
professional degrees such as medicine and nursing, which both incorporate 
extended placements in different workplaces as a part of the courses 
(University of East Anglia, 2019b, 2019a).  
1.3.3 MPharm in the Republic of Ireland, Scotland and Wales 
A five-year pharmacy degree, with placements integrated into the curriculum, 
was introduced in the Republic of Ireland in 2015 (The Pharmaceutical 
Society of Ireland, 2019). In this model, students undertake 6-weeks of 
shadow placements in their second year, 6-months of placements in their 
third-fourth year and 8-months of placement in their fifth year, across 
different workplace providers and different sectors of practice (The 
Pharmaceutical Society of Ireland, 2014). However, with no additional 
funding provided to deliver this five-year integrated degree, the approach 
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taken closely resembles the five-year degrees in England, where the 
workplace experience has been largely spread across the final two years of 
training. The students receive no salary for their placements and must pay 
an additional year of tuition fees to the university for their fifth year. Students 
completing this degree have raised reports of increased anxiety, mental ill 
health and financial worries. In addition, the roles undertaken during these 
placements are more akin to that of a pharmacy technician, rather than a 
learner who is training to be a pharmacist (O’Connor, 2016). 
In Scotland, a five-year integrated pharmacy degree will commence in 2020-
2021 and will include experiential placements as part of the degree. A new 
funding model will be introduced to support the additional costs associated 
with experiential learning (NHS Education for Scotland, 2018). 
In Wales, multi-sector pre-registration pharmacist training is being rolled out 
so that by 2023, all training posts will include a minimum of 4-weeks in each 
of the following sectors of practice; hospital, community and primary care 
(Health Education and Improvement Wales (HEIW), 2020).  
1.3.4  Funding model 
The MPharm degree in England is funded as a science degree and so 
receives £1,500 per student per year of funding from the Office for Students. 
In contrast, the funding allocated per medical/dentistry student per year is 
£10,000 (Office for Students, 2019). As a result, schools of pharmacy do not 
have the necessary resources to: 
 Employ staff to deal with the administrative burden associated with 
organising experiential placements. 
 Reimburse workplaces for training students. 
 Train educational supervisors. 
This lack of resource has likely contributed to the variations in the quantity 
and quality of experiential training offered at different schools of pharmacy 
(General Pharmaceutical Council, 2014; Jacob and Boyter, 2020).  
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The categorisation of pharmacy as a science degree has also affected which 
students are recruited to the pharmacy course, which is largely determined 
by academic performance alone, as interviews are not mandatory (Burns, 
2018). This contrasts other healthcare professional courses that recruit 
students based on their ability to demonstrate values akin to the NHS such 
as; working together for patients, compassion, respect and dignity 
(Department of Health, 2015; Health Education England, 2016). 
1.3.5  International pharmacy education 
Globally, pharmacy schools continue to expand and introduce experiential 
placements as an integral part of the university curriculum. In the United 
States of America (USA), the Accreditation Council for Pharmacy Education 
(ACPE) has included experiential placements as part of its accreditation 
criteria for the 4-year professional pharmacy postgraduate degree (PharmD). 
Admission to study for a PharmD normally requires completion of a minimum 
of two years of general undergraduate study. In the first two years of the 
PharmD, students are required to complete a structured and sequenced 
experiential programme called Introductory Pharmacy Practice Experience 
(IPPE). This requires a minimum 300 hours of placement experience. Later 
in the course (third and fourth year) students must complete their Advanced 
Pharmacy Practice Experience (APPE), consisting of a minimum of 36 
weeks (1440 hours) of placement in at least four mandatory settings; 
community pharmacy, general practice, hospital pharmacy and inpatient 
general medicine (Accreditation Council for Pharmacy Education, 2015).  
Whilst these mandatory placements provide a specified set amount of 
placement experience and more so than most pharmacy education courses 
globally, one opinion piece reports that the quantity of placements does not 
necessarily equal quality of learning (Cox, 2016). Through increasing the 
experiential focus of pharmacy training in the USA, concerns have been 
raised around the knowledge of pharmacists in topics such as medicinal 
chemistry and pharmaceutics (Skau, 2007). It has been argued in the USA 
and the UK that the introduction of experiential placements into a pharmacy 
degree must not come at the expense of necessary and important scientific 
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knowledge (Skau, 2007; The Pharmaceutical Journal, 2019). Pharmacists 
have a tendency towards wanting to establish scientific knowledge prior to 
application of this knowledge in a professional setting. There appears to be 
the underlying belief within the profession that ‘science’ comes first and the 
‘professional’ comes second. However, the development of the professional 
is just as important as the development of the scientist and professional 
development should be developed at all stages of the pharmacy curriculum 
(Taylor and Harding, 2007). 
The Australian Pharmacy Council stipulates that Schools of Pharmacy must 
incorporate an experiential placement programme as part of their course, but 
no minimum number of hours for placements is specified (Australian 
Pharmacy Council, 2017). At one university, pharmacy students must spend 
500 hours (12-13 weeks) of their 4-year degree undertaking experiential 
placements. Pharmacists who supervise these students on these placements 
are ‘volunteer preceptors’ as they receive no training, there are no formal 
feedback processes and no financial reimbursement for accepting students 
for placements (Lucas et al., 2018).  
1.3.6  Pre-registration tutors 
In order to become a pre-registration tutor in the UK, a GPhC registered 
pharmacist needs only to satisfy the following criteria:  
 Practising for at least three years in the sector of pharmacy they wish 
to become a tutor in. 
 Satisfy assessment requirements (if they are subject to a GPhC 
investigation).  
(General Pharmaceutical Council, 2018). 
Tutors receive no mandatory formal training, undergo no formal review 
process, do not need to meet any minimum standards and are not regulated 
in any way by the GPhC (Mills, Blenkinsopp and Black, 2013; General 
Pharmaceutical Council, 2018). The GPhC provides resources for tutoring, 
but some tutors have found these inadequate in preparing pharmacists for 
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their tutoring role (Jee, Schafheutle and Noyce, 2016; Davison, Bullen and 
Ling, 2019).  
Tutors often receive no formal recognition for their role from their employer 
i.e. the tutor role does not form a part of their job description, they receive no 
financial benefits for tutoring and employers are not obligated to allocate 
dedicated tutoring time for the pharmacist (Mills, Blenkinsopp and Black, 
2013; Jee, Schafheutle and Noyce, 2016; Davison, Bullen and Ling, 2019). 
It is becoming increasingly argued that systems of performance management 
and quality assurance should be introduced for pre-registration tutors and 
that their roles as supervisor, coach and assessor are not appropriate (Mills, 
Blenkinsopp and Black, 2013; Safdar, 2015; Jee, Schafheutle and Noyce, 
2019).  
The roles and functions of pre-registration tutors also differ according to the 
sector of practice. In hospital pharmacy, the pre-registration tutor maintains 
oversight but will be one of a number of pharmacists supervising the trainee 
throughout their year (Jee, Schafheutle and Noyce, 2016). In community 
pharmacy, the pre-registration tutor may be the only pharmacist in the 
pharmacy, hence the only pharmacist who is responsible for supervising the 
trainee.  
The pre-registration pharmacist tutoring model is distinctly different to that 
defined by the Nursing and Midwifery Council (NMC). In nursing, different 
individuals undertake the roles of practice supervisor, practice assessor and 
academic assessor (The Association for Perioperative Practice, 2018). Any 
registered nurse should be in a position to support nursing students to learn 
in the practice environment, in the capacity of a practice supervisor (Nursing 
and Midwifery Council, 2018c). Practice assessors are responsible for 
determining a student’s learning for their placement and will have relevant 
knowledge and experience appropriate to the programme outcomes they are 
assessing (Nursing and Midwifery Council, 2018b). Academic assessors 
monitor and judge students’ academic achievements during their nursing 
course. They work alongside the practice assessors to make 
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recommendations for progression to the next stage of the nursing course 
(Nursing and Midwifery Council, 2019). 
Foundation doctor training in the UK is a 2-year programme whereby 
foundation year (FY) doctors rotate through a variety of medical and surgical 
specialties within a hospital or collection of hospitals every 3-4 months. FY 
doctors have an educational supervisor, clinical supervisor and academic 
supervisor. The educational supervisor maintains overall responsibility for 
their training and a clinical supervisor is responsible for supervising the FY 
doctor’s educational progress during their rotation. Different individuals who 
receive specific training for their role must demonstrate they are competent 
in providing feedback and carrying out assessments to undertake these 
roles. The academic supervisor is responsible for overseeing and providing 
feedback on academic work (UK Foundation Programme, 2019). 
1.3.7  Hospital pre-registration pharmacist training 
Given the critical role the pre-registration year plays in the development of 
pharmacists as healthcare professionals, relatively little is known about how 
it succeeds or fails to equip trainees for their future practice as pharmacists 
(Jee, Schafheutle and Noyce, 2016). The hospital pharmacy pre-registration 
training programme is determined individually by each pre-registration 
manager/tutor at each hospital with little regulation from the GPhC (Jee, 
Schafheutle and Noyce, 2019). Approval as a pre-registration training site is 
granted by the GPhC on the evidence provided on an application form; site 
visits are only carried out if a problem is raised with the GPhC (Mills, 
Blenkinsopp and Black, 2013). Consequently, there is no ‘standard’ 
approach to training, but the model followed by most NHS hospitals involves 
trainees completing a series of ‘rotational blocks’ in different areas such as 
the dispensary, medicines information, the wards and technical services 
(Beswick and Bollington, 2003; Jee, Schafheutle and Noyce, 2016). 
During these rotational blocks, different members of the pharmacy team are 
assigned a pre-registration pharmacist, whom they are responsible for 
supervising for the duration of that rotation. These rotational block 
supervisors may not have received any training or be aware that they are 
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expected to supervise and train pre-registration pharmacists in their relevant 
clinical/technical area. Given that pre-registration tutors do not routinely 
receive any form of training for their role, it is unlikely that these supervising 
members of the pharmacy team are trained to support pre-registration 
pharmacists to learn and develop during their rotation.  
Pre-registration pharmacists have reported receiving little/no feedback from 
ward supervisors during their ward rotations. Any feedback which was 
obtained often related to a trainee’s failure to meet GPhC performance 
standard(s) and rarely consisted of positive messages (Jee, Schafheutle and 
Noyce, 2019). Pre-registration tutors may be unaware how their tutees are 
progressing through their various rotations, relying upon the assessment 
from colleagues  
“I’ve not actually been witness to what he’s [pre-registration pharmacist] 
been doing on the wards. But, again, we have had evidence that he is doing 
that on the wards because that’s been signed off by another pharmacist.” 
(Tutor 11, hospital – district general, round 3)” (Jee, Schafheutle and Noyce, 
2019) 
By comparison, block rotational models of training for medical professionals 
were commonplace a decade or more ago, but are slowly being phased out. 
The medical block rotational training model was underpinned by a series of 
assumptions regarding student’s development of clinical competency, 
namely:  
1. Frequent rotations expose students to more specialties, thus providing 
more opportunities to learn. 
2. Frequent rotations enable doctors to learn how to adapt to the 
different practices, understanding and developing skills to cope with 
the different environments. 
3. Frequent rotations promote autonomy and develop independence as 
trainees have to find their identity on their own in these different 
environments (Holmboe, Ginsburg and Bernabeo, 2011). 
Medical educators sought to understand the value of these assumptions by 
exploring learning in the workplace from a sociological perspective. 
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Sociological research found that trainees learnt new behaviours as a result of 
attaining membership in the field within which they were practising. It was 
hypothesised that rotating medical students, every 2-4 weeks, through 
different clinical areas and with different clinical teams may result in a 
delayed or prohibited ability of the student to acquire professional 
socialisation (Holmboe, Ginsburg and Bernabeo, 2011). 
Factors associated with students rotating frequently were reported: 
difficulties understanding the roles and responsibilities in each new 
environment, difficulties learning how to adjust to the new clinical culture and 
contending with frequent changes in staff and settings. Educators directing 
these rotational programmes identified students struggled with: 
 Their roles and responsibilities. 
 Displaying clinical skills. 
 Applying their knowledge. 
 Participating in self-directed learning. 
 Adjusting to the different environments they were working within 
(O’Brien, Cooke and Irby, 2007). 
Furthermore, moving training environments every 2-4 weeks, reinforced a 
transient model of relationship building with their supervising doctor, the 
multi-disciplinary team and patients. It did not provide opportunities for the 
students to engage in caring for patients in a more holistic manner (Holmboe, 
Ginsburg and Bernabeo, 2011). Rather, clinical training programmes should 
be designed to support trainees to develop inter-professional relationships 
and work as a part of the clinical team, which will diminish the ‘trainee as a 
tourist’ role (Holmboe, Ginsburg and Bernabeo, 2011). 
Hospital pre-registration pharmacist rotational block training often consists of 
rotations lasting 1-3 weeks. It is possible that some of the transition issues 
faced by medical students from rotating frequently, are also faced by pre-
registration pharmacists. Indeed, pre-registration pharmacists have found it 
difficult to undergo ‘professional socialisation’ during training, resulting in 
them being socially unprepared for the workplace and lacking the necessary 
interpersonal and communication skills (Taylor and Harding, 2007; Langley 
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and Aheer, 2010). Employers report that pre-registration pharmacists lack 
the necessary communication and time-management skills, the ability to 
undertake ethical decision making and are unable to work effectively in a 
multi-professional team, particularly with medics (Guile and Ahamed, 2011).  
1.4  Longitudinal placements 
The quality of learning experiences for medical students enrolled in 
programmes which incorporate block rotational models of training, has raised 
concerns over the opportunities students have to develop good working 
relationships with staff and the negative impact this has on patient care 
(Bernabeo et al., 2011). As a result, longitudinal placements (or longitudinal 
integrated clerkships) are becoming increasingly popular as the chosen 
arrangement in which medical students can experience learning in the 
workplace (Hirsh et al., 2007; Walters et al., 2012; Thistlethwaite et al., 
2013).  
Longitudinal placements is a broad term used to describe placements that 
enable students to: 
1. Provide care for patients over time. 
2. Build relationships with the clinicians looking after these patients. 
3. Achieve the learning objectives necessary for their course through 
these experiences (Poncelet and Hirsh, 2016). 
Several reviews exploring the literature surrounding longitudinal placements, 
have been undertaken (Walters et al., 2012; Thistlethwaite et al., 2013; 
Gheihman et al., 2018). Two of these reviews only included studies which 
had consisted of longitudinal placements lasting for at least 6-months, yet no 
rationale was provided as to why this cut-off was applied (Walters et al., 
2012; Gheihman et al., 2018). This may imply that the views of the medical 
education community are persuaded towards longitudinal placements lasting 
a minimum of 6 months (Thistlethwaite et al., 2013). 
However in their review, Thistlethwaite et al., (2013)., included studies which 
were a minimum of 13-weeks in length. Their rationale for including studies 
which were a minimum of 13-weeks in length, was that traditional short block 
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rotations typically only last for 8-weeks. Hence, any placement that was 
upwards of 13-weeks long, had continuity of patient care, mentorship, and 
involved trainees actively participating, was identified as a longitudinal 
placement, for the purposes of the review. 
The length, format, timing within the curriculum and clinical environments of 
placements included in all the reviews varied widely. Hence, the length of 
time, format or clinical setting of a longitudinal placement is not rigidly 
defined. Longitudinal placements can: 
 Range from 13-54 weeks. 
 Consist of just a few hours every week, to part-time, to full-time. 
 Take place from the first year to the final year of medical education. 
 Take place in primary or secondary care, across different specialties 
(Walters et al., 2012; Thistlethwaite et al., 2013; Poncelet and Hirsh, 
2016). 
It appears that whilst there is no universally accepted format for a 
longitudinal placement, if a placement is able to offer students opportunities 
to: care for patients over time, build relationships with staff, achieve the 
required learning objectives and is a minimum of at least 13-weeks long, it 
can be considered to be a longitudinal placement (Thistlethwaite et al., 2013; 
Poncelet and Hirsh, 2016).  
Continuity appears to be the key component to the longitudinal placement. 
Hence, whilst the length, format and clinical settings of longitudinal 
placements may be different to one another, so long as continuity of care, 
the clinical team and learning objectives are maintained, there is the potential 
for numerous benefits to be derived from longitudinal placements over 
traditional short block rotations. These benefits for medical students include:  
 Assuming greater responsibility for patient care as trust develops 
(Walters et al., 2011). 




 Possessing a better outlook on multidisciplinary practice compared to 
students who had not undertaken a longitudinal placement (Florence 
et al., 2007).  
 Improved mentorship (Bell et al., 2008). 
 Obtaining more feedback on performance (Bell et al., 2008) 
(O’Donoghue, McGrath and Cullen, 2015). 
 Improved confidence (Bell et al., 2008; Zink et al., 2008; Wamsley et 
al., 2009; O’Donoghue, McGrath and Cullen, 2015). 
 The opportunity to experience and provide continuity of care for 
patients (O’Donoghue, McGrath and Cullen, 2015). 
 Feeling ‘useful’ (Walters et al., 2011; O’Donoghue, McGrath and 
Cullen, 2015).  
 Became ‘novice’ members of the profession (Walters et al., 2011). 
 Individualised training (Zink et al., 2008). 
 Acquiring knowledge relevant to the students’ future practice (Zink et 
al., 2008; Wamsley et al., 2009).  
 Enhanced professionalism (O’Brien et al., 2012). 
 Greater patient-centeredness (Walters et al., 2012; O’Donoghue, 
McGrath and Cullen, 2015).  
 Development of clinical skills, team-working skills (Zink et al., 2008) 
(Wamsley et al., 2009). 
 Development of problem-solving skills (O’Donoghue, McGrath and 
Cullen, 2015). 
 Building a patient-centred approach to care (Ogur et al., 2007; Hirsh 
et al., 2012). 
 Progression into independent practice (O’Brien et al., 2012). 
Increasingly, there is becoming a compelling argument for using longitudinal 
placements instead of short block rotations in medical education 
(Thistlethwaite et al., 2013). Currently, no such argument exists for pharmacy 
education. However, as the role of the pharmacist continues to become more 
patient-centred, a training model which rotates hospital pre-registration 
pharmacists every 1-3 weeks may no longer be appropriate, given the 
clinical settings which hospital pharmacists now practise within and the 
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expectations for their developed role (Lord Carter of Coles, 2016). 
Longitudinal placements as part of hospital pre-registration pharmacist 
training may therefore warrant further investigation as a potential viable 
alternative to traditional block rotational models.   
1.5  Research study 
This research sought to explore the concept of introducing a ward placement 
into the hospital pre-registration year. If this was acceptable to stakeholders, 
it could be designed, implemented and evaluated. Funding for the study was 
provided by two NHS hospitals and the East of England pre-registration 
pharmacist training programme. The two hospitals also provided many of the 
stakeholders involved in this research and are referred to throughout this 
thesis as hospital 1 and hospital 2.   
In order to explore, design, implement and evaluate a ward placement for 
hospital pre-registration pharmacists, a research approach with a focus on 
learning theories, designing interventions, implementation methods and 
evaluative research methods was required. The next chapter focuses on the 
use of the design-based research approach as the basis through which 

















2.1  Introduction 
Chapter 1 provided an overview of the UK government agenda for the 
pharmacy profession, hospital pharmacy and pharmacy education. It also 
explored pre-registration tutor responsibilities and current models of hospital 
pre-registration pharmacist training. The pitfalls of block rotational 
placements for medical students were described and evidence was 
presented in support of longitudinal 13-week placements. This chapter 
describes the rationale behind the approach taken by the researcher (HK) in 
order to design, implement and evaluate a ward placement for hospital 
pre-registration pharmacists.  
2.2  Philosophical position 
The philosophical position of a researcher reveals the underlying 
assumptions they are making about their work. This enables the reader to 
understand the perspective of the researcher and relate this to the methods 
and findings presented in the research. If researchers fail to acknowledge the 
affect that their underlying assumptions can have on the research, then it can 
compromise the integrity of the research and its’ findings (Scotland, 2012).  
The most common philosophical positions (or worldviews), postpositivism 
and social constructivism, provide different perspectives on the meaning of 
reality and truth. Postpositivism describes how there is not one single reality, 
but that reality is subjective according to different persons. Social 
constructivism (also known as interpretivism) describes how researchers 
interpret the meaning behind participants’ experiences of the world. These 
worldviews promote understanding of social research through: 
 Ontology - study of being/reality.  
 Epistemology - how can I know reality/knowledge.  
 Methodology - what processes we use to attain knowledge  
(Crotty, 1998; Morgan, 2014; Creswell and Poth, 2017b).  
The philosophical position, pragmatism, has recently emerged from the 
above philosophical approaches for understanding truth and reality (Morgan, 
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2014). Pragmatism promotes a practical approach to research, starting with 
the question of ‘what works?’ (Hall, 2013; Morgan, 2014; R. Johnson and 
Christensen, 2014b; Creswell and Poth, 2017b).  
The pragmatist researcher aims to achieve a strong evidence base for which 
practices are effective at answering their research question(s) and produce 
change in the environment (Barab and Squire, 2004; R. Johnson and 
Christensen, 2014a). 
The pragmatic approach encourages researchers’ freedom to utilise 
whichever methodology and methods are necessary to answer their research 
question(s) (Morgan, 2014; R. B. Johnson and Christensen, 2014). However, 
this does not mean that researchers can adopt an ‘anything goes’ approach 
to selecting research methods (Denscombe, 2008). Rather, pragmatist 
researchers must describe and explain why they have chosen the methods 
they have chosen to answer their research question(s) (Morgan, 2014; R. 
Johnson and Christensen, 2014a). 
In this study, the researcher adopted a pragmatic philosophical approach to 
conducting the research. This led the researcher to explore, using the 
design-based research approach, how to design, implement and evaluate a 
ward placement for hospital pre-registration pharmacists (Barab and Squire, 
2004; McKenney and Reeves, 2018a).  
2.3  Design-based research 
Design-based research is not a methodology or a method, it is an approach 
that can be used to support an inquiry, particularly in the field of education. 
Design-based research is also known as educational design research 
(McKenney and Reeves, 2020). In this thesis, the terminology ‘design-based 
research’ is used to describe the approach taken. Readers should be aware 
that this also infers the educational design research approach.  
The design-based research (DBR) approach evolved from design 
experiments. Design experiments were first used to study learning in the 
classroom, as the need to study learning in the ‘real context’ arose (Brown, 
1992; Collins, Joseph and Bielaczyz, 2004).  This research identified that a 
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systematic approach for conducting design experiments needed to be 
developed and that practitioners would need to be involved (Collins, 1992). 
2.3.1  Purpose 
DBR seeks to improve practice through providing an opportunity for 
researchers and practitioners to design interventions and evaluate them, 
thus solving complex educational challenges and advancing knowledge 
concurrently (Wang and Hannafin, 2005; Anderson and Shattuck, 2012; Van 
den Akker et al., 2013; Getenet, 2019). DBR provides a structure for 
conducting research that allows complex educational challenges to be 
addressed using an iterative approach (McKenney and Reeves, 2012f). 
2.3.2  Practitioner involvement 
Practitioner involvement is one of the key elements of the DBR approach, as 
this enables practitioner participants to be viewed as ‘co-participants’ in the 
design of the intervention, rather than as subjects whom the intervention is 
carried out on (Barab and Squire, 2004). This collaboration requires effort on 
the part of both researchers and practitioners to bring about a cultural 
change in the way each party operates in the workplace and academia 
(Dolmans and Tigelaar, 2012; McKenney and Reeves, 2012a). 
The involvement of practitioners enhances the likelihood of securing an 
intervention which is then implemented successfully in practice (Plomp and 
Voogt, 2009). Therefore, the engagement and commitment of practitioners in 
the DBR process is key (Kelly, 2006; Walker, 2006). 
2.3.3  Theory 
The other central characteristic of the DBR approach is the use of theory to 
both inform the design of the intervention and the research methods 
employed to evaluate the intervention (Barab and Squire, 2004; Collins, 
Joseph and Bielaczyz, 2004; McKenney and Reeves, 2012a).  
The use of theory enables research findings to better influence educational 
practice in other settings through the development of a conceptual 
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framework, thus improving the transferability of the design intervention (Cobb 
et al., 2003; Barab and Squire, 2004; McKenney, Nieveen and Van den 
Akker, 2006). Methods which fail to incorporate theory into the design affects 
the ability of research findings to inform practice in other contexts (Wang and 
Hannafin, 2005). 
Using theory in the DBR approach also enables research findings to 
contribute to the theoretical knowledge as the theory is refined and further 
developed (Barab and Squire, 2004). This also makes DBR distinct from 
other methodologies such as service evaluation research or participatory 
action research, since neither of these advocate using theory to inform 
intervention or evaluation design (Barab and Squire, 2004; Dolmans and 
Tigelaar, 2012). 
The contribution to existing theoretical knowledge and/or the creation of new 
theories using the DBR approach may be achieved through the development 
of theoretical frameworks or local instruction theories, that may allow others 
to identify how learning can be supported in their context (Gravemeijer and 
Cobb, 2006; Loljekvist et al., 2016; Wolcott et al., 2019).  
2.3.4  Characteristics 
In addition to the use of practitioners and theory to inform intervention and 
research design, there are additional characteristics of DBR listed in brief 
below: 
1. Collaborative: engages key stakeholders at all stages. 
2. Theoretically focused: learning theories are used to facilitate design 
and results contribute to body of knowledge on learning theories.  
3. Authentic: research takes place in the natural context. 
4. Iterative: the design follows a cyclical process whereby designs are 
revisited and improved upon and learning theories are refined. 
5. Methodologically diverse: a range of methods are used throughout 




6. Practical: the intervention is tailored to benefit the learners, but not at 
a cost to the natural context where the research is taking place.  
7. Operational: the education intervention is properly understood and can 
therefore be applied in other settings. 
8. Contextually aware: researchers are aware of the variables that exist 
within the study (and their potential influence) but there is no attempt 
to control for these variables 
(Barab and Squire, 2004; Collins, Joseph and Bielaczyz, 2004; Wang 
and Hannafin, 2005; Dolmans and Tigelaar, 2012; McKenney and 
Reeves, 2012a; Wolcott et al., 2019). 
These combined characteristics make DBR a unique approach to improving 
educational research to better inform practice (Wolcott et al., 2019).  
2.3.5  Model 
The DBR approach requires the research to be undertaken in the ‘real 
context’ and not in a completely controlled environment because what 
happens in the real context is an essential part of the process (Barab and 
Squire, 2004).  
The approach involves a series of studies undertaken in the real context that 
are iterative in nature. Therefore, each study informs the design of the 
subsequent and the intervention design is refined and improved upon 
throughout (Cobb et al., 2003; Barab and Squire, 2004; Dolmans and 
Tigelaar, 2012). This allows the intervention and research design to remain 
flexible and open to change, which is often how things operate in practice 
(Barab and Squire, 2004). This approach to intervention design and 
development creates a cycle of continuous improvement (Kelly, 2006; 
Dolmans and Tigelaar, 2012; McKenney and Reeves, 2012f). 
DBR often begins with a problem which needs a creative solution; one which 
is developed over time using multiple stakeholder practitioners, a literature 
review and discussions with the research team (McKenney, Nieveen and 
Van den Akker, 2006; McKenney and Reeves, 2012a). The practitioners 
have the opportunity to give feedback and continue to develop the 
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intervention through the various iterative stages of the DBR approach. This 
empowers them to see how research can be used to influence their practice 
(Plomp and Voogt, 2009). 
The methods used in each study should be different, since the aims of the 
research at each stage will be distinct (Dolmans and Tigelaar, 2012). Hence, 
the researcher may need to employ different methods of data collection and 
analysis throughout the project in order to achieve a change in practice and 
contribute to the body of knowledge on learning theory (Cobb et al., 2003; 
Wang and Hannafin, 2005). 
McKenney and Reeves (2018)., identify a process of inquiry that can be used 
to support the design, implementation and evaluation of interventions to both 
inform theoretical understanding and bring about a change in practice 




(McKenney and Reeves, 2012f).  
 
During the exploration/analysis phase, a literature review is undertaken, key 
stakeholders are identified and data gathered on their views and practice 
context (McKenney and Reeves, 2012b).  
The design/construction phase is where the design intervention is built, 
which is grounded in both theory and reality. Often the design will need to go 
through several iterative cycles before being finalised. This phase does not 
involve empirical data collection as such, but requires involvement from key 
stakeholders to support the refinement of the design (McKenney and 
Reeves, 2012d).  
The evaluation/reflection phase involves the formal evaluation of the design 
intervention for the purposes of generating data to inform outputs for the next 
iterative version of the design (McKenney and Reeves, 2012e). The phase in 
which the intervention is being implemented will inform the evaluation 
strategy. The evaluation strategies are categorised into three stages: 
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 Alpha testing, exploring soundness and feasibility. 
 Beta testing, determining local viability and institutionalisation. 
 Gamma testing, identifying effectiveness and impact (McKenney and 
Reeves, 2018d). 
The evaluation strategy will be determined by the stage of implementation. 
For example, the first time an intervention is implemented, alpha testing 
would be conducted. Once the intervention has been implemented several 
times across multiple settings, the focus of the evaluation will gradually shift 
from alpha, to beta, to gamma testing (McKenney and Reeves, 2018d). 
During each phase, the researcher will utilise theoretical and practical 
elements of the approach. Figure 2 shows how these phases interact with 
one another. The bidirectional arrows indicate that all the phases are linked 





















Implementation and spread 
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2.3.6  Limitations 
DBR is time-consuming, risky and complicated to carry out. Over the course 
of the research project, participants may leave employment and both the 
setting and design may need to change. This reflects authentic practice but a 
constantly changing research design is fragile (Dolmans and Tigelaar, 2012).  
DBR also requires the researcher to take on additional roles such as 
designer, advisor and facilitator in order to implement the study (Barab and 
Kirshner, 2001; Cobb et al., 2003; Plomp, 2007; Dolmans and Tigelaar, 
2012).  
In addition, the researcher may need build a relationship with the 
stakeholders and participants in the study, which could result in participants 
being unwilling to criticise the intervention design. This could imply that the 
intervention works, despite a possible lack of evidence (Dolmans and 
Tigelaar, 2012). 
2.3.7  Role of the researcher 
The researcher’s relationship with the participants may also compromise the 
researcher’s ability to critically evaluate the research findings (Dolmans and 
Tigelaar, 2012). This may lead to the independence of the researcher being 
questioned and their research findings challenged due to the nature of their 
additional roles of designer, advisor and facilitator (Barab and Squire, 2004; 
Plomp, 2007). Therefore, the researcher must become adaptable, taking on 
these additional roles without compromising their ultimate role as a 
researcher.  
The researcher must remain flexible and be prepared to alter the intervention 
design if required and also ensure the study is not influenced (positively or 
negatively) by the stakeholders involved (Plomp, 2007). Thus, the researcher 
will need to have effective organisational and communication skills as well as 
a clear understanding of the research processes to enable them to support 
the participants and stakeholders to remain objective throughout (McKenney, 
Nieveen and Van den Akker, 2006: 84). 
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In addition, it is important to understand how the researcher’s attributes and 
background may have shaped their thinking with respect to the research, as 
this may influence the study (O’Leary, 2004b; Creswell and Poth, 2017d). 
Attributes such as the researcher’s gender, age, accent, ethnicity, 
professional role, social status and education experience may have 
contributed to how participants responded to them over the course of the 
research (Yardley, 2000; O’Leary, 2004b). These factors are important when 
one considers the position of power and influence of the researcher, 
particularly when the researcher is also the designer, facilitator and advisor 
(O’Leary, 2004b; Plomp, 2007).  
Characteristics such as the researcher’s age, gender, accent and ethnicity 
are fixed. These may or may not have influenced the participants in this 
research during data collection. It is not possible to determine whether or 
how these did affect the data collected. Hence, these characteristics of the 
researcher (HK) will not be discussed further.   
The researcher’s professional role, social status and education experience 
are more likely to have influenced the data obtained. In order that the reader 
may interpret the results in light of this information, it has been included 
below (Bunniss and Kelly, 2010).  
The researcher (HK) is a qualified pharmacist, having completed her 
MPharm degree at the University of Nottingham and her pre-registration 
training at a district general hospital in Dorset. The researcher worked for 
one year as a rotational hospital pharmacist at the same Trust she 
completed her pre-registration training at, before commencing her PhD. 
During this study, the researcher practised as a pharmacist at a local hospital 
on some Saturdays and occasionally during the working week but never at 
any hospitals involved in this research study. The researcher has previous 
experience conducting qualitative research (Kinsey et al., 2016) but has 
never worked as a pre-registration tutor or had any prior role in the education 
and training of pharmacy professionals. Since the researcher was a 
pharmacist, had trained and worked in a hospital setting, this may have 
affected the way participants responded to her during data collection. Her 
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previous experience may also have put her at risk of interpreting the data in 
the context of her own experiences, rather than that of the participants 
recruited to this research.  
Consequently, the researcher needed to be aware of her own background, 
assumptions and ideas in order to be able to be as objective as possible (for 
it is impossible in any research to be entirely objective) (O’Leary, 2004b; 
Creswell and Poth, 2017d). Practising ‘reflexivity’ (a term used to describe 
one’s ability to describe their own feelings, emotions and motives and how 
these may be influencing the research) is important to enable a researcher to 
be as objective as possible when collecting data. This allows the researcher 
to remain accountable to their thoughts and assumptions regarding the data, 
reducing their influence over the participants (O’Leary, 2004b; Bunniss and 
Kelly, 2010; Ormston et al., 2014). Below is a reflexive account of the 
researcher’s perspective of the research topic. 
February 2017 
Prior to commencing the research, I was very sceptical about the concept of 
introducing a ward placement for hospital pre-registration pharmacists. 
Despite the evidence presented in the medical education literature, I 
struggled to rationalise how an extended ward placement could provide 
greater access to learning opportunities for pre-registration pharmacists. 
Frequently, I reflected on my own rotational pre-registration experience, 
which I enjoyed and would not have changed looking back. I approached the 
research with scepticism and doubt.  
Throughout this research, the researcher (HK) had to detach herself from her 
own experiences as a pre-registration pharmacist and hospital pharmacist to 
enable her to be objective about the research. To support this process, the 
researcher kept a reflexive diary and discussed the data collection at regular 
meetings with the supervisory team. The researcher also sought out the 
support of the social learning theory group at the University of Manchester.  
The readers of this thesis may not concur with some of the interpretations 
made by the researcher, but understanding the researcher’s background 
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may help to mitigate the conclusions reached and help determine whether 
these findings are transferable to other settings (Holliday, 2007). 
2.3.8  The research team 
The research team consisted of the main researcher Hannah Kinsey (HK) 
and the PhD supervisory team; David Wright (DW), Jeremy Sokhi (JS) and 
Maria Christou (MC).  
The local collaborators consisted of the two chief pharmacists of the NHS 
hospitals part-funding this research.  
2.4  Qualitative research  
Qualitative research methods are often used in DBR studies, particularly at 
the initial stages because of the rich data needed to inform intervention 
design and evaluation (Barab and Squire, 2004).  
Qualitative research methods identify a research question or problem and 
seek to explore the meaning behind the question through collecting data 
from people in a natural, real-life setting. Analysis of this data produces 
patterns or themes which are interpreted by the researcher to contribute to 
the field under study (Creswell and Poth, 2017a).  
Qualitative research methods should be used when a comprehensive 
understanding of the research problem is needed which can only be 
determined through talking to people, giving them the opportunity to voice 
their experiences, views and perspectives on the research matter. The 
researcher is a central part of the research process as they gather data 
through talking to people, for example in focus groups or interviews (Creswell 
and Poth, 2017a).  
Data collected using qualitative methods builds a better understanding of the 
research context, facilitating a richer interpretation of results to identify new 
theoretical constructs. This contributes to a better understanding of the 
research area (Creswell and Poth, 2017a).  
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2.5  Validation 
Validity is an essential part of the DBR approach, as readers must be able to 
trust that the results are correctly interpreted and the data supports the 
claims made. Hence, designers and researchers must present enough 
information at each stage of the research process to enable readers to carry 
out critical evaluation (Obrenović, 2011; Van den Akker, 2013). 
Judging the quality of DBR can be difficult, as the approach is at risk of 
sampling bias, response bias, researcher bias and amassing large quantities 
of data that cannot be harnessed to answer the research question(s) (Brown, 
1992; Kelly, 2006).  However, the iterative nature of DBR studies can be 
used to build validity and trustworthiness into the research (Kennedy-Clark, 
2013).  
Since all the studies in this research adopted a qualitative approach, the 
criteria for determining validity in qualitative research studies will be utilised. 
Validation in qualitative research seeks to establish the accuracy of results, 
through exploring the processes used by the research methods, to determine 
if sufficient measures were put in place to ensure validity of findings 
(Creswell and Poth, 2017c). 
Nine validation strategies are described, which recommend that researchers 
should employ at least two strategies in each qualitative research study to 
confirm validation of results. These nine validation strategies are presented 
through three lenses; the researcher’s lens, the participant’s lens and the 
reader’s lens (Creswell and Poth, 2017c). 
Researcher’s lens 
 Triangulation. 
 Disconfirming evidence. 
 Reflexivity. 
Participant’s lens 
 Member checking or seeking participant feedback. 
 Prolonged engagement in the field. 
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 Collaborating with participants. 
Reader’s lens 
 External audits. 
 Generating thick rich descriptions. 
 Peer review of the data. 
(Creswell and Poth, 2017c). 
Researcher’s lens 
Triangulation describes collecting and analysing data from multiple sources, 
allowing the research phenomenon to be explored from multiple 
perspectives, thus increasing the credibility of the findings (Lincoln and 
Guba, 1985; Mukhalalati, 2016; Creswell and Poth, 2017c; Amin et al., 
2020). Often, DBR studies will incorporate several participants and a range 
of data collection methods, hence triangulation of the data becomes a natural 
part of the research design (McKenney, Nieveen and Van den Akker, 2006). 
Disconfirming evidence involves the reporting of data that does not fit the 
pattern or theme of other data findings. This demonstrates the researcher is 
reporting the real results, since not all evidence acquired in a real life setting 
will be identical, some of it will be different (Creswell and Poth, 2017c). 
Presenting data that contradicts other findings, theory or literature, allows the 
researcher to explore why these data exist. This enhances the interpretation 
of the data and reinforces trustworthiness (Amin et al., 2020). 
Reflexivity describes the researcher’s role and their background, enabling 
the reader to better understand the perspectives and interpretations the 
researcher has made regarding the data (Creswell and Poth, 2017c). 
Participant’s lens 
Member checking involves participants viewing and commenting on the 
researcher’s interpretations of the data to determine the credibility of the 
findings (Lincoln and Guba, 1985; Creswell and Poth, 2017c). By giving 
participants the opportunity to review the data collected and/or the 
researcher’s interpretations enables them to clarify outstanding points, 
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correct any errors and provide any additional context or background where 
necessary (Lincoln and Guba, 1985). However, even if participants disagree 
with researcher’s interpretations of the data, they may choose not to tell the 
researcher, out of fear they could be seen as ‘impolite’ (Lincoln and Guba, 
1985). 
Prolonged engagement in the field of research allows the researcher to build 
a relationship with participants and gatekeepers. This relationship permits 
the researcher to double check for any misinformation which may have crept 
into the study but requires close long-term contact with participants to carry 
out (Lincoln and Guba, 1985; Creswell and Poth, 2017c). Prolonged 
engagement may also result in participants wanting to ‘please’ the 
researcher with their answers to interview questions. However, the 
researcher’s extended time in the field should enable them to recognise their 
own influence on the participants and the research context in order to 
account for this phenomena (Lincoln and Guba, 1985). 
Collaborating with participants describes how the researcher involved 
participants throughout the research process from design, to implementation 
and analysis of results. Participant involvement in the research will vary but 
studies which utilise participants more heavily will often be better supported 
and the findings will be used to inform future practice (Patton, 2015; Creswell 
and Poth, 2017c). 
Reader or reviewer’s lens 
External audits involve a person not connected to the study examining the 
research methods, results and interpretations to assess whether the 
conclusions are supported by the data (Lincoln and Guba, 1985; Creswell 
and Poth, 2017c). In DBR, splitting the research into different phases can 
help establish whether conclusions are supported by the data, since the 
results from a previous phase inform the research design for the subsequent 
phase (Kennedy-Clark, 2013). 
Generating a thick rich description helps to confer transferability of research 
findings to other settings because the detail enables readers to draw 
inferences about whether the research context and research findings would 
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be applicable to their setting (Lincoln and Guba, 1985; Creswell and Poth, 
2017c).   
Qualitative studies in pharmacy that focus on barriers and facilitators of an 
intervention in a specific context may not contain enough description to 
enable readers to infer whether these results are applicable to their context. 
Therefore, researchers should seek to provide enough rich description of the 
data to lead to meaningful findings that can be interpreted by others (Amin et 
al., 2020). 
Peer review or debriefing with another member of the research team 
provides additional rigour. The peer debriefer is described as a ‘devil’s 
advocate’ who probes the lead researcher about their study findings, 
interpretations and asks difficult questions about the data (Lincoln and Guba, 
1985; Creswell and Poth, 2017c)  
For each of the studies conducted as part of this research, the reader must 
make an assessment as to whether they are confident that the studies meet 
at least two of the validation criteria listed above, which will determine the 
validity of the results presented.   
2.6  Generalisability 
Generalisability of results describes the ability of research findings from one 
study to have applicability to another similar research population (McKenney 
and Reeves, 2012a). In DBR, the approach taken intends to understand 
what has happened and why it has happened in one context and provide 
guidance to others undertaking the same, or similar work in another context 
(Barab and Squire, 2004).  
Generalisability is enhanced when the researcher can demonstrate that the 
education intervention can be replicated successfully across multiple 
organisations (McKenney and Reeves, 2012a). As a result of this replication, 
it will become clearer which theoretical findings and which aspects of the 
education intervention are applicable across organisations and which ones 
are not (McKenney and Reeves, 2012a). Therefore, DBR studies that involve 
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implementing education interventions in multiple settings, will elicit results 
more generalisable to other contexts.   
Thus, generalisability of results using the DBR approach involves readers 
taking the theoretical contributions and guidance of the practical intervention 
and applying it to their own settings (Brown, 1992; Dolmans and Tigelaar, 
2012; McKenney and Reeves, 2012a). 
Determining generalisability of DBR findings often consists of two steps. In 
the first instance, the researcher must describe the characteristics of the 
intervention, the context in which it was applied and the resulting theoretical 
insights. Following this, any subsequent consumer of the design intervention 
must transfer and translate the education intervention to their context using 
the information provided by the researcher (McKenney and Reeves, 2012a). 
Ultimately, it is the individual readers who will have to make inferences 
regarding the generalisability of results, based on the information provided, 
to assess whether the research findings have applicability in their setting(s) 
(Brown, 1992; McKenney, Nieveen and Van den Akker, 2006; Dolmans and 
Tigelaar, 2012; McKenney and Reeves, 2012f). 
2.7 Thesis structure 
Introducing a ward placement for hospital pre-registration pharmacists 
requires a redesign of the learning environment in order to accommodate a 
new learner onto the hospital ward. DBR approaches have been used 
successfully in previous studies to redesign the work-based learning 
environment utilising practitioner involvement and have been recommended 
for redesigning pharmacy education (Getenet, 2019; Wolcott et al., 2019). 
The application of DBR principles in this research first requires a thorough 
understanding of learning theories and their relevance to pre-registration 
pharmacist education and training. The next chapter describes the 
theoretical constructs underpinning this research and their applicability to 
pharmacy education and training.  
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The structure of this thesis has been organised in accordance with the 
different phases of DBR. Table 1 presents the phases of the DBR process 
and which project they linked to.  
Table 1: Phases of design-based research   
DBR phase Purpose 
Analysis and exploration Chapter 4: Establish the views of key 
stakeholders regarding the introduction 
of a ward placement for pre-registration 
pharmacists  
Design and construction Chapter 5: Design and construction of a 
ward placement 
Prototype implementation and 
evaluation 
Chapter 6: Evaluation of a prototype 
ward placement for a pre-registration 
pharmacist 
Longitudinal placement 
implementation and evaluation 
Chapter 7: Evaluation of the 13-week 




implementation and spread 
Chapter 8: Discussion and 

























3.1  Introduction 
In chapter 2, design-based research (DBR) was presented as the chosen 
approach for this research, which aims to develop a ward placement as part 
of an alternative model for hospital pre-registration pharmacist training. The 
DBR approach requires an understanding of learning theories in order to 
effectively design and analyse study findings (Barab and Squire, 2004; Torre 
et al., 2006). Learning theories enable researchers to better understand the 
research context and can inform the design of education interventions 
(McKenney and Reeves, 2012c; Wolcott et al., 2019).  
This chapter explains four learning theories and applies their principles to 
pharmacist education and training. The theories being explored include: 
experiential learning, situated learning, communities of practice and 
landscapes of practice. Each of these theories builds upon the principles of 
the previous and represent an evolution of thought on learning in social 
settings, such as the workplace.  
‘Experiential learning’ theory, emphasises the importance of gathering and 
reflecting on experience, to support learning (Kolb, 1984). 
‘Situated learning’ theory, describes the importance of the learning 
environment. It focuses on the role of the mentor providing opportunities for 
learning (Lave and Wenger, 1991).  
‘Communities of Practice’ explains the role of the wider community in 
providing access to learning opportunities (Wenger, 1998). 
‘Landscapes of practice’ describes the process of moving between different 
communities of practice and building an identity (Wenger-Trayner et al., 
2014). 
3.1.1 Reflexivity 
The researcher’s (HK) reflexive account regarding the use of learning 




When I came to realise that I needed to understand and apply learning 
theories as part of this research, I was initially confused. I was not a 
sociologist and could not understand why an appreciation of learning 
theories was an important part of the DBR approach. Initially, I struggled to 
identify learning theories that were helpful and found myself getting frustrated 
with the vast expanse of literature relating to learning theories. It was whilst 
reading a thesis, which had used communities of practice learning theory, 
that I came across the social learning theory course at the University of 
Manchester. I enrolled onto the course and as a result, was able to 
understand how learning theories could better enhance my understanding of 
the research context. The course helped me determine which learning 
theories to incorporate as part of this research and how to think more like a 
researcher, as I learnt how to apply each learning theory in the context of 
pharmacy education. 
3.2  Experiential learning  
Experiential learning describes how learners move through a ‘learning cycle’ 
as they acquire experience (Kolb, 1984). Each time a learning cycle is 
completed and a new one begins, the assumption is that learning occurs at a 
higher level than before (Kolb, 1984; Poore, Cullen and Schaar, 2014). In 
order to achieve the best possible learning from their experience, the 
individual must move through each of the four phases of the learning cycle: 
1. Concrete experience – the learner will participate in the activity e.g. a 
pre-registration pharmacist taking a medication history from a patient. 
2. Reflective observation – the learner reflects on this experience e.g. a 
pre-registration pharmacist writing a reflective piece of evidence for 
their portfolio. 
3. Abstract conceptualisation - the learner considers the importance of 
the experience, discussing their experience with others and considers 
what could have been done differently to improve their performance 
e.g. a pre-registration pharmacist discusses their experience with their 
pre-registration tutor.  
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4. Active experimentation – the learner using what was learned to inform 
their future practice e.g. a pre-registration pharmacist practising their 
introduction to patient consultations with their tutor ((Kolb, 1984). 
In order to illustrate this learning cycle, Figure 3 outlines these four phases. 
 
 
Figure 3: Experiential Learning Cycle by Kolb (Kolb, 1984) 
Different people may prefer to learn in a particular phase(s) of the learning 
cycle and this inclination is referred to as someone’s preferred ‘learning 
style’. A person’s individual learning style may be influenced by their 
personality or choice of career. People can shift and adapt their preferred 
learning style as they move into new careers or take on new roles. It is 
proposed that nine different combinations of learning style exist (Kolb, 1984; 
Joy and Kolb, 2009). Whilst a person may prefer to learn in one stage of the 
learning cycle over another, there is a lack of evidence to support teaching 
people according to their preferred learning style (Coffield et al., 2004; 
Massa and Mayer, 2006; Pashler et al., 2008).  
Regardless of which phase of the learning cycle people prefer to learn in, the 
importance of acquiring experience to support learning is essential for 
healthcare professionals’ training (Mann, 2011; Yardley, Teunissen and 

























Dornan, 2012). An estimated 80% of practitioners’ knowledge is acquired 
from learning in the workplace. Therefore, experiential placements as part of 
medical education support students to derive knowledge and meaning from 
these real-life experiences (Yardley, Teunissen and Dornan, 2012; Dornan et 
al., 2019). 
The quantity, length and nature of experiential placements in the pharmacy 
degree varies between universities (Jacob and Boyter, 2020). Some students 
will, have acquired experience from working in pharmacy as a counter 
assistant, dispenser or technician. The value of these experiences should not 
be dismissed, but is must be acknowledged that the student’s role here 
focused on providing a service to patients, not on learning. Students are not 
expected to meet learning outcomes, generate evidence or formally reflect 
on their experiences. This is distinctly different to experiential placements 
that are integral to a formal curriculum, whereby a student is supernumerary. 
The student should learn from their experiences through meeting learning 
outcomes, generating evidence, acquiring competencies and formally 
reflecting. Therefore, whilst working in pharmacy will support some learning, 
it is not a substitute for an organised experiential placement that places the 
student’s learning at the centre.  
The GPhC has recently begun to recommend the inclusion of more 
experiential placements during the degree (Mantzourani and Hughes, 2015; 
General Pharmaceutical Council, 2019a). However, short experiential 
placements for pharmacy students does not always result in learning which 
enhances a pharmacy students’ preparedness for practice (Jee, Schafheutle 
and Noyce, 2019). Consequently, experience for the sake of experience 
doesn’t necessarily result in learning, if placements are not designed and 
implemented effectively. Without sufficient funding for experiential 
placements within the pharmacy degree, it will not be feasible for universities 
to reimburse workplaces or train supervising pharmacists.  
Therefore, currently, pre-registration pharmacist training remains the first 
substantive and formal learning opportunity for most pharmacist trainees to: 
acquire experience on a continuous basis, participate in an organised 
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training programme, meet learning objectives and generate evidence from 
reflecting on their experiences (Schafheutle et al., 2012, 2013; Jee, 
Schafheutle and Noyce, 2016, 2019). As such, the environment within which 
pre-registration pharmacist training takes place is vital for learning and 
development. Situated learning theory describes the importance of the 
environment and the social context for the acquisition of experiences that 
can lead to learning (Mann, 2011).  
3.3  Situated learning  
Situated learning theory describes how learning is embedded within a social 
context (environment), where an apprentice learns from more experienced 
individuals. Thus, the social responsibility for learning is shared between an 
apprentice and master. In order for an apprentice to learn effectively from 
their master, they must be adopted into the community of more experienced 
individuals (Lave and Wenger, 1991). Lave and Wenger (1991: 98)., define a 
community of practice in situated learning theory as:  
“a set of relations among persons, activity, and world, over time and in 
relation with other tangential and overlapping communities of practice”  
Lave and Wenger (1991)., describe how, when the apprentice joins the 
community of practice, they will initially exist at the periphery of the 
community. If the apprentice is to be successful as a learner, they must 
transition from the periphery to the centre of the community of practice. The 
master will need to support the apprentice to make this transition and it will 
take time for this to happen. This transition from peripheral to full member 
over time occurs through a process called ‘legitimate peripheral participation’ 
(LPP). 
LPP describes how apprentices (or newcomers to a community) are 
supported to learn and develop through interacting with already established 
members in the community of practice. Established members are 
responsible for providing opportunities for newcomers to learn in their 
community (Lave and Wenger, 1991; Spouse, 1998). The more time a 
newcomer spends in a community of practice, the more opportunities they 
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will have to interact with established members, learn effectively and acquire 
more responsibilities that will help them acquire full membership (Lave and 
Wenger, 1991). 
LPP is both the means to support newcomers to become full participants in a 
community of practice but also the mechanism by which they can be 
excluded if they are denied opportunities to participate in meaningful practice 
(Lave and Wenger, 1991; Handley, Sturdy and Fincham, 2006). This has 
been observed in communities, such as the meat-cutters, where apprentices 
were used as a form of cheap labour and denied opportunities to take part in 
more sophisticated levels of practice (Lave and Wenger, 1991; Handley, 
Sturdy and Fincham, 2006). Menial activities that marginalise newcomers 
make it difficult to obtain full membership (Lave and Wenger, 1991).  
Currently, there has been little research to explore whether hospital 
pharmacy departments operate as communities of practice (Difrancesco, 
2011). Nonetheless, if for a moment it were to be assumed that hospital 
pharmacy departments have the potential to behave as a community of 
practice, then situated learning can be applied to hospital pharmacist 
pre-registration training programmes. The pre-registration tutor (master) is 
responsible for supporting the pre-registration pharmacist (apprentice) to 
transition through legitimate peripheral participation to participate in the full 
membership in a pharmacy community of practice. The pre-registration 
pharmacist interacts with established members of the pharmacy community 
of practice and acquires more responsibilities for independent practice.  
It is important that newcomers to a community of practice are given enough 
time to learn through LPP. Student nurses found it more difficult to acquire 
responsibilities, contextualise experiences and participate in meaningful 
practice during short placements and this affected their ability to learn (Cope, 
Cuthbertson and Stoddart, 2000). As such, it is important to note that simply 
by being present in the environment where experience in the ‘real-life’ setting 
is provided, does not necessarily result in effective learning (Cope, 
Cuthbertson and Stoddart, 2000). Therefore, whilst experiential learning 
theory emphasises the importance of experience with regards to learning, 
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situated learning theory highlights the need for the context of the experience 
to be appropriately developed, stressing the role of tutors (masters), and 
established members to enable newcomers to transition effectively through a 
community of practice during a placement. 
This has implications for the way hospital pre-registration pharmacist training 
is structured, which is predominantly pharmacy department-based and 
comprised of short block rotations in different technical and clinical areas. 
Situated learning theory suggests that exposing pre-registration pharmacists 
to a range of environments to provide opportunities for ‘experiential learning’ 
may not afford trainees enough time to undergo legitimate peripheral 
participation. Nursing students found that in order for their learning to be 
effective they needed to earn the trust of established members in the 
community of practice through participating authentically in professional 
practice and being socially accepted – both of which take time (Cope, 
Cuthbertson and Stoddart, 2000). 
Hospital pre-registration pharmacists have reported that they do not have 
enough responsibilities during their training (Jee, Schafheutle and Noyce, 
2016); suggesting that they have not experienced legitimate peripheral 
participation, which may have affected their ability to learn. During hospital 
pre-registration training, trainees rotate through different clinical/technical 
areas with different pharmacists and/or technicians. These individuals have 
an important role in supporting the pre-registration pharmacist to legitimately 
participate in the practice of the pharmacy team. However, these 
pharmacists/technicians may not have the time or skills to support the 
pre-registration pharmacists to legitimately participate in their 
clinical/technical area during the short block rotation.  
The pre-registration manager/tutor organises short block rotational 
pre-registration programmes and reviews the evidence pre-registration 
pharmacists generate from these experiences. Pre-registration tutors have a 
role to play in supporting supervising pharmacists/technicians and 
developing training programmes that support pre-registration pharmacists to 
legitimately participate in activities. Yet, pre-registration tutors receive: 
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 Little/no education and training, on learning theories, designing 
training programmes, providing feedback on performance, managing 
trainees in difficulty.  
 No formal recognition for their tutoring role in a job description, career 
progression or additional pay/remuneration. 
 Insufficient time to support the participation of pre-registration 
pharmacists to be legitimised (Mills, Blenkinsopp and Black, 2013; 
Jee, Schafheutle and Noyce, 2016; Davison, Bullen and Ling, 2019). 
Consequently, tutors may be ill-equipped for supporting pre-registration 
pharmacists to learn from their experiences through legitimate peripheral 
participation. The application of situated learning theory to pre-registration 
training reveals the importance of supervising pharmacists and 
pre-registration tutors in supporting pre-registration pharmacists to learn from 
their experiences.   
Communities of practice learning theory better describes the social 
interactions amongst members of a community of practice. The theory 
identifies the features of a community of practice that enable it to become a 
supportive learning environment.  
3.4  Communities of practice 
Communities of Practice theory draws attention to the social practises of 
communities where learning is taking place. What constitutes a community of 
practice evolved from situated learning theory, and was redefined in 
communities of practice theory as: 
“a group of people who share a concern or a passion for something they do, 
and learn how to do it better as they interact regularly”  
(Wenger-Trayner and Wenger-Trayner, 2018) 
Communities of practice theory highlights that not all groups of people 
working together will collectively form a community of practice, but that those 
which do, will provide better social environments for learning to take place in.  
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Identifying whether a group of individuals has formed a community of 
practice may be done through exploring whether they display the following 
practices:  
1. Joint enterprise – members are all working towards the same common 
cause, seeking to achieve the same thing. 
2. Shared repertoire - members use the same tools and resources, 
stories and routines to be able to achieve their common cause.  
3. Mutual engagement – members are willing to work together, share 
knowledge with one another and develop healthy working 
relationships (Wenger, 1998). 
Joint enterprise 
Joint enterprise describes the common goal to which all members of the 
community of practice are working towards and their accountability to one 
another for achieving this goal. This sense of accountability develops as 
members learn what acceptable/unacceptable behaviour is and negotiate 
this practice within the community. The drive towards achieving the joint 
enterprise directs the social energy and motivation of members to work in the 
community to realise this (Wenger, 1998).  
Shared repertoire 
Over time, the joint pursuit of enterprise creates a repertoire of resources 
and knowledge which members share and can include specific activities, 
guidance, tools, routines and abbreviations. These are things which the 
community has adopted over the course of its existence and which have 
become part of its practice (Wenger, 1998).  
Mutual Engagement 
Mutual engagement between members of the community enables good 
working relationships to be established, which, when sustained over time, 
allows participants to become more central members of the community. The 
community of practice may not always need to be a peaceful and 
harmonious place for it to function effectively; conflict may also help to 
develop the practice of a community (Wenger, 1998).  
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Indicators for the presence of a community of practice 
In addition to these individual interactions that take place between members 
of a community of practice, there are a further 14 indicators that could be 




Table 2: Indicators for the presence of a community of practice and proposed 
domain, reproduced from (Li et al., 2009a). 
Indicator CoP domains 
Sustained mutual relationships – harmonious or 
conflictual 
Mutual engagement 
Shared ways of engaging in doing things together 
Mutual engagement 
Joint enterprise 
The rapid flow of information and propagation of 
innovation 
Mutual engagement 
Absence of introductory preambles, as if 
conversations and interactions were merely the 
continuation of an ongoing process 
Mutual engagement 
Shared repertoire 
Very quick setup of a problem to be discussed 
Mutual engagement  
Shared repertoire 
Substantial overlap in participants’ descriptions of 
who belongs 
Mutual engagement 
Knowing what others know, what they can do and 




Mutually defining identities Shared repertoire 
The ability to assess the appropriateness of actions 
and products 
Shared repertoire 
Specific tools, representations and other artefacts Shared repertoire 
Local lore, shared stories, inside jokes, knowing 
laughter 
Shared repertoire 
Jargon and shortcuts to communication as well as 
the ease of producing new ones 
Mutual engagement 
Shared repertoire 
Certain styles recognised as displaying 
membership 
Mutual engagement 
A shared discourse reflecting a certain perspective 





These indicators may be useful for determining the extent to which a group 
of people operate effectively as a community of practice, but their abstract 
nature makes them difficult to apply (Li et al., 2009a). In a systematic review 
of the literature, four characteristics indicative that a community of practice 
had formed amongst a group of individuals were identified. These are: 
1. Social interaction (individuals interacting with one another). 
2. Knowledge-sharing (knowledge is relevant). 
3. Knowledge-creation (new ways of ‘doing things’). 
4. Identity-building (building a professional identity). 
(Li et al., 2009b) 
However, not all characteristics were consistently present in every 
community of practice included in the review, suggesting that the ability of a 
group of individuals to effectively function as a community of practice may 
vary (Li et al., 2009b; Terry et al., 2020).  
3.4.1  Communities of practice in healthcare 
Communities of practice have been used in the different ways within the 
healthcare setting to improve practice through the sharing and creating of 
new of knowledge amongst healthcare professionals (Li et al., 2009b; 
Ranmuthugala et al., 2011; Terry et al., 2020). The sharing of knowledge is 
particularly important for trainee and novice healthcare professionals, since 
they will need to acquire knowledge and skills in order to transition from the 
periphery of a community to the centre (Terry et al., 2020). Inherently, 
communities of practice can promote interprofessional working in the 
healthcare setting if an experienced leader is willing and able to demonstrate 
this (Oulet et al., 2009). 
The Nursing and Midwifery Council (NMC) state that at least 2300 hours (of 
the 4600 hours) of student nurse clinical training should involve the student 
working as part of a team dedicated to providing care for patients (Nursing 
and Midwifery Council, 2018a). 
Terry et al. (2020)., identified a series of enablers and barriers to building a 
successful community of practice that supports student and novice nurses 
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(also referred to as newcomers) to develop in the healthcare setting. The 
enablers include: 
1) Environment – newcomers feel comfortable, are able to participate 
and are familiar with ward staff (Jørgensen and Hadders, 2015). 
2) Support from community members – members are willing to help the 
newcomers in their role and make an effort to include them in social 
and professional conversations (Thrysoe et al., 2012; Walsh, 2015). 
3) Welcome, acceptance and belonging – the newcomers were expected 
by the members, were welcomed on arrival and were given 
responsibilities to facilitate their learning (Ranse and Grealish, 2007; 
Jørgensen and Hadders, 2015). 
 
The newcomers needed to be able to build trust with their mentor so having 
a mentor who was approachable, patient, friendly and supportive was 
important for sustaining the learning environment (Lewis and Kelly, 2018). 
The barriers to creating a community of practice that supported student and 
novice nurses to develop were: 
1) Alienation – when newcomers felt overlooked, unwelcomed or treated 
with indifference which affected their ability to contribute (Ranse and 
Grealish, 2007; Thrysoe et al., 2010; Jørgensen and Hadders, 2015). 
2) Marginalisation – newcomers were given token access to the 
community of practice but were denied full participatory rights, they 
were not accepted professionally by the core members and could not 
contribute fully (Thrysoe et al., 2012). 
3) Frustrations – when newcomers did not know what to do, or who to 
ask or were frustrated by their own lack of knowledge or competence, 
not being viewed as supernumerary (Thrysoe et al., 2012; Jørgensen 
and Hadders, 2015). 
 
Hospital wards have been identified and described as operating as 
communities of practice, but the role of the pharmacist within these ward 
communities of practice remains undefined and unidentified in the literature. 
Traditionally, hospital pharmacists have been primarily located within 
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pharmacy departments, only visiting wards to carry out medicines-related 
activities. This could account for the absence of the role of the pharmacist 
from the community of practice literature exploring the hospital ward. 
However, pharmacists are now required to undertake more patient-facing 
roles, which will, in the majority of cases, take place on the hospital ward 
(Lord Carter of Coles, 2016). Therefore, in order to understand the role of the 
pharmacist both within the pharmacy department and on the hospital ward, 
landscapes of practice must be explored. 
3.5  Landscapes of practice 
Landscapes of practice describe how individuals can belong to more than 
one community of practice at any one time and often are either peripheral or 
full members of several (Handley, Sturdy and Fincham, 2006). Each 
community of practice will look different, with unique practices, enterprises, 
ways of working and sharing knowledge (Handley, Sturdy and Fincham, 
2006). Since each community of practice will be unique, this results in the 
creation of boundaries around communities of practice (Wenger, 1999 
p.103). These multiple communities of practice, with their respective 
boundaries are called a ‘landscape of practice’ (Wenger-Trayner et al., 2014 
p.13). 
It is not possible to participate competently in every community of practice in 
a given landscape. But, having an awareness and knowledge of how other 
communities of practice function, can enable a person to navigate their 
personal landscape of practice effectively (Wenger-Trayner and Wenger-
Trayner, 2014). 
In a hospital, numerous professional staff groups are organised according to 
speciality. There is the potential for many different communities of practice to 
exist, thus creating a landscape of practice within the hospital. The 
boundaries between these different communities of practice may be obvious, 
such as membership in a profession, whilst others may be subtle, such as 




Crossing the boundary from one community of practice into another can be 
difficult, as boundaries into other communities can be confusing places 
where members use jargon to communicate or share inside jokes which may 
alienate the non-member (Wenger-Trayner et al., 2014 p.5 p.17).  
Crossing the boundary does have the potential to provide unexpected 
learning opportunities as non-members and members interact. They can 
learn to share practice and identify opportunities for working together. But, if 
the practice shared at the boundary encounter is seen by either side as 
irrelevant and unimportant, then time has been wasted as nothing has been 
learnt (Wenger-Trayner et al., 2014 p.17-18).  
So whilst crossing boundaries between different communities of practice 
holds great potential for learning, it also carries the risk of wasting people’s 
time (Wenger-Trayner et al., 2014 p.17). In order to cross a boundary into 
another community successfully, the person may require support from an 
individual known as a ‘broker’. A broker is someone who can introduce and 
provide access to the practice of the community the person is hoping to join 
(Wenger, 1999 p.105).  
Hospital staff may belong to their ‘professional’ community of practice and 
their ‘ward/specialty area’ community of practice. For example, nurses may 
consider themselves a member of their professional community, a ‘nurses 
community of practice’ and a member of the community on the ward which 
they work, ‘ward 12 community of practice’ (Cope, Cuthbertson and Stoddart, 
2000; Wenger-Trayner et al., 2014).  
Landscapes of practice declare that learning involves the creation of an 
identity, a discovery of who one is within the landscape of practice. 
Therefore, how a person navigates and experiences their landscape of 
practice as they move through it will shape a persons’ identity. Some 
communities of practice a person may interact with will have a lasting impact 
on their identity, but some will not. Some communities of practice will be 
ignored entirely or just visited. The journey a person takes through this 
landscape will shape how they determine their identity. How effective they 
will be in the landscape will be determined by the extent to which they embed 
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into each community of practice (Wenger-Trayner and Wenger-Trayner, 
2014). 
3.5.1 Modes of identification 
In order to become a member of a community of practice, a person must 
build their identity across their landscape of practice so that both they and 
others know, in which communities of practice they are a full member.  
There are three indicators, known as ‘modes of identification’, that can be 
used to determine the extent to which a person is a member of a community 
of practice. These are: 
1. Engagement – engaging with the practice of the community, 
contributing to the conversation, using resources, discussing topics 
with members.  
2. Imagination – building a picture of the landscape that helps a person 
to understand where they fit, what their role is and how they can 
participate. 
3. Alignment – a position of agreement or alliance with the context that 
works in a two-way process so that people can influence others to 
align with them (Wenger-Trayner and Wenger-Trayner, 2014). 
These modes of identification enable a person to make sense of their 
landscape of practice and their position within each community. These 
modes of identification, can also exist across boundaries between 
communities as well. Engagement can take place at a boundary if the 
community is willing to engage with the newcomer, but the newcomer may 
find it more difficult to participate in alignment at a boundary encounter as 
they won’t necessarily have an awareness of the practices and routines of 
the community (Wenger-Trayner and Wenger-Trayner, 2014 p.22).  
The modes of identification are separate from one another and when applied 
together, they are most effective at helping people to identify where their 
practice is located across a landscape. If a person only engages with a 
community, they are at risk of simply accepting the ‘status quo’ and not 
seeking to imagine a better way of doing things or being prepared to 
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influence positive change over the community. Similarly, if a person only 
imagines how and where they could participate in a community, but does not 
engage in the process of doing so, they also will not be able to transition into 
full membership in the community of practice. Therefore, it is through 
combining each of these modes of identification that a person is able to 
determine where they are located in their landscape of practice, including 
their peripherality or centrality within each community of practice (Wenger-
Trayner and Wenger-Trayner, 2014). 
Pre-registration pharmacist training lasts for 1-year and does not guarantee 
employment in the same hospital once training has completed. Hence, there 
may be a disconnect between how much a pre-registration pharmacist may 
be willing to engage; since they may plan to only be there for a short time. 
However, the longevity of the training year, the need for tutor sign-off and the 
GPhC exam may well transcend any apathy or lack of willingness for 
pre-registration pharmacists to engage in pre-registration training.  
The public expects healthcare professionals to be competent practitioners in 
their own field of expertise and sufficiently knowledgeable about other 
practices in the landscape, which are relevant to them. Competence is 
achieved when a practitioner is sufficiently knowledgeable and skilled at 
performing their role within a given community of practice. Knowledgeability 
is the ability to practise competently across several communities of practice 
(the landscape of practice). Therefore, learning to become a healthcare 
professional is about developing an identity of competence in relevant 
communities of practice and knowledgeability across a landscape of practice 
(Wenger-Trayner and Wenger-Trayner, 2014). Hence, pharmacists must 
develop competence in relevant communities of practice (e.g. ward and 
pharmacy department) and knowledgeability across their landscape of 
practice (e.g. hospital).  
Learning to become an effective healthcare professional is therefore not just 
about obtaining ‘book knowledge’ but also about developing competence, 
learning how to successfully move between communities of practice and 
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acquiring knowledgeability about the relevant landscape(s) of practice 
(Wenger-Trayner and Wenger-Trayner, 2014 p.23). 
3.6  Summary 
This chapter has described several learning theories and applied their 
principles to pharmacy, medical and nursing education. The design-based 
research approach advocates that theory must be used to inform study 
design, implementation and evaluation to enable greater applicability of the 
research to other settings (Barab and Squire, 2004).  
Experiential learning theory conceptualises the importance of experiential 
placements to enhance learning. Situated learning theory highlights the role 
of the supervising pharmacist and tutor in supporting pre-registration 
pharmacists to develop through legitimate peripheral participation.  
Communities of practice theory explores the behaviours and attributes of a 
community of practice; mutual engagement, shared repertoire and joint 
enterprise. Landscapes of practice describes the boundaries that exist 
between different communities of practice and how crossing these 
boundaries can provide opportunities for learning. The journey that a person 
takes through a landscape of practice will ultimately shape their identity.  
The introduction of a ward placement for pre-registration pharmacists using 
these social learning theories to inform design is a complex research 
agenda. Design-based research offers a framework within which this 
intervention can be explored, designed, implemented and evaluated to 
contribute to the knowledge of learning theory and inform the development of 



















4.1  Introduction  
The previous chapter described four learning theories that are relevant to 
pharmacy education and training: 
 Experiential learning  
 Situated learning 
 Communities of practice 
 Landscapes of practice 
These theories will be applied to the results generated in this chapter, which 
describes the explorative work undertaken to determine current 
pre-registration training models and identify possible design features of a 
ward placement. 
4.1.1  Design-based research: Analysis and exploration 
The DBR approach involves first carrying out explorative work to establish 
the research area, such as through a literature review. This may be followed 
by engaging with stakeholders to determine their views on the research area. 
The analysis and explorative phase of design-based research allows the 
research area to be defined and provides the platform for the intervention 
design to be established (McKenney and Reeves, 2012b).  
Involving stakeholders at the early stages of research is important since 
those who will be directly impacted by the research should have input into 
how it will be conducted. This in turn, creates a network of people who will 
shape the study and be prepared to participate in it (McKenney and Reeves, 
2012b).  
4.2  Aim and Objectives  
Aim: 
Determine current pre-registration training and pharmacist practice models in 
hospitals and identify possible design features for a pre-registration 
pharmacist ward placement. 
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Objectives:   
1. Describe current hospital pharmacist pre-registration training 
models. 
2. Describe current pharmacist practice on hospital wards. 
3. Identify barriers and enablers to implementing a ward 
placement during the pre-registration year.  
4. Explore views on the design of a new ward placement.  
These aim and objectives were used to inform the research methods, the 
study design and identify stakeholders who could be approached to take part 
in this research (McKenney and Reeves, 2012b).  
4.3  Method 
4.3.1  Ethical approval 
Ethical approval for this study was obtained from University of East Anglia 
Research and Ethics Committee (see appendix 1) and governance approval 
from the Health Research Authority (see appendix 2). Information that could 
lead to the identification of participants has been redacted from these 
approvals. 
4.3.2 Qualitative methods 
Qualitative methods are of particular value in the analysis and explorative 
DBR phase due to their ability to gather rich descriptions of participants 
views on the research topic (Barab and Squire, 2004). The most common 
form of qualitative data collection occurs through interviews and focus 
groups.  
4.3.2.1  Interviews 
Interviews are a discussion between the researcher and a participant. An 
interview conducted effectively may appear to the casual observer as an 
everyday conversation between two individuals, but the roles of researcher 
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and participant are distinct, with the interview process requiring both parties 
to work hard in order to answer the research questions (Yeo et al., 2014).  
The types of interview can vary from a structured question and answer 
format, where the aim is to achieve standardisation, to an unstructured 
format, which does not use already determined questions and is more 
conversational (O’Leary, 2004a). Most interviews in a research setting tend 
to fall somewhere in the centre in what is commonly known as a 
‘semi-structured’ interview, whereby a series of discussion points are laid out 
in a topic guide. These discussion points can be covered in any order and 
the researcher may still ask questions of the participants which are not 
covered in the topic guide (O’Leary, 2004a).  
The semi-structured interview enables the researcher to obtain data in order 
to answer their research questions, whilst also allowing opportunity for 
listening and responding to participants, using probing questions (O’Leary, 
2004a; Brinkmann and Kvale, 2015a). However, this can create a lack of 
consistency if the researcher does not always ask exactly the same 
questions at each interview (Flick, 2014b).  
Interviews enable participants to provide descriptive accounts of their 
experience and are a useful tool for the researcher to understand 
participants’ individual decision-making processes and thoughts regarding 
the research topic (Lewis and McNaughton Nicholls, 2014; Brinkmann and 
Kvale, 2015a). Interviews allow individuals to share their feelings with the 
researcher, which they may feel unable to do in a group setting. They allow a 
broad range of topics to be discussed, giving the researcher the opportunity 
to generate rich data (Yeo et al., 2014). 
During an interview, the researcher builds a picture of the participant’s world, 
learning how they make sense of their experiences and derive meaning from 
what is taking place. This enables the researcher to interpret and 
characterise their views in a way that is true to the meaning of what the 
participant intended (Miller and Glassner, 2016). 
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Generating new knowledge in the context of the interview has brought about 
apprehension from some researchers, who question the stability and validity 
of data which may not be applicable in the context of research outside of the 
interview i.e. in the ‘real world’ (Yeo et al., 2014). However, choosing to 
reject data collected during an interview as inapplicable outside of that 
context may result in precedence being given to the interpretation of 
researchers, rather than participants (Yeo et al., 2014).  
Most qualitative researchers take a pragmatic view on this matter, concluding 
that data generated during interviews has meaning outside of the interview 
environment (Yeo et al., 2014; Brinkmann and Kvale, 2015a; Miller and 
Glassner, 2016). A pragmatic view was taken in this research, recognising 
that the knowledge created in an interview, would have meaning outside of 
the interview context (Ormston et al., 2014). 
4.3.2.2  Focus groups 
Focus groups involve the researcher facilitating a discussion amongst a 
group of two or more participants. Focus groups differ from interviews, since 
they do not always allow for the detailed exploration of participants’ 
experiences. Instead, focus groups offer an opportunity for participants to 
interact and discuss the research topic (Flick, 2014a). During these 
discussions, participants share knowledge, generate new ideas and 
challenge one another’s perspectives. This often leads to the creation of new 
concepts. Focus groups are useful when the research question requires 
participants to think creatively, as collectively, they refine their thinking and 
problem solve together (Lewis and McNaughton Nicholls, 2014). Participants 
may also ‘interview’ one another as they seek to understand their peer’s 
perspectives. This enables the researcher to ‘listen in’ to the conversation, 
resulting in them being less influential than in an interview setting and allows 
for more spontaneous discussion (Finch, Lewis and Turley, 2014). 
When participants in a focus group hold different roles outside of the context 
of the focus group, there may be a hierarchical structure in play. This may 
result in participants perceiving a power imbalance. Participants who 
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perceive themselves as having less power may be less inclined to speak out 
(Finch, Lewis and Turley, 2014). Therefore, in mixed role focus groups, the 
researcher should be aware of any power imbalances that may exist 
amongst participants and take appropriate remedial action.  
4.3.2.3  Summary  
Interviews and focus groups both gather data in ways that allow the 
participant to reflect, explain and clarify their experiences. This enables the 
researcher to interpret this data more effectively, as they have greater insight 
into the perspectives of the participant.  
 
This study utilised both interviews and focus groups to generate data to 
answer the research aim and objectives. Focus groups were used more 
often as this format provided the opportunity for participants to discuss their 
ideas and solve problems together. Interviews were held with participants 
who had specific in-depth knowledge relating to learning in the workplace or 
where focus groups were not practical.  
4.3.3 Reflexivity  
Reflexivity should be accounted for by the researcher at all stages of the 
research process so that any potential influences can be recorded (Amin et 
al., 2020). Here, the researcher (HK) recounts how her past experiences 
may have shaped her interpretation of the data.  
September 2017 
Prior to commencing data collection for this study, I was uncertain of how 
participants would respond to the idea of introducing a ward placement for 
pre-registration pharmacists. At this stage, I myself was still very uncertain as 
to how or if a ward placement could work and so was eager to hear the views 
of stakeholder participants. I was aware that my own pre-registration training 
may influence how I interpreted these results and the ensuing design of the 
placement and determined to take all measures necessary to ensure my own 
influence was as minimal as possible. Therefore, I arranged meetings with a 
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member of the research team (JS) in between data collection to discuss the 
data.  
4.3.4  Study design 
The study design was determined by the supervisory team and local 
collaborators (chief pharmacists) at the hospitals who part-funded this study. 
The research team and local collaborators identified stakeholder participants 
whose role and previous experiences could satisfy the aim and objectives for 
this study. These stakeholders included: 
 Chief pharmacists 
 Pre-registration managers 
 Newly qualified pharmacists 
 Hospital diploma tutors 
 Multi-disciplinary team members including doctors and nurses 
 Healthcare professional placement facilitators 
4.3.4.1  Inclusion criteria  
Convenience sampling was used to recruit potential participants from each of 
these stakeholder groups using the following gatekeepers: 
1. Director of the pre-registration pharmacist programme in the East of 
England. 
2. Chief pharmacist/deputy chief pharmacist at hospital 1. 
3. Chief pharmacist/deputy chief pharmacist at hospital 2. 
4. Director of the postgraduate pharmacist clinical diploma. 
5. Professor of Pharmacy Practice at the University of East Anglia. 
The research team agreed a minimum amount of prior experience in 
respective job roles for potential participants, in order to ensure participants 
had sufficient breadth of experience or recent experience of the research 




 Employed as a chief or deputy chief pharmacist in a hospital within the 
region. 
Pre-registration managers/tutors: 
 Employed in hospital pharmacy within the region. 
 Worked as a tutor for a minimum of 3 years. 
 Currently tutoring a pre-registration pharmacist or managing the 
tutoring of pre-registration pharmacists. 
Postgraduate hospital diploma tutor: 
 Currently mentoring a diploma pharmacist within a hospital in the 
region. 
 Worked as a diploma tutor for a minimum of 2 years. 
Newly Qualified Pharmacist: 
 Employed in a hospital pharmacy within the region. 
 Qualified for fewer than 2 years. 
 Conducted their pre-registration training in hospital pharmacy (this 
may have taken place at any hospital in the UK). 
Multi-disciplinary focus groups:  
 Employed at either Hospital 1 or Hospital 2. 
 One of the following professionals: 
o Ward Sister. 
o Ward Nurse. 
o Senior clinical Pharmacist. 
o Ward Pharmacist. 
o Doctor of the grade FY1 – ST3. 
o Doctor of the grade ST4 – Consultant.  
Healthcare professional placement facilitators:  
 Participants must have knowledge pertaining to conducting clinical 
placements for healthcare students/professionals. 
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4.3.4.2  Study organisation 
The pharmacist participant focus groups were conducted first, to enable the 
researcher to gather some initial data on the type of ward suitable for hosting 
the multi-disciplinary placement. This enabled the researcher to approach 
the gatekeepers (chief pharmacists at hospitals 1 and 2) to select a suitable 
ward, which may include a possible ward to host a ward placement, from 
which to recruit the multi-disciplinary team stakeholders to a focus group. 
Hence, this study was divided into phases: 
Phase 1a: Focus groups with pharmacist stakeholders 
Phase 1b: Focus groups with multi-disciplinary team stakeholders 
Phase 2: Interviews with individuals with experience of facilitating 
placements for medical and allied healthcare professional students.   
 
Phases 1 and 2 were undertaken concurrently. The data collected from 
phase 1a informed the researcher of the individuals who should be 
approached and invited to take part in the multi-disciplinary focus group in 


















          Figure 4: Phase 1 flow diagram   
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4.3.4.3  Recruitment 
On behalf of the researcher, the gatekeepers emailed individuals meeting the 
inclusion criteria, participant information sheets (appendices 3-4) and 
consent forms at least one week prior to the focus group/interview taking 
place. Individuals who were interested in taking part in the research 
responded directly to the researcher, who arranged a suitable date/time and 
venue for the focus group/interview to take place. No incentives were offered 
to participants. 
4.3.4.4  Data collection 
A semi-structured topic guide was used at each focus group and interview 
(appendices 5 and 6). Topics for discussion included:  
 Pre-registration pharmacist training. 
 Hospital pharmacist working practices.  
 The concept of introducing a ward placement into the pre-registration 
training programme.  
In spite of the researcher having an awareness of the benefits of longitudinal 
placements in medical education, the participants were not asked by the 
researcher to comment on the introduction of a longitudinal placement. The 
participants were asked only comment on the introduction of a ward 
placement generally – the only reference given to the design of the ward 
placement was that it could be no longer than 6-months. This stipulation 
came from the local collaborators, who wanted this maximum timeframe 
applied. The rationale for this decision was based on the GPhC accrediting 
6-month split pre-registration training programmes between hospital and 
industry at the time.  
During the focus group/interview, broad open-ended questions were asked 
initially, followed by probing questions, to allow participants to elaborate their 
views (McKenney and Reeves, 2012b). Focus groups and interviews took 
place at the participants’ workplace, in private meeting rooms and 
occasionally at conference venues. The researcher (HK) conducted the 
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focus groups accompanied by a member of the research team or colleague 
at the University of East Anglia (UEA) to assist with moderation. Interviews 
were conducted by the researcher alone. Participants had opportunities to 
ask the researcher any questions before the focus group/interview 
commenced and afterwards as well. The focus groups/ interviews were 
audio-recorded and written informed consent was obtained prior to recording.  
Participants were made aware they were being audio-recorded for the 
purposes of the research and their identity would be anonymised. 
Participants were asked to refrain from discussing specific patient details and 
aspects of their working life which may not have been appropriate. No such 
discussions were disclosed.  
Upon completion of the focus group/interview, the audio-recordings were 
transferred from the device to the university computer and stored in a 
password protected folder. Consent forms were locked in a filing cabinet in a 
research office with restricted access.  
4.3.4.5  Data analysis  
The researcher transcribed one focus group and interview. A member of 
administrative staff employed at the UEA transcribed subsequent focus 
group and interview recordings. Some researchers prefer to transcribe their 
own research material as it enables the researcher to become closer to the 
data and provide greater insight into the interview style of the researcher 
(Brinkmann and Kvale, 2015b). However, due to the time constraints with 
respect to implementing this project, it was not possible for the researcher to 
undertake transcription and meet the deadlines associated with this 
research. The researcher checked all transcriptions for accuracy. 
The transcribing process preserved participant anonymity. Punctuation was 
added, where applicable, to the transcript and care was taken to ensure it did 
not alter the meaning of the sentence. The data was managed and stored 
using NVivo QSR International (version 11), 
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Inductive thematic analysis, following the six-step method was undertaken on 
the data (Braun and Clarke, 2006). This allowed the data to be coded and 
organised into groups and themes:  
Step 1: Familiarisation with the data (repeated reading). 
Step 2: Generate initial codes (short descriptions). 
Step 3: Searching for themes (group codes to categories). 
Step 4: Review themes (resort categories – seek research team 
support). 
Step 5: Defining and naming themes (label themes). 
Step 6: Produce the report (write up results). 
The researcher (HK) familiarised herself with the data through the 
transcription and checking stage. She reflected on these results in her 
reflexive diary. 
Initial codes were generated which were then grouped together. Gradually, 
over time, through continually revisiting the data, subthemes and themes 
emerged. There is some concern that by coding, sorting and restructuring 
the data in this manner, the meaning of the initial sentence or paragraph may 
be lost. However, this was mitigated through keeping the reflexive diary and 
discussions with the research team (Miles and Huberman, 1994). 
The coding and theme generation was undertaken by the researcher (HK), 
who was supported by a member of the research team (JS), who checked 
the coding for accuracy. Second-checking of coding is recommended in 
thematic analysis. Additionally, when the designer and researcher is the 
same individual; it is important work is checked by others to ensure 
trustworthiness and integrity (Barab and Squire, 2004; Kennedy-Clark, 2013; 
Creswell and Poth, 2017c). 
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4.3.4.6  Validation strategies 
Nine validation strategies are described by Creswell and Poth (2017)., who 
suggest that at least two validation strategies should be used in each 
qualitative study to validate results. 
This study utilised five validation strategies (triangulation, generating rich 
descriptions, reflexivity, peer debriefing, disconfirming evidence) to ensure 
an accurate presentation and interpretation of the results, so that the reader 
may have confidence that the findings presented are valid.  
Participants from different healthcare professions, different roles and places 
of work were recruited to this study, enabling multiple perspectives to be 
explored; allowing the data to be triangulated. This enabled rich data to be 
generated providing detailed descriptive accounts of the current training 
model and working practices of hospital pharmacists. Disconfirming evidence 
was provided as participants shared different views. A reflexive account of 
the researcher described her views and the steps taken to peer debrief the 
study findings with another member of the research team (JS) regarding the 
interpretation of results.  
The remaining four validation strategies that were not used as part of this 
study were: member checking, prolonged engagement in the field, 
collaborating with participants and external audits. Prolonged engagement in 
the field and collaborating with participants were not appropriate to carry out 
as part of this study, which sought to capture a snapshot perspective of the 
views of participants. Member checking could not be undertaken, as it took 
the researcher more than 6 months to fully analyse and interpret this data. 
Hence, it is unlikely that participants would have been able to remember 
what was discussed and so member checking would have yielded no added 
value and may have produced confounding data. An external audit was not 
conducted since the researcher (HK) liaised with the research team, who 
worked with her to ensure the data supports the interpretations made.   
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4.4  Results 
Thirty-seven people were recruited to this study. The table below presents 
the focus group/interview they took part in, their role and their assigned 
participant identification code. The decision was made by the research team 
not to gather participant demographic information such as gender, age, 
ethnicity as this could lead to the identification of participants.  






Focus group 1 
Newly qualified hospital 
pharmacist 
NQ1 - NQ5 
Focus group 2 
Newly qualified hospital 
pharmacist 
NQ11 – NQ19 
Focus group 3 Pre-registration manager PM1 – PM5 
Focus group 4 Chief Pharmacist CP1 – CP4 
Focus group 5 Diploma tutor DT1 – DT3 
Interview  Doctor DR1 
Focus group 6 Doctor DR2 – DR5 
Focus group 7 Nurse & Ward Pharmacist NS1 & WP1 
Focus group 8 Nurse NS2 – NS3 
Interviews Placement facilitator PF1 - PF4 
 
The newly qualified hospital pharmacists, pre-registration managers, chief 
pharmacists and diploma tutors were recruited from networks across the 
East of England. The participants worked for different organisations and had 
varying levels of experience in their given role. The doctors, nurses and ward 
pharmacist were recruited from hospitals 1 & 2. The placement facilitators 
were recruited from the UEA and held different positions of responsibility for 
facilitating placements for healthcare professional students, including: 




Initially, the study design intended for the multi-disciplinary focus groups to 
consist of pharmacists, nurses and doctors but difficulties were encountered 
trying to arrange a time when it was convenient for all these individuals. To 
overcome this, a focus group or interview was conducted with each 
participant based on their availability. Often, when research is conducted in 
the real context, there is a compromise between what is ideal and what is 
possible (McKenney and Reeves, 2012b).  
Prior to some interviews/focus groups commencing, the participants asked 
the researcher (HK) about her background, whether she was a pharmacist 
and whether she had previous experience working in a hospital. The 
researcher answered these questions prior to commencing the recording but 
did not discuss her previous experiences with the participants. Four key 
themes and accompanying subthemes were identified from the data 








Current training model 





Qualifying and practising as a pharmacist 
GPhC requirements 
Pharmacy department wants to maintain 
control 
Perceived Enablers 








Responsibility and supervision 
Activities 
Recruitment 
Working with key stakeholders 
4.4.1 Context 
All pharmacist participants discussed the current training model for 
pre-registration pharmacists. Newly qualified pharmacists expressed 
discontent with the block rotational model. This model fostered a culture of 
shadowing and there were limited opportunities as trainees to work as part of 
the multi-disciplinary team.   
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Diploma tutors and newly qualified pharmacists identified specific gaps in 
pre-registration training such as decision-making, which affected the ability of 
pharmacists to practise confidently upon registration.  
The conditions for pharmacists working in hospital described the lack of time 
pharmacists have to carry out patient-facing roles and how pharmacists were 
not considered part of the ward team. Participants believed that patient care 
could be improved if pharmacists had an enhanced role on the ward. 
4.4.1.1 Experiential placements 
Newly qualified pharmacists described how their pharmacy degree had not 
prepared them for hospital pre-registration training. This was attributed to 
large quantities of didactic teaching in seemingly less important topics for 
practising as a pharmacist. Placement facilitators acknowledged experiential 
placements as part of the allied healthcare and medical degrees supported 
the workforce to develop the clinical and person-centred skills necessary for 
future practice.   
 “…our [medical] graduates are very well prepared when they go into practice 
and some of that is because they’ve had a five-year course that has had 
interaction with patients and placement all the way through…” PF2 
4.4.1.2 Current training model 
4.4.1.2.1 Block rotational training 
Pre-registration managers were aware of the lack of experiential placements 
during the pharmacy degree and that some trainees may have no prior 
experience working in a pharmacy setting. The pre-registration pharmacist 
training programme consisted of a series of rotations through different clinical 
and technical areas, the dispensary often being the first area trainees rotated 
in, followed by other areas in the pharmacy department and then the wards. 
Newly qualified pharmacists encountered a range of difficulties as a result of 
moving around so frequently; namely not having a working relationship with 
ward staff.   
“I found it really difficult that we moved around loads…in our pre-reg we 
moved somewhere different every week and if you’re on the same ward, you 
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know the same ward staff, you know what the ward do, you know what the 
doctors do and you’d have the same pharmacist so…you’d understand 
what’s expected of you…” NQ17 
The newly qualified pharmacists also identified differences in pharmacists’ 
supervision styles as a barrier to rotating effectively. Supervising pharmacists 
were sometimes unaware of the stage of training the pre-registration 
pharmacist had reached. Trainees were often uncertain of what their 
supervising pharmacist expected from them. Each supervising pharmacist 
expected different levels of independent practice and trainees struggled to 
understand where the boundaries for their practice lay on any given rotation. 
“…depending on who you were being supervised by, depends greatly on 
what they are happy for you to be doing or not and that actually is really quite 
tricky as a pre-reg to know what that person wants” NQ14 
These transitions between teams and environments meant it delayed the 
pre-registration pharmacists’ professional socialisation. Newly qualified 
pharmacists identified that the time taken to learn what their role was as a 
trainee during each ward rotation was a waste of time and acted as a barrier 
to integrating with staff on the ward. Pre-registration managers, diploma 
tutors or chief pharmacists did not identify the lack of opportunities to apply 
learning in practice during rotations. 
“you had a week and then by the end of the week, you kind of vaguely knew 
what clinically you needed to know, but then hadn’t actually had any practical 
experience applying that” NQ14 
Staffing shortages also affected the quality of learning opportunities available 
for pre-registration pharmacists. This was due to the trainees undertaking 
more technical roles, which required less pharmacist support, as opposed to 
accessing opportunities to learn alongside other members of the healthcare 
team.  
“…because we’re [pharmacy department] short [staffed] we get them 
[pre-registration pharmacists] doing MR’s [medicines reconciliations]…and 
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discharges and they’re not…find[ing] out about the patients…sit[ting] in the 
MDT [multi-disciplinary team meeting] with the doctors…” WP1 
4.4.1.2.2 Longer rotations 
During the last few weeks of the pre-registration year, some newly qualified 
pharmacists described how they were allocated to work on one ward and 
that they enjoyed this experience because they got to know the ward team. A 
longer period of time on one ward enabled the trainees to begin to 
understand how the ward functioned and develop better working 
relationships with staff. However, fewer rotations during the pre-registration 
year did leave the trainees feeling more nervous about sitting the registration 
exam, due to the perceived reduction in breadth of experience. 
“in my pre-reg…we didn’t rotate as much so I was…a few months on 
the…same ward and in a way it was good because I got to…know the staff, 
get to know how it works…[but] when it came to the exam, there were loads 
of areas that I hadn’t worked in…” NQ13 
Medical students and ward staff reported greatest satisfaction with longer 
placements. This was attributed to the students having the opportunity to 
work as part of the team; delivering care to patients in that setting.  
 “…students really like that [placement in final year] because until that point 
they’ve sort of dipped in and out of departments and they’ve not really been 
able to get to know anybody or feel like they’ve become part of the team…” 
PF2 
4.4.1.2.3 Shadowing 
The pre-registration training model fostered a culture of shadowing. Trainees 
were unable to access opportunities to practise independently under the 
supervision of a pharmacist. The consequences of pre-registration 
pharmacists spending too much time shadowing others resulted in newly 
qualified pharmacists lacking the practical skills to perform their role once 
registered.   
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“…we literally just spent the entire year shadowing then day 1 as a 
pharmacist you’re like ‘Urgh! Don’t actually know how to do any of this 
myself!’” NQ5 
The ward pharmacist was also aware that trainees spent large periods of 
time shadowing. This prohibited the trainees from gathering evidence to 
demonstrate they have achieved GPhC performance standards. 
“…at the moment when they [pre-registration pharmacists] shadow, they’re 
watching us [pharmacists] do it [work] which doesn’t give them the 
evidence…” WP1 
Pre-registration pharmacists described how shadowing pharmacists was 
frustrating and boring. This was partly attributed to the trainees feeling like a 
burden to the pharmacists supervising them. The pre-registration 
pharmacists couldn’t contribute to patient care and lost enthusiasm for their 
role. All newly qualified pharmacists in focus group 2 identified with the 
feeling of burden during their training. The pre-registration managers and 
chief pharmacists did not identify the trainees as a burden to the department 
or the wards.   
“…you [pre-registration pharmacist] do feel like you’re getting in people’s 
way…feeling like I was a burden on everyone else that is training me… I 
think if you yeah had a purpose… had responsibilities made decisions…it 
would have made it a lot easier to integrate into being an actual pharmacist” 
NQ16 
Placement facilitators emphasised that the supernumerary status of trainee 
healthcare professionals should enable them to participate at work in an 
active capacity. This would allow students to more easily achieve their 
learning outcomes, rather than shadowing others.  
“…students…get a lot more out of working in a supernumerary 
capacity…than they do shadowing…to develop…professional confidence 
and competence…‘doing’ is far preferable…” PF1 
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None of these sentiments were shared by the pre-registration managers who 
considered the rotational training model was producing effective 
pharmacists. This was justified by the high pass rate of hospital 
pre-registration pharmacists at the registration assessment. 
“…it’s [success of training programme] proven in the pass rate isn’t it? That 
the pre-reg’s are passing at quite a high rate” PM5  
4.4.1.2.4 Registration exam 
The rotational model of pre-registration pharmacist training may be designed 
and structured to provide trainees with a range of experiences, reflecting the 
breadth of knowledge required to pass the registration exam. This does not 
necessarily result in well-rounded pharmacists. 
“…at the moment we have a system [rotational training model] that works…in 
order for them to pass their pre-reg exam and actually qualify as a 
pharmacist. Whether that produces a good pharmacist at the end of it, I don’t 
know” CP4 
For most pharmacist participants, the purpose of the pre-registration year 
was to ensure the trainees passed the registration assessment. 
Pre-registration managers acknowledged there could be a tendency to 
design training programmes that only considered the exam and not the future 
practise of the pharmacist. Some pre-registration pharmacists became 
completely exam-focussed in their approach to learning and were only 
prepared to access learning opportunities that would benefit them in the 
exam.  
“…I want them [pre-registration pharmacists] not to be in that mind-set of 
‘this is what I need to know to pass the exam’ and sometimes I think they 
are” PM4 
The pre-registration year was trying to serve two purposes; the registration 
assessment and the future professional practice of a pharmacist. Therefore, 
certain activities in the training year will serve one of these better than the 
other. This can be confusing and frustrating for trainees.   
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“the pre-reg [year] is mainly there…to pass the pre-reg exam, so obviously 
it’s got to prepare you for a future as a pharmacist. But…there would be 
things you’d be doing in the pre-reg exam you won’t be doing as a hospital 
pharmacist but you need to do them to qualify and to be able to pass that 
exam…” NQ18 
4.4.1.2.5 Gaps in training 
Newly qualified pharmacists found their pre-registration training equipped 
them with the necessary clinical knowledge for practising as a pharmacist but 
not the practical elements of managing a ward and making decisions. 
Qualified pharmacists made all decision-making during the pre-registration 
year. This left the trainees underprepared for making decisions when 
registered.  
“I think it [pre-registration year] probably prepared you in terms of knowledge 
… but… time management and being able to manage a ward and…make 
decisions [it didn’t]” NQ11 
4.4.1.3 Pharmacist working conditions 
Pharmacists described how their day is often fragmented, as they have 
multiple responsibilities across different departments. This affected their 
ability to fully integrate into a ward team, as the length of time they could 
spend on the ward was insufficient to attend the multi-disciplinary team 
meetings and be viewed as a member of the team. 
“…if you’ve got two or three wards or whatever you might be there [on one 
ward] for like an hour and that’s it and they [ward staff] don’t really see you 
as part of the team…” NQ11 
Pharmacists recognised that they might be known for ‘telling-off’ their 
colleagues when they have made mistakes prescribing or administering 
medicines. The pharmacists’ green pen was identified as the most proactive 
means of communication with the medical team ,which disappointed the 
doctors, as they found face-to-face communication more effective.  
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“I mean the green pen is usually the most [pause, laughter] proactive way of 
[communicating] …we don’t talk enough…talking I think can achieve a lot 
because then you [doctor] learn things as well…” DR5 
Diploma tutors identified that newly qualified pharmacists do not always 
understand the bed pressures faced by the ward staff and so do not realise 
the urgency of patient discharge. This lack of understanding can result in 
pharmacists refusing to fulfil prescriptions for patients whose discharge 
paperwork may be completed later on in the working day. This would affect 
the workload of the pharmacy department. 
“… last minute discharge, but what you [pharmacists] don’t see is the front 
door pressure that everyone [ward staff] is pulling their hair out and there’s 
nowhere to put any patients…and we’re [pharmacy team] kind of going ‘oh 
it’s too late, you know we can’t deal with that. We need ample warning to sort 
this out’…” DT2 
Nurses noted the inaccessibility of pharmacists in the afternoons affected 
their capability to provide an organised and pre-emptive medication 
discharge service. This working relationship fostered a reactive pharmacy 
service and was turning into a cycle where ultimately patients were suffering 
through delayed discharges and a lack of access to pharmacy staff who 
could have conversations about medicines. The lack of time pharmacists 
spent on the ward was viewed as the main contributing factor for the lack of 
patient counselling. There was a perception amongst participants from 
different hospitals that there were multiple missed opportunities for talking to 
patients about their medicines.  
“…even people that come in with…bag loads of medicines and they’re all out 
of date, that’s never questioned. We [staff] just chuck them away 
but…there’s often a question that needs to be had...’” NS1  
These working conditions left pharmacists acknowledging their patients 
weren’t getting the attention they needed.  
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“I know the patient more from a drug chart than actually if I walked past 
them, which is sad isn’t it?” WP1 
4.4.2  Perceived Barriers 
Perceived barriers for introducing a ward placement varied widely and were 
almost exclusively reported by pharmacist participants. The absence of a 
rationale for changing the pre-registration training was a considerable barrier 
for chief pharmacists and pre-registration managers.  
This risk to patients from introducing the placement was described with 
reference to confusion over how supervision and accountability 
arrangements would work. Unmet expectations for learning and the risk of 
excessive menial activities during a ward placement were also identified. 
The control over pre-registration training by the GPhC and the pharmacy 
department was perceived to be threatened by the proposed introduction of a 
ward placement. 
4.4.2.1  Rationale 
Pre-registration managers described how the current rotational 
pre-registration training model has the capacity to prepare pre-registration 
pharmacists for their career; no clear rationale for introducing a ward 
placement was identified. Half a day spent with allied healthcare 
professionals was viewed as being enough exposure to appreciate what their 
role is and how they operate in the hospital. There were no benefits of being 
placed on a ward for a longer period of time that translated into professional 
pharmacist practice. 
“…so at the moment you know the programmes that we offer do work… I’m 
not sure what the advantage is of having this new programme over the 
existing so…why would we want to rock the boat basically?” PM4 
4.4.2.2  Supervision  
Pharmacist participants expressed uncertainty over the ward staff’s capability 
to oversee a pre-registration pharmacist completing a ward placement. This 
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was attributed to non-pharmacy staff lacking sufficient knowledge of the 
GPhC requirements, the clinical capabilities of a pre-registration pharmacist 
and understanding that pre-registration pharmacists are unregistered 
healthcare professionals. 
“…[ward] staff, if they don’t truly understand that you’re [pre-registration 
pharmacist], just not allowed to do something, they will keep on pushing…for 
you to do it… I think maybe someone [pre-registration pharmacist] who was 
bowed to pressure a bit more, could potentially find themselves in quite a 
dangerous situation” NQ5 
Patient harm could arise from the pre-registration pharmacists’ unconscious 
incompetence and the lack of direct pharmacist supervision overseeing their 
activities. The accountability in the event of such a mistake made by the 
pre-registration pharmacist when the qualified pharmacist was absent from 
the ward was of concern to all pharmacist participants.  
“…unconscious incompetence…they [pre-registration pharmacists] don’t 
know what they don’t know … and so if you throw them on a ward 
unsupervised by another pharmacist…[it] could be dangerous for patient’s 
care” PM4 
The perceived lack of supervision during the ward placement was a source 
of anxiety for the pre-registration managers and chief pharmacists. Sharing 
supervision with other healthcare professionals was not an option for most 
pharmacist participants, partly due to non-pharmacy healthcare 
professionals’ perceived lack of medicines knowledge and the shift patterns 
of ward staff.  
“…I won’t feel comfortable leaving them [pre-registration pharmacist] 
supervised by a nurse or a medical team because the medical teams are 
very transient…there’s not the consistency and this is why we have a tutor 
and this is why we manage all these things closely” PM4  
The ward pharmacist input into delivering the ward placement was perceived 
to be significant and would be an additional burden to their already very 
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heavy workload. Pre-registration managers perceived that the wards would 
be too busy to manage a pre-registration pharmacist. For newly qualified 
pharmacists, the concept of having to supervise a pre-registration pharmacist 
everyday appeared inconceivable.  
“… would you [ward pharmacist] want a pre-reg with you…for an extended 
period of time? Cos they do slow you down…it does put a massive strain on 
your workload” NQ12 
The individual personality of the pre-registration pharmacist could also affect 
how they worked on the ward, pre-registration pharmacists who are 
overconfident may cause patient harm and those who are less confident may 
become a burden to the ward.  
“…the problem…with pre-reg’s is some are over confident and obviously will 
give advice when they’re probably not…experienced enough to give that 
advice and then some will be worried to give any advice…there’s like a real 
different spectrum of pre-reg’s and what they do and you need to kind of 
harness that before you let them loose on the ward” NQ16 
The supervision of medical and physician associate students during their 
placements were managed differently to pre-registration pharmacists since 
these students did not have an allocated ‘supervisor’ during their placement, 
or indeed someone who monitors their activities. Rather, the medical team 
share responsibility for overseeing their activities. Due to the newer role of 
the physician associates, the day-to-day supervision of these students 
remains open to interpretation by doctors.  
“…they’ve [physician associates] got to be under medical supervision…that 
can be used in a very loose sense or in a very tight sense and it’s open to 
interpretation…there are no set learning objectives for them…it [syllabus] 
basically…20 sheets of paper maximum…” PF3 
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4.4.2.3 Menial tasks  
Chief pharmacists expressed concerns that the placement would only ever 
be able to offer pre-registration pharmacists the opportunity to shadow other 
members of the multi-disciplinary team and not afford the chance to gain 
independence through acquiring more responsibility from working on the 
ward. Members of the multi-disciplinary team highlighted the risk of trainees 
being utilised to provide a pharmacy service to the ward and not being able 
to access potential learning opportunities.  
“… my only other concern is being taken advantage of…knowing from 
medical students, they sometimes fall into almost service provision role …” 
DR1 
If pre-registration pharmacists fell into a service provision role, there was a 
perceived risk that they could also be asked to perform tasks that would not 
benefit their learning. In addition, pharmacist participants also reported the 
pre-registration pharmacist would not have enough work to do on a hospital 
ward, as much of the ward activities are not medicines-based.  
“…I would hate for a pre-reg to spend a prolonged period of time on a ward 
where they’re actually only learning something or doing something of any 
pharmaceutical value for about an hour and a half a day. And they were 
spending the remaining six hours stood there like a spare wotsit at a 
wedding, or learning how to make a bed. Because that is not going to do 
anything for them once they’ve qualified” CP4 
Pre-registration managers noted the clinical knowledge of the pre-registration 
pharmacist could improve during a ward placement. However, the additional 
time spent learning about patient cases and producing care plans would 
result in extra work for the pre-registration manager, which they did not have 
time for. In addition, a ward placement that involved producing care plans 
would give the pre-registration pharmacists an unrealistic expectation of the 
pharmacy service they could offer once qualified.  
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“… if you…had your pre-reg writing a completely comprehensive care plan 
for every patient…they’re going to come out with very very sound clinical 
knowledge. But then somebody has got to…review that with them…[and] as 
soon as they qualify they’ve…got to see their 26 patients in two hours…” 
PM3 
4.4.2.4 Qualifying and practising as a pharmacist 
The introduction of an extended ward placement would result in fewer 
rotations overall in the training year; hence to accommodate a ward 
placement, some rotations would need to be removed or shortened. This 
was unacceptable to some participants who did not want the timetable 
altered. 
“you need your…stores, procurement knowledge, you need…dispensary, 
screening and checking stuff as you’re underpinning…pharmacist role” DT2 
The ward placement could also limit the conditions and medicines 
pre-registration pharmacists would become acquainted with, which may 
affect their ability to pass the registration exam. The absence of any 
assurances from the researcher that the trainees could still pass the 
registration exam as a result of introducing a ward placement was an 
identified barrier. 
“…if we put them on a ward…they’re not going to get exposure to…all the 
different diseases…” PM5 
Apprehension over whether a ward placement would enable pre-registration 
pharmacists to acquire the knowledge and skills required to prepare them for 
practise as a qualified pharmacist was a concern. Information relating to 
medicines such as doses, interactions, monitoring of medicines would be 
difficult to learn on a hospital ward. Furthermore, a ward placement may not 
be suitable for producing pharmacists who are able to cope with the 




“… you’ve got these trainees, they’ve just come out of uni who we’re trying to 
turn into good clinical pharmacists…and you’re just going to stick them on a 
ward with I don’t know who…I’m not sure like if that’s all going to actually 
result in a well-rounded pre-reg who can cope with the constraints that our 
clinical teams are facing right now…” PM5 
4.4.2.5 GPhC requirements 
Apprehension surrounding pre-registration pharmacists being able to meet 
the GPhC requirements during the ward placement were frequently raised. 
Pre-registration managers were concerned the ward staff would not be able 
to support the trainees to become professional pharmacists because they 
had not undergone the GPhC accreditation process themselves. Thus, the 
supervision of pre-registration pharmacists by non-pharmacy healthcare 
professionals was conflicting with the supervisory requirements determined 
by the GPhC.  
“…leaving them [pre-registration pharmacists] unsupervised [by a 
pharmacist]….I think we’re running a legal risk about what GPhC say that 
pre-reg’s are allowed to do” PM5 
Other points regarding the legal boundaries of practice for pre-registration 
pharmacists also extended to giving advice to healthcare professionals. The 
lack of indemnity insurance for pre-registration pharmacists to give advice 
could leave them exposed.  
”… they [pre-registration pharmacists] can’t be referred to for advice 
…they’re not legally qualified, therefore they can’t give that advice…” PM5 
Questions over whether the pre-registration pharmacists would be able to 
acquire sufficient evidence in support of having achieved the GPhC 
performance standards were also raised by chief pharmacists. Doubts were 
cast over the ability of a ward placement to ensure the performance 
standards could be achieved.  
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“…there is a fundamental section of those competencies I see it will be really 
difficult [to achieve]…simply by being on the ward” CP3 
4.4.2.6 Pharmacy department wants to maintain control  
A ward placement would place the control of pre-registration training into the 
hands of the ward pharmacist and other members of the multi-disciplinary 
team. The sharing of pre-registration pharmacist training with other 
professions was described by chief pharmacists and pre-registration 
managers as ‘losing control’. This view was not expressed by diploma tutors, 
newly qualified pharmacists or members of the multi-disciplinary ward team. 
“…I think we’re [chief pharmacists] control freaks aren’t we?...we still want to 
maintain control of this [training programmes]. If we said ‘Ok let’s just leave 
them on the ward for six months and come back and see what we find…’ we 
haven’t got control of that and I would have no confidence that we would 
have a competent pharmacist at the end of the year” CP1 
The pre-registration managers identified no place for the pre-registration 
pharmacists within the ward teams. In particular, when the ward teams were 
perceived to be short staffed they would not be able to host pre-registration 
pharmacists on a ward placement. In addition, there was the perception that 
very few ward activities related to medicines. Hence, the role and purpose of 
a pre-registration pharmacist would be obsolete.  
“…how do they fit in that team [pause]? When you know that wards are 
struggling” PM2  
4.4.3 Perceived Enablers 
Newly qualified pharmacists, placement facilitators and multi-disciplinary 
team members identified the potential for pre-registration pharmacists to 
work as members of the ward team during a ward placement. Benefits 
associated with working as part of this team could include improving patient 
care.   
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Multi-disciplinary team participants were supportive of the project and 
presented arguments for why their wards were appropriate for hosting a ward 
placement. 
4.4.3.1 Part of the team 
Doctors, placement facilitators and newly qualified pharmacists recognised 
that being part of a team provided more learning opportunities. A longer 
length of time in one place, was more conducive to team building/working.    
“…we [doctors] found…the longer you are on a placement, the more you get 
out of it. So, although it’s nice to see breadth, sometimes it’s helpful to 
ingrain yourself in a team. You certainly get more opportunities the longer 
you are in one particular place” DR1 
Taking part in ward activities such as multi-disciplinary team meetings and 
consultant ward rounds could provide learning opportunities. Newly qualified 
pharmacists expressed a desire to acquire more responsibilities so that they 
could better contribute to patient care on the ward. 
“…I think from the point of view of learning it would be better to do it 
[pharmacy activities] yourself and then you would feel more involved and part 
of the team, like you’re contributing rather than just shadowing.” NQ3  
4.4.3.2 Potential benefits 
Newly qualified pharmacists, diploma tutors, doctors and nurses believed the 
placement could better prepare trainees for independent practice, through 
better understanding patient flow and the roles of other healthcare 
professionals. Enhanced confidence, communication and consultation skills 
were all viewed as potential positive outcomes for pre-registration 
pharmacists as a result of a ward placement. Doctors reflected on their own 
training, citing experiential placements on the hospital wards as a better 
environment for learning than university. 
“… the more you [trainee healthcare professional] are on the ward…the 
better it is for you after you’ve qualified. You’re more confident, you’re more 
comfortable in that situation…that’s more important than those four years of 
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studying…what I learnt from my experience with the doctor is much more 
than what I learnt as a student…” DR1 
Being present on the ward enables the pre-registration pharmacist to gain 
exposure to the decision-making processes carried out by the 
multi-disciplinary team. Newly qualified pharmacists and the ward pharmacist 
acknowledged this exposure would be one of the most meaningful learning 
opportunities for the pre-registration pharmacist. Exposure to the 
decision-making process was the first step to enabling pharmacists to 
become a part of the team, supporting them to become confident decision 
makers.   
“…I think decision making is probably the most important thing…also to be 
part of the ward team…a key member of the team, rather than just 
somebody who just appears every morning and then disappears…” NQ15 
The ward placement was an opportunity to raise the profile of pharmacy in 
the hospital amongst other healthcare professionals and make the pharmacy 
service more visible and present.  
“it [placement] will probably be good for…people’s attitude towards us 
[pharmacy] cos sometimes it can be quite negative and I think if you’ve got 
someone that’s there for a long time…it might start to improve their [ward 
staff] attitudes about pharmacy” NQ11 
One placement facilitator acknowledged that the role of pharmacists has 
expanded over the years both in primary and secondary care and that there 
was scope for it to expand further within the hospital. Crucial though, was the 
ability of pharmacists to understand how hospital wards operate and 
determine how pharmacists can utilise their skills to expand their role.  
“…we’ve seen in the past the role of pharmacy has expanded out, we’ve 
seen them taking far greater responsibility for things out in the community 
and within the trust. So, as I said, is there a future role for ward pharmacists 
beyond what there is now? And if you [pharmacist] understand how a ward 
functions you might be the person that can shape that” PF4 
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4.4.3.3 Interprofessional working 
The introduction of a ward placement could enable pre-registration 
pharmacists to work more closely with patients and other members of the 
healthcare team. The learning opportunities available because of this 
working relationship may include attending ward meetings and contributing to 
discussions about patient’s care.  
“…being on the ward rounds…so they can understand what’s going on with 
the care of the patient…so that they’re actually contributing to the patient 
care whilst they’re on the ward” DT3 
Doctors explained that patients benefitted from the pharmacists involvement 
in their care. The doctors drew a link between the continuity of the ward 
environment and the subsequent building of a working relationship.  
“…I think having the pharmacist and having some continuity is important 
because…they [pharmacists] get to know us [doctors] and the dialogue is a 
lot better…even for them [pre-registration pharmacists]…some amount of 
continuity may be a good thing cos then you build up a rapport…” DR5 
However, some chief pharmacists and pre-registration managers viewed 
interprofessional working differently, perceiving the value of working with 
other healthcare professionals to be limited to a few days.   
“my thoughts are that it’s perhaps of value to spend a fortnight on the 
ward…” CP4 
Doctors wanted their prescribing decisions to be challenged and they 
recognised that they currently lack someone in their team who can perform 
this role. 
“…what you need is…a member of your team challenges a consultant 
because it’s very easy to get [to]…’what I say is the law’ whereas actually 
being challenged by someone is helpful from the day to day aspect…I found 




4.4.3.4 Ward culture 
The proposed placement wards were identified as calm and supportive 
learning environments for trainee healthcare professionals. The ward teams 
had been established for a number of years and the positive learning culture 
stemmed from the ward sister and consultants. 
“…it [proposed placement ward] seems to be a supportive environment. 
They [students and training healthcare professionals] seem to enjoy their 
stay here…so that culture seems to be embedded on the ward and I think 
that’s mainly down to the ward sister. I think she encourages them ….” DR5 
Ward staff expressed support for introducing a ward placement for 
pre-registration pharmacists in their ward setting, Older People’s Medicine 
(OPM). OPM was an appropriate specialty because of the patient group, 
older adults with a range of long-term conditions who would be taking a 
variety of medicines. The pre-registration pharmacist’s supernumerary status 
would allow them to access learning opportunities on the ward.  
“… that [being supernumerary]…helps the learning culture…because then 
they [pre-registration pharmacist] know that there isn’t that other 
pressure…it’s important [the pre-registration pharmacist]…sees themselves 
as a member of the team…that’s one of the key aspects the multidisciplinary 
team and no one is more important or less important… everyone has a role 
to play” DR5 
Newly qualified pharmacists recognised being a part of a ward team, both 
socially and professionally would ultimately result in better outcomes for 
patients. Despite never having had pre-registration pharmacists based on 
their ward before, the nurses were resolute that a place existed for 
pre-registration pharmacists to come, be part of the team and learn. Nurses 
identified a range of activities for pre-registration pharmacists to get involved 
in during the placement.  
“… being on a ward is not only useful to them [pre-registration 
pharmacist]…very useful to the medical and nursing team…cos having a 
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constant pharmacist there whether they’re pre-reg or not saves a lot of 
time…just having somebody you can ask questions to that’s readily available 
would be hugely useful…in terms of like learning…being familiar with like 
that daily prescribing like that we do on a general medical ward would be 
amazing for [their] learning and knowledge” DR3 
Doctors expressed a desire for a symbiotic relationship to exist on the ward 
placement between themselves and the pre-registration pharmacist. They 
demonstrated an awareness of needing to meet the needs of the learner, 
particularly during consultant ward rounds and being available to assist with 
answering questions and discussing problems.  
“…I take quite a strong interest in…pharmacology and medications…part of 
it [placement] is what they [pre-registration pharmacist] can get out of 
it…Because I teach whatever they want…I tend to find teaching works best if 
placements work best if again there’s a symbiosis really of what people want 
to get out of it…” DR1 
Finally, hospital wards are training environments all year round and the 
concept of another learner from a different profession within the 
multi-disciplinary team wouldn’t be something which the ward staff were 
unfamiliar with.  
“…they’re [ward staff] very used to pre-registration students. Wards are full of 
pre-registration students….so I don’t think you’d have problems with them 
understanding the concept [of a pre-registration pharmacist placement] at all. 
It would be very familiar to them…” PF1 
4.4.4 Design 
The design of the ward placement covered different topics including the 
guidance and structure of the placement, how the placement should meet 
the GPhC performance standards and which activities should be 




All participants advocated for the introduction of clear guidance for the ward 
placement. This guidance should support the pre-registration pharmacists 
and their supervisors to define the scope of their role on the ward, as well as 
how the placement can meet GPhC requirements. Defined learning 
outcomes were also necessary to inform the design of the placement.  
“…the fundamental thing is first of all what is the outcome that we want to get 
out of this [placement]?...If we understand the outcome, we can then say well 
‘how would we design a programme which would deliver that outcome?’…” 
CP3 
4.4.4.2 Structure  
In addition to a set of clear learning outcomes, a defined structure for the 
ward placement was a necessary feature. This could help safeguard the 
pre-registration pharmacist from abandonment by the pharmacy department 
or the ward. 
“I think it [the placement] would have to be very structured about what they 
[pre-registration pharmacists] should be doing on their time on the ward” 
NQ15 
All pharmacist participants believed the ward placement should take place 
once the trainee had experienced working within the hospital pharmacy 
department. Pharmacists believed the trainees should embed themselves 
into the pharmacy team first. Trainees would need to learn the names and 
roles of staff working in pharmacy and learn how to perform pharmacy-based 
activities, such as dispensing, prior to commencing a ward placement.   
 “…the whole point of them starting up in dispensary is to also give them a 




4.4.4.3 Placement length 
The suggested placement length ranged from half a day to six months with 
no real consistency. Newly qualified pharmacists, doctors and nurses 
showed a greater affinity towards longer placements. Doctors who had 
undertaken placements as a part of their initial education and training 
identified that learning opportunities arose as a result of embedding 
themselves for several months in a team.  
“…by about month three was when I got comfortable with my first job and 
then had to leave by month four so I think maybe three month placements. I 
think any less than that may not necessarily be beneficial” DR3 
4.4.4.4 Responsibility and supervision 
Attending multi-disciplinary team meetings and discussions as part of the 
placement were identified as opportunities to help pre-registration 
pharmacists establish their purpose on the ward. Being more involved in the 
regular ward practices would allow the trainees to build trust which would 
lead to more responsibilities earlier in their training; with the potential to 
result in a more competent and confident pharmacist. 
“…the most important thing is that pre-reg’s have responsibility earlier on and 
that they have that they feel every day they feel that they have a 
purpose…that will make them a better pharmacist in the end” NQ17 
Giving advice to healthcare professionals about a patient’s treatment was 
something pharmacist participants felt very strongly should not occur unless 
this advice had been checked by a qualified pharmacist first.  
“…I don’t think that I would be very comfortable to be leaving my pre-reg on 
a ward by themselves to be verifying medicines, giving advice to doctors…” 
NQ5 
Newly qualified pharmacists discussed potential ‘supervisors’ for the ward 
placement and identified the ward clerk and the ward co-ordinator as 
individuals who could support and supervise the pre-registration pharmacist.  
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“…the ward clerk and the co-ordinator and they’re good from a work 
perspective as well because they know who’s going home, they know about 
transport so you’re always communicating with them about where TTOs 
are…” NQ3 
Other non-pharmacy members of staff were not perceived to be suitable 
supervisors for the pre-registration pharmacists.  
“…there’s a lot of members of staff that don’t really know the difference 
between the different roles of the pharmacy team…and what we are allowed 
and not allowed to do…” NQ5 
Working on the ward was recognised by one of the doctors as putting the 
pre-registration pharmacist at risk of falling into a service provision role. The 
need for effective supervision and good pharmacists would be necessary 
when considering the design of the placement to ensure this did not happen.  
“…my only other concern is being taken advantage of…would it just be more 
of an administerial learning experience rather than a clinical/theoretical one? 
Obviously if they’ve got sensible supervisors and decent pharmacists that 
would…be fine…but knowing from medical students they sometimes fall into 
a…service provision role rather than one they feel comfortable with…I 
suppose as long as there’s a robust feedback loop and supervision…then 
that should be easily stoppable” DR1  
4.4.4.5 Activities  
Possible activities pre-registration pharmacists could undertake as a part of 
the ward placement were described as enablers for either the ward staff or 
the trainee. Some activities, such as attending the multi-disciplinary board 
round meeting were deemed more central to the placement than others. 
Pharmacists reported not having enough time to attend these meetings 
during the working day and as a result, felt as though the potential role they 
could play on the ward was lost. However, should pre-registration 
pharmacists attend these meetings, this would enable greater collaboration 
between pharmacy and the ward.  
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“…if the pre-reg attended those [multi-disciplinary board round 
meetings]…they could feedback anything relevant to the pharmacist” NQ14 
Spending time learning about the responsibilities of the healthcare 
assistants, such as conducting patient observations was viewed as 
beneficial. Other activities such as washing patients or making beds were not 
recommended. However, supporting nursing staff to administer patient’s 
medicines was cited as an important learning opportunity because that 
practical knowledge would be useful when the trainees qualified as 
pharmacists.  
“…drug rounds because it’s something that we [pharmacists] don’t really do. 
And until you’re asked by nurses ‘Can I do x y z with this?’ And you come 
across the situation you have to deal with. You don’t really necessarily know 
that, other than maybe the theoretical, but the actual practical of how do I do 
this?...Just seeing the practical difficulties in…being the individual to 
administer those medications” DT2 
Getting involved in activities on the ward that would benefit patients was 
important and included conducting medicines reconciliations and attending 
consultant ward rounds.  
“… supporting the meds rec process on the ward…being on the ward rounds 
as well, so they can understand what’s going on with the care of the patient 
…the ward staff will probably find them valuable if…they’re actually 
contributing to the patient care whilst they’re on the ward” DT3 
Taking an active role in the patient discharge process was also 
recommended as an essential activity the pre-registration pharmacist could 
undertake. The opportunity for the pre-registration pharmacist to be involved 
in having conversations with patients about their medicines as a part of this 
was also key.  
“…being involved in discharging and then talking to patients about their 
medicines and make sure they understand about the changes…” NS1  
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Newly qualified pharmacists’ focus group 1 (NQ1-NQ5) suggested activities 
which would traditionally be viewed as the pharmacy assistant’s role such as 
cleaning the drug cupboard, going to get medicines from the dispensary and 
carrying out controlled drugs audits. These activities could be considered 
less ambitious than suggestions from focus group 2 (NQ11-NQ19). Focus 
group 1 participants articulated more passionately that their pre-registration 
training had not prepared them for independent practice than focus group 2, 
who were more confident.  
4.4.4.6 Recruitment 
There was disagreement regarding how the pre-registration pharmacists 
should be selected to take part in the placement, with some participants 
favouring a rigorous selection process and others favouring a random 
choice.  
“I think you should do it [choose the pre-registration pharmacists] randomly, 
pulling straws. Otherwise I think it would be really unfair to a study because 
you’re…bound to choose the more enthusiastic better etc. students to do 
your project …” PF3 
4.4.4.7 Working with key stakeholders 
The placement facilitators recognised that the success of the placement 
would rest on the engagement of the hospital staff and their willingness to 
work with the researcher to develop the placement. A long preparation and 
lead in time would be important because the researcher would be relying on 
the goodwill of busy people.  
 “…if you [researcher] get practice [the hospital staff] on board that’s the key 
thing…if they’re 100% behind you, they will make it work, so I think working 
with all of your stakeholders…doing it in person and just building up networks 
and relationships, there doesn’t seem to be a shortcut to that…” PF1 
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4.5  Discussion  
4.5.1 Main findings 
The results from this study provide a comprehensive picture of 
pre-registration training, the practice of the ward pharmacist and the barriers 
and enablers to introducing a ward placement. Newly qualified pharmacists 
were dissatisfied with their pre-registration training experiences, explaining 
that large amounts of their time was spent shadowing pharmacists and there 
was a lack of opportunities for them to practise autonomously. However, 
chief pharmacists and pre-registration managers did not find fault in these 
rotational pre-registration training programmes because trainees were 
passing the registration assessment. This highlighted that the marker for a 
successful pre-registration training programme is measured against the 
ability of the trainee to pass a knowledge-based multiple-choice registration 
assessment, not on their ability to practice as a pharmacist.  
The working conditions and practices of hospital pharmacists revealed the 
lack of time afforded for pharmacists to carry out activities which are 
patient-facing. Frequently, pharmacists are not considered members of the 
ward teams. The main barriers to introducing a ward placement into the 
pre-registration year included the GPhC registration assessment and the 
GPhC supervision requirements.  
Enablers for the placement included the potential it held for supporting 
pre-registration pharmacists to become part of the ward team, which would 
improve interprofessional working. In addition, the nurses and doctors 
participating in this research advocated that their wards would be good hosts 
for the placement because the culture was supportive and learner-friendly.  
The design of the placement covered a range of topics and there was a 
consistent message from all participants that the design should have clear, 
guidance, structure and supervisory arrangements.  
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4.5.2 Strengths and limitations 
This study succeeded in exploring the research context and identifying 
features of the placement’s design, through engaging with multi-disciplinary 
practitioner stakeholders. This is a key feature of the DBR approach that 
supports the researcher to design education interventions that will work in 
practice (Barab and Squire, 2004). The interpretation of the data is 
trustworthy, since triangulation, generating rich descriptions, reflexivity, peer 
debriefing and disconfirming evidence were used to confirm validity of the 
study findings.  
Pre-registration pharmacists were not recruited to this study because this 
data was collected within the first 5 months of the pre-registration year. 
Hence, trainee’s ability to provide perspectives on pre-registration training 
may have been limited because they were at early stage in their training 
year. The research team tried to account for this by recruiting newly qualified 
pharmacists who had been registered for fewer than two years.  
Only a small number of participants from each professional group were 
recruited to this study and so these results may not be generalisable to the 
wider population of that professional group. However, the aim of this study 
was not to seek to generalise the views of these participants to the wider 
population, but rather establish current training practices and seek multiple 
stakeholder perspectives on the introduction of a ward placement for 
pre-registration pharmacists at hospitals 1 and 2.  
During data collection, participants frequently asked the researcher if they 
were a pharmacist, had they worked in a hospital before, when they qualified 
and once, where they attended university. It was important to the participants 
(particularly nurses), that they knew they were talking to someone who 
understood the ward context. The researcher needed to use her previous 
experience of working as a hospital pharmacist to gain credibility and build 
trust with the participants. The researcher did not discuss her previous 
experiences of working as a hospital pharmacist with the participants. 
However, it is possible this affected the data collected and so is presented as 
a limitation of this study. 
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4.5.3 Main discussion  
The contextual descriptions provided by participants in this study suggest 
that hospital pharmacists are not currently practising as a member of the 
ward community of practice. One doctor acknowledged that the most 
proactive form of communication from their ward pharmacist was the green 
pen, implying the sharing of knowledge between pharmacist and doctors is 
limited. An example of ward pharmacists refusing to fulfil discharge 
prescriptions for patients whose paperwork was completed late in the day 
was described, thus demonstrating that the pharmacists’ joint enterprise is 
not aligned to that of their ward but rather, the pharmacy department.  
The peripheral nature of the ward pharmacist within the ward community of 
practice is not necessarily reflective of a failure of the individual pharmacist 
to build relationships with the ward team but represents a wider systems 
failure of the training and working practices of pharmacists. During the 
degree, pharmacy students do not train in the workplace, develop 
interprofessional skills or learn to make decisions with other healthcare 
professionals. Hospital pre-registration training rarely includes long periods 
on one ward, where trainees can learn how to build effective working 
relationships. Hence, working on a ward as a newly qualified pharmacist can 
be daunting and intimidating when very little training over five years has 
prepared them for this role. The newly qualified pharmacists in this study did 
not consider themselves part of the ward team. 
Barriers to pharmacists crossing the boundary into full membership within the 
ward community of practice were identified in this study as the pharmacist’s 
multiple departmental responsibilities, non-attendance at multi-disciplinary 
meetings and limited presence on the ward. In addition, there may not be an 
identified person who can act as a ‘broker’ to the pharmacist to support their 
transition onto the ward. Furthermore, the limited time a hospital pharmacist 
may be present on a ward during the day would restrict the ability of any 
potential broker to support the pharmacist’s integration into the ward 
community of practice. This could result in the pharmacist only ever 
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achieving peripheral membership in the ward community of practice, as they 
cannot cross the boundary into the ward community of practice.  
The peripheral nature of the ward pharmacist in the ward community of 
practice appears to hold consequences for the training of pre-registration 
pharmacists. These results show that pre-registration pharmacists spend 
large amounts of time shadowing the ward pharmacist whilst they work and 
performing large quantities of medicines reconciliations. In the ‘meat-cutter 
community’ observed by Lave and Wenger (1991), apprentices were denied 
the opportunity to participate in meaningful practice, instead being used as a 
form of cheap labour, thus marginalising the apprentices and making it 
difficult for them to participate in more sophisticated practice.  
In this study, evidence has been presented to suggest that the ward 
pharmacist cannot act as a broker to provide the pre-registration pharmacist 
with access to more sophisticated levels of practice through learning 
opportunities on the ward, since the pharmacist themselves holds only 
peripheral ward membership. This presents significant challenges for ward 
pharmacists as they cannot share the responsibility for training on the ward 
with other ward staff. This contributes to the feeling of burden pre-registration 
pharmacists experience during training. Pre-registration managers identified 
that they were reluctant to introduce a ward placement onto busy wards, 
which could suggest that they also perceive pre-registration pharmacists as a 
burden to a ward.  
One solution to overcoming this sense of burden was highlighted by the 
doctors in this study who acknowledged that if a pre-registration pharmacist 
could perform useful duties on the ward, then they would not become a 
burden. Doctors, nurses and placement facilitators expressed a different 
concern; that pre-registration pharmacists were at risk of falling into a service 
provision role. This perspective may imply a lack of awareness regarding the 
capability and competence of a pre-registration pharmacist but also suggests 
that with the proper training and enough time, pre-registration pharmacists 
could become useful members of the ward team. 
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In the current training model, pre-registration pharmacists usually rotate 
every 1-3 weeks, depending on the hospital. Difficulties associated with 
frequent rotations were described by newly qualified pharmacists who found 
that not knowing the ward staff was a barrier to their ability to build 
relationships with them. Communities of practice describes the importance of 
time with respect to establishing membership within a community to enable 
access to learning opportunities (Wenger, 1998). Therefore, it is unlikely that 
pre-registration pharmacists would be able to acquire even peripheral 
membership in ward communities of practice when they are only on the ward 
for such short periods. Short rotations further limit the ability of 
pre-registration pharmacists to take advantage of the learning opportunities 
that are available on the ward.  
The registration exam assesses a broad curriculum of topic areas including; 
the cardiovascular system, anaesthesia and malignant disease (General 
Pharmaceutical Council, 2020d). It is possible that pre-registration managers 
and tutors have designed hospital pre-registration training programmes to 
reflect the nature of the registration assessment, covering a wide range of 
specialties to ensure trainees are exposed to the different topic areas the 
registration assessment covers. However, as Holmboe et al. (2011)., 
identified, the assumption that more rotations equals more learning 
opportunities is not supported by sociology, learning theory or evidence from 
the literature. Communities of practice describes how membership within a 
community of practitioners enables trainees to access more learning 
opportunities, develop competence and establish their own practitioner 
identity (Wenger, 1998). Crucially, situated learning emphasises the 
importance of time, highlighting that it takes time for people to acquire 
membership within a community of practice and that they may need to be 
supported by more experienced members (brokers) to attain membership 
within the community (Lave and Wenger, 1991; Wenger, 1998; Wenger-
Trayner et al., 2014). The results from this study infer that pre-registration 
pharmacists are not given enough time during their rotations on hospital 
wards to enable them to develop skills such as decision-making to prepare 
them for practice. Decision-making is an important skill for pharmacists. If 
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newly qualified pharmacists struggle to make decisions, or perform the basic 
functions of a pharmacist, the question must be asked why the 
pre-registration tutor signed off trainees as ‘fit to practise’. This may be due 
to the GPhC’s lack of training, support and accreditation processes. 
When one newly qualified pharmacist reported having longer placements on 
fewer wards, they expressed anxiety over sitting the registration assessment. 
The pre-registration year serves two purposes: the trainee’s future practice 
as a pharmacist and the registration assessment. Pre-registration managers 
and tutors must therefore design training programmes that can prepare 
trainees to succeed in both. Pre-registration managers and tutors are 
expected to do this with no formal training on education, designing training 
programmes, assessing progress, supervising trainees and often have no 
protected time for carrying out educational activities from their employer 
(Mills, Blenkinsopp and Black, 2013; General Pharmaceutical Council, 2018).  
The registration assessment and GPhC performance standards were 
identified as some of the barriers to introducing a ward placement. The 
absence of any guarantees that trainees undertaking a ward placement 
would still be able to pass the registration assessment was of concern to the 
chief pharmacists and pre-registration managers. This, combined with the 
absence of a clear rationale for introducing a ward placement, there not 
being enough for a pre-registration pharmacist to do on a ward, and the risk 
to patients from pre-registration pharmacists giving out incorrect advice, led 
pre-registration managers to reject incorporating a ward placement as part of 
pre-registration pharmacist training. Building relationships with ward staff or 
working as part of the ward team were not discussed by the chief 
pharmacists or pre-registration managers. This could suggest that these 
individuals do not currently, and have never, attained full membership in a 
ward community of practice and so cannot identify the possible learning 
opportunities that may arise as a result of membership.  
Supervision of the pre-registration pharmacists by non-pharmacy members 
of staff was considered a barrier to introducing a ward placement as there 
appeared to be a culture of fear amongst the pharmacist participants 
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regarding the potential for pre-registration pharmacists to give out incorrect 
advice to other healthcare professionals. It is possible this culture of fear may 
originate from an offence committed under Section 64 of the Medicines Act 
1968 by a pre-registration pharmacist and pharmacist. The pre-registration 
pharmacist dispensed peppermint water to a baby that contained a 20-fold 
excess of chloroform, causing the baby to experience cardiac arrest and die. 
The pre-registration pharmacist prepared and dispensed the peppermint 
water incorrectly. The pharmacist did not check the quantities used to 
prepare the formulation. The pharmacist faced the same charges under the 
Medicines Act as the pre-registration pharmacist (Nathan, 2003). Hence, 
there may be a reluctance from pharmacists to provide pre-registration 
pharmacists with more autonomy during short block rotations because the 
pharmacist does not have enough time to understand the competence of the 
pre-registration pharmacist. Therefore, to protect patients and themselves, 
pharmacists do not provide pre-registration pharmacists with sufficient 
autonomy to develop the skills needed to practice as a pharmacist, such as 
decision-making.  
Newly qualified pharmacists suggested that, in the absence of a pharmacist, 
the ward clerk or discharge coordinator could act as supervisors to the 
pre-registration pharmacist during a ward placement. It is possible that this 
suggestion reflects the current practice of these pharmacists; the ward clerk 
and discharge coordinator may be the individuals these newly qualified 
pharmacists interact with most frequently on the ward. The ward clerk and 
discharge coordinator will possess information on new patients admitted to 
the ward and those preparing for discharge.  
The placement facilitators highlighted that the concept of ‘pre-registration’ 
healthcare professionals was not a new concept to ward teams. Examples 
were given of how medical and physicians associate students were not 
allocated to specific doctors, but rather to teams and wards in a more flexible 
approach to supervision. Yet, chief pharmacists made it clear that a ward 
placement could invoke a loss of control over pre-registration training and the 
ability of non-pharmacy healthcare professionals to supervise pre-registration 
pharmacists on wards was questionable.  
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Chief pharmacists and pre-registration managers also identified that there 
would not be enough medicines-related activities for pre-registration 
pharmacists to become involved with on a hospital ward and they were at 
risk of becoming a spare part. This perspective was not shared by the ward 
pharmacist, doctors or nurses who listed a variety of activities 
pre-registration pharmacists could get involved with on the ward, which 
included attending consultant ward rounds, conducting patient observations 
and supporting medicines administration. However, it was pointed out that 
these activities may not help pre-registration pharmacists to pass the 
registration assessment, demonstrating again the challenge of the 
pre-registration year to both equip trainees for practice and prepare them for 
the registration assessment.  
The suggested length of time for the ward placement varied. Pharmacist 
participants generally favoured shorter placements, wanting to ensure 
trainees could undertake rotations in multiple areas to equip trainees to pass 
the registration assessment. Doctors and nurses recommended longer 
placements to enable the pre-registration pharmacist to have sufficient time 
to embed themselves into the ward team. Often, medical and nursing 
participants reflected on their own experiences as junior members of staff 
and recalled how long it took them to embed into a team.  
All participants advocated for clear guidance, structure and supervisory 
arrangements for the pre-registration pharmacist and one placement 
facilitator addressed the researcher directly when describing the importance 
of maintaining good working relationships with the stakeholders involved in 
the research, which the DBR approach advocates for (Barab and Squire, 
2004). 
4.5.4 Summary 
The results from this study have contextualised hospital pre-registration 
training, ward pharmacist working practices and discovered the role the 
registration assessment has in the design and delivery of hospital 
pre-registration training in ways not previously identified in the literature.  
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Short rotational placements are standard practice, resulting in trainees’ 
observing the practice of the pharmacist whilst they work and performing 
large quantities of medicines reconciliations. The rotational training model 
has been designed to reflect the nature of the registration assessment and 
does not support trainees to develop the interprofessional and 
decision-making skills necessary for practice as a pharmacist. These results 
have highlighted that the assumptions held about rotational training in 
medical education also apply to pre-registration pharmacist training 
(Holmboe, Ginsburg and Bernabeo, 2011).   
The registration assessment was the principal barrier to introducing a ward 
placement. Since hospital pre-registration pharmacists were passing the 
registration assessment, there was little incentive for pre-registration 
managers to ‘rock the boat’ and change their training model. Chief 
pharmacists were concerned a ward placement would not enable 
pre-registration pharmacists to acquire the knowledge needed in order to 
pass the registration assessment. Resistance to developing a ward 
placement for pre-registration pharmacists came from within the pharmacy 
profession, namely chief pharmacists and pre-registration managers, who 
argued that such training would not fulfil the requirements of the GPhC. 
Conversely, doctors and nurses expressed support for the ward placement 
and gave reasons why their ward would be a suitable environment for a 
pre-registration pharmacist placement. Newly qualified pharmacists 
expressed a desire to build relationships with ward staff and enhance their 
ward experience prior to registering as pharmacists. These individuals went 
on to suggest design features of the ward placement such as, a clear 


















5.1  Introduction 
The previous chapter described the explorative work undertaken on the 
introduction of a ward placement for hospital pre-registration pharmacists. 
The thematic analysis identified four key themes; context, barriers, enablers 
and design. The design theme highlighted possible features of the ward 
placement and was made up of the following subthemes:  
 Guidance 
 Structure 




 Working with stakeholders 
Participants made a number of recommendations, namely that the ward 
placement should have clear guidance and structure, appropriate pharmacist 
and ward staff supervision and pre-registration pharmacists should 
undertake medicines-related ward activities. Whilst the placement length and 
recruitment strategy for pre-registration pharmacists to the ward placement 
were discussed, no agreement was reached amongst the participants. This 
chapter describes the methods used to design the ward placement and the 
resultant key features of the placement design.  
5.1.1  Design-based research: Design and construction 
Design and construction is the second phase of the DBR approach. It 
describes how an educational intervention should be developed using 
practitioners and learning theory to inform design and delivery of the 
intervention. To design and construct the ward placement, the methods were 
informed by McKenney and Reeves and are outlined below (McKenney and 
Reeves, 2012a). 
Designing an educational intervention often involves two stages, developing 
‘design requirements’ followed by ‘design propositions’. Design requirements 
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are the features that the design must deliver when the intervention is 
implemented. For example, ‘the pre-registration pharmacist must be properly 
supervised’ is an example of a design requirement.   
Design propositions are the practical elements of the design that support the 
intervention to deliver the design requirements. The design propositions 
represent the ‘how’ aspect of the intervention. Design propositions are often 
vague and undefined at the start of the design and construction process. 
Through multiple rounds of refinement, the researcher and a carefully 
selected group of key stakeholders, tease out the details to produce a design 
that is informed by theory, literature and explorative work. For example, ‘the 
pre-registration pharmacist will be supervised by the ward pharmacist, with 
support from the ward sister’ is an example of a design proposition.   
The design requirements should be established first and once these have 
been outlined, ideas can be further refined to determine the design 
propositions. This two-stage process also enables researchers/designers to 
better distinguish between the essential and supportive elements of the 
intervention.  
Designing an education intervention is an iterative process that is 
continuously adjusted, as ongoing feedback is sought from a team of 
practitioner stakeholders. Involving practitioner stakeholders increases the 
likelihood that the intervention design will work in the research context. This 
team of stakeholders should include practitioners who work in, or with, the 
area where the intervention will be implemented. They should also be 
multi-disciplinary where possible and have a range of experiences and roles 
(Reeves, 2005; Wang and Hannafin, 2005; Wolcott et al., 2019).  
5.1.1.1  Designing for learning 
In addition to utilising practitioner stakeholders, the DBR approach also uses 
theory to inform intervention design, implementation and evaluation (Wolcott 
et al., 2019).  
Experiential learning theory describes how experience leads to learning 
through learner’s reflecting and identifying ways to improve their practice 
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(Kolb, 1984). The ward placement, should therefore provide opportunities for 
pre-registration pharmacists to reflect on their experiences in order to learn 
from them.  
Situated learning theory identifies the importance of the social context and 
the significant role more experienced individuals (masters) play in supporting 
those with less experience (apprentices) to develop through legitimate 
peripheral participation (Lave and Wenger, 1991). Consequently, the ward 
placement design should enable opportunities for legitimate peripheral 
participation to take place, through supporting interactions between 
experienced ward staff (e.g. pharmacist/nurses/doctors) and the 
pre-registration pharmacists.  
Communities of practice theory describes how it is not possible to design 
learning itself, but that an environment can be organised to enable learning 
to become a part of social practice. To enable this to happen, designs must 
remain flexible and unrestricted so that rare learning opportunities can be 
exploited. Learning objectives, access to resources, discussions about the 
work and participation in meaningful activities are ways in which an 
environment can be organised to support learning. Individuals known as 
‘brokers’ may be needed to support trainees to transition into membership 
within the community of practice (Wenger, 1998). 
Drawing from communities of practice theory, it is therefore important to 
consider these points when developing the placement design:   
 Pre-registration pharmacists are supported by their pre-registration 
tutor and ward supervisor(s), to agree daily and longer-term objectives 
that will enable the trainee to plan for learning. 
 The pre-registration pharmacists are suitably equipped with access to 
the relevant computer systems and are trained to use pharmacy 
resources to find information e.g. medicines information resources. 
 The pre-registration pharmacists should attend multi-disciplinary team 
meetings, where the care of patients is discussed. 
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 The pre-registration pharmacist can participate in activities on the 
ward that are meaningful to their future practice. 
 Members of staff who could act as potential ‘brokers’ for the 
pre-registration pharmacists are identified and given the opportunity to 
undertake a ‘brokering’ role. 
The design process should be well documented so that readers can see the 
different iterations of the design and understand how the final design came to 
exist. This will enable the research to better contribute to the literature 
regarding the theoretical understanding of designing interventions (Ormel et 
al., 2012). 
5.1.1.2  Design requirements and propositions 
The explorative work (chapter 4) determined some of the design 
requirements for the ward placement, such as the placement needing to 
have a clear structure and clear guidance. However, it failed to identity all 
design requirements needed to inform the development of the placement and 
was not able to determine any of the design propositions for the ward 
placement.  
Brown and Stockman (2013)., reported that thematic analysis of their data 
was not detailed enough for the development of their communication 
technology-based intervention. They found that as codes were grouped 
together and themes generated, their data became less useful for informing 
the intervention design. A review of the six-step method of thematic analysis 
is presented below:  
Step 1: Familiarisation with the data (repeated reading). 
Step 2: Generation of initial codes (short descriptions). 
Step 3: Searching for themes (group codes to categories). 
Step 4: Reviewing of themes (re-sort categories – seek research team 
support). 
Step 5: Defining and naming themes (label themes). 
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Step 6: Production of the report (write up results). 
(Braun and Clarke, 2006). 
Brown and Stockman (2013)., explained that steps 1-3 of thematic analysis 
were beneficial to undertake for the purpose of designing the intervention, 
since this data was more detailed. However, steps 4-6 lacked sufficient detail 
to be useful for designing the intervention (Brown and Stockman, 2013).  
Whilst the main elements which require consideration in designing a ward 
placement for pre-registration pharmacists have been identified from the 
design theme of the thematic analysis (chapter 4), there is significant detail 
missing. According to DBR, the ward placement should be developed in an 
iterative manner using practitioner stakeholders and learning theory 
(McKenney and Reeves, 2012a).  
The methods selected for data collection and analysis to inform the 
placement design, should be based on the pragmatic philosophical 
underpinning of this research by asking the question of ‘what works?’ 
(Morgan, 2014; Creswell and Poth, 2017b). In this case, the more detailed 
the analysis, the more useful it will be for informing the design propositions 
and requirements.  
5.2  Aim and objectives  
Aim:  
Design a ward placement as part of the training programme for hospital 
pre-registration pharmacists. 
Objectives:   
 Identify key features of the placement design such as length and timing. 
 Describe the activities pre-registration pharmacists will participate in. 
 Describe how the placement design should be implemented. 
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5.3  Method  
5.3.1  Ethical approval 
Ethical approval for this study was obtained from the University of East 
Anglia Research and Ethics Committee (appendix 1) and governance 
approval from the Health Research Authority (appendix 2). Please note that 
information that could lead to the identification of participants, has been 
redacted from these approvals. 
5.3.2  Reflexivity  
In DBR studies, the researcher is also the designer of the intervention and 
should therefore remain objective, flexible and adaptable; taking great care 
to ensure their role as designer of the intervention does not compromise their 
role as researcher of the intervention (Plomp, 2007). During the design of the 
intervention, it is important that researchers do not impose their own beliefs 
regarding the intervention design on the stakeholders. Rather, they should 
seek to gather the views of stakeholders to inform the development of the 
intervention (Reeves, 2005; Wang and Hannafin, 2005; Getenet, 2019).  
Practising reflexivity can enable researchers to identify any potential ideas or 
opinions they have regarding the design of the intervention, which can then 
be addressed by the research team (Amin et al., 2020). Below is the reflexive 
account of the researcher (HK) regarding the design of the ward placement:  
March 2018 
Prior to commencing the design process there were many things I was still 
uncertain of regarding the placement design. Namely, what the placement 
would involve on a day-to-day basis and how the supervision arrangements 
would work. However, I also had ideas of what the design should 
incorporate. These included pre-registration pharmacists attending 
consultant ward rounds and observing the medicines administration process. 
From my review of the literature, I also wanted to develop a longitudinal 




I did not want to let these ideas influence the stakeholders and subsequent 
placement design. Having an awareness of how my own views could 
influence the stakeholder participants helped me to devise a method for 
designing the ward placement that harnessed the participant’s ideas and 
allowed me to be transparent about my own.  
5.3.3  Study design 
The study design consists of three phases: 
Phase 1: Determining the design requirements and propositions. 
Phase 2: Working with key stakeholders to develop the placement design. 
Phase 3: Obtaining agreement from a multi-stakeholder advisory panel on 
placement design. 
The figure below provides an overview of each phase:  
---
 
Figure 5: Chapter 5 Process 
Phase 1
• The principles of framework analysis are applied to the 
qualitative data generated in chapter 4 to determine the design 
requirements and propositions.
Phase 2
• A group of key stakeholders at each hospital work with the 
researcher to refine the design requirements and propositions of 
the placement. 
Phase 3
• The placement design (which incorporates the selected 
requirements and propositions) is presented to a multi-
stakeholder advisory panel to confirm agreement. 
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5.3.3.1  Phase 1 
Determining the design requirements and propositions 
Data generated by the design theme in Chapter 4 did not provide sufficient 
detail to inform the placement design. This data needed to be re-analysed in 
order to determine the design requirements and propositions of the ward 
placement. 
The ‘Framework Method’ is a systematic step-by-step analysis of qualitative 
data which involves displaying the results in detailed matrices (Gale et al., 
2013). The following stages were applied to the data generated in the design 
theme of Chapter 4:  
 Stage 1: Transcription (Chapter 4). 
 Stage 2: Familiarisation with the data (Chapter 4). 
 Stage 3: Coding (Chapter 4). 
Stage 4: Develop a working analytical framework (Chapter 5). 
Stage 5: Applying the analytical framework (Chapter 5). 
Stage 6: Charting data into the framework matrix (Chapter 5). 
Stage 7: Interpreting the data (Chapter 5). 
(Gale et al., 2013). 
Stages 1-3 
Transcription, familiarisation with the data and initial coding were completed 
as part of the thematic analysis presented in Chapter 4. The initial codes 
ascribed to the data were developed during the thematic analysis and were 
stored in an NVivo QSR International Version 11 database. 
Stage 4 
The working analytical framework was developed based on the aim and 
objectives of the research. The two categories within the framework were 




The coded data (not the corresponding quotes) and participants IDs were 
inputted into either a ‘Design requirements’ or ‘Design propositions’ 
framework matrix. Microsoft Excel® was used to store and manage the data. 
For example, the code ‘Activities must be mapped to the GPhC performance 
standards’ CP3, DT3, DT2 was inserted into the requirements spreadsheet. 
Stage 6 
Within each matrix, the codes were then grouped and organised according to 
their design feature. For example, all the codes that related the placement 
design to the GPhC (like the example above), were organised under the 
requirement ‘GPhC’.  
Stage 7 
Data was then interpreted to inform the placement design requirements and 
propositions.  
Unanticipated additional consideration  
During analysis, it became apparent that codes relating to what the 
placement should not incorporate were also important for designing the ward 
placement. Hence, the researcher created a third part to the analytical 
framework, named ‘Design concerns’. 
The Framework Method was applied in the same way as described above, to 
insert codes relating to the concerns that participants raised regarding the 
design of a ward placement. 
For example, this included codes such as ‘Risk to patient safety’ PM4, PM2, 
NQ3, NQ5, PM5. 
5.3.3.2  Phase 2 
Working with key stakeholders to develop the placement design 
Involving practitioner stakeholders is a key part of the DBR approach to 
designing an intervention (McKenney and Reeves, 2012d). Practitioner 
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stakeholders at hospitals 1 and 2 were identified and approached to work 
with the researcher to interpret and refine the design requirements and 
propositions generated during phase 1 of this study.  
At hospital 1, the stakeholder group consisted of: 
 Pre-registration pharmacist 
 Pre-registration pharmacist manager  
 Deputy chief pharmacist  
 Ward sister (of proposed placement ward) 
At hospital 2, the stakeholder group consisted of: 
 Pre-registration pharmacist manager 
 Pre-registration tutor 
 Deputy chief pharmacist (also ward pharmacist of proposed 
placement ward) 
 Ward sister (of proposed placement ward) 
 Ward consultant (of proposed placement ward) 
The researcher met with the stakeholder group at hospital 1 five times and 
the stakeholder group at hospital 2 six times to discuss the data relating to 
the requirements and propositions. These meetings took place 6-9 months 
prior to the ward placement commencing.  
The stakeholder groups identified which design requirements and 
propositions they would take forward and incorporate into the ward 
placement design and which ones would be discarded. 
These meetings did not involve any formal data collection and analysis, 
which is not unusual during the design and construction phases of the DBR 
approach (McKenney and Reeves, 2012d).  
The researcher (HK) met regularly with the research team (DW, JS, MC) 
separately from the stakeholder groups, to update on progress of the 
placement design. The research team challenged the researcher regarding 
certain decisions and provided an opportunity for the design to be critically 
reviewed at various stages. 
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5.3.3.3  Phase 3  
Obtaining agreement from a multi-stakeholder advisory panel on the 
placement design. 
Subjecting proposed intervention designs to appraisal by experts, is 
recommended as part of the DBR approach (McKenney and Reeves, 
2012d). The preliminary placement design determined in phase 2 was 
presented to a multi-disciplinary stakeholder advisory panel at each hospital 
in phase 3.  
Participant recruitment 
The inclusion criteria for persons attending the advisory panel were: 
1) Participants must be employed at one of the hospitals and one of the 
professions listed below: 
- Doctor of the grade FY1 – ST3  
- Doctor of the grade ST4 – Consultant  
- Senior Nurse (deputy sister or above) 
- Ward Nurse 
- Senior pharmacist (Band 8 or above) 
- Ward Pharmacist 
- Pre-registration tutor  
- Pharmacist previously involved in the ‘Integrated Care Pharmacist’ 
programme  
2) Participants may be patients or public involvement (PPI) (there may 
be up to two on the advisory panel)  
Participants who were part of the practitioner stakeholder groups were 
emailed directly by the researcher, since they were well-known to the 
researcher.  
Participants from the wards which had been highlighted as potential hosts for 
the placements were recruited using the chief pharmacist/deputy chief 
pharmacist as gatekeepers, who contacted the relevant staff members on 
behalf of the researcher. 
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Individuals who sat on the pre-registration pharmacist PPI group were 
approached using the pre-registration pharmacist programme director as a 
gatekeeper. 
The panel lasted one working day (10am – 4pm, with a 1 hour lunch break 
and tea/coffee breaks) at hospital 1 and an afternoon (1pm – 4pm with a 
working lunch and a tea/coffee break) at hospital 2. The difference in time 
allowance for each advisory panel was due to staff availability and different 
working patterns.  
The first multi-stakeholder advisory panel was held at hospital 1 because the 
placement design was more comprehensive in the earlier stages. The 
findings from the multi-stakeholder advisory panel at hospital 1 informed the 
discussions at hospital 2.   
Advisory Panel Format 
The advisory panels were facilitated by the researcher and an independent 
person not associated with the research team or with either hospital. The 
independent person was a pharmacist, with extensive experience of chairing 
meetings, who led the discussions during the advisory panel.  
At the start of the advisory panel, the researcher presented information on 
current pharmacy education and training (for the benefit of non-pharmacy 
members of staff), study rationale and learning theory. Participants 
discussed the following topics: 
- Learning outcomes for pre-registration pharmacists. 
- Preparation of the pre-registration pharmacists prior to placement. 
- Recruitment of pre-registration pharmacists to the placement. 
- Week 1 induction. 
- Key activities that could be undertaken during placement e.g. 
medicines management, attendance at board rounds (NB: board 
rounds are meetings where staff members discuss each patient on 
the ward, updating one another on diagnosis, the clinical 
management plan and co-ordinating discharges). 
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- Role and the boundaries of the role of the pre-registration 
pharmacists. 
- Workplace assessment tools. 
- General logistical matters e.g. precise timing of the placement 
within the year. 
- Placement timeline in accordance with proposed activities. 
Once each topic, or specific element of the placement design had been 
discussed, the chair asked the participants if they agreed with each decision. 
If no objections, suggestions or corrections were made, the chair moved onto 
discuss the next design feature of the placement.  
At the end of each advisory panel, the researcher compiled meeting minutes, 
updated the appropriate documents and emailed them to all participants. 
Reimbursement 
In the case of participants who attended the advisory panel during their 
working hours, their hospital received £200 reimbursement for the time of the 
member of staff. Participants who attended the advisory panel during their 
own time received £200 directly. The incentives were offered in recognition 
that participants were required to take several hours out of their day to 
participate.  
Data collection 
The advisory panels were audio-recorded using two digital recording 
devices. Written informed consent was obtained prior to conducting the 
recording. 
Data analysis 
The audio recordings were not analysed but were used by the researcher 




5.3.3.4 Validation strategies 
This study has utilised five out of the nine validation strategies for 
determining credibility of the data: member checking, prolonged engagement 
in the field, collaborating with participants, peer review of the data and 
reflexivity.   
Providing the practitioner stakeholders with the placement requirements and 
propositions gave them the opportunity to review the data, clarify 
suggestions, provide additional background and support or refute certain 
design ideas. Hence, a type of member checking was carried out on the data 
gathered during the explorative phase, enhancing the credibility of these 
findings (Lincoln and Guba, 1985; Creswell and Poth, 2017c). 
The researcher met with the research team regularly to provide updates on 
the progress of the placement design. The team challenged the researcher 
to defend certain decisions about the placement design, carrying out a form 
of peer review (Creswell and Poth, 2017c). 
The researcher has provided a reflexive account which includes her ideas for 
the design of the ward placement, enabling the reader to better understand 
the researcher’s perspectives regarding the placement design (Creswell and 
Poth, 2017c). 
The remaining four validation strategies: triangulation, disconfirming 
evidence, external audit and rich descriptions were not used. Since this study 
did not analyse any empirical data it was not possible to triangulate, generate 
disconfirming evidence or rich descriptions as a part of this research. 
Carrying out an external audit would have provided additional rigour to the 
study findings; however, this was not possible given the time constraints in 
preparing the placement design for implementation. 
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5.4  Results  
5.4.1  Phase 1 
5.4.1.1 Placement requirements 
Twelve categories of placement requirements were established from the 
explorative data: 
 Length of placement 
 Timing of placement 
 Ward type 
 GPhC requirements 
 Selection process 
 Supervision criteria 
 Support 
 General guidance 
 Clear role 
 Advice giving 
 Assessment of pre-registration pharmacist 
 Team need to be happy 
An extract from the placement design requirement matrix has been included 




Table 5: Placement requirement (extract from appendix 7).  
Requirement 
subclass 




1-2 weeks CP1 CP4  
3 months NS2 NS3 DR5 




Random selection PF3   
Hospital/research team to select CP2   
Supervision 
criteria 
Someone who understands 
GPhC performance standards 
DT3   
Pre-reg must not be left 
unsupervised by pharmacy 
PM5   
Advice giving Pre-reg should not give advice to 
staff 
PM3   
Pre-reg cannot give advice in the 
absence of a pharmacist 
NQ17 NQ12 NQ14 
 
5.4.1.2 Placement propositions  
Once the design requirements had been established, the researcher worked 
with the stakeholder groups to determine the design propositions. Fourteen 
categories were identified from the explorative data regarding placement 
design propositions: 
 Pharmacy assistant 
 General pharmacy 
 Advanced pharmacy 
 Patient-centred activities 
 Working with doctors 
 Working with nurses 
 Ward type criteria 
 Training prior to placement 
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 Personality of the pre-registration pharmacist 
 Who could supervise 
 Who could not supervise 
 Pre-registration pharmacist guidance 
 Ward staff guidance 
 Knowing the role of the pre-registration pharmacist 
An extract from the placement design proposition matrix has been included 
below. For the full list of design propositions, see appendix 8. 
Table 6: Placement propositions (extract from appendix 8). 
Proposition 
subclass 




Patient own drug 
checks 
NQ17 CP4 PM5 PM4  
Clinical pre-screening CP3     
Check discharge 
letters 





Antibiotic stewardship NQ12 NQ15 NS1 WP1 DR5 
Support deprescribing WP1 NS1 DR1 DR5  
Challenge consultant 
decisions 





teaching with junior 
doctors 
DR1     
Work in older persons 
acute/day admissions 
unit 





5.4.1.3 Placement concerns 
The concerns surrounding the placement and its design were extensive and 
varied across all participant groups. Seventeen categories of concerns were 
identified: 
 Generic concerns 
 Placement serves no purpose 
 Patient care 
 Tutor specific concerns 
 Learning outcomes 
 GPhC  
 Supervision 
 Ward team 
 Advice giving 
 GPhC assessment 
 Overall pre-registration year 
 Understanding of the pre-registration pharmacist’s role 
 Ward work 
 Registration 
 Recruitment 
 Personality of the pre-registration pharmacist 
 Nursing fears 
An extract from the placement concerns matrix has been included below in 




Table 7: Placement concerns (extract from appendix 9). 
Concern 
subclass 
Concern Who said so? 
General 
concerns 
Pre-reg will lose identity 
as a pharmacist 
PM5 
    
Placement will not meet 
training needs of pre-reg 
PM4 
    
Reputation of pharmacy 
damaged if pre-reg makes 
mistake 
PM2 PM5 PM4 CP3 CP4 
Patient 
care 
Risk to safety of patient 
care 







supervision to nursing or 
medical teams 
PM4 
    
Tutor is expected to pick 
up the evidence produced 
from the placement 
PM5     
Learning 
outcomes 
Outcomes for this 
placement are not clear 
CP3 CP1 
   
Pre-reg distracted from 
achieving their learning 
outcomes by ward staff 
PM5 
    
GPhC Placement will turn into a 
shadowing exercise where 




   
Pre-reg not able to meet 
the GPhC performance 
standards on the ward 
PM4 CP3 










Holistic patient focus doesn't require the 
pre-reg to be on a ward - rather ethos of 
pharmacy needs to change 
CP3 CP4 CP1 
Why is this placement being done? Not 
clear what it is trying to achieve 
CP3 CP4  
Supervision No pharmacist supervision will result in 
pre-reg not learning the right 
information or how to do the right thing 
PM3   
Pre-reg can't do anything which isn't 
checked by a pharmacist 
CP3   
Daily oversight of pre-reg is difficult to 
achieve when they aren't in pharmacy 
department 
CP3   
How would personality of the pre-reg 
cope being unsupervised - some would 
not cope 
PM5   
Worry that other professions would 
want pharmacists to supervise their 
pre-registration students 
PM2    
No pharmacist supervision will result in 
pre-reg doing menial roles 
PM2    
Pharmacy staff too busy to supervise 
pre-reg on placement 




5.4.2 Phase 2 
5.4.2.1 Placement requirements 
Discussing the placement requirements with the stakeholder groups led to 
the stakeholders identifying the following design requirements:  
 Placement to take place in the middle of the pre-registration year. 
 An Older Persons Medicine (OPM) ward should host the placement. 
 Placement activities must map to the GPhC performance standards. 
 Working hours should be the same as pharmacy; Mon-Fri, 9am-5pm. 
 Guidance on the role of the pre-registration pharmacist must be 
determined. 
 The placement must have defined learning objectives. 
Despite the quantity of data regarding the placement length generated from 
the explorative discussions, there was no clear recommendation or 
agreement amongst the stakeholders. Proposed lengths ranged from half a 
day to six months. Due to the need to determine a placement length at an 
early stage in the design process, the researcher proposed that the 
placement length should be a minimum of 13-weeks, in line with the literature 
surrounding longitudinal placements (Thistlethwaite et al., 2013).  
The stakeholder group at hospital 1 accepted a 13-week ward placement. 
However, hospital 2 rejected the proposal for a 13-week placement and 
supported a placement for 6-7 weeks in length. After several iterations of the 
6-7 week placement had been discussed between the researcher and 
stakeholders, the evidence supporting 13-week placements was 
reconsidered and the stakeholders at hospital 2 agreed to a 13-week 
placement. 
5.4.2.2 Placement propositions 
Discussing the placement propositions with the stakeholder groups led to the 
stakeholders identifying the following design propositions:  
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 Continue to participate in the pharmacy-related activities on the ward 
e.g. medicines reconciliations. 
 Be involved in activities that support patients to manage their 
medicines e.g. counselling patients. 
 Attend multi-disciplinary team meetings (board rounds). 
 Attend consultant ward rounds. 
 Observe medicines administration rounds. 
The design propositions reflected the characteristics of a longitudinal 
placement. The placement should provide opportunities for pre-registration 
pharmacists to care for patients, build good working relationships with the 
ward team and achieve the GPhC performance standards (Poncelet and 
Hirsh, 2016).  
The stakeholder groups determined that pre-registration pharmacists could 
assess a patient’s ability to self-administer medicines and give advice to 
healthcare professionals, provided a registered pharmacist had checked this 
where applicable.  
Administering medicines, taking blood and clerking patients into the ward, 
were propositions that were deemed unsuitable for the pre-registration 
pharmacists during their ward placement. 
The placement propositions identified in phase 1 did not include the concept 
of the trainees gathering feedback on their performance over the course of 
their placement, although one participant (NQ4) did suggest using a mini 
peer assessment tool. The researcher (HK) initiated conversations with the 
stakeholders on the use of workplace assessment tools for pre-registration 
pharmacists during the ward placement, suggesting they could be 
redesigned for pre-registration training. The stakeholders supported this idea 
of incorporating workplace assessment tools into the ward placement.  
Over the course of the meetings with the key stakeholders, a placement 
design began to unfold. At both hospitals, the first placement design listed 
the activities participants had agreed upon, distributed across a 7-week 
(appendix 10) or 13-week period (appendix 11). Following further 
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stakeholder meetings, this design evolved to incorporate a series of learning 
objectives, a preliminary timetable and more detailed information on activities 
such as patient observations, board rounds and medicines administration 
(appendix 12). 
The views of the stakeholder group at each hospital were largely similar, the 
main differences being the length of placement and the responsibilities of the 
pre-registration pharmacists on the ward. The nurse stakeholder at hospital 1 
led discussions on what the responsibilities of the pre-registration 
pharmacists on the ward should consist of. These discussions did not occur 
at hospital 2 due to the extensive discussions surrounding placement length.  
Following the completion of the stakeholder meetings, the placement design 
for each hospital was almost identical in nature, with variations only arising 
as a result of the ward context i.e. some learning opportunities were 
available at one hospital due to the nature of the placement ward. However, 
this outline still only provided some of the details necessary for implementing 
the placement. Other important details had not been finalised and these 
included: 
 Recruitment of the trainees to the placement 
 Role boundaries 
 Key activities 
 Timetable 
 Induction 
5.4.2.3 Placement concerns 
The placement concerns fell broadly into two categories: 
1. Concerns relating to what the ward placement design should not 
incorporate.  
2. Concerns which could not be addressed by the placement design e.g. 





Concerns the placement design should not incorporate 
The researcher made the conscious decision not to share any of the data 
relating to the placement concerns with the stakeholder groups, as this might 
hamper design discussions. Rather, the research team revisited the 
placement concerns related to what the ward placement design should not 
incorporate. This ensured that as discussions with the practitioner 
stakeholders took place, the design did not incorporate these features.  
Concerns regarding whether the ward placement would meet the GPhC 
requirements and if pre-registration pharmacists would be able to achieve 
their performance standards on the placement, were addressed through 
mapping potential outcomes of the placement to the GPhC performance 
standards (see appendix 13) in order to obtain GPhC approval (appendix 
14). 
Concerns over the willingness, availability and competence of the ward staff 
(doctors and nurses) to play a role in the supervision of the pre-registration 
pharmacists, was extensive in the phase 1 data. Working closely with the 
practitioner stakeholders helped address some of these concerns, as the 
nurses and consultant expressed willingness to be involved and were not 
concerned about limited availability and lack of support for the project.  
Concerns the placement design could not address 
The concerns which the placement design could not address in the design 
phase largely consisted of fears about ‘the worst case scenario’ from 
implementing a ward placement. These included concerns such as:  
 Some pre-registration pharmacists not coping during the placement. 
 Other professions would want pharmacists to supervise their 
pre-registration students. 
 No pharmacist supervision would result in pre-registration pharmacists 
performing menial roles on the ward.  
During the design phase, it was not possible to predict whether these 
concerns would come to pass. Hence, only through implementing the ward 
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placement would it be possible to determine if these concerns would be 
applicable to the ward placement.  
5.4.3  Phase 3 
At hospital 1, eight stakeholders attended the panel and included: 
pre-registration pharmacist manager, pre-registration pharmacist, ward 
sister, ward pharmacist, nurse educator, newly qualified pharmacist           
(<2 years’ experience) and two PPI members.  
At hospital 2, twelve stakeholders attended the advisory panel and included; 
deputy chief pharmacist (also ward pharmacist), pre-registration manager, 
pre-registration tutor, newly qualified pharmacist (<2 years’ experience), 
pre-registration pharmacist, ward sister, two ward nurses, two deputy sisters 
and two PPI members.  
The results from the hospital 1 advisory panel were presented and agreed 
upon by the hospital 2 advisory panel, resulting in a longitudinal placement 
design that was almost identical, with variations only arising from the 
different ward contexts.  
The main design features of the longitudinal ward placement are presented 
in this chapter, with a full list in appendix 15.  
5.4.3.1 Learning outcomes 
Learning outcomes were agreed: 
• Perform pharmacist ward based clinical activities under supervision. 
• Demonstrate effective time-management, prioritisation and 
organisational skills. 
• Demonstrate effective communication and consultation skills with 
patients. 
• Demonstrate effective inter-professional working. 
• Apply knowledge in the context of clinical decision-making. 
• Critically appraise prescriptions and develop personalised 
management plans for patients. 
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• Evaluate own learning experiences during the placement. 
5.4.3.2 Preparation prior to placement 
Pre-registration tutors should be sufficiently prepared and aware of the 
placement design and its objectives. Ward staff should expect the 
pre-registration pharmacist’s arrival prior to placement and have an 
awareness of the placement’s design.  
The pre-registration pharmacists should have discussions with their tutor 
prior to commencing the placement about their role, responsibilities and 
learning outcomes.  
5.4.3.3 Recruitment of pre-registration pharmacists to placement 
Pre-registration pharmacists would be asked to volunteer for the placement 
and if more pre-registration pharmacists volunteered than there were 
available placements, the trainees would be selected randomly.  
5.4.3.4 Induction 
A one-week induction period on the ward (included in the 13-week 
timeframe) would be developed and implemented by the ward sisters. Ideas 
were shared for what the induction week could involve at each hospital and 
are listed below in table 8.  
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Meet the team Yes Yes 
Roles of healthcare professionals within 
the team 
Yes Yes 
Overview of working hours and range of 
activities 
Yes Yes 
Supervision and mentoring arrangements Yes Yes 
Overview of how ward operates Yes Yes 
Orientation of the ward; location of ward 
items e.g. equipment, medicines 
Yes Yes 
Understand transfer of care issues Yes Yes 
Patient Observations training Yes Yes 
Answering the ward telephone Yes Yes 
Orientation of medical notes Yes No 
Training on accessing patients' records Yes No 
Training on viewing pathology results Yes No 
Training on viewing medical history Yes No 
Training on what to do when the crash bell 
goes 
N/A Yes 
Orientation of relevant Trust guidelines N/A Yes 
 
The reason for not incorporating some of the proposed induction activities at 
hospital 2 was due to the pre-registration pharmacists having already 
completed these activities as part of their standard rotational hospital 
training.  
Training on what to do when the crash bell sounded and the orientation of 
relevant Trust guidelines were not discussed by the panellists at hospital 1, 
as these ideas were put forward by the panellists at hospital 2.  
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5.4.3.5 Placement logistics 
At hospital 1, the pre-registration pharmacists should conduct their 
placements sequentially to avoid them being placed on the ward at the same 
time so that ward staff are not overwhelmed.   
The pre-registration pharmacists should have sufficient time to acquaint 
themselves with the pharmacy staff and department procedures before 
commencing the ward placement. The timing of the placement within the 
year should also avoid taking place too close to the registration assessment. 
Possible start times of November and February for each of the 
pre-registration pharmacists were proposed. 
At hospital 2, pharmacist panellists advocated for the pre-registration 
pharmacist completing their ‘Medicines Information’ rotation prior to the 
placement commencing. A start time of January was agreed upon for the 
hospital 2 pre-registration pharmacist.  
5.4.3.6 Key activities 
Specific activities that the pre-registration pharmacists could get involved 
with on the ward were discussed and grouped into the following categories:  
 Medicines management 
 Patient observations 
 Attendance at board round 
 Attendance at medicines administration round 
 Attendance at ward rounds 
 Implementing Trust guidelines 
 Patient-centred discharge planning 
The key activities listed in the medicines management category have been 
included below. For a list of all categories and activities, see appendix 15. 
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Assist ward staff with 
individual patient ordering 
of medicines 
Yes Yes 
A1.1-A1.8    
A2.1-2.4    
A3.1-A3.5    
A4.1-A4.8   
A5.1-A5.7    
B1.1-B1.12   
B2.1-B2.9    
C1.9    
C1.11-C1.12    
C2.1-C2.9    
C2.11 
 
Completing Patient Own 




Dealing with medication 
supply queries 
Yes Yes 





Support ward staff to 
monitor therapeutic drug 
levels for specified patients 
and drugs 
Yes Yes 
Update the patient 







During the advisory panel, participants suggested groups of key activities 
which were missing from this list that included:  
 Working in the day assessment unit.  
 Patient counselling. 
 Patient’s self-administration of medicines. 
 Responding to medicines information queries. 
139 
 
 An ‘other’ category of opportunistic activities that did not fit into one of 
the above activity groups.   
All of these activities were added to the placement design. The patient and 
public involvement members on the panel were receptive to pre-registration 
pharmacists supporting patients to self-administer their medicines.  
5.4.3.7 Responsibilities 
In phase 2, the practitioner stakeholders identified that determining the 
responsibilities of the pre-registration pharmacists was important. The 
researcher compiled the information from these discussions to present two 
categories of responsibilities to the panellists. The independent chair invited 
panellists to comment and reach agreement on each responsibility. A full list 











Not a routine expectation, but trainees could assist healthcare 
assistants if the ward is busy. 
Yes Yes 
Washing patients 
Trainees should be aware of how patients are washed but should 
not be actively involved in washing patients. Yes Yes 
Walk patients to the toilet 
Trainees should not escort patients to the toilet independently but 
should find a relevant member of staff to assist. Yes Yes 
Talk to patients about 
medicines 
Trainees should have holistic discussions with patients about their 
medicines that go beyond the medication history and discharge 
counselling. 
Yes Yes 
Dispense urgent medicines 
Trainees should assist the ward to facilitate urgent discharges 
which may include dispensing items in main pharmacy. These 
items should still be checked by a pharmacist. 
Yes Yes 
Discharge planning 
Trainees should assist with managing discharges, ensuring 
patients have enough medicines and liaising with the ward 
pharmacist. 
Yes Yes 
Ensure patients have 
enough to drink/are eating 
Trainees should not assist patients with food but can provide 
patients with drinks.  Yes Yes 
Mobilising patients and 
role if patients fall 
Trainees should have an awareness of and should know who to 




5.4.3.8 Workplace assessment tools 
Six workplace assessment tools were proposed to the panels: 
1. Mini Clinical Evaluation Exercise (Mini-CEX). 
2. Direct Observed Procedure (DOP). 
3. Consultation Observation Tool (COT). 
4. Intervention Recording (IR). 
5. Case Based Discussion (CBD). 
6. Mini Peer Assessment Tool (Mini-PAT). 
Concerns were raised about the over-assessment of the pre-registration 
pharmacists, since they already have to complete ‘competency assessments’ 
that require them to perform certain technical activities. This was particularly 
relevant when discussing the ‘Direct Observation of Procedure’ (DOP) tool, 
which was viewed as a duplication of the already existing competency 
assessments used at hospital 1. Therefore, the DOP tool was removed as a 
possible workplace assessment tool to include as part of the placement. 
5.4.3.9 Proposed timetable 
Panellists agreed that the proposed placement timetable (see table 11) was 
appropriate given that the responsibilities evolved over time to become more 
complex in nature (NB: This is not the final placement timetable – the final 
table can be found in 7.3.2.2).  
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Learning agreement Develop plan  
Pharmacy Activities;  
POD, MR, Ordering 
Achieved 
competency 




Utilises Medicines Management skills to support 
staff with patient discharges 
Review clinical discharge summaries (amending 
where necessary), conducting discharge counselling 
Ward Induction  Induction  
Patient Observations  Training Conduct observations  
Pharmaceutical care 
planning 
 Training and practice Implementation to support ward pharmacist 
Board rounds  Attendance and Observation Contributes if appropriate 








Conducts assessments independently; liaising with 
primary care providers on discharge 
Patient Counselling  
Orientation from ward pharmacist 
where trainee will receive training and 
opportunity to practice 
Competency assessment for patient counselling; 
conduct independently 
Consultant ward round  Attendance and Observation; supporting medical team and communicating with pharmacist 
Responding to staff and 
patient MI queries 
 Practice and implement responses under ward pharmacist supervision 
Guidelines 
implementation  














Work under supervision of healthcare professional to 
assist with clerk-in patients 
Audit  
Identification of audit topic and completion of audit data 















The placement design would be communicated to the pre-registration 
pharmacists, their tutors and the ward staff via a workbook. Prior to the 
placement commencing, meetings would be arranged with these individuals 
and the researcher. These meetings would involve distributing the workbook, 
explaining the placement and providing a final opportunity for participants to 
ask any questions before the longitudinal placement study commenced.  
5.5 Discussion 
5.5.1 Main findings 
This chapter has described how a pragmatic approach to designing a ward 
placement for hospital pre-registration pharmacists was carried out using the 
methodological principles of DBR (McKenney and Reeves, 2012d; Morgan, 
2014).  
A longitudinal 13-week placement design was developed during practitioner 
stakeholder meetings and at multi-disciplinary stakeholder advisory panels. 
The design at both hospitals was for the most part identical, with minor 
adaptations only arising due to specific aspects of patient care that took 
place on one ward but not the other. The placement design involved 
pre-registration pharmacists participating in medicines management 
activities, observing the medicines administration process, attending board 
rounds and consultant ward rounds. The responsibilities of the 
pre-registration pharmacists during the placement were outlined and 
included them talking to patients about their medicines and supporting the 
discharge process.  
The placement would be implemented on Older Persons Medicine (OPM) 
wards, in the middle of the hospital pre-registration year. The working hours 
of the pre-registration pharmacists during the placement would reflect the 
opening hours of their respective pharmacy department, so that there were 
pharmacists available to support. Learning outcomes and a timetable were 
developed to support the trainees manage themselves during the placement. 
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A series of workplace assessment tools were developed to encourage the 
pre-registration pharmacists to gather feedback on their performance. The 
placement design would be implemented via a workbook and through 
meetings with the pre-registration pharmacists, their tutors and the ward 
staff.  
5.5.2 Strengths and limitations  
The additional role of the researcher (HK) as designer of the placement 
enabled her to participate in discussions with the practitioner stakeholders 
regarding the placement design. This allowed her to update the placement 
design in ‘real-time’ and ensure that the research aim and objectives were 
met.  
The researcher as designer of the placement may be considered a limitation 
of this research. Her presence may have influenced the decisions of 
practitioner stakeholders regarding the design of the placement. Indeed, the 
researcher made several suggestions regarding the design of the placement. 
Namely the placement length, the use of a workbook and workplace 
assessment tools.  
The researcher had extensive knowledge of the literature and learning 
theory, which could enhance the placement design. During the design 
process, researchers should not impose their own beliefs regarding the 
intervention design onto practitioner stakeholders (Reeves, 2005; Wang and 
Hannafin, 2005; Getenet, 2019). However, decision-making during the 
design process will often involve trade-offs between what is theoretically the 
ideal and what is practical to deliver (McKenney and Reeves, 2012d). Ideally, 
the researcher would not have put forward any suggestions for the 
placement design to the stakeholder groups. Yet, this did not present a 
practical solution to achieving the aim and objectives of this study. In order to 
account for the researcher’s suggestions, they were discussed extensively 
with the practitioner stakeholders and agreed upon before being incorporated 
into the ward placement design.  
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The practitioner stakeholder meetings took place 6-9 months prior to the 
ward placement commencing, hence there was a long lead-in time to 
prepare for the implementation of the placement. This enabled the placement 
to undergo multiple draft designs and allowed the stakeholders to discuss, 
reflect and change their minds at various stages of the design process 
without feeling under pressure. However, it is worth considering that not all 
interventions will have such a long lead-in time, hence may not be able to 
undergo as many alterations and revisions.   
Challenges were encountered when recruiting doctors to participate in 
stakeholder meetings and at the advisory panels. This was due to the 
doctors working on the proposed placement wards being unable to leave the 
ward/clinic to attend these meetings. Only when evaluating the 
implementation of the ward placement will it be possible to determine if the 
absence of a doctor’s input into the placement design at hospital 1 affected 
the placement in any way.  
A small number of participants were involved in determining the placement 
design. Hence, their perspectives on what a ward placement for 
pre-registration pharmacists should include may not be generalisable to 
other hospitals and pre-registration pharmacist training programmes. 
However, at this stage, this study did not intend for the ward placement 
design to be generalisable to every hospital context or pre-registration 
training programme, rather it was intended to be specific for the context of 
the hospital wards and training programmes in this study.  
5.5.3 The DBR approach 
The thematic analysis carried out in Chapter 4 failed to identify the 
placement design requirements and propositions needed to inform its design. 
This study confirmed that higher level coding of data generated from 
thematic analysis does not support the design of complex interventions. 
The framework method was used successfully to identify the placement 
design requirements and propositions from the qualitative data. This 
indicates that the framework method could be applied by other design-based 
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researchers to identify intervention design requirements and propositions 
(Gale et al., 2013).  
During the collation of the design requirements and propositions, an 
additional set of codes relating to concerns participants raised in the 
explorative phase were identified. Some concerns appeared to be based on 
individuals ‘worst fears’ about the placement, rather than on anything which 
the placement design could specifically address.  
Other concerns related to possible consequences of the ward placement that 
could be prevented through careful design. For example, concerns raised 
over whether the GPhC would approve of the placement led the research 
team to acquire accreditation from the GPhC for the longitudinal placement. 
This involved mapping the activities of the placement to the GPhC 
performance standards. This reassured the pharmacist participants that the 
placement design was appropriate. These concerns were useful for 
‘checking’ the design of the placement as it progressed.  
The identification and use of participants’ concerns regarding the design and 
implementation of an intervention has not been previously described in the 
DBR literature. Concerns raised by participants could enhance the design of 
an intervention and warrants further investigation as a part of the design and 
construction phase of the DBR approach. 
5.5.4 Stakeholder input into the design 
Practitioner stakeholder input as a part of the DBR approach is important for 
improving the ability of the intervention design to be implemented 
successfully in the practice setting. During the phase 2 stakeholder 
meetings, the practitioners appeared to become more invested in the 
placement and began to assume more responsibility for identifying solutions 
to the problems they identified. Since the stakeholders were assuming more 
ownership over the placement, this may enhance their motivation to 
implement the placement effectively. Only through evaluating the ward 
placement will it be possible to determine if the practitioners involved in 
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designing the placement were more motivated to ensure its implementation 
was successful.  
5.5.5 Design features 
In phase 2, the length of the placement – 13 weeks – was suggested by the 
researcher in the absence of agreement in the explorative data and amongst 
stakeholder participants. Whilst having the researcher propose the 
placement length was not theoretically ideal, it was a practical solution to the 
challenge faced by the stakeholders of determining the placement length. 
Medical education literature identifies that longitudinal placements which are 
a minimum of 13-weeks provide an enhanced learning experience compared 
to short placements (Thistlethwaite et al., 2013).   
Clear learning outcomes, guidance and structure of the placement were 
design requirements identified in phase 1. During phase 2, stakeholders 
discussed these features at length and were keen to ensure the placement 
had sufficient guidance as to enable effective implementation, but not so 
much that the placement became constrained by it. Communities of practice 
theory recommends that training programmes retain a certain degree of 
flexibility to allow learners to explore learning opportunities which are of 
interest to them in the social setting (Wenger, 1998). It was therefore 
pertinent that the placement design, communicated through the workbook, 
should emphasise the flexible nature of the design.  
During the advisory panels, the ward sisters volunteered to arrange a week 
of induction activities that would involve the pre-registration pharmacists 
spending time with different members of staff and learning about their roles. 
This formal element of the placement design may enable the ward sisters to 
informally act as ‘brokers’ for the pre-registration pharmacists and support 
their integration onto the ward. 
Key activities pre-registration pharmacists could participate in during the 
placement were grouped into categories including: medicines management, 
the board round, the medicines administration round and the consultant ward 
round. The majority of activities proposed involved the pre-registration 
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pharmacists working with nursing or medical staff. These activities set the 
ward placement apart from traditional rotational ward placements where in 
the main, the pre-registration pharmacist’s time would be spent with the 
pharmacist conducting only medicines-related activities. The stakeholders 
set a new precedent for pre-registration pharmacist training in designing a 
ward placement that involved opportunities for learning and working 
alongside nurses and doctors in an integrated manner.  
Communities of practice emphasises that learning takes place during social 
interactions, particularly when those interactions occur between experienced 
members of the community and newcomers (Wenger, 1998). Since 
pre-registration pharmacists would be newcomers to the ward, opportunities 
for them to participate in activities with experienced members of the ward 
team may enhance their learning experience during the placement. 
Communities of practice highlights the need for responsibilities and activities 
to be relevant to the future practice of the learner (Wenger, 1998). In phase 
3, the responsibilities of the pre-registration pharmacists during the 
placement were prioritised according to the future practice of the trainees as 
hospital pharmacists. Other activities that involved providing the more 
personal aspects of patients’ care were deemed inappropriate for the 
pre-registration pharmacists to be carrying out.  
A series of workplace assessment tools were developed by the researcher to 
support the trainees to gather feedback and reflect on their experiences. 
Experiential learning theory highlights that reflecting on one’s experiences 
are an important part of learning, hence the workplace assessment tools may 
enhance the learning experience of the pre-registration pharmacists (Kolb, 
1984).  
5.5.6 Summary 
This study utilised the DBR approach successfully to develop a ward 
placement design that was acceptable to practitioner stakeholders from 
different disciplines at both hospitals. The design is underpinned by learning 
theory, informed by the literature and has involved practitioner stakeholders 
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at all levels of the design process to improve its chance of being 
implemented successfully. 
A 13-week longitudinal ward placement as part of hospital pre-registration 
pharmacist training represents a substantial shift away from the standard 1-3 
week ward rotations usually experienced by pre-registration pharmacists. 
Hence, in order to ensure that the placement design was feasible and 
appropriate, a prototype placement should be tested initially (McKenney and 
Reeves, 2018c). The following chapter describes the evaluation of a 
















Chapter 6 Prototype 




Chapter 5 described the process of designing the ward placement. Key 
features of the placement design such as the length (13-weeks), timing 
(middle of the pre-registration year) and activities pre-registration 
pharmacists could participate in (e.g. consultant ward rounds) were 
determined.  
Concerns regarding the introduction of a ward placement were also 
identified, which included: 
 The placement could pose a risk to patient care. 
 The pre-registration tutor would be uncomfortable leaving the 
pre-registration pharmacist to work under the supervision of nursing or 
medical teams. 
 The pre-registration pharmacist would not be able to meet the GPhC 
performance standards during the placement.  
 
Where possible, the research team tried to address the concerns raised, for 
example obtaining GPhC approval for the placement and working closely 
with nurses and doctors to design the placement. However, it was not 
possible to address all concerns raised in the design stage, since the 
placement needed implementing to determine if the concerns would be 
realised.  
This chapter describes the implementation and evaluation of a prototype 
ward placement for a pre-registration pharmacist at hospital 1. 
6.1.1  Design-based research: Prototyping 
A prototype is a smaller version of the intervention, is intentionally not 
full-scale and is often developed to test just certain elements of the 
intervention. It is not possible for all the small details of an education 
intervention to be determined in the planning stages, hence prototypes can 
be useful to help clarify certain aspects of the design; what works, what 
doesn’t and what needs to be improved (McKenney and Reeves, 2012d; 
Wensveen and Matthews, 2014). 
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Prototypes built by multi-disciplinary teams that include practitioners are 
often designed and implemented more successfully. This is because 
practitioners help to ensure the design is both feasible and achievable in the 
context it will be implemented in. Prototyping may be carried out in 
successive phases and may be used to ascertain why the intervention works 
in a particular context and what characteristics are essential or non-essential 
to the design of the intervention (McKenney, 2001; McKenney and Reeves, 
2012d). 
Evaluating an educational intervention often involves identifying ways to 
improve the intervention and assessing its overall value. Often, it is not 
possible to ascertain all the ways in which an intervention can be improved 
and what its overall value is through just one evaluation. Therefore, the 
different phases of an evaluation may be separated depending on what the 
focus of the research question is at each stage of the intervention’s 
implementation (McKenney and Reeves, 2018d). 
When carrying out an evaluation on a prototype, or intended intervention, 
alpha testing may be conducted. Alpha testing concerns the soundness and 
feasibility of the intervention design. Studies which utilise alpha testing seek 
to determine how the design is implemented through exploring the 
application of the design requirements and propositions (soundness). The 
cost of implementing the intervention may also be explored and could include 
establishing the potential financial, emotional and human resource costs 
involved in its implementation (feasibility) (McKenney and Reeves, 2018d). 
Alpha testing explores what (if any) changes need to be made to the 
intervention design or the way it is implemented. Results from alpha testing 
may reveal the need for redesign of certain elements of the intervention and 
any changes must be carried out swiftly and documented clearly (McKenney 
and Reeves, 2012d). 
This study sought to evaluate a 4-week prototype pre-registration pharmacist 
ward placement. The aim and objectives of the research were aligned with 
the principles of alpha testing the prototype in order to establish the feasibility 
of the design.  
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6.2  Aim and Objectives 
Aim: 
Evaluate how key design features of the prototype placement were 
implemented in practice. 
Objectives: 
 Establish whether the placement’s design features were suitable 
for the purposes of pre-registration pharmacists’ training. 
 Identify areas for placement redesign. 
6.3 Methods 
6.3.1 Ethical approval 
Ethical approval (service evaluation) for this study was obtained from 
University of East Anglia Research and Ethics Committee (see appendix 17) 
reference number 2017/2018 132. Local approval for this service evaluation 
to be carried out was provided by the deputy chief pharmacist at hospital 1 
(appendix 18). 
6.3.2 Prototype Design 
6.3.2.1 Ward context 
It is important that in design-based research, the local context is described in 
sufficient detail to enable the reader to draw conclusions about the 
applicability of the research findings to their own local context (McKenney, 
Nieveen and Van den Akker, 2006). 
Hospital 1 is a large district general hospital. The ward pharmacy service is 
divided into teams, who work within five specialties; acute admissions, 
medicine, surgery, oncology/haematology and older people’s medicine. 
Pharmacists and technicians are allocated to a particular team, who then 
provide services to specific wards allocated to them by the lead team 
pharmacist. Pharmacists and technicians may be required to cover several 
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wards on the same day. The teams are often comprised of senior and junior 
pharmacists with some technician support. Wards that care for patients with 
more complex needs, or wards with a higher turnover of patients, are more 
likely to have a senior pharmacist and technician allocated. 
The ward where the pre-registration pharmacist longitudinal placement (and 
therefore the prototype placement) could be held was suggested by the 
deputy chief pharmacist at hospital 1, citing a positive relationship between 
the pharmacy and the ward as the primary rationale for selecting this ward. 
The placement ward was an Older Patients Medical (OPM) ward with 28 
acute beds, both male and female. The ward was staffed by two consultants 
and a range of junior doctors graded from FY1 to registrar. The ward was 
managed by a sister who was supported by three deputy sisters and 
seventeen registered staff nurses, covering night and day shifts. The ward 
also had a discharge coordinator, ward clerk, physiotherapists and 
occupational therapists who worked regularly on the ward. 
The pharmacist who had been regularly covering the ward was on maternity 
leave, resulting in the ward being covered by a variety of other pharmacists. 
When the prototype placement commenced, one pharmacist, who was also 
the pre-registration tutor, volunteered to work as the ward pharmacist for the 
duration of the prototype placement. Dedicated ward pharmacist cover was 
approximately two hours each morning. In the afternoons, one pharmacist 
(usually junior) would cover the prototype placement ward and three other 
OPM wards. This pharmacist held a phone for the ward nurses/doctors to 
make contact if they needed medicines, discharge prescriptions or answers 
to medicine queries.  
The placement ward regularly hosted sixth form students and students from 
the nursing, medical, occupational therapy and physiotherapy professions. 
The ward leadership team, comprising the consultants and sister, had been 
established on the ward for several years.  
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6.3.2.2 Prototype placement design 
A 4-week prototype placement was developed in collaboration with 
stakeholders (pre-registration pharmacist, pre-registration tutor and ward 
sister) at hospital 1 (see table 12 for the timetable). One meeting was held 
between the researcher and these stakeholders to discuss the design and 
implementation of the prototype placement.  
During this meeting, the design for the longitudinal placement was presented 
and decisions were made about what would be incorporated into the 
prototype placement. It was agreed that the 1-week induction arranged by 
the ward sister would be implemented and the following three weeks would 
involve the pre-registration pharmacist testing all but one of the key design 
features of the longitudinal placement – the audit.  
The researcher amended the timetable accordingly and developed a 
workbook to support the placement (see appendix 19). The workbook 
contained the placement timetable and suggested activities. The intention of 
the workbook was to communicate the placement design in a practical and 
useful way to the pre-registration pharmacist and ward staff.  
The prototype placement was held in July i.e. the final month of a 
pre-registration pharmacist’s training year, after the registration assessment. 
The pre-registration pharmacist worked on the ward on Monday to Friday; 
9am-5pm with no other pharmacy departmental responsibilities such as 
dispensing or checking slots. The pre-registration tutor was present on the 
ward for approximately three hours each day to support the pre-registration 
pharmacist and available via the phone when not based on the ward. The 
additional hour of pharmacist support available during the prototype 
placement was provided to incorporate teaching and learning opportunities 
for the pre-registration pharmacist. 
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Week 1 Week 2 Week 3 Week 4 
Introductions to ward staff and 




Pharmacy Activities;  
POD, MR, Ordering 
Achieved 
competency 




Utilises Medicines Management skills to support ward pharmacist and nursing staff with patient 
discharges.  
Ward Induction  Induction  
Patient Observations  Training Conduct observations independently 
Board rounds  Attendance and reporting to ward pharmacist 
Medicines administration  Observation at lunchtime rounds Observe OM/PM round 
Self-administration of 
Medicines Assessment 
 Observation and practice  
Patient Counselling  Practice patient counselling using evidence tools to support development 
Consultant ward round  
Attendance and Observation; supporting medical team and communicating with ward 
pharmacist 
Responding to staff and patient 
Medicines information queries 
 
Practice and implement responses under ward pharmacist supervision where 
applicable 




Training and practice with ward pharmacist Implementation 
Work in the day assessment 
unit 
 Training from staff in day assessment unit 
Perform pharmacist 








Work in ED 
Patient handovers e.g. General all-purpose 
handover with medical and nursing staff 





The researcher’s reflexive account from this study is included below: 
June 2018 
Prior to the prototype placement commencing, I was still quite uncertain 
about how the placement would be implemented on a day-to-day basis. I did 
not know if the pre-registration pharmacist would be supported by the ward 
team or viewed as an inconvenience.  
I wanted the prototype placement to work well. I was confident that the 
placement design was as thorough and detailed as it could possibly be, prior 
to implementation.  
6.3.4 Study design  
Due to the need to capture rich detailed descriptions of potential 
amendments to the placement design as part of alpha testing, qualitative 
research methods were used during this study.  
The research team identified that the individuals who would be able to 
provide rich data regarding the finer details of the prototype placement, 
would be the pre-registration pharmacist, pre-registration tutor (also the ward 
pharmacist) and the ward sister. These individuals were invited, via email, by 
the researcher (HK) to participate in the evaluation since these individuals 
were well-known to the researcher. A participant information sheet and 
consent form were provided (appendix 20). 
Following the completion of the prototype placement, the pre-registration 
pharmacist was invited to participate in a face-to-face interview with the 
researcher (HK). The tutor and ward sister were invited to participate in a 
focus group with the researcher.  
6.3.4.1 Data collection 
The researcher conducted the interview and the focus group in a meeting 
room at hospital 1. Prior to the interview/focus group commencing, the 
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researcher emphasised the importance of gathering an honest and 
constructive account from each of the participants, of what happened during 
the placement. A semi-structured topic guide (appendices 21 and 22) 
explored: 
 The participants’ experience of the prototype placement. 
 How the workbook was utilised. 
 The supervision arrangements. 
 How the pre-registration pharmacist interacted with ward staff.  
The interview and focus group were audio-recorded. Written informed 
consent obtained prior to recording commencing. Participants were aware 
they were being audio-recorded for the purposes of research and that their 
identity would be anonymised.  
The researcher transferred the audio-recordings from the devices to the 
university computer, stored them in a password protected folder and deleted 
the recordings from the devices. The consent forms were locked in a filing 
cabinet in an office with restricted access.  
6.3.4.2 Data analysis 
The audio recordings were transcribed verbatim by the researcher; 
participant anonymity was preserved during the process. NVivo QSR 
International (version 11) was used to store and manage the data. 
The Framework Method was applied to the data(Gale et al., 2013). The 
framework was developed using the key features of the placement design. 
Initial codes and the participants’ corresponding ID were coded into the 
relevant design feature. A Microsoft Word® table was used to organise the 
data.  
 An inductive thematic analysis, following the six-step method was 
undertaken on the data (Braun and Clarke, 2006). Coding and theme 
generation was undertaken by the researcher (HK) whose work was checked 
by another member of the research team (JS).  
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6.3.4.3 Validation strategies 
This study used five validation strategies to confirm trustworthiness of the 
data: reflexivity, triangulation, rich descriptions, collaborating with participants 
and peer review.  
The researcher’s reflexive account highlights that she was aware of her own 
perspectives, which had partially been influenced by the collaboration with 
participants on the prototype placement design. The data could be 
triangulated through gathering thick rich descriptions from different 
participants during data collection and this analysis was checked by another 
member of the research team (JS).  
The remaining five validation strategies (disconfirming evidence, member 
checking, prolonged engagement in the field, external audits) were not used 
to confirm trustworthiness in the data.  
Due to the small numbers of participants in this study, it was not possible to 
generate disconfirming evidence. Similarly, due to the short nature of the 
intervention (4-weeks) a prolonged period of engagement in the field was not 
viable.  
Member checking and external audits were not carried out on the data. This 
level of validation of the data would have meant going beyond what would be 
expected during alpha testing.  
6.4 Results  
Three individuals were recruited to this study; the pre-registration pharmacist 
(PP), pre-registration pharmacist tutor (also ward pharmacist) (PT) and ward 
sister (WS) at hospital 1. 
6.4.1 Framework analysis 
The framework matrix is presented in table 13. The analytical framework is 
shaded in grey and results presented in the left-hand column, with the 
researcher’s recommendations for the design of the longitudinal placement 
described in the right hand column. 
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Table 13: Framework analysis  
Result Recommendation for design 
Ward induction 
During induction, PP: 
 Attended consultant ward round (PP). 
 Spent time with an infection control nurse (PP). 
 Visited a microbiology lab, only useful if interested in 
microbiology (PP).  
PP might not have needed a whole week of induction but 
appeared to enjoy it (WS). 
Longitudinal pre-registration pharmacists could spend more time 
with physiotherapists (PP). 
Consultant ward round and spending time with the infection 
control nurse to remain as part of the ward induction. 
Spending time in the microbiology lab will be removed from 
future ward inductions. 
Induction to remain 1-week long.  





Pharmacy activities; POD, MR, ordering 
PP could not balance learning on the ward with being 
responsible for carrying out all the pharmacy activities without 
support from a pharmacist (PP). 
Ideally, the longitudinal pre-registration pharmacists should be 
signed off on doing medicines reconciliations (MRs) prior to 
commencing their placement, but if they are not that could be a 
good thing, as it will prevent the trainee from being used to 
perform these tasks (PP). 
Placement design continues to emphasise that the ward 
pharmacist provides the essential pharmacy service to the 
ward.  
Placement design modified to include verbal communication 
to pre-registration tutors that where possible, the 
pre-registration pharmacists should have completed their 




PP involvement in patient discharges meant there were fewer 
failed discharges (WS).  
 
The placement design should continue to incorporate 
discharge planning as one of the main activities 





Observed patient observations taking place by healthcare 
assistants – did not perform any independently (PP). 
Placement design should be modified to remove 
pre-registration pharmacists conducting patient observations 
independently and be replaced with observation only.  
 
Board rounds 
PP attended the board round every morning, which was useful 
for him and ward staff (WS). 
Placement design should continue to include daily attendance 
in board rounds. 
 
Medicines administration 
PP observed some medicines administration, PEG tube, oral, IV 
– it was good to get an idea of how the different types of 
administration are carried out (PP). 
Placement design should continue to incorporate 
pre-registration pharmacists observing different types of 
administration such as PEG, IV, TPN, NG, as well as oral.  
 
Self-administration of medicines - patient assessment 
PP was not involved in assessing patients to determine if they 
would be able to self-administer their medicines as he was too 
busy with other pharmacy responsibilities on the ward (PP). 
Placement design should continue to incorporate 
pre-registration pharmacists supporting patients to 
self-administer their medicines where possible.  
 
Patient counselling 
PP did not counsel patients directly, but worked to ensure all the 
relevant information was communicated on the discharge letter. 
PP acknowledged that he could have got more involved in 
counselling patients (PP). 
Placement design modified to emphasise ward pharmacist 
support required to enable pre-registration pharmacists to 









Consultant ward round 
Attended consultant ward rounds most days (PP). 
Consultants were not asking many questions of PP during the 
ward rounds as they were not fully aware of what the role of a 
pre-registration pharmacist is (PP). 
Consultant ward rounds to remain part of the placement 
design.  
Placement design modified to include verbal communication 
to pre-registration tutors regarding the role of the 
pre-registration pharmacist being communicated to the 
consultants. 
 
Responding to staff and patient medicines information queries 
PP did not receive many staff or patient medication queries 
during the placement (PP). 
Responding to medication queries to remain a part of the 
placement design. 
 
Guidelines implementation e.g. antibiotic stewardship 
PP would locate and share relevant swallowing difficulties and 
other relevant trust guidance with staff (PP). 
Placement design modified to include the recommendation 
that where possible, the ‘Medicines Information’ rotation 
should take place prior to the ward placement commencing. 
Since, this is not a feature of the longitudinal placement 
design as such, this should be communicated verbally to the 
pre-registration tutors. 
 
Work in the day assessment unit 
PP did lots of MRs on patients admitted to the day assessment 
unit (WS). 
Spoke to consultants, physios, occupational therapists in the 
day assessment unit (PP). 
Working in the day assessment unit to continue as part of the 





Ward is the right place to host the longitudinal placement due to 
its calm environment under the leadership of WS (PT). 
The longitudinal ward placement will continue to be hosted on 




Therapeutic drug level monitoring – not many patients who 
needed this, so PP did not get involved (PP). 
PP attended a panel review (medicines-related meeting) with 
the ward sister (WS). 
PP supported WS to complete mandatory medicines-related 
audits (WS). 
Therapeutic drug monitoring to remain a part of the ‘additional 
activities’ aspect of the placement design. 
Continue to incorporate medicines-related meetings which the 
ward sister attends, as part of the ‘additional activities’ 
section. 
Continue to include pre-registration pharmacist supporting 




PP would liaise with WS each morning and discuss his plan for 
the day with her, she would provide additional guidance where 
necessary (WS). 
Longitudinal pre-registration pharmacists will need more 
pharmacist supervision at the start, which should then decrease 
over time (PT). 
Daily oversight of the pre-registration pharmacist by the ward 
sister, to remain in the placement design.  
Placement design modified to include verbal communication 
to pre-registration tutors implementing ward placements that 
ward pharmacist support is required more at the start of the 
placement, decreasing over time.  
 
Workbook 
The workbook was used by PP and WS during the placement 
(WS).  
A typical working day and top tips on working with the ward 
team could be incorporated into the workbook (PP). 
The workbook was proportional to what was needed for the 
placement (PT). 
The workbook will continue to be the medium through which 
the placement design is communicated. 
The workbook will be amended to include information on a 
typical working day and top tips on working with the ward 
team. 







Workplace assessment tools 
Useful for achieving evidence that is not just reflective, the 
checkboxes for meeting performance standards are good (PP). 
Uncertain of which workplace tool to apply in different situations 
(PP). 
The tools were used with doctors and nurses who were able to 
provide feedback but did not feel able to tick off the relevant 
performance standards (PP). 
No modifications necessary to the format of the workplace 
assessment tools. 
Additional guidance will need to be included as part of the 
placement design on when the different tools should be used. 
Workplace assessment tools guidance, will continue to 
recommend the tools can be completed by non-pharmacy 
healthcare professionals.   
 
Support 
Ward sister was very supportive of PP. However, she may lack 
awareness of the trainee’s competence to perform medicines 
management activities (PP). 
PT was always available to PP when needed (WS). 
Ward pharmacist is going to need to be hands-on for the first 
few weeks of the placement, they cannot just “drop in, do stuff, 
leave” (PP). 
PP was not always supported by other pharmacists in the 
department (WS).  
Pharmacy department short staffing affected the amount of 
support PP received (PP). 
Placement design will continue to have the ward pharmacist 
retaining responsibility for checking and oversight of the 
pre-registration pharmacist’s medicines-related competence. 
Placement design will continue to have a contactable ward 
pharmacist.  
Placement design will continue to have a ward pharmacist 
who spends sufficient time supporting the development of the 
pre-registration pharmacist.  
Placement design modified to include verbal communication 
to pre-registration tutors regarding the role of the 
pre-registration pharmacist being communicated to the whole 
pharmacy team. 
Not possible to amend the placement design to account for 
short staffing, but where possible, short staffing should not 







Role of the pre-registration pharmacist 
Longitudinal pre-registration pharmacists must be 
supernumerary on the ward (PP). 
The placement design will continue to recommend that the 
pre-registration pharmacists are supernumerary during the 
ward placement.  
 
Other 
The progression of activities on the ward should be gradual and 
the longitudinal pre-registration pharmacists should not be given 
too much responsibility at the start (PP). 
PP was not involved in making patient beds (WS). 
The placement design will continue to reflect a gradual 
progression in responsibility for the pre-registration 
pharmacists. 
The placement design will continue to recommend that 
pre-registration pharmacists are not involved in making beds 




6.4.2 Thematic analysis 
Six themes were identified from the thematic analysis; orientation, 
description, part of the team, behaviour, outcomes and recommendations. 
The table below presents each of the themes and associated subthemes. 










Part of the team - 




In this chapter, only the orientation, part of the team and outcomes themes 
will be presented to avoid duplication. This is due to there being substantial 
overlap between the other themes and the results presented in the 
framework analysis. 
6.4.2.1 Orientation 
The orientation theme describes the routine of pharmacists working on the 
placement ward prior to the implementation of the prototype placement. 
Pharmacists working on the placement ward worked in isolation from other 
members of ward staff and were not considered part of the ward team. It 
concerned the sister that pharmacists often appeared intentionally withdrawn 
from the ward team. 
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“…Normal ward pharmacist will never answer the phone. Phone’s ringing in 
front of them, they will let it ring because they wouldn’t know [who to give it 
to]” WS 
The absence of a dedicated ward pharmacist working on the ward in the 
afternoons to fulfil discharge prescriptions affected patients who were often 
delayed leaving the hospital as they were waiting for their medicines. When 
pharmacists did come to work on the ward, they spent most of their time 
working at the computer (NB: hospital 1 does not have electronic 
prescribing).  
6.4.2.2 Part of the team 
The importance of a good working relationship between the ward pharmacist 
and the trainee was emphasised; the trainee needed to be comfortable both 
asking the ward pharmacist questions and for additional support when they 
needed it. Over the course of the placement, trust was built between the 
pharmacist and the trainee, which led to them being given more 
responsibilities.  
“… pre-reg is… one of those you can trust and…can delegate to and…gets 
on with everything” PT 
The ward sister described how through participating in the prototype 
placement, she could now understand the vision and the rationale behind 
training pre-registration pharmacists on the ward, so that they could become 
a part of the multi-disciplinary team. 
“…at the beginning when I came into this [project] I didn’t understand at all 
what it was all about….now I can see [and understand]…I am sure at the 
other end [of the longitudinal placement] we will hopefully have another [PP] 
who will be able to work on a ward, have good skills, be able to see how a 
ward runs and that the MDT [multi-disciplinary team] of a ward is pivotal for it 
all to function…” WS 
Participants gave many examples and accounts of how the pre-registration 
pharmacist had become a part of the ward team and how this affected the 
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working practices of the staff, ultimately benefitting the patients through a 
safer and more efficient discharge process.  
“…[pre-registration pharmacist] being part of the team made, I think, the best 
part of it [prototype placement] all” WS 
Attending the board round enabled the pre-registration pharmacist to build a 
picture of the order of discharges and gather medical and social information 
regarding the patient. As the placement progressed, the pre-registration 
pharmacist built good working relationships with the consultants and junior 
doctors which led to more dialogue surrounding each patient’s medicines.   
“…[ward consultant] on the board round, if there’s a medicine thing he’ll ask 
about it, turn to [pre-reg pharmacist]. [Pre-reg pharmacist] will say ‘I’ll look at 
that’ and…they’ve quite bonded actually” SN 
The pre-registration pharmacist joined in with the social activities of the ward, 
even acquiring a fond nickname from the staff. He interacted well with the 
ward staff, made an effort to get to know everybody and had been cheerful. 
This was evidenced by the pre-registration pharmacist answering the ward 
phone and not sitting at a computer. 
“…He answers the telephone, phone’s ringing, he’ll answer the phone…he 
can take it to the [ward clerk] he knows who people are now doesn’t he? 
That’s made the difference...” WS 
6.4.2.3 Outcomes 
The pre-registration pharmacist went the ‘extra mile’ for the patients on the 
ward through facilitating discharges to happen in a timely manner, speaking 
to relatives, liaising with social workers and suggesting alternative 
formulations for patients. The pre-registration pharmacist developed a better 
understanding of complex discharges and how a pharmacist can support this 
process.  
“…Psychiatrists wanted us to do [covert administration of medicines for a 
patient]…we don’t have a…very good policy here…and [pre-registration 
pharmacist] said ‘well why don’t we try elixirs, then we can still use normal 
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medicines in elixirs?’…he [PP] went the extra [mile] to get her [patient’s] 
drugs in her…that’s something that if we had pharmacy only popping in to 
the ward we wouldn’t have [found that solution]…” WS 
The evolution of the pre-registration pharmacist from trainee to healthcare 
professional left the ward pharmacist feeling superfluous to the ward. The 
outcome which was the most beneficial to the ward staff, was having an 
accessible member of pharmacy staff on the ward all day, to address 
medicines-related queries, process orders and facilitate patient discharges. 
Ultimately, this led to the ward wanting to retain the pre-registration 
pharmacist as their regular ward pharmacist once he had qualified.  
“…I’ve asked to keep him…[PP] should be allocated to [ward] forevermore 
as my ward pharmacist…” WS 
The prototype placement resulted in the ward sister acquiring an 
understanding of how to manage the placement and how to explain the role 
of the pre-registration pharmacist to their staff; namely referring to him as the 
equivalent of a third-year nursing student. She also acknowledged that PP 
joined the ward at a much later stage in his training and that the longitudinal 
placement trainees would be working on the ward from a much earlier point 
and so would need more support from the staff.  
“this [longitudinal placement] is gonna be new…to my girls [staff nurses] cos 
they’ll all expect a [PP] won’t they? Their expectations will be high so I 
just…on my huddles [ward meetings] is explaining that…” WS 
6.5 Discussion 
6.5.1 Main findings 
The prototype placement was implemented as the design intended and the 
analysis established that the placement’s design was suitable for the 
purposes of pre-registration pharmacist training. Areas for placement 
redesign were identified and included: patient observations, induction 
activities and additional guidance for the workplace assessment tools.  
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The selected placement ward was described as being “the right ward” to host 
the longitudinal placement and the workbook was appropriate for the 
placement. The supervision arrangements between the pre-registration tutor 
and ward sister worked effectively and the pre-registration pharmacist was 
able to contribute to improving patient care. 
These results indicate that the design of the ward placement is sound and 
appropriate. Benefits for patients, the ward team and pre-registration 
pharmacists were identified. Therefore, the design for the 13-week 
longitudinal placement for hospital pre-registration pharmacists should 
progress to the next phase; implementation.  
6.5.2 Strengths and limitations  
This study only involved one pre-registration pharmacist conducting a 
4-week prototype placement on one hospital ward. It is therefore small-scale, 
only collecting data from three participants – all of whom were involved in the 
design of the prototype placement, which was extensive. This may have 
enabled the participants to implement the placement more successfully since 
they had expert knowledge of the placement and were committed to the 
project. The results generated may reflect the extensive preparatory design 
work that was undertaken and social desirability bias of the participants. 
Therefore, the results may not be generalisable to other settings where the 
participants have not participated to the same extent in the preparations of 
the intervention prototype. However, the purpose of this study was not to 
generate data that would be generalisable to other settings. Rather, the 
purpose of alpha testing the prototype intervention was to evaluate how the 
placement was implemented, establish whether the design was suitable and 
identify areas for placement redesign.   
The study aim and objectives were met, with only minor modifications 
identified for placement redesign. However, since all three participants were 
involved in the design, this may have affected their ability and/or willingness 
to criticise the placement to the researcher. The researcher endeavoured to 
account for this at the start of the interview/focus group by emphasising the 
need for honest reflective accounts from the participants.  
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The use of thematic and framework analysis to evaluate the data, 
strengthened the study since the results enable the reader to recognise 
design modifications easily whilst also providing the wider context of what 
took place during the prototype placement, revealing the positive effect that it 
had on patient care. Five validation strategies (reflexivity, triangulation, rich 
descriptions, collaborating with participants and peer review) were used to 
confirm trustworthiness of the data generated, demonstrating the strengths of 
the methods used to collect and analyse the data.  
Incorporating a 4-week placement at the end of a pre-registration training 
programme is not exceptionally different to what happens in standard 
rotational programmes where the trainee is often allocated their own ward to 
manage towards the end of their training year. Additionally, 4-week rotations 
through ward areas are not uncommon for some hospital pre-registration 
training programmes. The prototype placement failed to test two of the most 
important design features of the longitudinal ward placement, the length of 
time and place within the middle of the pre-registration year. Prototypes are 
intentionally small-scale versions of the main intervention; hence a 4-week 
prototype placement was appropriate for this stage of testing. Ideally, the 
prototype placement would have been implemented in the middle of the 
pre-registration pharmacist’s training year. However, this was not possible 
within the timeframe available, so implementation of the longitudinal 13-week 
ward placement will need to be conducted to determine the effect of these 
design features.  
The evaluation of the ward placement did not explore the feasibility of the 
prototype placement, the financial, emotional and human resource cost 
associated with implementing the placement. However, since pre-registration 
pharmacists are salaried, there was no perceived financial cost associated 
with the introduction of the ward placement. Whilst the costs of the emotional 
and human resource effort were not explored in full, there appeared to have 
been some human resource cost associated with implementing the 
placement; namely the supervision time of the healthcare professionals. 
However, it appeared that this was more than repaid in full, since the 
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pre-registration pharmacist was able to contribute to patient care on the 
ward.  
6.5.3 Design features 
The analysis established that the placement design was suitable for the 
purposes of pre-registration pharmacist training. Prior concerns, such as 
patient care being compromised, ineffective supervision and an inability to 
meet GPhC performance standards, were not realised during the prototype 
placement. This suggests these views may be unfounded. However, this 
study was small-scale and of limited duration, so it is not possible to draw 
definitive conclusions.  
Communities of practice indicates that it takes time for an individual to 
become a member and that being able to contribute to the practice of the 
community is an important step towards full membership (Wenger, 1998). 
Over the course of the prototype placement, the pre-registration pharmacist 
was able to use his knowledge and skills to support the discharge process in 
a way that was different to a traditional ward pharmacist. The pre-registration 
pharmacist’s knowledge and relationship with the ward team gave him 
access to the ward’s shared repertoire. Regular attendance at board rounds 
and consultant ward rounds enabled the trainee to participate in activities 
that encouraged mutual engagement. This culminated in him being able to 
better understand the joint enterprise of the ward and contribute to it – 
namely through supporting patient discharges. The pre-registration 
pharmacist appeared to become a member of the ward team quickly, which 
may not reflect reality. His fast-track journey to membership could reflect the 
prior relationship he had with the ward sister from participating in the 
prototype placement design discussions and that he was able to be 
incredibly useful to the ward as he was at the very end of his pre-registration 
year. It was also apparent that the ward pharmacist service prior to the 
prototype placement had been insufficient to meet the demands of the 
workload. Hence, ward staff were more welcoming and motivated to 
incorporate the pre-registration pharmacist as part of the ward team, since 
he brought valuable resource and skill to their workforce. 
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Features of the placement design that enabled the pre-registration 
pharmacist to build relationships with the ward staff included, the ward 
induction, the board round and the consultant ward round. It was important 
that the doctors were aware of the pre-registration pharmacist’s role during 
these activities and could ask questions of the trainee. 
The ward sister designed and managed the ward induction, which included 
opportunities for the pre-registration pharmacist to spend time with other staff 
members, learn their names and observe how the ward worked. The ward 
induction appeared to be an effective way to facilitate the brokering role of 
the ward sister.  
Whilst it would be useful for the ward staff (particularly the pharmacist) if the 
pre-registration pharmacists were signed-off on all their pharmacy-related 
ward competencies prior to the placement, it could result in the trainee 
performing all of these tasks and not accessing learning opportunities on the 
ward. Hence, maintaining the supernumerary status of the pre-registration 
pharmacist is important during the placement. The ward pharmacist should 
continue to provide the main pharmacy service to the ward, ensuring that the 
pre-registration pharmacists are able to access other learning opportunities, 
such as the consultant ward round.  
Notably, the need for effective pharmacist supervision at the start of the 
prototype placement was described. This enabled the trainee to take 
advantage of other activities such as attending the consultant ward rounds. 
Situated learning theory highlights the importance of the ‘master’ in training 
the ‘apprentice’ in their trade, through legitimate peripheral participation 
(Lave and Wenger, 1991). Therefore, in order for pre-registration 
pharmacists to gain the most experience from ward placements, the ward 
pharmacists will need to provide ongoing support and supervision.  
The ward sister and pre-registration tutor had a good working relationship, 
describing how they would check-in with one another regularly to discuss the 
pre-registration pharmacist’s progress. The supervisory model appeared to 
function well with the ward sister assuming responsibility for the daily 
activities of the pre-registration pharmacist on the ward and the 
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pre-registration tutor assuming responsibility for the training aspects of the 
pre-registration pharmacist’s role. It was difficult for the ward sister to judge 
the competence of the pre-registration pharmacist when he was carrying out 
pharmacy responsibilities on the ward. This indicates that the pharmacist will 
need to retain overall responsibility for oversight of the pre-registration 
pharmacists’ activities.  
The workplace assessment tools were used by the pre-registration 
pharmacist with the pre-registration tutor, doctors and nurses. The trainee 
found the tools useful and the format user-friendly. However, the need for 
better guidance on when and in which situations to use the tools was 
recommended. Additionally, doctors and nurses did not feel able to comment 
on whether the pre-registration pharmacist had met the relevant GPhC 
performance standards. Hence, the ward pharmacist may be the most 
appropriate member of staff for pre-registration pharmacists to conduct 
workplace assessment tools with.  
Patient observations were intended to be an activity that the pre-registration 
pharmacist would conduct independently. However, the prototype placement 
revealed that conducting patient observations on patients independently was 
not appropriate and that this activity should remain the responsibility of the 
nursing team. The longitudinal ward placement design will need to be 
modified to reflect this finding.  
The pre-registration pharmacist was not able to experience all of the design 
features of the prototype placement within the 4-week period. Activities which 
could not be fully experienced included: patient counselling, implementing 
Trust guidelines, working in the day assessment unit, patient’s 
self-administration of medicines, responding to medicine information queries 
and additional activities. Each of these features should be incorporated as 
part of the longitudinal placement and their inclusion in future placement 
designs determined thereafter.   
The evaluation of the prototype placement revealed improvements that 
would need to be made to the longitudinal placement design. Many of these 
improvements were small and often consisted of better communication 
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between the ward pharmacist/pharmacy department and the doctors and 
nurses, such as explaining the role of the pre-registration pharmacist to the 
ward consultants. It is important that these minor improvements are not 
overlooked and appropriate ways to communicate these are initiated. This is 
due to the fact that it is unlikely this information could be incorporated into 
the placement workbook. 
6.5.4 Summary 
The prototype placement established that the design features were suitable 
for the purposes of pre-registration pharmacists’ training and also identified 
areas for redesign. The placement was implemented as intended and 
recommendations for the longitudinal ward placement were provided. 
This prototype demonstrated that introducing a ward placement during the 
hospital pre-registration year is possible and is likely to have advantages for 
trainees. Therefore, the intervention should progress to the next phase; 















Chapter 7 Longitudinal placement 




Chapter 6 described the implementation of a 4-week prototype placement on 
an Older Persons Medicine (OPM) ward at hospital 1. Alpha testing was 
undertaken on the prototype placement to establish whether any revisions to 
the design of the placement were needed. The following suggestions for 
redesigning certain elements of the placement included:  
 Ward induction activities to reflect the practice of the trainee on the 
ward. 
 Patient observations conducted by the trainees alongside healthcare 
assistants or nurses. 
 Additional information regarding the use of workplace assessment 
tools. 
The prototype placement identified that the design of the 13-week 
longitudinal placement was appropriate for pre-registration pharmacist 
training and should be implemented. This chapter describes the 
implementation and evaluation of a 13-week longitudinal ward placement for 
three hospital pre-registration pharmacists.  
7.1.1 Design-based research: Evaluation and reflection 
The evaluation and reflection phase of DBR involves evaluating the 
intervention in order to generate data to inform the next iterative version of 
the intervention. Theoretical insights and refinements, to the intervention’s 
design propositions, may be identified to support the ongoing development of 
the intervention (McKenney and Reeves, 2018d). 
Evaluations of interventions often consist of identifying ways to improve the 
intervention and its overall value. The six foci, which are essential to the 
evaluation of educational design research, include: soundness, feasibility, 
local viability, institutionalisation, effectiveness and impact. It is not 
necessary for an evaluation to explore every focus and it is not appropriate to 
test all of these at once in the same study. Rather, studies should focus on 
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evaluating different foci at different stages of intervention development 
(McKenney and Reeves, 2018d).  
The different stages of intervention development are: 
1. Alpha testing - initial intentions (design) of the intervention. 
2. Beta testing - how the intervention is implemented in practice. 
3. Gamma testing - what the outputs/effects are. 
 
Each stage of the intervention development requires the evaluation to focus 
on identifying certain points. Alpha testing concerns the design’s initial 
intentions with the focus of the research questions centred on establishing 
the soundness and feasibility of the intervention. Beta testing explores how 
an intervention is implemented in practice, the research questions focus on 
the local viability and institutionalisation of the intervention. Gamma testing 
concentrates on the effectiveness and impact of the intervention’s outputs 
(McKenney and Reeves, 2018d). 
The evaluation of the prototype ward placement (chapter 6) explored the 
soundness of the ward placement, establishing that the proposed placement 
design was suitable for the purposes of pre-registration pharmacist training 
and the design requirements and propositions were appropriate.  
When an intervention is operating as the design intended, beta testing is 
used to focus the research aim and objectives on exploring the intervention’s 
local viability and institutionalisation. An intervention’s local viability refers to 
how and why it is able to survive in the research context. This involves 
exploring whether the intervention was implemented as designed (fidelity) or 
whether the participants changed the way they implemented it (adaptations). 
Institutionalisation describes how an intervention can become incorporated 
as part of the organisation’s practice. Participants may be asked to comment 
on the replicability of the intervention’s implementation across other settings 
(McKenney and Reeves, 2018d). 
Beta testing also explores the concept of ‘tolerance’ which describes how 
precisely specific elements (design requirements/propositions) of the 
intervention need to be implemented for the intervention to meet its 
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outcomes. If an intervention has a high tolerance this means the design does 
not need to be implemented with a high degree of accuracy to ensure the 
same outcomes. If however, an intervention has a low tolerance, in order for 
it to meet its outcomes; the design needs to be implemented according to its 
specification. Therefore, it is important that testing of specific design 
requirements/propositions of the intervention is carried out in multiple 
settings to explore which of them have a high or low tolerance (McKenney 
and Reeves, 2018d). 
Gamma testing refers to attainment and is used to determine both the 
effectiveness and impact of the intervention i.e. the degree to which the 
intervention is meeting its objectives and producing the desired change in the 
real-life context. However, it is not possible to determine the true 
effectiveness and impact of an intervention if it has not been fully developed 
and implemented in different settings (McKenney and Reeves, 2018d).  
Since this study involves evaluating the implementation of the 13-week 
longitudinal ward placement for hospital pre-registration pharmacists, the 
focus of the evaluation should be beta testing. The placement’s local viability 
and institutionalisation should be where the research questions are directed. 
Whilst these may be the central point of the evaluation, it does not exclude 
the gathering of data on the soundness and feasibility of the longitudinal 
placement (alpha testing) or the effectiveness and impact (gamma testing) 
as these will help inform the local viability and institutionalisation.  
7.2 Aim and objectives 
Aim: 
Evaluate the implementation of the longitudinal ward placement, 
investigating how and why the placement endured and produce 
recommendations for its establishment in hospital pre-registration pharmacist 






1. Describe the placement as delivered: which design features were 
implemented, how they were implemented, whether they were adapted 
and if not implemented, explore reasons why. 
2. Investigate how the placement survived on the ward and why (local 
viability). 
3. Explore how the placement might become a part of pre-registration 
pharmacist training in these hospitals and other organisations 
(institutionalisation).  
7.3 Method 
7.3.1 Ethical approval 
Ethical approval for this study was obtained from the University of East 
Anglia Research and Ethics Committee (see appendix 23) and governance 
approval from the Health Research Authority (see appendix 24).  Please be 
aware that information that could lead to the identification of participants has 
been redacted from these approvals. 
7.3.2 Placement Design  
7.3.2.1 Context 
A description of where an intervention is taking place must be produced in 
detail to enable the reader to draw conclusions about the applicability of the 
research findings to their own local context (McKenney, Nieveen and Van 
den Akker, 2006). 
Information regarding the context of hospital 1 can be found in section 
6.3.2.1. 
Hospital 2 is a large teaching hospital. The ward pharmacy service is tailored 
to the needs of the ward, resulting in some wards having ward pharmacy 
cover Monday to Friday, 9am-5pm whereas others have 2-hourly visits. Most 
wards receive pharmacy technician support; this ranges from Monday to 
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Friday, 9am-5pm, daily visits or three times per week. Pharmacy technician 
duties include both medicines reconciliation and medicines management.  
The ward hosting the longitudinal placement was suggested by the deputy 
chief pharmacist, who was also the ward pharmacist. He described the 
already established positive relationship with the senior nursing staff and 
consultants as one of the drivers for proposing this ward. 
The placement ward was an OPM ward, specialising in the care of older 
patients who had undergone operations, most frequently, for hip fractures. 
The ward comprised of 39 beds and patient’s care was managed by three 
consultants and five junior doctors. The ward was managed by one ward 
sister who was supported by a team of deputy sisters and registered staff 
nurses. Other staff included: a discharge coordinator, ward clerk, specialist 
nurse, physiotherapists and occupational therapists.  
Ward pharmacist cover was provided by the same pharmacist who spent 
approximately 2 hours on the ward each day. When not based directly on the 
ward, he was always available, via the phone, to the pre-registration 
pharmacist. There was no pharmacy technician support during the 
longitudinal placement. 
7.3.2.2 Design 
All three pre-registration pharmacists were allocated to work on the OPM 
placement ward Monday-Friday; 9am-5pm. The pre-registration pharmacists 
still attended pharmacy departmental pre-registration training during their 
longitudinal placement and continued their two-weekly meetings with their 
pre-registration tutors. They did not undertake any dispensary slots during 
the placement. All the pre-registration pharmacists had a 1-week induction 
period on the ward, arranged by the ward sisters.  
The final placement design, including the timetable (table 15), a list of roles 
and responsibilities, suggested activities and workplace assessment tools 




To facilitate the implementation of the placement, a practice management 
team at both hospitals was established, consisting of the: 
 Deputy chief pharmacist 
 Pre-registration manager 
 Pre-registration tutor 
 Ward sister 
 Ward geriatrician 
Their collective role was to:  
 Ensure that the day-to-day running and management of the 
placement was maintained. 
 Safeguard the learning needs of the pre-registration pharmacist. 
 Uphold the safety of patients and staff. 
 Implement the placement in a safe and constructive way. 
 Meet informally to update one another on the pre-registration 
pharmacist’s progress and development. 
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Week 4-5 Week 6-7 Week 8-9 Week 10-11 Week 12-13 
Learning agreement Develop plan  Review plan  Review plan  
Pharmacy Activities;  
POD, MR, Ordering 
 Work towards achieving competencies 
Conducts independently referring to ward pharmacist when 
necessary 
Discharge Planning  
Utilises Medicines Management skills and 
works with pharmacist to support staff with 
patient discharges 





Patient Observations  Observe observations by ward staff 
Pharmaceutical care 
planning 
 Training and practice Implementation to support ward pharmacist 
Board rounds  
Attendance and Observation, updates patient 
list 
Contributes if appropriate 
Medicines administration  
Observation of oral 
medicines administration 
Observation of IV medicines 
administration 
Support administration & 




 Observation and practise with pharmacist 
Conducts assessments independently, liaising 
with primary care providers on discharge 
Patient Counselling  
Orientation from ward pharmacist where pre-
reg will receive training and opportunity to 
practise 
Completion of evidence tools to support 
development of consultation skills 
Consultant ward round  Attendance and Observation; supporting medical team and communicating with pharmacist 
Responding to staff and 
patient MI queries 
 
Practise and implement responses under ward pharmacist supervision; completing Evidence 






relevant guidelines  
Training and practise 
Implementation with support 
from ward pharmacist 
Work in the day 
assessment unit 
 Observation and Training 
Work under supervision of healthcare 
professional to assist with caring for patients 
Audit  Identification of audit topic Audit data collection  Write-up Presentation 
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7.2.2.2 Recruitment to the longitudinal placement 
Recruitment of pre-registration pharmacists to each hospital was undertaken 
at a national level through the ORIEL system with neither the hospitals nor 
the research team having any direct involvement in their selection.  
Prior to commencing their training, all pre-registration pharmacists at both 
hospitals were informed about the longitudinal ward placement. Upon 
commencing their training, information sessions were held for the 
pre-registration pharmacists by the researcher. At hospital 2, a further 
information session was held by the ward. Following this, pre-registration 
pharmacists were invited to volunteer to participate in the longitudinal ward 
placement. Two pre-registration pharmacists at hospital 1 and one 
pre-registration pharmacist at hospital 2 volunteered.  
The researcher (HK) held a further information session with all three 
volunteer pre-registration pharmacists. This session provided information 
about the research process and the placement design. During the session, 
the pre-registration pharmacists were told that they could ‘opt-out’ of the 
longitudinal placement at any point and return to the rotational training 
model.  
The pre-registration pharmacists undertaking the longitudinal ward 
placement, received the same Trust induction and pre-registration tutor 
support as the non-longitudinal placement pre-registration pharmacists at 
both hospitals. Table 16 provides some information regarding the 












PRA 1 14-26 
Pre-registration pharmacist 
B 
PRB 2 23-35 
Pre-registration pharmacist 
C 
PRC 1 27-40 
 
7.3.3 Reflexivity  
DBR studies frequently engage the same person as designer, facilitator, 
researcher and evaluator (McKenney and Reeves, 2018d). In the early 
stages of developing and evaluating an intervention, it is advisable that 
researchers undertake these multiple roles as they are able to learn from and 
with participants as the intervention unfolds. The researchers will hear about 
problems, adaptations and recommendations firsthand from the participants, 
which can have a greater impact on the intervention redesign than an 
external evaluator (Nieveen and Folmer, 2013).  
Therefore, having the same individual perform all of these roles can be 
advantageous as it provides opportunities for ‘live redesign’, resulting in 
faster changes to the intervention and improved understanding for the 
researcher (McKenney and Reeves, 2018d). 
However, the risk of bias influencing the study findings is substantial as the 
likelihood of participants giving socially desirable feedback, when they know 
the designer is also the evaluator, is enhanced (McKenney and Reeves, 
2018d).  
Triangulation, early stage formative evaluations and reflexive accounts may 
help to mitigate some of this. The researcher should clearly describe their 
role and involvement in the practice context, discussing any potential 
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influence they may have had on the data (Nieveen and Folmer, 2013; 
McKenney and Reeves, 2018d). Below is the researcher’s reflexive account: 
September 2018 
Bouyed by the positive experience of the pre-registration pharmacist in the 
prototype placement, I was hopeful that the longitudinal placement would 
yield similar results. I was uncertain of exactly how the placement would 
function day-to-day, especially when the trainees were at a much earlier 
stage in their pre-registration year. However, I was convinced that we had 
done as much work as possible to prepare for the placement and was 
optimistic that the placement would be well received by the trainees and 
ward staff.  
During the design and prototype phases, I built good working relationships 
with the pharmacy staff, senior nursing staff and consultants on the 
placement wards at both hospitals. I was aware that their input into the 
design and implementation of the longitudinal placement may affect their 
objectivity and willingness to provide honest critical feedback on the 
placement. Therefore, I knew that during data collection, I would need to 
encourage the participants to be completely honest with me about their 
opinions and experiences of the placement. I would also have to remain 
objective during the evaluation, assuming the role of researcher – rather than 
designer or facilitator.  
I was aware that when it came to analysing the data, I would need to work 
thoroughly and carefully to ensure that my interpretations of the data were as 
objective as possible. Hence, I spent a great deal of time researching and 
designing my approach to data analysis in order to ensure trustworthiness. 
7.3.4 Intervening 
During DBR studies, the researcher may have to intervene in the design 
and/or implementation of the study during data collection. These 
interventions give the researcher the opportunity to unlock the learning 
potential that arises from such events, ultimately contributing to an enhanced 
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theoretical understanding (Cobb and Bowers, 1999; Barab and Squire, 
2004). 
Intervening in research studies in this way draws criticism as the researcher 
is believed to be ‘contaminating’ the research environment. Design-based 
researchers argue that these interventions produce helpful models to apply 
to other contexts in the future and are a necessary part of the process (Cobb 
and Bowers, 1999; Barab and Squire, 2004). 
Since the longitudinal placement was being implemented in the ‘real-life’ 
setting, it was necessary for the research team to build in contingency plans, 
should the researcher need to intervene during the research. The following 
plan was devised: 
During data collection, if the researcher (HK) became aware of any practice 
which could be unsafe for trainees, staff or patients, she would first report 
this to the research team. The research team would then advise whether the 
practice team at either or both hospitals need be informed of any changes 
that need to be made to the placement design or implementation.   
7.3.5 Study design 
In order to achieve the research aim and objectives of this study, the 
pragmatic philosophical approach explains that the methods used to collect 
and analyse data should be selected based on their ability to achieve these 
(Morgan, 2014; R. Johnson and Christensen, 2014a; McKenney and 
Reeves, 2018d).  
The first time an intervention is implemented, it should be evaluated both 
early-on in the process and frequently (McKenney and Reeves, 2018d). 
Qualitative longitudinal research enables interventions to be studied 
frequently as it involves collecting data from the same participants over two 
or more time points, with sufficient time intervals in-between, to have allowed 
a change to occur. This enables participants to reflect on their experiences, 
describe changes that are happening in ‘real time’ and predict what their 
experiences might be in the future (Neale, 2019a).  
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Qualitative longitudinal research studies often involve small numbers of 
participants who are interviewed within a modest timeframe. This generates 
rich data which connects time to change, enabling participants to ‘rewrite’ 
their narrative as they journey through the intervention (Holland and 
Thomson, 2009; Neale, 2019a).  
The research team identified that since the pre-registration pharmacists were 
the ones experiencing the ward placement, they were the people best placed 
to describe changes happening in ‘real-time’. Hence, the pre-registration 
pharmacists were interviewed four times over the course of this study.  
In order to triangulate the experiences of the pre-registration pharmacists 
during the ward placement, gathering data from other individuals, such as 
the ward staff and pre-registration tutors, would allow multiple perspectives 
to be explored and improve the validity of the findings (Lincoln and Guba, 
1985; Creswell and Poth, 2017c; McKenney and Reeves, 2018d). Since the 
ward staff and pre-registration tutors were not themselves experiencing the 
intervention, it was not appropriate to apply qualitative longitudinal research 
methods to these participants. Hence, ward staff and pre-registration tutors 
were interviewed once as part of this study. 
7.3.5.1 Inclusion criteria 
With respect to the 13-week longitudinal ward placement at hospitals 1 and 
2, individuals must have fulfilled one of the following inclusion criteria:  
1. Participating pre-registration pharmacist in the longitudinal ward 
placement, OR 
2. Pre-registration pharmacist tutor (educational supervisor) of the 
participating pre-registration pharmacist, OR 
3. Staff member located on a participating ward, with sufficient 
day-to-day proximity with the pre-registration pharmacist, to be able to 




On behalf of the researcher, gatekeepers (deputy chief pharmacists at 
hospitals 1 and 2) emailed participant information sheets (appendices 26 and 
27) and consent forms (appendix 28), at least one week prior to the interview 
taking place to potential participants meeting the inclusion criteria. Potential 
participants interested in taking part, responded directly to the researcher 
(HK) stating their availability to participate. A mutually convenient time was 
arranged for the interview.  
Some participants were interviewed more than once at hospital 1 as there 
were two pre-registration pharmacists completing their longitudinal 
placement on the same ward. Once participants had completed their first 
interview, the researcher obtained their consent to contact them directly 
regarding a subsequent interview. 
7.3.5.3 Data collection  
Pre-registration pharmacists 
The pre-registration pharmacists were interviewed four times over the course 
of the placement:  
 Prior to placement commencing (week 0).  
 Week 3/4/5.  
 Week 7/8.  
 After placement finished (week 14). 
A fifth interview was planned, as part of the research design, to occur 
following the end of the pre-registration year, but this did not take place. This 
was due to the large quantity of data amassed from the first four interviews. 
The research team determined that there would be little value-added from 
conducting a fifth interview with each trainee.  
A semi-structured topic guide was used at all interviews. The topic guide 
used during the week 0 interview (appendix 29) included the following 
discussion areas:  
190 
 
 Why the participant chose to do a pharmacy degree. 
 Reason(s) for volunteering for the longitudinal placement. 
 Prior work experience. 
The topic guide used during subsequent interviews (appendix 30) included 
the following elements for discussion:  
 The trainee’s interactions with the ward staff. 
 Activities undertaken. 
 Learning experiences. 
Following each interview, the topic guide was modified slightly to enable the 
researcher to follow-up on topics discussed at previous interviews. This 
helped ensure consistency with the topics discussed between the 
pre-registration pharmacists and allowed the researcher to revisit emerging 
topics as the pre-registration pharmacist progressed through their placement.  
Pre-registration tutors 
The pre-registration tutors were interviewed once per trainee at week 14 
(appendix 31). The discussion points included: 
 Support and supervisory arrangements for the pre-registration 
pharmacist. 
 Resources such as the workbook and workplace assessment tools. 
 Development of the pre-registration pharmacist. 
Staff  
The ward staff were interviewed once per trainee at week 14 (appendix 32). 
The discussion points included:  
 The staff member’s interactions with the pre-registration pharmacist. 
 The working practices of the staff members and whether these 
changed as a result of the pre-registration pharmacist’s presence on 
the ward. 





Remuneration for staff time was made to the relevant hospital trust (£25 per 
participant per interview).    
Data management 
The interviews took place in private meeting rooms located within the 
hospitals in normal working hours and were audio-recorded using two 
recording devices. Informed written consent was obtained prior to recording. 
Interviews with pre-registration pharmacists were transcribed verbatim by the 
researcher; interviews with ward staff were transcribed verbatim by the 
researcher and an administrative assistant at the UEA whose role it is to 
transcribe. All identifying data such as names were anonymised during the 
transcription phase. Another member of the research team (JS) read the first 
few interview transcripts and provided feedback and guidance to the 
researcher (HK) on how to improve her interview technique. 
Consent forms were securely stored at UEA in a locked filing cabinet in an 
office with restricted access. Audio recordings were downloaded onto a 
secure password protected UEA computer and then deleted from the 
recording device. Participant’s personal data was destroyed following the 
end of this PhD.  Research data will be destroyed after 10 years of research 
publication as per university policy. Principles of the Data Protection Act 
2018 were followed with respect to data storage, processing, and 
destruction. 
Non-longitudinal placement pre-registration pharmacists 
Following the completion of the longitudinal placements, the deputy chief 
pharmacists at both hospitals expressed a desire for a focus group to be 
conducted with the pre-registration pharmacists who had not completed the 
longitudinal placement and had undertaken the usual short block rotations as 
part of pre-registration training. The researcher (HK) obtained ethical 
approval and conducted these focus groups. However, these results have 
not been included in this thesis since this data does not satisfy the aim and 
objectives of the study.  
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7.3.5.4 Analysing longitudinal data 
Due to the added dimension of time in qualitative longitudinal research 
studies, the analysis is more complex. Capturing change over time in the 
analysis of qualitative longitudinal data can be challenging.  
This process of analysing qualitative longitudinal data is not well described in 
the literature (Grossoehme and Lipstein, 2016; Neale, 2019b). There are no 
strict rules to follow when conducting qualitative longitudinal analysis (Neale, 
2019b). The longitudinal data generated by the pre-registration pharmacists 
over the course of their four interviews requires an analytical approach that is 
bespoke and designed to ensure the aim and objectives of the research can 
be achieved.  
Therefore, the process of analysis described in this study is unique and was 
developed to ensure that readers can be confident the data presented is 
trustworthy. A pragmatic approach underpinned the development of this 
method of analysis, which drew upon the principles of trajectory analysis, 
framework analysis and abductive analysis (Gale et al., 2013; Tavory and 
Timmermans, 2014b; Grossoehme and Lipstein, 2016). 
7.3.5.4.1 Trajectory analysis 
Grossoeheme (2016)., identified that qualitative longitudinal research studies 
may be analysed using a recurrent cross-sectional or trajectory approach. 
Recurrent cross-sectional analyses focus on a change over time of the entire 
study sample at different time points. Trajectory analysis focuses on the 
personal experiences of the change over time of one person or a small 
group.  
In research that intends to compare the effect of an intervention at two 
separate time points, cross-sectional analyses would be preferred. When 
research aims to explore the experiences or processes of the change over 
time, with emphasis on the individual journey, the trajectory approach would 
be more appropriate. The research aim and objectives are used to determine 
whether a cross-sectional, trajectory or a combination of the two approaches 
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should be used to analyse the data generated (Grossoehme and Lipstein, 
2016). 
Since this study sought to evaluate the individual experience of each 
pre-registration pharmacist during the longitudinal placement, a trajectory 
approach should be applied to the data.  
Trajectory analysis involves two phases: 
Phase 1: Coding and organising of the data by time e.g. week 0. 
Phase 2: Coding and organising of the data by case      
e.g. Pre-registration pharmacist A (PRA). 
Framework analysis may be applied to the longitudinal data to facilitate its 
organisation in the trajectory approach (Grossoehme and Lipstein, 2016). 
 7.3.5.4.2 Framework analysis 
Framework analysis is recommended for analysing longitudinal qualitative 
data and generating results which contribute to the theoretical field (Gale et 
al., 2013; Grossoehme and Lipstein, 2016; McKenney and Reeves, 2018b). 
Framework analysis involves creating a framework which coded data are 
sorted into. A deductive, inductive or abductive approach may be used to 
carry out framework analysis (Gale et al., 2013; Tavory and Timmermans, 
2014b). 
Framework analysis using a deductive approach involves the research team 
creating a framework. The framework is created before coding and 
organising the data begins and is therefore, predetermined. The content of 
the framework is informed by the aim and objectives, the literature and 
theory. Once the framework is complete, the data is coded and organised 
into the sections within the framework. The deductive approach is useful 
when the research team have a clear idea of what they need to identify from 
the data to answer the research question. However, the deductive approach 
to designing a framework can fail to identify emerging themes within the 




Framework analysis using an inductive approach involves undertaking 
coding on a few transcripts. These codes are grouped into categories and 
themes. These themes determine the framework. This framework is then 
applied to the remaining transcripts. These remaining transcripts are coded 
and the data organised into this framework (Gale et al., 2013). The inductive 
approach to framework analysis is useful for strengthening or challenging 
established theories or findings elsewhere in the field (Tavory and 
Timmermans, 2014b). However, inductive approaches often involve the 
researcher approaching the research area with potentially little 
understanding of the theoretical field. This can have consequences for data 
analysis, since researchers cannot identify which data is ‘surprising’ or posit 
why this might be so. This may prevent research findings from contributing to 
the wider field (Tavory and Timmermans, 2014a).  
The deductive and inductive approaches have advantages and 
disadvantages. Importantly, neither of them lead to the creation of new 
theories, as they do not promote creative thinking, which a design-based 
research approach advocates (Barab and Squire, 2004; Tavory and 
Timmermans, 2014b). Therefore, it is necessary to identify an approach to 
framework analysis that achieves the research aim and objectives and 
contributes to the field of learning theory.  
The pragmatic philosophical notion of ‘abduction’ (an innovative process 
focussed on using unexpected research findings to develop new hypotheses 
and theories) has been developed into a methodological approach known as 
‘abductive analysis’. Through applying methods which allow researchers to 
identify and theorise about why ‘surprising’ research data has emerged, 
abductive analysis supports theory refinement and construction, thus 
enabling research data to contribute to the theoretical field (Tavory and 
Timmermans, 2014b, 2014c, 2014a). 
There is not a singular prescriptive method for conducting abductive 
analysis. The principles of revisiting the data, de-familiarising the data and 
alternative casing should be applied to methods to enable theory refinement 
and construction (Timmermans and Tavory, 2012). To conduct abductive 
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analysis successfully, the research design must link to multiple theories and 
also provide the opportunity for ‘surprising’ ‘unexpected’ and ‘negative cases’ 
to emerge (Timmermans and Tavory, 2012).  
This study sought to apply the principles of abductive analysis to the data. To 
achieve this, a framework was first created, which would allow both the 
trajectory and abductive approaches to data analysis to be conducted.  
7.3.5.4.3 The framework: phase 1 
The first phase of trajectory analysis involves the coding and organising of 
the data by time. A coding tree was created in NVivo QSR International 
(version 12) to analyse the data. Four ‘1st order nodes’ were created for each 
of the time-points the data was collected from the pre-registration 
pharmacists: 
 Week 0 
 Week 3/4/5 
 Week 7/8 
 Week 14 
To create the ‘2nd order nodes’, the principles of abductive analysis were 
drawn upon. The research aim and objectives were used to inform the ‘2nd 
order nodes’, whilst also leaving room to explore ‘surprising data’. The 
following coding tree was created: 
 Week 0 
o Implementation (objective 1) 
o Local viability (objective 2) 
o Institutionalisation (objective 3) 
o ‘Surprising’ data (which does not fit into one of the other nodes) 
 Week 3/4/5 
o Implementation 
o Local viability 
o Institutionalisation 
o ‘Surprising’ data 
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 Week 7/8 
o Implementation 
o Local viability 
o Institutionalisation 
o ‘Surprising’ data 
 Week 14 
o Implementation 
o Local viability 
o Institutionalisation 
o ‘Surprising’ data 
7.3.5.4.3.1 Data analysis 
Once the coding tree was established, the process of analysing each 
interview transcript began. PRA’s transcripts were analysed first, followed by 
PRB and PRC. The steps below describe the process of analysing the data:  
Step 1: Initial coding. 
Sections of the transcript are assigned codes which are descriptions of the 
key piece of information contained within that quote from the transcript. 
An example quote from pre-registration pharmacist A during her week 3 
interview is provided below: 
“…my favourite moment [is] watching all the drug rounds…seeing patients 
that can’t swallow…and watching them [nurses] crush them [tablets] and 
…watching someone administer insulin…this is a good learning 
moment…”A3 
This quote was given the code: A3. Drug rounds. 
The code ‘A3. Drug rounds’ tells the researcher that the quotes present in 
this code belong to pre-registration pharmacist A and were collected at the 
week 3 interview.  
Step 2: Sort code into framework.  
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The codes are sorted into the framework. The code: A3. Drug rounds was 
sorted into the node Implementation. In the coding tree in NVivo, this would 
appear as such:  
 Week 3/4/5 
o Implementation 
 A3. Drug rounds  
Repeat: This process was repeated until all twelve pre-registration 
pharmacist transcripts had been coded and the codes sorted into the 
framework.  
7.3.5.4.4 The framework: phase 2 
The second phase of trajectory analysis involves the coding and organising 
of the data by case, i.e. by pre-registration pharmacist. Another coding tree 
was created in NVivo QSR International (version 12) to analyse the data. 
Three ‘1st order nodes’ were created for each of the pre-registration 




The ‘2nd order nodes’ were intentionally identical to the ‘2nd order nodes’ in 
the first coding tree, since the research aim was the same. Hence, this 
coding tree was created:  
 PRA 
o Implementation  
o Local viability  
o Institutionalisation  
o ‘Surprising’ data  
 PRB 
o Implementation 




o ‘Surprising’ data 
 PRC 
o Implementation 
o Local viability 
o Institutionalisation 
o ‘Surprising’ data 
7.3.5.4.4.1 Data analysis  
Once the second coding tree was established, the process of organising the 
data into the framework began. The codes generated from the initial coding 
process undertaken as part of the analysis under the first coding tree were 
not changed. The codes and their corresponding quotes were copied and 
pasted from the first coding tree into the second coding tree.  
Step 3: Identify code from first coding tree.  
The example code is identified from the first coding tree: A3. Drug rounds.  
 Week 3/4/5 
o Implementation 
 A3. Drug rounds  
The node ‘A3. Drug rounds’ is copied from the first coding tree.  
Step 4: Identify the correct place to insert the code into the second coding 
tree. 
The code ‘A3. Drug rounds’ tells the researcher that the quotes present in 
this code belong to pre-registration pharmacist A and were collected at the 
week 3 interview. Therefore, since this code was generated by pre-
registration pharmacist A under the ‘Implementation’ category. In the second 
coding tree, this code is inserted as follows: 
 PRA 
o Implementation  
 A3. Drug rounds 
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Repeat: This process is repeated for all the codes generated by the first 
coding tree.  
7.3.5.5 Analysing non-longitudinal data 
The data generated by the week 14 interviews with the pre-registration tutors 
and ward staff were not longitudinal, there was only one time point. Hence, 
the first phase of trajectory analysis could not be performed on this data.  
However, these data could be coded according to the principles of the 
second coding tree i.e. by pre-registration pharmacist. A third coding tree 
was in NVivo QSR International version 12 created for the pre-registration 
tutors and ward staff: 
 PRA staff 
o Implementation  
o Local viability  
o Institutionalisation  
o ‘Surprising’ data  
 PRB staff 
o Implementation  
o Local viability  
o Institutionalisation  
o ‘Surprising’ data  
 PRC staff 
o Implementation  
o Local viability  
o Institutionalisation  
o ‘Surprising’ data  
The interview transcripts for the staff were coded and organised into the 
framework.   
7.3.5.6 Summary of analysis 
Three coding trees were created: 
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1. Time tree for pre-registration pharmacist data. 
2. Case tree for pre-registration pharmacist data. 
3. Case tree for pre-registration tutor and ward staff data.  
Trajectory analysis was applied to the longitudinal data generated by the 
pre-registration pharmacists. The process of analysing this data within the 
trajectory approach was informed by framework and abductive analysis.  
7.3.5.7 Validation strategies 
It is recommended that a research study should meet at least two of the nine 
validation strategies in order to be considered trustworthy (Creswell and 
Poth, 2017c). This study used six validation strategies to confirm 
trustworthiness of the data: reflexivity, triangulation, rich descriptions, 
disconfirming evidence, prolonged engagement in the field and peer review.  
The reflexive account of the researcher draws attention to the already 
positive working relationships that existed between her and the staff involved 
in implementing the placement. She acknowledges her prior beliefs that the 
placement would be implemented with a high degree of success because 
those involved in implementation had played a large role in the design and 
were invested in a successful outcome.  
The study design captured the views of pre-registration pharmacists and 
members of staff working on the placement ward. This allowed the data 
generated by the pre-registration pharmacists to be triangulated with data 
from the ward staff.  
Interviews with the pre-registration pharmacists generated rich descriptions 
of their experiences. Disconfirming evidence was highlighted and is further 
explored in the results and discussion.  
The researcher’s prolonged engagement in the field with the pre-registration 
pharmacists allowed them to build rapport as the interviews progressed. The 




Peer review was undertaken on the interview transcripts and data analysis 
by another member of the research team (JS) who provided assurance that 
the coding undertaken by the researcher (HK) was accurate. 
The outstanding validation strategies (collaborating with participants, 
member checking, external audits) for confirming trustworthiness of the data 
were not carried out during this study. Collaborating with participants would 
not have been appropriate during the evaluation of the longitudinal 
placement. Member checking and external audits would go above what is 
required to confirm trustworthiness from data generated during the first round 
of intervention implementation, where beta testing is informing the aim and 
objectives of the study.  
7.4 Results  
The pre-registration pharmacists who volunteered for the longitudinal 
placement came from different universities. None were undergraduate 
students at the University of East Anglia and therefore did not know the 
research team prior to commencing their training.  
Twelve interviews with three pre-registration pharmacists were carried out. 
The interviews lasted approximately 20-90 minutes. All the interviews from 
week 3 onwards lasted over an hour with each trainee. Every effort was 
made to ensure that the pre-registration pharmacists were interviewed within 
the same week as one another, but due to logistical reasons this could not 
always be arranged due to annual leave or attendance at residential 
pre-registration pharmacist teaching programmes.  
Twenty interviews with fourteen members of staff were carried out across the 
two hospitals. These interviews lasted approximately 7-30 minutes. Since the 
placements for PRA and PRC at hospital 1 were conducted on the same 
ward in a sequential fashion, some members of staff were interviewed twice. 
For the different interviews, they have been given a different identifying code. 




Due to the large quantities of data collected in this study, not all of it could be 
presented in this chapter. Hence, additional quotes have been provided in 
appendix 33 for further reference. Table 17 captures the role of the 
participant, the hospital they were based at, the week of their interview and 




Table 17: Participants in the longitudinal placement study. 








0 A0 - 
3 A3 - 
7 A7 - 




0 B0 - 
4 B4 - 
7 B7 - 




0 C0 - 
5 C5 - 
8 C8 - 








Ward sister AWS CWS 
Deputy sister  ADS CDS 
Staff nurse  ASN1 - 
Staff nurse  ASN2 - 
Consultant  ACONS - 
Junior doctor  ACMT - 
PRB 
Ward pharmacist  
2 14 
BWP - 
Ward sister  BWS - 
Deputy sister  BDS - 
Staff nurse  BSN - 
Consultant  BCONS - 
Junior doctor  BFY1 - 
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Ward pharmacist  CWP APT2 
Ward sister  CWS AWS 
Deputy sister  CDS ADS 
Staff nurse  CSN - 
Consultant  CCONS - 
 
The results have been presented by the themes within the framework. Within 
each theme, the data has been arranged in chronological order where 
applicable. In some themes, where there was variation in results between the 
pre-registration pharmacists, the data has been presented separately, by 
pre-registration pharmacist. Data from the ward staff has been interspersed 
throughout the themes to triangulate the experience of the pre-registration 
pharmacist, or in some cases, provide disconfirming evidence to that of the 
pre-registration pharmacist. The themes and subthemes are presented in 








Ward experience prior to placement 
Placement wards 
Implementation 
Placement design  
The ward pharmacist 
The ward team 
The pre-registration pharmacists 
Local viability 
Part of the team 
Enriched learning experience 
Development as a professional 
Improved pharmacy service 
Institutionalisation 
Continuation of the placement 
Preparation for the placement 
Length of the placement 
Timing of the placement 
Qualities of the ward and ward staff 
Qualities of the ward pharmacist 
Qualities of the pre-registration pharmacist 
Support and supervision 
7.4.1 Background 
The ‘Surprising data’ element to the framework was identified as the 
‘Background’ information. This theme provides an overview of each of the 
pre-registration pharmacists, their previous pharmacy experience, 
motivations for volunteering for the ward placement and some experiences of 
their rotational ward training prior to the longitudinal placement commencing. 
Additional information on the placement wards has also been provided, to 
give the reader a greater understanding of the background and context within 
which this research took place. This will help the reader to determine 
whether these results are applicable to their setting.  
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7.4.1.1 Pre-registration pharmacists  
Prior to commencing their placement, the pre-registration pharmacists 
discussed their pharmacy degree, the extent of their previous work 
experience and described some of the reasons why they had volunteered to 
participate.  
Pre-registration pharmacist A (PRA) 
PRA wanted to undertake more placements during her degree to develop a 
better knowledge of medicines, particularly around medicine administration. 
She described how not knowing the answers to medicines administration 
questions made her feel inadequate as a future pharmacist.  
PRA had previous community pharmacy experience, but always wanted to 
work in hospital pharmacy because she did not find community pharmacy 
enough of a stimulating learning environment.  
PRA’s desire to work as part of the team on a ward was the biggest driver 
behind her volunteering to participate in the longitudinal placement. Yet, she 
was worried about whether she would be useful to the ward team because 
she had not completed all her pharmacy-related competencies and did not 
want to be standing around with nothing to do during the placement.  
Pre-registration pharmacist B (PRB) 
PRB had undertaken community pharmacy summer placements but did not 
enjoy some of them because the environment had not been friendly and 
could feel isolating. PRB was attracted to the hospital setting because she 
would have the support of a team and more opportunities to interact with 
patients.  
During her degree, PRB enjoyed the clinical modules because they were 
more relevant for practising as a pharmacist. She described being able to 
learn better from doing rather than reading or listening; she identified herself 
as a hands-on learner.  
207 
 
PRB volunteered for the placement because she wanted the opportunity to 
become part of a team and viewed the placement as an opportunity for a 
unique learning experience. 
PRB did not have any concerns about the placement but described how 
pharmacists in the department were worried that she was going to turn into 
the ‘ward skivvy’ and be the ‘nurse’s slave’ when the ward got too busy. 
However, PRB did not envision that happening, since she considered there 
were too many people on the ward who had a vested interest in ensuring that 
this would not happen. 
Pre-registration pharmacist C (PRC)  
PRC had previously worked as a healthcare assistant (HCA) in hospital, 
which he described as ‘not an easy job’ and highlighted that HCAs need to 
be passionate about wanting to help people.  
PRC did not enjoy studying topics at university that were not relevant for his 
future practice as a pharmacist. PRC instead preferred clinical modules and 
placements because they gave him the opportunity to understand how 
medicines affect the lives of patients and the role of the pharmacist in those 
interactions. 
PRC volunteered for the longitudinal ward placement to learn more about 
how pharmacists can work with other healthcare professionals on a ward to 
deliver good patient care. PRC expressed concerns over the level of support 
he would receive from the ward pharmacist during the longitudinal 
placement. 
7.4.1.2 Ward experience prior to placement 
The pre-registration pharmacists described some of their experiences 
working on the wards during their rotational training before they commenced 
their longitudinal placement. They noticed that frequently, ward staff did not 
know the name of the pharmacist. Pharmacists would often only order the 
necessary medicines and carry out the medicines reconciliations before 
leaving the ward.  
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In addition, the ward pharmacists did not spend much time with the trainees. 
Once the trainees were able to order medicines and conduct medicines 
reconciliations, they were frequently assigned these tasks by the ward 
pharmacists. Once these tasks were completed, the trainees were 
encouraged by the pharmacists to study in the library or return to the 
pharmacy department to carry out dispensary duties. Hence there was 
little/no one-to-one training and support. This resulted in the trainees 
undertaking large amounts of shadowing with limited opportunities to work 
with non-pharmacy healthcare professionals and often feeling ‘in the way’ on 
the wards. Consequently, trainees focused more on seeking to acquire 
knowledge relevant for the registration assessment, rather than seeking to 
develop as a member of the healthcare team. 
“…as pre reg’s…nobody knows who we are…we don’t really know what’s 
going on… and wards are busy and when you’re shadowing, you’re 
inevitably ‘in the way’. Someone wants to get to the computer; someone 
wants to get to the notes and you’re just kind of stood there watching 
everything go on around you…” B14 
7.4.1.3 Placement wards 
Hospital 1 
At hospital 1, the ward sister and consultants had worked together for 
several years and were responsible for establishing a supportive ward 
culture. They set good examples, involving staff in decision-making, enabling 
the team to be efficient and organised with their work. PRA identified the 
ward team as being ‘pro pharmacy’ in their approach. The staff welcomed 
the pre-registration pharmacists, who felt valued by the ward staff and the 
trainees were motivated to work hard and become involved.  
APT1 was initially concerned that the prototype placement could have misled 
the nursing staff’s expectations regarding what PRA could contribute. 
However, the nursing staff appeared to recognise at an early stage of the 
placement that PRA was not at the same stage in her training as the 
209 
 
prototype pre-registration pharmacist had been and could identify some of 
her limitations.  
Hospital 2 
Similarly, the placement ward at hospital 2 was a supportive training 
environment for all types of student learners. The presence of the 
pre-registration pharmacist did not remove training opportunities from other 
learners on the ward and at no point was the ward overburdened with large 
numbers of trainees. The opinion and input of pharmacy staff was sought 
when making decisions about a patient’s care.  
“…the doctors and the consultants…they’re quite pro pharmacy. They love 
having…the pharmacy input…they’re quite keen on getting pharmacists out 
onto the wards…” B14 
Previously held assumptions that wards would be too busy and would not be 
interested in supporting the longitudinal placement were not reported. 
Rather, the ward staff were humbled that they had been nominated by the 
deputy chief pharmacist to participate in the study.  
Hospitals 1 and 2 
Both placement wards were established learning environments for trainee 
healthcare professionals, hence training was part of the ward culture. 
Notably, the pre-registration pharmacists also identified that both placement 
wards were supportive of the role the pharmacy team in the care of patients. 
The ward staff reported that the researcher prepared them well for what to 
expect, but that some of them struggled to visualise exactly how the 
placement would work and where the pre-registration pharmacist would fit in. 
However, once the placement began, these concerns appeared to fade 
away, as the trainees became involved in ward activities. 
7.4.2 Implementation  
This theme describes how certain key features of the placement’s design 
were implemented by the trainees and ward staff. The main design features 
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explored included the resources (workbook and workplace assessment 
tools), induction, board rounds and consultant ward rounds. 
The ward pharmacists heavily influenced the way the placement was 
implemented. Each trainee experienced different types of input from their 
ward pharmacist(s), leading to adaptations to the placement’s design by the 
pre-registration pharmacist. 
This contrasted to the way in which the ward teams (nurses, doctors and 
other allied healthcare professionals and staff) implemented the placement at 
each hospital, which appeared to be largely similar.  
7.4.2.1 Placement design 
7.4.2.1.1 Resources 
The workbook was used by all the pre-registration pharmacists and was 
most useful to them at the start of their placement. It helped provide an 
overview of what the placement involved and how it should be implemented. 
It was often referred to in discussions about potential learning opportunities 
between the trainees and the ward sisters. The flexibility of the placement 
design, as documented in the workbook, was a positive feature. 
However, trainees reported that the format of the workbook was sometimes 
confusing, potentially duplicating other pre-registration training resources and 
increasing their workload. PRB appeared to use the workbook as a reference 
for the placement less than PRA and PRC, citing the already heavy 
pre-registration pharmacist workload as one of the reasons for this. In 
addition, the workbook had become almost redundant by the middle of the 
placement for all the trainees as they no longer needed to refer to it for 
guidance. They had gained a better understanding of what they wanted to 
learn and who to approach regarding the different learning opportunities, so 
were able to manage this themselves, without relying on the workbook. 
The workplace assessment tools were most frequently used with 
pharmacists but also occasionally with senior nurses and doctors. The tools 
helped the trainees to achieve competence in GPhC performance standards. 
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They also reported receiving more constructive feedback when using the 
tools. Overall, PRB used the tools less often than PRC and PRA. The ward 
pharmacist for PRB (BWP) explained that he gave a lot of feedback during 
the placement, but that he and PRB did not document this in a formal way. 
The ward pharmacist and pre-registration tutor at hospital 1 supported the 
use of the workplace assessment tools, acknowledging that experience of 
using them in pre-registration training would be beneficial to the trainees 
during their diploma. 
7.4.2.1.2 Induction 
The trainees undertook a 1-week induction programme, developed by the 
ward sisters. The induction programmes included attending board rounds, 
consultant ward rounds, spending time with specialist nurses, staff nurses, 
junior doctors and the discharge coordinator.  
7.4.2.1.3 Tutor meetings 
All the pre-registration pharmacists continued to meet with their 
pre-registration tutors every two weeks throughout their placement. PRA’s 
and PRB’s tutor meetings were held in the pharmacy department and PRC’s 
meetings were held in the ward consultation room. PRC’s tutor (CPT) was 
not the ward pharmacist but chose to attend the ward to hold their meetings 
there. This provided the opportunity for CPT to gather feedback from the 
nursing staff on PRC’s performance and also enabled CPT to access ward 
resources when PRC was presenting a case-based discussion.  
During their tutor meetings, the pre-registration pharmacists continued to 
have their evidence reviewed, demonstrating they had met the GPhC 
performance standards during the placement.  
“…it’s [placement] been really helpful in terms of gathering evidence…so 
[APT1] has been able to sign me off on quite a few [performance standards] 
…the other pre-reg’s were like ‘how many have you written so far?’…I was 
like ‘I’ve got a fair few off of [placement ward]’ and they’re like ‘whoa I’m 
really struggling’ and I was like ‘well you should do [placement]’” A3  
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7.4.2.1.4 Relationship with pharmacy 
Throughout the placement, the pre-registration pharmacists stored their 
belongings in the pharmacy department, beginning their day in pharmacy 
and where possible, continuing to take lunch breaks with pharmacy staff 
members. The trainees regularly visited the dispensary to collect medicines 
for their ward and continued to invest in building relationships with the 
pharmacy team, which was important when they needed urgent items 
dispensing. They described how they tried to work effectively with both the 
pharmacy department and the ward to ensure a positive relationship with 
both departments was maintained during their placement.   
“…sometimes if it’s a late [patient] discharge I’ll just come down [to 
pharmacy], apologise and wait…or give them a hand with dispensing it…and 
then I’ll take it back up [to the ward]…and I think they’re [dispensary staff] 
appreciating it a lot more…I think it’s building a relationship with everyone” 
A7 
7.4.2.1.5 Adaptations 
Upon completing the MRs and orders on the placement ward, PRA would 
then liaise with the wider pharmacy team, visit other wards and complete 
MRs and orders there. During the first few weeks of her longitudinal 
placement, PRA was unclear of her role on the ward once the MRs and 
orders had been completed.  
This reflects an adaptation to the placement design, since the initial design 
intended for the pre-registration pharmacists to work solely on the one ward 
for the duration of the placement. PRB and PRC did not adapt the placement 
in this way.  
7.4.2.4.6 Board round 
The trainees were first introduced to the ward staff during the morning board 
rounds by either the ward sister (at hospital 1) or the ward pharmacist (at 
hospital 2). Through attending the board round, the trainees learnt the names 
of staff and gathered information regarding changes in patient’s therapy and 
213 
 
plans for discharge. The medical and social information about the patients 
enabled them to better prioritise their work on the ward and optimise 
medicines accordingly.  
7.4.2.4.7 Ward round 
All the pre-registration pharmacists attended consultant-led ward rounds; 
PRB appeared to attend these most frequently. During the ward rounds, the 
pre-registration pharmacists raised queries regarding the patient’s drug 
history and answered formulation and stock questions. Having an awareness 
of drug interactions and an easily contactable pharmacist were important for 
the pre-registration pharmacists when attending the ward rounds, since the 
consultants frequently asked the pre-registration pharmacists 
medicine-related questions. Often, they did not know the answer, but would 
always find out and report back. All the pre-registration pharmacists reported 
feeling included on the ward rounds, which the consultants tailored, making 
them more medicines focussed. The junior doctors also found the availability 
of the pre-registration pharmacist on the ward round a useful resource for 
medicines-related queries.  
“...she [PRB] was quite happy just to come on the ward rounds to be asked 
questions…and it was good because rather than phoning someone up to ask 
them a medicine question, you’ve got someone there. I challenged her a 
bit…I think she learnt a lot…we tried to involve her it was though she was a 
junior doctor…” BCONS 
7.4.2.4.8 Activity summary 
Activities the pre-registration pharmacists participated in regularly included: 
attending medicines administration rounds, answering medicines-related 
queries, carrying out audits, checking patient’s blood results and checking 
patient’s observations. As well as these, each pre-registration pharmacist 
also described unique opportunities that had arisen during the ward 
placement such as:  
 Attending surgery (PRB). 
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 Completing last offices on a patient (PRA & PRB). 
 Conducting a home visit with an occupational therapist (PRB). 
 Attending consultant ward rounds in A&E (PRB). 
 Attending consultant clinics (PRB & PRC). 
 Attending the day assessment unit (PRA & PRC). 
 Observing pre-operation assessments (PRB). 
 Cannulation (PRA). 
 Attending meetings with the ward sister (PRC). 
 Conducting antibiotic audits with the ward sister (PRC). 
Observing and participating in these clinical procedures helped the trainees 
to contextualise their knowledge and they described how things began to 
make more sense to them.  
7.4.2.4.9 Personal care 
As the placement design intended, the pre-registration pharmacists were not 
involved in providing personal care to patients; nursing staff and 
pre-registration tutors agreed this was the correct decision. The trainees 
were not placed under any pressure to provide care in this way and were 
treated by the ward staff as ‘pharmacists-in-training’.  
“…they [pharmacists] were more worried that if they [ward staff] were really 
short of nurses, they would start overstepping the line…‘Oh [PRB] can you 
just feed this patient?...’ whereas that hasn’t happened at all…they’re not 
expecting me to be a nurse…I don’t feel like the ward skivvy…” B4 
7.4.2.4.10 Routine 
By the middle of the placement, all the trainees had begun to establish a 
routine on the ward. Specific activities such as, attending the board round, 
identifying new patients, preparing discharge medicines, ordering medicines 
and communicating with the ward pharmacist, all became part of the daily 
routine of the pre-registration pharmacists, which helped cultivate a sense of 
‘belonging’. PRA and PRB appeared to thrive in their respective routines; 
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their confidence to work in a team improved, which helped better prepare 
them for independent working.  
“…when I was on [placement ward], I’d come in and I knew exactly what I 
needed to do…I knew what was coming…I really enjoyed being in the team 
and…having my place in a team” B14 
7.4.2.4.11 Knowledge sharing 
From the midpoint of the placement, PRA had begun to grasp which 
resources were important for her role on the ward. She printed out the 
relevant medicines-related guidelines from the hospital intranet and put them 
into a pack so she could continue to access them when there was not a 
computer available for her to use.   
All the pre-registration pharmacists gave examples of occasions when they 
had shared their knowledge of medicines with the staff on the ward. The 
complexity of knowledge shared evolved from the storage of medicines to 
the administration and dosing of medicines. 
The sharing of their knowledge and giving advice to other healthcare 
professionals, without first checking with the ward pharmacist, was 
acceptable if the pre-registration pharmacist had used guidance or reliable 
resources to determine the correct answer. If the pre-registration 
pharmacists were uncertain of their answer, they would contact a pharmacist 
to check that their advice was correct.  
“…in terms of giving out advice…that’s always…a grey area…so long as I’m 
using…guidelines he’s [BWP] happy for me to give that [advice] directly; 
provided I’m not just remembering it off the top of my head…” B4 
7.4.2.4.12 Self-directed time-management 
When the trainees were not carrying out pharmacy-related medicine tasks or 
seeking out training/shadowing opportunities with members of the 
multi-disciplinary team, they would spend time reading patients’ notes and 
learning about their conditions. They practised clinically screening 
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prescriptions using all the available resources to them on the ward. PRB 
appeared to have more support, than PRA and PRC, to develop her clinical 
screening skills. 
“… clinically screening TTOs quite often [BWP] asks me to look at them and I 
go through them and highlight any issues and then discuss the issues with 
him and then we come up with a plan together…” B4 
7.4.2.2 The ward pharmacist 
Each pre-registration pharmacist experienced different levels of pharmacist 
supervision during their placement. PRA was supervised by three ward 
pharmacists over the course of her placement. PRB and PRC were allocated 
just one ward pharmacist for the duration of their ward placements.  
PRA 
The first ward pharmacist who supervised PRA from weeks 1-4 of her 
placement, was a recently qualified rotational pharmacist. The recently 
qualified pharmacist covered two to three wards each morning, had a 1-hour 
checking slot in pharmacy and covered patient discharges for up to four 
wards each afternoon. Hence, he was not present on the placement ward for 
long periods of time each day and his absence was keenly felt by both PRA 
and the nurses.  
“…I feel like this [absence of a pharmacist from a ward] is when you risk 
them [ward staff] losing their trust or faith in pharmacy as a profession 
because…everyone else has done their bits and then it…comes down to 
‘why isn’t pharmacy doing their bit?’ But then if you look at the timetable and 
[ward pharmacist] is doing…101 things that can make it difficult…cos if he’s 
[pharmacist] then gone for four hours…nothing gets done in terms of 
pharmacy…that’s when it [work] piles up” A3 
The absence of a ward pharmacist for so many hours of the day, coupled 
with the lack of senior pharmacist support, was a concern for the ward sister. 
Upon completing the A3 interview, at the request of PRA, the researcher 
(HK) spoke to the ward sister (AWS) to discuss her concerns regarding the 
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lack of senior pharmacist support. Following this conversation, the 
researcher discussed this matter with the deputy chief pharmacist who then 
arranged for the education and training lead (also PRA’s tutor (APT1)) to be 
allocated as the ward pharmacist for weeks 5-8 of PRA’s placement. APT1 
had a good relationship with AWS and shared the supervision and training of 
PRA with AWS. APT1 enjoyed the experience of having dedicated time to 
provide training opportunities for PRA. As an Advanced Clinical Practitioner, 
APT1 also used his additional knowledge and skills regarding diagnosis and 
clinical assessment of patients to enhance the educational experience for 
PRA.  
During week 8 of PRA’s placement, APT1 left the hospital Trust to seek 
employment elsewhere.  A band 7 rotational pharmacist was allocated to the 
placement ward for the final weeks of the placement. PRA’s new 
pre-registration tutor (APT2) grappled with trying to provide education and 
training opportunities for PRA during the final weeks of her placement, whilst 
managing other responsibilities. 
“I think she [PRA] could have done with a bit more support from a senior 
pharmacist, a lot of the time it does seem like she’s on her own…I 
know…they’re [pharmacy] quite stretched, but maybe a little bit more input, 
someone…checking and supporting her…she obviously has questions and 
things she needs to ask people. It’s a bit difficult when you’re on your own 
and you’ve got…lots of people on the ward…asking her lots of things…” ADS 
PRB 
The ward pharmacist for PRB, (BWP) held senior pharmacy departmental 
roles in addition to acting as the ward pharmacist for the placement ward. 
PRB described how at the start of the placement, BWP had been on the 
ward almost all day for at least the first week. Over time, BWP’s presence on 
the ward decreased in line with PRB’s development. PRB enjoyed the 
process of acquiring more of this independence and felt as though it 
happened in a natural and safe way, as BWP continued to oversee her work. 
This enabled PRB to have the freedom to make decisions and mistakes in a 
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controlled and safe way, thereby gaining more confidence and 
independence. 
BWP endeavoured to tailor the training he provided according to the type of 
learner the pre-registration pharmacist was. He observed PRB, discussed 
patients, frequently asked her to explain the rationale behind her 
decision-making and asked her to prioritise the patients in order of urgency.  
“My approach, is…it depends on your student… probably the old-fashioned 
way…see one, do one, teach one… I would get her to look into things and 
report back...” BWP 
BWP encouraged PRB to participate in the learning opportunities that arose 
from close working alongside staff, such as ward rounds and clinics whilst 
BWP completed the pharmacy-related tasks e.g. MRs and To Take Out 
discharge medicines (TTOs). This was in contrast to PRB’s prior experience 
of ward placements in the rotational model, where a large proportion of her 
work involved conducting MRs whilst the pharmacist screened prescriptions 
or participated in discussions with the ward team. As PRB acquired more 
independence towards the end of her placement, BWP came to the ward 
less, usually only mid-morning to check her work. PRB would do all the 
preparatory work and attend the ward meetings, then communicate with 
BWP via phone, which prescriptions he needed to screen and check. The 
increased responsibility she acquired was gradual and natural.  
BWP enjoyed ‘acting as a consultant’ during the placement, training PRB 
and observing her development. This model worked effectively for both, 
allowing PRB to be working almost independently on the ward by the end of 
the placement, with little input from BWP. 
“…I am used to being like a consultant…In a sense that she [PRB] would do 
the med recs, she would report back. I got her to do basically the duties of a 
band 6 pharmacist…she would be able to ring me up and say ‘Mrs X is now 





The ward pharmacist for PRC, (CWP) held several senior pharmacy 
departmental roles. CWP was acting as maternity cover for the lead 
pharmacist in OPM and a few weeks prior to PRC’s placement, had been 
promoted to a senior role within the pharmacy department. She was 
promoted within the hospital, so at the time of PRC’s longitudinal placement, 
CWP was effectively performing three roles: her pharmacist responsibilities, 
OPM maternity lead cover and a senior departmental pharmacy role. In 
addition to these, CWP was also in the process of undertaking her 
independent prescribing course during the longitudinal placement and acted 
as the ward pharmacist for up to three wards on any given day.  
At the beginning of his placement, CWP worked closely with PRC and 
encouraged him to complete a number of workplace assessment tools and 
tested his clinical knowledge regularly. She was a consistent presence on 
the ward and when not working on the ward directly, was always available 
via the phone.  
CWP would observe PRC carrying out certain tasks on the ward initially, then 
over time PRC began carrying out more tasks independently. This allowed 
him to ‘practise being the pharmacist’, knowing that his work was still being 
checked.  
Further into the placement, PRC struggled to access some of the learning 
opportunities due to the number of responsibilities CWP was juggling.  
PRC’s hard work and valuable contribution, whilst CWP was undertaking her 
prescribing course, had not gone unnoticed. CWP had made a point of 
thanking him for his hard work, which helped PRC to feel valued and 
appreciated in his role on the ward.  
“…it’s [pharmacy department] been really short [staffed]…this week she’s 
[CWP] had other commitments…but…she was saying…that …she’s happy 
with…how I’m progressing and she actually said ‘thank you’ for my help this 
week which…is good to hear…positive feedback makes me feel like a valued 
member of the team…” C8 
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However, due to extreme short staffing in the pharmacy department at 
hospital 1, from week 8 onwards there was little one-to-one pharmacist 
support. This affected PRC’s ability to attend the board or ward rounds as he 
did not have time to attend, since he needed to carry out the MRs, orders 
and TTOs.  When CWP could attend the ward, there was no time for 
one-to-one teaching or training. PRC’s development appeared to freeze 
when the pharmacist support was withdrawn. 
“…initially it was good, we [CWP and PRC] were seeing new patients 
together…we would look at blood results, I’d attend board rounds… so it was 
really good…the first 6 7 8 weeks…there was a lot of education and 
training…it was really going well until the pharmacist involvement started 
to…decline…” C14 
The ward sister (CWS) was concerned about the staffing levels in pharmacy 
and the extent to which PRC had been practising on the ward independently 
by taking on additional roles to cover the vacancies. CWS acknowledged that 
she could not assess whether or not PRC was competent and capable 
enough to be left to manage the ward on his own, from a pharmacy point of 
view. CWS believed that PRC was not supported enough by the pharmacy 
department during this time.  
Despite this, CWS did not find that the lack of pharmacist support affected 
PRC’s ability to interact and work within the ward team. CWS turned the lack 
of support into a positive regarding PRC’s professional attitude and how well 
he was coping. PRC’s tutor (CPT) and the ward pharmacist (CWP) were 
unaware of the ward sister’s (CWS’) concerns regarding the lack of 
pharmacy support.  
However, the deputy sister (CDS) reported that PRC had been supervised 
appropriately by the pharmacy department. She believed he had a better 
support system of pharmacists around him than PRA had experienced, 
which enabled him to have more dedicated time to learning rather than just 
providing a pharmacy service to the ward.  
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7.4.2.3 The ward team 
Hospital 1 
The ward sister (AWS, CWS) checked in on an almost daily basis with the 
pre-registration pharmacists to find out how they were doing. She provided 
access to learning opportunities on the ward through liaising with the relevant 
staff. She made a concerted effort to ensure that the learning experiences of 
the pre-registration pharmacists was prioritised. She took steps to prevent 
the pre-registration pharmacists from being used solely in a service delivery 
role by both the pharmacy department and the ward.  
“…in the afternoons [AWS] always says to me ‘…if you’ve got pre-reg 
reading to do, just make sure you prioritise and do that’. So, she always 
makes sure that you’re on top of everything and on top of your learning that 
you’re not just there to do a job and go home…” A14  
Hospital 2 
PRB and the ward sister (BWS) would check-in with each other every day to 
establish PRB’s routine; the ward pharmacist (BWP) was the first person 
PRB would approach with any questions. Since PRB had been introduced 
properly to the ward team by the pharmacist, the ward staff believed this 
made it easier for her to integrate into the team.  
Hospital 1 and 2 
For all three pre-registration pharmacists, it appeared that the importance of 
the ward sister and pharmacist in introducing them to other members of staff 
and providing opportunities for them to get involved, lessened over time. This 
was due to the ability of the pre-registration pharmacists to access other 
members of staff on the ward directly to seek out opportunities to work 
together. 
“…because of the…communication I had with the doctors, I was then able 
to…have a conversation with them about changing things on drug charts or 
having a look at bloods and…amending medications” A14 
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7.4.2.4 The pre-registration pharmacists 
PRA was described as friendly, eager and likeable by the ward staff. Despite 
the early stage of her pre-registration training, she worked hard and fitted 
into the team well, using her initiative to support the ward and patients. She 
gathered evidence independently on the ward and was keen to learn.  
PRC was described as willing to help, keen to learn, approachable, 
professional and friendly. He was reserved and appeared shy, but this did 
not affect his ability to embed into the ward team and build good 
relationships. His regular presence on the ward helped and he positioned 
himself in an area close to the ward team, rather than in a secluded spot, 
where some pharmacists preferred to work.  
PRB was self-motivated, professional, approachable, capable and 
enthusiastic. She frequently went the ‘extra mile’ for patients, demonstrating 
compassionate care and a desire to work hard. She was aware of her 
limitations, keen to learn, prepared to grasp every opportunity and do the 
absolute best she could.  
7.4.3 Local viability  
Local viability describes how and why the longitudinal placement survived as 
an intervention during its implementation on the hospital wards. Over the 
course of the placement, each pre-registration pharmacist identified 
themselves as becoming part of the ward team. Becoming part of the ward 
team afforded the trainees a richer learning experience, the opportunity to 
develop their professional identity. This led to the placement wards stating 
they had received an improved pharmacy service. 
Membership in the ward team led to benefits for trainees, ward staff and 
patients, all of which contributed to ensuring the longitudinal placement did 
not just survive, but rather, thrived in this research setting.  
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7.4.3.1 Part of the team  
Learning the names of the ward staff was an important first-step for the 
pre-registration pharmacists in becoming members of the team, as this 
allowed them to initiate small interactions and begin conversations. Later, the 
trainees were included in troubleshooting conversations with the doctors and 
nurses. There was no longer a perceived professional barrier between them.  
“…I feel like once I’ve been on a ward round with them [doctors] and I’ve had 
a conversation…there’s more of a working relationship there … [having a] 
normal interaction ‘oh can you just grab the notes?’…breaks down that 
[professional] divide, cos you’ve had an interaction. You have spoken to 
each other, it’s literally as simple as that” B4  
The first four weeks of the placement were the most important for 
establishing good working relationships and the board rounds helped the 
trainees to do this. However, these relationships were not fully formed after 
just four weeks, as the trainees’ unease in approaching the ward staff with 
queries was still evident. PRC was annotating drug charts with prescription 
queries, rather than speaking to doctors and insisting that nurses adhere to 
the strict 4-hour TTO notice time for patients who required medication 
compliance aid dispensing.   
Gradually, this began to change as the staff began to interact differently with 
the trainees because of their continuous presence on the ward. Initially, the 
nurses took an authoritarian approach with PRA, giving her strict instructions 
as to what they needed her to do. But by the midpoint of her placement, the 
nurses were involving PRA in the decision-making process, seeking her 
opinion, rather than dictating to her.  
From the midpoint of their placements, the ward sisters had allocated the 
pre-registration pharmacists as supervisors to students from other healthcare 
disciplines. The trainees enjoyed this experience and it helped them develop 
their interpersonal skills and acquire evidence in support of meeting the 
GPhC performance standards.  
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The trainee’s continuous presence on the ward, over a number of weeks, 
enabled them to undertake more useful tasks. This helped the trainees feel 
as though they were contributing to the work of the ward and were part of the 
ward team. The trainees were able to better understand the roles and 
responsibilities of each healthcare professional. The pharmacy-related tasks 
which the doctors needed to complete, such as MR queries, were actioned 
more swiftly. The ward staff preferred having the consistent pharmacy 
presence on the ward. 
“…she [PRB] fitted in extremely well, and the ward…embraced her…she 
very soon become part of the team, so they all miss her…I might be out of 
job (laughter), cos they might prefer [PRB] to me. Cos [PRB] was always 
there and I’m not there that much…” BWP 
All the trainees identified becoming a part of the team by the end of their 
placement. PRB identified becoming a part of the ward team the earliest, 
followed by PRA and then PRC. One of the ways the trainees knew they had 
become part of the ward team was when they were able to participate in the 
social conversations.  
“…we [ward staff and PRC] just have a chat really about pretty much 
everything from football…[to] Neighbours… and I think that’s one way that 
kind of helped me immerse in the team…they don’t see me like an outsider, 
they see me as part and parcel of the team…” C14 
By comparison, the feeling of ‘non-membership’ within ward teams, was a 
common experience when the pre-registration pharmacists described their 
previous short ward rotations. Hence, becoming part of the ward team during 
the longitudinal placement was an important achievement for the trainees.  
“…I didn’t feel like I was ‘in the way’ on [placement ward] which was quite 
nice…cos they [ward staff] all knew who I was and they knew why I was 
there and I was always around…I felt like I had a place on the ward and I 
fitted into the team…’” B14 
225 
 
Despite becoming members of the ward team during their placement, the 
practice of the senior ward staff did not change as a result of the 
pre-registration pharmacist’s presence.  
“ …we [ward staff] went along with our everyday normal practice…” BDS 
7.4.3.2 Enriched learning experience 
The trainees described how they learnt more during the longitudinal 
placement than during their degree or short ward rotations. They attributed 
the opportunity to learn more from having established membership within the 
ward team. The placement gave the trainees a better understanding of how a 
ward functions and the roles of the different members of staff. Attending 
board rounds, ward rounds and medicines administration rounds were the 
main activities that provided a richer understanding of the ward context. 
Through regular attendance on the ward rounds, the trainees were able to 
build a better clinical picture of their patients. Becoming part of the ward 
team enabled PRB to learn the prescribing habits of the consultants. 
“…one consultant…stops them [certain medicines] in every patient…I know 
certain drugs [he] will…always stop…it [this knowledge] makes me feel more 
useful on the ward…it’s better to be part of a team because I feel like I’m 
learning a lot more…” B7 
The ward rounds were identified as one of the most useful learning 
experiences, since the consultants often incorporated teaching and learning 
opportunities for the pre-registration pharmacists. Trainees were often asked 
medicines-related questions by the consultants during ward rounds, which 
helped them to learn. The consultants enjoyed interacting with the 
pre-registration pharmacists and engaged them in clinical decision-making.    
“… his [ACONS] ward rounds really good…cos he…doesn’t just leave you 
there…to sit and watch…he asks questions ‘…so…from a pharmacy angle, 
look at this drug chart, what do we need to do?’…so it gets you 




The consultants were viewed as approachable by the staff and students on 
the ward, which helped create a more inclusive learning environment. The 
consultants would occasionally take the trainees to different wards to learn 
about different medicine or patient groups. Hence, membership in the ward 
team resulted in the pre-registration pharmacists being offered learning 
opportunities beyond those immediately available on the ward.  
PRB and PRC were offered the opportunity to attend consultant clinics. This 
enabled them to observe the consultants take a different approach to 
decision-making and problem solving. BCONS believed that through 
attending his clinics, PRB would be better equipped for making decisions and 
advising doctors on the deprescribing of medicines in the future.  
Opportunities for sharing knowledge and training opportunities were not 
limited to the consultant ward round or the clinic. All the pre-registration 
pharmacists described instances when they would interact and learn with the 
doctors, nurses, physiotherapists, occupational therapists and discharge 
coordinator in a non-ward-round setting. Interacting with different healthcare 
professionals helped the trainees to understand the wider picture of a 
patient’s care and treatment.  
“…sometimes we’ll [foundation year doctors and PRA] sit down and have a 
chat about what we’ve seen…so they’ve been able to explain to me how 
ECGs are supposed to be read and [ACONS] was showing me how you look 
at a chest X-Ray, a knee X-ray and the different conditions like osteoarthritis, 
osteomyelitis different things like that...” A7 
Building friendships, as well as positive working relationships, with the ward 
staff, facilitated other learning opportunities. The junior doctors would support 
the trainees in their learning about medicines, explaining different clinical 
conditions and treatment pathways from the medical perspective. By the 
middle of her placement, the ward staff were inviting PRA to participate in 
medicine-focussed activities on the ward. The pre-registration tutors 




“…there’s more that we [pre-registration tutors] could contribute in…greater 
depth in a prolonged period [on a ward]…what I liked about it the most, it 
has…certainly improved…their learning…” APT1  
All the pre-registration pharmacists reported that one of the most profound 
things they learnt on the ward was that it was ‘ok’ for them admit that they did 
not know the answer to a question, but that they would look it up and get 
back to the staff. Initially, they felt under pressure to get things right, but 
gradually learnt that it was ‘ok’ to look things up and check first. Each time 
the trainees had to look up an answer, they learnt and remembered the 
answers for the next time they were asked the same question. They were not 
just completing tasks and ‘ticking boxes’ during the placement. 
“…I think I’m a lot more prepared now [for the registration assessment]…cos 
of the placement and just being exposed to different conditions 
and…treatment options constantly…being on the ward…you’re forced to 
learn cos it’s there in front of you” A7 
The application of their clinical knowledge also improved as the trainees 
gained a more in-depth understanding of each patient, their clinical 
conditions and treatment plans. The opportunities for reflecting on their 
practice, to consolidate what they had learnt, was also easier during the ward 
placement because of the supportive learning culture on the wards. The 
improved application of knowledge increased the trainees’ confidence and 
willingness to be involved in the decision-making process because they were 
no longer memorising information to learn for the exam. Rather they were 
learning from their experiences of how to treat patients in a holistic manner. 
“…prior to my ward placement…I knew the names of medications but…[not] 
how to apply them. Whereas now…I feel like I know…because I’ve been on 
the wards…I feel a lot more confident …because I have that experience to 
back up what I say…I feel like it’s…triggered me…not to just sit there and 
read things out of a book, which I think the other pre-reg’s are doing because 
they haven’t had that clinical face-to-face.” A7 
As well as identifying occasions and opportunities for sharing knowledge on 
the ward, such as through the consultant ward round, clinics and building 
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good relationships and friendships with the doctors, the pre-registration 
pharmacists also identified barriers to learning during the placement. This 
centred on the absence of the ward pharmacist, which inhibited PRA and 
PRC from accessing pharmaceutical knowledge and the multi-disciplinary 
team activities.  
PRA acknowledged that when APT1 was working with her on the ward, the 
learning opportunities she was able to experience increased exponentially 
because of his presence. Similarly, BWP’s approach to training and wealth of 
experience meant that the learning opportunities he could provide were rich 
and varied. Due to the longitudinal nature of the placement, he was also 
more prepared to invest in effectively training PRB from the beginning of her 
placement.  
“I’m learning a lot because he [BWP] is so pro, like ‘this will be a success’. 
He’s [BWP] properly teaching me. Cos I think it’s quite easy…for a lot of 
pharmacists to be like ‘ok you just see the new patients and do their meds 
rec’…but you almost just become a med history machine…whereas [BWP] is 
very conscious [that doesn’t happen]…” B4 
Under the pharmacists’ supervision, the trainees could amass more 
responsibility, practise making decisions independently and have someone 
with whom they could discuss pharmaceutical issues. It was important for the 
ward pharmacist to prioritise the trainees’ learning experience on the ward 
and not use them exclusively to provide a pharmacy service.  
The longitudinal placement reduced the trainees’ exposure to other 
specialties in the hospital as they were unable to rotate through as many 
clinical areas. Yet the trainees did not feel disadvantaged by this since they 
were learning more during the longitudinal placement, than during their short 
ward rotations.  
7.4.3.3 Development as a professional  
During the placement, the ward staff grew to trust the trainees. This resulted 
in the trainees being given more responsibilities on the ward. Upon becoming 
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members of the ward team, the trainees were also able to establish their 
identity as future pharmacists and they grew in confidence. 
7.4.3.3.1 Trust and responsibility 
Over the course of the placement, the pharmacist, nurses and doctors grew 
to trust the trainees, resulting in them being given more responsibilities. 
Towards the end of their placements, the trainees were often left to carry out 
the pharmacy-related activities alone, which were then checked by the 
pharmacist. The trainees were trusted by the ward pharmacists to escalate 
their concerns and get in touch with them regarding any uncertainties. The 
nurses regularly observed BWP questioning PRB on her clinical knowledge, 
which reassured the nurses that PRB’s knowledge was sufficient for her to 
practise more independently over the course of the placement.  
“…a couple of weeks before she [PRB] left, [BWP] almost used to…leave her 
to…do the job…I think he felt he had the ability to trust her…she was still 
supported but she was also working independently in the realms of what she 
could do within her scope of practice as a student” BWS 
This gave the staff confidence that they could trust the trainees to answer 
medicine-related queries correctly, adding to the pre-registration 
pharmacists’ responsibilities and reinforcing their sense of belonging to the 
ward team.  
“…a lot of his [PRC’s] evidences reflect…quite a lot of responsibility…on his 
behalf. So, I think that’s really good…we sort of thrust him into the action and 
I think that prepares him more for once he’s qualified…” CPT 
A symbol of the trust that was developing between PRC and CWS was a key 
to the ward drug cupboards, an indicator to PRC that he was entering into 
membership within the ward team.  
“…[ward sister]…gave me a key [to the drug cupboards] …apparently…other 
pharmacists, they’ve been asking her but she never gave them one cos they 
keep breaking it. So I went and asked her nicely…[and] she’s given me one 
[waves key]” C8 
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The growing levels of trust culminated in the trainees’ undertaking more work 
independently, which was second checked by the pharmacist. This allowed 
the trainees to make mistakes in a safe way and learn from them, thereby 
improving their confidence.  
7.4.3.3.2 Establishing an identity 
At the start of their ward placement, PRA and PRC described how the ward 
staff at hospital 1 were not fully aware of their role. This caused some 
concern for the pre-registration pharmacists when they were asked to 
perform certain tasks, which lay outside of their competence. Comparatively, 
PRB did not experience as much uncertainty over what her role on the ward 
involved. The nurses treated PRB as a pharmacist but understood that there 
were certain things she could not do because she was not yet qualified. It 
was important to the pre-registration pharmacists that the ward staff 
understood the limitations of their role on the ward. This helped the trainees 
to feel more relaxed. It also ensured safer practising as an unregistered 
healthcare professional. 
“…[if] people around you know your limitations…you don’t really…feel 
pressured…they know that they’ll have to wait for 10 minutes…they’re not 
breathing down my neck expecting me to give them the answer…” C8 
By the midpoint of the placement, the ward staff understood PRA’s role; that 
she was not a qualified pharmacist. But at the same time point, not all staff 
understood PRC’s role, which left him feeling as though his identity had not 
been fully established.  
“…[I am] ‘establishing’ [an identity on the ward]…if you…ask me in 2 weeks’ 
time, it’ll probably be a different answer…it’s still ongoing…not everyone is 
crystal clear as to my limitations…you still get the odd nurse 
that…shrugs…when you tell them ‘no I can’t do this’…I think I’m 
establishing…it’s loading [draws circle in the air], identity loading…” C8 
Due to PRC working for extended periods independently, the ward staff’s 
ability to fully grasp PRC’s ‘pre-registration’ status was affected. The ward 
sister and deputy sisters had to continuously remind staff that he was a 
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pre-registration pharmacist. Despite this, by the end of the placement, 
enough staff on the ward appeared to understand PRC’s role for him to find 
his identity had been established.  
7.4.3.3.3 Confidence and independence 
The trainees rarely had the opportunity to build relationships with patients 
during their rotational training. This was due to the trainees only being 
present on the ward for short periods of time, during which, they only briefly 
interacted with patients. The trainees’ confidence to interact with patients 
grew and was attributed to the length of the placement. 
“…toward the end and midway he [PRC] seemed to be more confident with 
working independently…he would refer less to me…and he…[took] more 
clinical initiatives in providing pharmaceutical care for the patients; having 
more confidence by having stayed on the ward for a while and knowing what 
to do already.” CWP  
Establishing a routine on the ward helped the pre-registration pharmacists to 
become more independent; it made them feel like a healthcare professional 
and not a trainee whose priorities were only aligned to the GPhC registration 
requirements. This reinforced the trainees’ perceptions that they were part of 
the ward team.  
The ability to think for oneself and practise decision-making independently 
was important for the trainees’ professional development as they cultivated 
their own individual practice and transitioned from student to healthcare 
professional. The transition of PRC into an independent practitioner was 
identified by the quality of evidence he was producing.  
“the evidence is stronger…once he got onto [placement] ward because he 
got given a lot more responsibility, a lot more independence. So instead of… 
‘I saw’ or ‘I witnessed’ or ‘I watched’…or ‘I helped’…[it’s now] ‘I did this’,  ‘I 
spoke to this person’, ‘I confirmed this’… it’s…taking that next step really. I’d 
like to think some of it might have been…[because] you’re given a fixed 
place for 13 weeks…” CPT 
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7.4.3.4 Improved pharmacy service 
Membership within the ward team enabled the trainees to offer a more 
responsive pharmacy service to the wards. This supported the local viability 
of the placement because the trainees were able to become useful members 
of the ward team and make valuable contributions to patient care, the most 
notable of which was the proactive discharge service.  
7.4.3.4.1 The pre-registration pharmacist service 
The ward staff described the pharmacy service they received prior to the 
placement, as mainly conducting MRs and transcribing orders. Since they 
were not considered part of the ward team this precluded the pharmacists 
from learning about and being able to contribute more to patient care. This 
also led to poorer joint decision-making as consultants were less likely to 
trust the prescribing advice of a pharmacist they did not know or work with. 
“…I think when pharmacists are [reviewing medicines]…they need to be able 
to be look at that [prescription] and going ‘that drug’s rubbish…’ and at the 
moment that’s not happening. Partly that’s…[because] they do not have the 
time, partly that’s [because] they have no idea…who I am…If [BWP] phones 
me up, I listen to him. But if I’m on another ward...you [consultant] get a 
phone call from someone [pharmacist] you’ve never met before…you’re less 
likely to get a good decision” BCONS 
By comparison, the all-day presence of the trainees meant that they were 
able to support all the medicines-related activities, providing more 
person-centred advice and medicines optimisation for each individual patient.  
“…when you get people [pharmacists] that just come up for the day, they 
don’t understand…but they’re [pre-registration pharmacists] 
ward-based…they’re forward thinking about discharges…it’s their ward so 
it’s their priority to make sure that they’ve got everything up and 
ready…there’s a different way of thinking…I think it works much better this 
way…and I think she [PRA] feels like she belongs here…it’s like coming 
back home all the time…” AWS  
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Due to the pre-registration pharmacists having a greater understanding of 
the ward environment and its demands, they devised ‘workarounds’ to 
bypass some of the pharmacy rules regarding how quickly, or in what order 
medicines were dispensed for patients. When urgent items needed 
dispensing, the trainees used creative ways to ‘bypass the queue’ in the 
dispensary and obtain the medicines their patients needed. The trainees 
empathised with the challenges faced by the nurses regarding delays in 
acquiring medicines, preparing discharges, or contacting a pharmacist. 
The ward staff benefitted from these ‘workarounds’ the trainees introduced 
and the consistent availability of the pre-registration pharmacists to answer 
questions and acquire urgent medicines. The trainees acted as effective 
intermediaries between the doctors, nurses and the designated ward 
pharmacist, enabling any medication or prescription queries to be identified 
and resolved more efficiently.  
The longitudinal placement gave the pre-registration pharmacists a context in 
which they could practise being a pharmacist. They were able to learn how 
and where the role of the ward pharmacist was on the placement ward and 
reflect on what kind of ward pharmacist they wanted to be. The presence of 
the pre-registration pharmacists reduced the workload of the ward 
pharmacists, who also enjoyed the experience of training and supporting the 
pre-registration pharmacists to develop during the placement.  
“…[PRB] was a constant presence on the ward…from my point of view…I 
benefitted tremendously and [placement ward] has, because she…knew the 
patients and can answer a lot of questions” BWP 
Overall, the longitudinal placement led to the ward receiving a pharmacy 
service that was beneficial to the pre-registration pharmacists, the ward staff 
and the patients.  
“…it’s [the placement] mutually beneficial, from our perspective you have a 
pharmacist presence on the wards on a regular basis, and for a longer 
period, and that can benefit us in many ways, seeking information, ensuring 
we have the necessary medication available on time…it greatly enhances 
the discharge process…from their [trainee] perspective…it’s a positive 
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learning experience for them. So I feel that’s why it benefits both of us” 
CCONS 
7.4.3.4.2 Patient care 
The pre-registration pharmacists sought to model their practice on the 
behaviour and attributes of the ward team, which changed the way they 
contributed to patient care. Becoming part of the ward team enabled the 
trainees to learn how they could contribute to enhancing the patient 
experience. As a result, the trainees were no longer only interested in a 
patient’s medicines (as was the case during their rotational training) rather, 
they also sought to learn about the patient’s medical history, social history 
and recent test results. This patient-centred approach improved how the 
trainees clinically screened a patient’s prescription. The board round was the 
formal ward activity which all the trainees attended and were able to learn 
about the holistic care of each patient. PRC shared an example of how 
through attending the board round, he learnt that a patient had been 
experiencing haematuria (blood in the urine) overnight. Upon clinically 
screening the patient’s drug chart, he noticed that the patient was currently 
taking Apixaban (blood thinning medication). After highlighting this to the 
pharmacist, he discussed it with the doctors, resulting in the medication 
being withheld whilst the cause of the active bleed was investigated.  
Re-evaluating how they provided pharmaceutical care to patients resulted in 
the trainees realising that their patients did not always present as perfect 
‘textbook cases’. Hence, clinical guidelines and recommended treatment 
pathways could not always be applied to each patient, particularly if the 
patient had multiple long-term conditions. This enabled the trainees to learn 
about the importance of providing personalised individual care for each 
patient based on their medical condition(s) and lifestyle choices, which led to 
them interacting with patients in different ways.  
“…it [the placement] enables her [PRB] to see a slightly different side and 
think about things in a different way…she ended up seeing patients less as 
drug charts and more as patients…” BCONS 
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This was viewed as a positive change as patient care was perceived to have 
been enhanced during the longitudinal placement. There were no accounts 
of how patient care had been put at risk or quality reduced during the 
placement. Rather, it appeared that patient care had been improved through 
the wards receiving an enhanced pharmacy service. Common interventions 
the pre-registration pharmacists carried out included: optimising medicines, 
counselling patients and providing more effective discharge service.  
 “…I think it over all improves the patient experience…the more professionals 
who are involved in it makes it safer and I think the patients would like it as 
well” ACONS 
Spending more time with patients meant that trainees could relate to them in 
more meaningful ways, often taking the time to chat to the patient about their 
family and how they were doing generally. The pre-registration pharmacists 
found that this began to build a better level of trust with their patients, who 
they thought were then more likely to be honest about their adherence, 
experience of side-effects or beliefs about their medicines; ultimately leading 
to a better use of medicines.  
The trainees had the opportunity to review every patient on the ward 
(something which the ward pharmacist would not have the time to do in a 
2-hour visit). They could ask the staff questions and did not need to spend 
long periods of time trawling through patients’ notes to understand their 
clinical condition(s). The improved relationship between the trainees and 
ward staff appeared to enhance patient safety through promoting honesty 
between the junior doctors and pre-registration pharmacists.   
“…I’ve built up a relationship with some of the junior doctors…we’d just 
discuss things and I’d go to them with a question…‘is there a reason why 
they [consultant] chose this antibiotic?’…sometimes…the reason was ‘I’m 
not sure, but that’s what he [consultant] told me to prescribe, so I’ll find out 
and get back to you’ but I just wonder whether, had we not had a bit of a 
relationship…whether they would have been as honest…” B14 
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7.4.3.4.3 Patient discharges 
In addition to providing a more holistic pharmacy service to patients, the 
pre-registration pharmacists also provided a more efficient discharge service. 
Due to the all-day presence of the trainees on the ward and the length of 
time they were based there, they were able to develop a greater appreciation 
and understanding of how the discharge process on the ward worked, 
particularly its complexity for older patients. The trainees described how their 
prior perceptions regarding patient discharge were flawed and saw the 
potential for their role to contribute to a more proactive and efficient patient 
discharge service.  
“…now I understand what everyone else does in the hospital and why they 
make certain decisions…So things like late discharges…before I used to go 
‘argh, clearly they’d [doctors] know if a person’s going home’ but now I know 
that [is not the case]…the nurses also explained…how much they get 
charged if there’s a failed [discharge] if they book transport…so I think it’s 
put…a sense of urgency for me to complete tasks cos… you don’t want this 
responsibility…if everyone’s all done their bit and it’s just pharmacy that’s not 
done theirs…” A7 
The ability of the trainees to turnaround discharges in a timelier manner was 
noticed by all staff, particularly the pharmacists who acknowledged the 
trainees’ presence contributed to fewer delayed or failed discharges due to 
medicines. The trainees could also discuss the medicines with the patient 
before dispensing took place. This reduced the dispensary workload and 
appeared to save both time and money; ultimately resulting in patients being 
discharged sooner. The trainees were able to acquire the discharge 
information through attending the board rounds. This meant nurses’ time was 
not taken away from caring for sick patients to chase the pharmacy team for 




7.4.4 Institutionalisation  
Participants believed that the longitudinal ward placement should be 
incorporated into the pre-registration pharmacist training programmes at both 
hospitals the following year. The longitudinal placement was viewed as the 
future model of hospital pre-registration pharmacist training and 
recommendations were provided for institutionalisation as part of standard 
practice. Recommendations included, the preparation, length and timing, as 
well as the desirable qualities of the people involved in delivering and 
participating in the longitudinal ward placement. 
7.4.4.1 Continuation of the placement 
Every participant recommended that the longitudinal placement should 
continue as part of the hospital pre-registration training programme. It was 
viewed as the direction of travel for the pharmacy profession as it improved 
the learning experience and upheld patient safety. The placement shaped 
the trainees into better future pharmacists who understood the value of 
becoming part of the ward team. This led to them using their acquired 
knowledge and skills to provide an enhanced pharmacy service to patients.  
“it’s [the placement] got to make a better pharmacist at the end. To have an 
understanding of… the entire team on the ward, the patient journey…the 
valuable input the pharmacy element is…that makes a big impact…” BDS 
The future of hospital pharmacists’ practice was viewed as being located on 
the ward, working as part of the ward team. Therefore, training on the 
hospital ward would lead to better patient outcomes if pharmacists became 
part of the ward teams.  
“…she’s a member of the team, not just someone who comes in to 
troubleshoot…[it] is the future; having a ward based pharmacist…they can 
push things forward… figure out problems…they can only do that if they 
know us [ward staff]…” BCONS 
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7.4.4.2 Preparation for the placement 
Prior to the start of their ward placement, the trainees agreed that they 
needed to spend time working in the pharmacy department first. This would 
allow them to build relationships with the pharmacy team and learn how to 
perform the necessary pharmacy competencies such as dispensing, 
medicines reconciliation (MR), ordering medication and transcribing a drug 
chart. This would support the trainees to be more useful to the ward team 
during their placement.   
7.4.4.3 Length of the placement 
According to PRA and PRB, 13-weeks was the optimum length for the ward 
placement. If the placement was any shorter, they would not have had the 
time to properly build relationships with the ward team and participate in all 
their desired learning opportunities. PRC recommended that the placement 
length should be reduced to 10-weeks because his learning and 
development did not continue to progress during the last 3 weeks of his 
placement. 
“…after six weeks the pre-reg will…get the hang of things and … there will 
be the temptation [for the pharmacy department]…[to be] left on the ward by 
yourself which is really not the best thing…everything can be actioned within 
ten weeks…” C14 
Shortening or breaking up the placement was not an attractive option for the 
ward staff who found the independent practice towards the end of the 
placement was beneficial for the trainees, patients and themselves. The 
exception to this was APT2, who recommended that the longitudinal ward 
placement should be broken down into shorter sections, such as three 
4-week blocks interspersed throughout the year. The rationale behind this 
was, this model would better reflect the working practices of hospital 




7.4.4.4 Timing of the placement 
PRA commenced her placement in November and recommended that it 
should have started later in the training year so that she could be more 
useful to the ward when she arrived. However, she acknowledged that the 
benefit of doing it earlier meant that it influenced her later rotations and 
training. PRB and PRC commenced their placement after Christmas, which 
they found was a suitable time in their training timetable because they had 
completed their pharmacy-related competencies, so could be more useful to 
the ward team and were not distracted by the registration assessment. 
Staff recognised that it was important for the trainees to become embedded 
in the pharmacy team prior to commencing their longitudinal placement. 
Some staff believed that once the pharmacy-related competencies were 
achieved, the longitudinal placement could commence, even if this was 
before Christmas. Avoiding the placement running into late May and early 
June was preferable since the pre-registration pharmacists would likely be 
using this time to revise, rather than trying to seek out learning opportunities 
on the ward.  
7.4.4.5 Qualities of the ward and ward staff 
In order to incorporate the longitudinal placement as part of the standard 
pre-registration pharmacist training programme, the desirable qualities of a 
potential host ward were identified; the ward should be generalist (rather 
than specialist) to reflect the generalist nature of the registration assessment.  
The trainees and nursing staff favoured wards that had a low patient 
turnover, enabling the trainees to build a rapport with the patients over time. 
However, BWP, believed the placement could work well on wards which had 
higher patient turnover. These wards would likely be generalist and would 
have a greater pharmacy presence compared to wards with a lower patient 
turnover.   
As well as the qualities of the ward itself, the qualities of the ward staff were 
also important when considering which wards should be selected to host a 
longitudinal placement. The ward staff should be part of a relatively stable 
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team with a core group of individuals who were committed to the ward 
long-term.  
“…the staff have to be welcoming…and approachable and friendly…it has to 
be a ward where…pharmacy input is needed…I think that the ward sister has 
to be…dedicated to development of new members of staff …” C14 
The learning environment on the ward should be positive; some wards are 
already set-up to accept and train learners effectively so these areas may be 
more willing and keener to host a longitudinal pre-registration pharmacist 
placement. If the learning environment is hostile towards trainees, then a 
13-week placement would be a long and less enjoyable experience for the 
pre-registration pharmacists. 
Concerns were raised over whether a longitudinal placement would be 
effective on a ward where the input of the pharmacy team was not valued i.e. 
the ward staff were not ‘pro pharmacy’. The views and attitudes of the 
medical and nursing teams on the ward should therefore be considered 
when selecting a ward for hosting the placement. Wards which are led by 
junior consultants may be more appropriate as they have more time than 
senior consultants and therefore may be more willing to invest in training 
activities.  
“…befriend a consultant who’s going to drive it forward…pick a ward…where 
the consultants are very approachable…it’s all [down to] who leads it. You’ve 
got to have somebody who’s going to show an interest in it [and] has a bit of 
time…” BCONS 
7.4.4.6 Qualities of the ward pharmacist 
The ward pharmacist should enjoy teaching, be good at identifying potential 
learning opportunities, be passionate about developing people, 
approachable, friendly and have good communication skills. 
“…if [the ward pharmacist] doesn’t enjoy teaching, then this project…would 
be very one-sided. I will…just be doing duties without gaining anything from 
it. But because the pharmacist that I’ve been with likes teaching and 
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explaining stuff I really benefit…I don’t see it as me just going on there to just 
perform tasks or duties, I go there to learn…” C8 
The ward pharmacist also needed to be sufficiently senior and dedicated to 
that placement ward to give the pre-registration pharmacist some 
consistency in their supervision and to convey the ‘pre-registration’ status of 
the trainees to ward staff. The ward sister (CWS) cautioned having ward 
pharmacists who were undertaking multiple roles and responsibilities as this 
appeared to have negative effects on the training opportunities for the 
pre-registration pharmacist. 
“…she’s [CWP] on a huge course and trying to do a job as well. I can see it’s 
really tough for her…but someone always loses out on these things…if it’s 
[placement] not set up [correctly] and I think this time it’s the pre-reg student 
[PRC], that’s the only person who has lost out on this…” CWS 
7.4.4.7 Qualities of the pre-registration pharmacist 
Qualities that the pre-registration pharmacists undertaking a longitudinal 
ward placement should display were listed by participants and included: 
enthusiasm, a proactive attitude, self-motivation, good interpersonal skills, a 
desire for learning, teamwork skills, ability to use ones’ initiative, a long 
concentration span, good communication skills, being open-minded, 
sociable, aware of their limitations and be prepared to research answers to 
questions. They would also need to be adaptable to any unexpected learning 
opportunities that may arise on the ward.  
Confidence and a willingness to be involved were also desirable qualities for 
the pre-registration pharmacists since their role, whist supernumerary, still 
involved supporting the workplace activities. The proactive attitude of the 
trainees in this study made them easy for the staff to work with. 
“They have to have a degree of confidence, but not over confidence, they 
have to be…self-motivated…a willingness to go out and ask…an ability to 
roll up their sleeves and get on with it…do the nitty gritty…” BWP 
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Not all pre-registration pharmacists would potentially suit the longitudinal 
placement as a training model, particularly if they had a nervous disposition 
and could find the responsibility difficult to manage. Additionally, less 
confident trainees would be at risk of becoming a burden to the ward staff, 
who would need to give additional support. This could be a further challenge 
for the ward staff who were also responsible for training students from their 
own professions. 
The pre-registration pharmacists in this study were self-motivated, became 
part of the team and were a useful resource to the staff and patients. They 
were described as helpful, capable, reliable, friendly, nice, likeable, 
self-motivated, flexible, approachable, hard workers, professional, punctual 
and engaged. The staff made it clear that the results of the placement may 
have been different had the trainees been less motivated. 
“…There was never a sense that she [PRB] was a burden, a hindrance…but 
I think you have to understand that is part of her personality. Whether that 
would have been different with someone different, I don’t know.” BWP 
All the ward staff emphasised that the success of the placement was largely 
dependent on the personality of the trainee. Those who are enthusiastic and 
keen to make the most of the opportunities would be the people who got the 
most out of the experience. If the pre-registration pharmacists did not grasp 
the opportunities to learn on the ward, then they were at risk of the 
placement becoming a shadowing exercise.   
7.4.4.8 Support and supervision 
Both ward sisters reported uncertainty over the level of support and 
supervision the trainees would need from themselves and the ward 
pharmacist. At hospital 1, the trainees (PRA and PRC) did not receive the 
amount of pharmacist supervision and educational support the ward sister 
(AWS, CWS) expected.  
Members of the medical team at both hospitals also recommended there 
should be greater clarity regarding their roles in supporting the 
pre-registration pharmacists. The medical team also wanted more 
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information about the pre-registration pharmacist training programme and 
structure generally. This would help the doctors to better define what is 
expected from them and the trainee during the longitudinal placement. 
“…I think we have…[to] define as to what is expected from both sides, the 
trainee as well as the doctors…From my point of view…should I be talking to 
her a bit more? Or asking her more questions? Or liaising with her…in 
a…more structured way? And also from her point of view…should she be 
doing a couple of ward rounds a week?...” ACONS 
The presence of the pre-registration pharmacists on the ward round created 
an additional level of pressure for the consultants, who were also responsible 
for teaching the junior doctors and medical students. The logistics of having 
a pre-registration pharmacist present on a ward round, which can take up to 
four hours, was also a challenge for the trainees and ward pharmacists. A 
suggestion was made to have the pre-registration pharmacist join a ward 
round once a week or just occasionally with different consultants. 
7.5 Discussion 
7.5.1 Main findings 
The longitudinal placement was implemented largely as the design intended 
by each of the pre-registration pharmacists and ward staff across the two 
hospitals. Local adaptations to the placement were made as a result of the 
availability and experience of the ward pharmacist.  
The longitudinal placement survived; none of the pre-registration 
pharmacists chose to finish their placement before the 13-weeks were 
completed and all went on to recommend it should be incorporated as part of 
the hospital pre-registration pharmacist training. The pre-registration 
pharmacists became part of the ward team, leading to an enriched learning 
experience, improved professional development and an enhanced pharmacy 
service to the ward. The trainees acquiring membership within the ward team 
was the mechanism through which the placement was able to thrive in this 
research setting.  
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Recommendations for the modification of the placement design and 
implementation in other hospitals were made. These focused largely on the 
qualities of the individuals implementing the placement. Enablers for 
supporting longitudinal placements to be implemented successfully in the 
future included: ward staff having a ‘pro pharmacy’ attitude, a ward 
pharmacist who is experienced and passionate about developing people and 
a pre-registration pharmacist who is motivated to become a part of the ward 
team. These enablers emphasise the need for sufficient stakeholder buy-in, 
in order to facilitate successful implementation of a longitudinal ward 
placement.  
Unexpectedly, the longitudinal placement brought additional benefits for 
patients receiving treatment on these wards. Reports of fewer failed 
discharges, more patient counselling and more medicine-related queries 
being answered by the trainees took place. This could indicate that the 
patient experience was likely to be safer and superior to the contemporary 
pharmacy service these wards received prior to the placement. However, the 
ward staff did acknowledge that these additional benefits largely arose as a 
result of the drive, motivation and competence of the pre-registration 
pharmacists involved in this study and that these benefits may not be 
observed with trainees who are not self-motivated to engage in ward 
activities.  
7.5.2 Strengths and limitations 
Beta testing of the intervention allowed the longitudinal placement’s local 
viability and institutionalisation to be explored. Longitudinal qualitative 
research methods enabled the placement to be evaluated early-on and 
frequently throughout implementation, as recommended in design-based 
research (McKenney and Reeves, 2018d). Collecting data from the 
pre-registration pharmacists at intervals during their placement, revealed the 
rough time point each of the trainees acquired membership in the ward team. 
These results established a link between membership in the ward team and 
the viability of the placement.   
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The study collected data from pre-registration pharmacists at logical time 
points, with sufficient space between them to have allowed a change to 
occur, following the principles of qualitative longitudinal research (Neale, 
2019a). Data was also collected from staff members working closely with the 
pre-registration pharmacists during the placement, thus triangulating the data 
and in nearly all cases, confirming the pre-registration pharmacists’ 
perceptions of their experiences; particularly their membership within the 
ward team. 
Due to the dual role of the researcher (HK) as designer and evaluator of the 
placement, a bespoke approach to data analysis was developed. This was 
informed by the trajectory approach, using framework and abductive analysis 
(Gale et al., 2013; Tavory and Timmermans, 2014a; Grossoehme and 
Lipstein, 2016). Research into qualitative longitudinal analysis is a relatively 
new field and is still being defined. Hence, this method of analysis will 
contribute to a wider conversation on how researchers can conduct 
longitudinal qualitative analysis on data generated in longitudinal studies.  
This study only implemented the longitudinal 13-week ward placement at two 
hospitals with three pre-registration pharmacists. The small numbers of 
participants in the study was ethical, since this was the first time the 
placement was introduced.  
The staff working on the wards where the placement was implemented were 
heavily involved in the placement design. The involvement of these 
stakeholders during the design phases improved the likelihood that the 
longitudinal placement would be implemented successfully. Hence, the 
conditions for introducing a longitudinal ward placement were optimised for 
the purposes of this research study. This may mean that the results may not 
be generalisable to other hospitals, wards and pre-registration pharmacists. 
However, detailed descriptions of the ward context have been provided to 
help readers determine if these results are transferable to other settings.  
Social desirability bias may have been present in this study because of the 
already established good working relationship between the researcher (HK) 
and the ward staff implementing the placement at both hospitals. There is 
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limited disconfirming evidence present in this dataset, which could indicate 
that participants may have been unwilling to criticise the placement to the 
researcher. The researcher endeavoured to account for the possibility of 
social desirability bias by emphasising the importance of honesty from the 
participants at the start of each interview. However, it is possible that some 
participants chose not to disclose any criticisms or reservations about the 
placement directly to the researcher; hence this is presented as a limitation 
of this study.  
In addition, the trainees were aware that they, together with their tutor and 
the ward team, were being interviewed by the researcher. The trainees were 
described as self-motivated, friendly and wanting to get ‘stuck-in’. The 
presence of the researcher may have increased the likelihood that these 
trainees made more of a concerted effort during the longitudinal placement 
than trainees who might otherwise not be followed-up by a researcher. It is 
therefore possible that social desirability bias may have also affected the 
extent of engagement of the trainees. As well as this, selection bias may 
have been present in this study as the pre-registration pharmacists all 
volunteered to participate in the longitudinal placement. 
Prior to the implementation of the longitudinal placement, the researcher did 
not undertake any observations or interviews with ward staff to establish 
whether the wards nominated to participate in this study operated as a 
community of practice. Ideally, the researcher would have sought to 
understand the extent to which the joint enterprise, shared repertoire and 
mutual engagement activities, took place between staff members. However, 
due to constrained timeframes with respect to implementing the longitudinal 
ward placements, it was not possible to conduct this research prior to the 
placement commencing. Instead, evidence to suggest the presence of a 
community of practice on both placement wards emerged during interviews 
with the pre-registration pharmacists and ward staff at the end of the 
longitudinal ward placement (week 14). Social interactions, knowledge 
sharing, knowledge creation and identity building were all present between 
the trainees and the ward staff, confirming that the wards were functioning as 
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communities of practice, which the trainees became members of (Li et al., 
2009a). 
The wards selected to participate in this study were chosen by the deputy 
chief pharmacists at both hospitals because of their already existing positive 
relationship with the pharmacy department. They were wards that the 
trainees identified as being ‘pro pharmacy’. It is possible that if the 
longitudinal placement were to be repeated on wards that were not           
‘pro pharmacy’, the results generated could be different. This could have 
resulted in the trainees being alienated and marginalised (Terry et al., 2020). 
Thus, preventing them from gaining membership by staff members already 
part of the team. This has been known to occur in communities of practice 
(Wenger, 1998). 
Finally, the placement design was crafted carefully and thoroughly over a 
series of months with a team of multi-disciplinary stakeholders. The same 
level of detailed planning does not go into short rotational blocks during the 
pre-registration year. Therefore, introducing a ward placement that has been 
designed with a multi-disciplinary team and has an educational ethos, into a 
short block rotational training programme, may artificially enhance the 
experience.  
7.5.3 Implementation 
The workbook was an effective way of communicating the longitudinal 
placement design to the pre-registration pharmacists and staff supporting the 
placement. The trainees did not need to refer to the workbook for guidance 
on how to implement the placement from the middle of their placement 
onwards. This was due to the trainees’ ability to establish a routine for 
themselves and build effective working relationships with the ward team, 
which enabled them to approach individual members of staff directly to seek 
out learning opportunities that they wanted to pursue. This suggests that 
pre-registration pharmacists are better able to make the most of 
opportunities to learn on the ward when they know and are known by the 
ward staff. Hence, once the trainees became part of the ward team, there 
was no ongoing reliance on the workbook.  
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The uptake of the workplace assessment tools varied between the trainees. 
Uptake appeared to be influenced by the ward pharmacist and 
pre-registration tutor. At hospital 1, the trainees were encouraged to use their 
tools more by the ward pharmacist and their tutors, than at hospital 2. The 
pharmacists at hospital 1 identified that learning to use the workplace 
assessment tools during pre-registration training would support the trainees 
during their diploma later on in their career.  
Being welcomed, accepted and made to feel like you belong is one of the 
enablers of a community of practice that supports student and novice nurses 
to develop in the healthcare setting (Ranse and Grealish, 2007; Jørgensen 
and Hadders, 2015; Terry et al., 2020). The pre-registration pharmacists’ 
arrival on the wards was expected. They were introduced formally at the 
board round. The 1-week induction at the start of the placement was 
organised and facilitated by the ward sister at each hospital. This formal 
arrangement required the ward sisters to provide access to the staff 
members and cultural practices that were part of the ward community of 
practice. Therefore, through the induction programme and ongoing oversight 
of the trainees, the ward sisters acted as ‘brokers’; introducing the 
pre-registration pharmacists to the ward community of practice (Wenger, 
1999 p.105).  
At hospital 1, the ward sister (AWS, CWS), appeared to be the sole broker 
responsible for providing access to the ward community of practice. At 
hospital 2, the ward sister (BWS) and ward pharmacist (BWP), appeared to 
have a joint ‘brokering’ role. This is likely due to the ward pharmacist (BWP) 
having good working relationships with the ward staff and already being 
considered a member of the team due to the number of years he had been 
provided a pharmacy service to that ward. Hence, it was natural for both the 
pharmacist and sister to be involved in supporting PRB enter into the ward 
community of practice. This contrasts to the role of the pharmacists at 
hospital 1, who were rotational and had not been working on the ward for 
long periods of time prior to the placement commencing. Hence, their ability 
to ‘broker’ PRA or PRC into the ward community of practice was made more 
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difficult when the pharmacists themselves had not had the opportunity to 
embed into the ward team. 
PRB identified becoming a part of the ward team at an earlier stage of the 
longitudinal placement than PRA and PRC. This may have been because 
PRB had both the pharmacist and sister acting as brokers for her. This 
highlights the need for the ward team to be involved in the planning and 
delivery of the placement; particularly the ward induction.  
Throughout their placement, the trainees continued to emphasise the 
importance of maintaining effective working relationships with the pharmacy 
team. The trainees retained their identities as members of the hospital 
pharmacy department. They recognised that in order to carry out their role on 
the ward effectively, they needed access to, support from pharmacists, 
information/knowledge about medicines and medicines from the dispensary. 
The longitudinal placement provided the opportunity for the pre-registration 
pharmacists to move between the pharmacy department and the ward 
community of practice, applying their knowledge of one to enhance the way 
they served the other. Landscapes of practice describes how healthcare 
professionals are expected to move between different communities of 
practice and have sufficient competence to practise effectively in each 
(Wenger-Trayner and Wenger-Trayner, 2014). Through navigating the 
pharmacy department and ward communities of practice, the trainees were 
able to develop as healthcare professionals and establish their identity in 
both settings through acquiring trust, responsibility, confidence and 
independence. Working as members of both teams is where the future role 
of hospital pharmacists’ practice is located (Lord Carter of Coles, 2016).  
The board round and consultant ward rounds were key features of the 
placement design that were implemented largely as intended. The trainees 
attended them regularly, actively participating towards the end of their 
placement. However, PRC’s ability to attend the board round and consultant 
ward rounds towards the end of his placement was affected by the absence 
of a ward pharmacist. PRC did not have the time to attend the board round 
or consultant ward rounds, since he needed to undertake other 
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responsibilities such as MRs and ordering. It is appropriate that the presence 
of the ward pharmacist decreases over the course of the longitudinal 
placement, to allow the pre-registration pharmacist to have more autonomy. 
However, it is important that ward pharmacist support is not withdrawn too 
early or unexpectedly. Conversations between the ward pharmacist, tutor 
and trainee about supervision and autonomy will need to take place at 
regular intervals during the placement. It may be that the workplace 
assessment tools could be used to facilitate these conversations. The 
trainee’s performance in these assessments could be used to determine how 
and when they are given more autonomy by the ward pharmacist. 
Pharmacist support should not be withdrawn before the pre-registration 
pharmacist has had the opportunity to build their confidence, earn the trust of 
the ward team, practise some activities independently and begun 
establishing their identity.  
Characteristics which indicate a community of practice has formed include 
both knowledge-sharing and knowledge-creation (Li et al., 2009a). Within the 
first few weeks of the longitudinal placement commencing, the 
pre-registration pharmacists were sharing their knowledge of medicines with 
members of the ward team. This indicates that the pre-registration 
pharmacists’ trajectory from the start of the placement was focused on 
entering into the ward community of practice. The type of knowledge shared 
between the pre-registration pharmacists and ward staff evolved, becoming 
more complex over time. This led the trainees to establish new ways of doing 
things, such as developing ‘workarounds’ to ensure that medicines arrived 
swiftly and promptly on the ward. The board and ward rounds were the 
formal events which saw the ward staff share their knowledge with the 
trainees in a structured way. These events were very influential as the 
knowledge acquired enriched the trainees’ learning experience. This type of 
training on the board and ward round, forced the trainees to learn and think 
for themselves. The board round provided the trainees with more information 
about the medical and social situation of each patient. Access to this 
information enhanced the service they were able to provide, as the trainees 
could identify which medicines might need to be withheld or adjusted.  
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The placement was implemented as intended, one adaptation to the 
placement was observed. During PRA’s placement, she visited other wards 
within the hospital to support the medicines reconciliations (MRs) process, 
rather than remaining solely on the placement ward, as the design intended. 
At the start of her longitudinal placement, PRA was supervised by a recently 
qualified pharmacist who was present on the ward for only very short periods 
of time and had many other responsibilities within the hospital. The lack of 
experience of this pharmacist will most likely have affected his ability to direct 
and support PRA in her role on the ward. Situated learning theory describes 
the importance of the mentor supporting an apprentice in a community of 
practice. If apprentices/newcomers do not know what to do in the community, 
or lack the competence to be useful, as was the case with PRA, this 
frustrates their efforts to become part of the community of practice (Thrysoe 
et al., 2012; Jørgensen and Hadders, 2015; Terry et al., 2020). Hence, in the 
case of PRA, she sought guidance from pharmacists on other wards and 
looked for ways to be useful to the pharmacy team in these other areas. 
However, this behaviour changed when PRA’s pre-registration tutor (APT1), 
was allocated to the placement ward. APT1 was experienced, passionate 
about developing people and had a good working relationship with the ward 
sister. This resulted in PRA receiving dedicated one-to-one training and 
support from this pharmacist, that helped her learn how to become a useful 
member of the ward team and thus integrate into the ward community of 
practice.  
The differences in the implementation of each longitudinal placement 
appeared to be influenced by the ward pharmacist. Legitimate peripheral 
participation describes how newcomers need to be supported by more 
experienced members of a community to progress from apprentice to 
mastery (Lave and Wenger, 1991). The ward pharmacist support PRB 
received was more in-depth to that of PRA and PRC, hence her ability to 
move into membership within the ward team happened sooner. If the ward 
pharmacist is unavailable, too junior or too busy, then they are not able to 
support the pre-registration pharmacist to legitimately participate in the ward 
community. Nurses and doctors cannot support pre-registration pharmacists 
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to undergo legitimate peripheral participation. This is because the 
pre-registration pharmacist is learning how to become a pharmacist and 
consequently, needs input from a pharmacist to develop their pharmacist 
skills. The results from this study indicate that pharmacist support needs to 
be concentrated at the start of the placement. Gradually, over time, this 
should reduce in line with the pre-registration pharmacist’s development.  
A friendly environment, sufficient support from the ward team and being 
welcomed are all enablers for supporting student and novice nurses to 
develop their knowledge and skills in a community of practice (Terry et al., 
2020). The ward teams at both hospitals were supportive learning 
environments; they were friendly, welcoming, keen to build relationships and 
involve the trainees in activities on the ward. It appears from this small-scale 
study that the same is true for pre-registration pharmacists seeking to 
develop as healthcare professionals. Additionally, the pre-registration 
pharmacists found that they became more comfortable practising on the 
ward when other staff members were aware of their role and limitations. This 
is an important finding, given that it is not reported elsewhere in the literature.  
7.5.4 Local viability 
It was the middle of their placement before the trainees began to feel like 
they were part of the ward team. Situated learning theory emphasises that it 
takes time for a person to become a member of a community of practice 
(Lave and Wenger, 1991). Certain features of the placement design 
appeared to influence the speed and extent to which each of the trainees 
was able to acquire membership within the ward team. These included: the 
presence/role of the ward pharmacist, the ability of the trainee to be useful, 
the extent to which the trainees were trusted and given responsibilities and 
the rate at which the trainees developed their role and identity on the ward.  
Landscapes of practice describes how three ‘modes of identification’ can be 
used to determine the extent to which a person is considered a member of a 
community of practice. These are: engagement, imagination and alignment 
(Wenger-Trayner and Wenger-Trayner, 2014). Each of the pre-registration 
pharmacists were engaged with the practice of the ward and used their 
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imagination to participate meaningfully by creating ‘workarounds’ to improve 
the staff and patient experience. The trainees appeared to partially influence 
the practice of the staff nurses and junior doctors. Through questioning the 
prescribing decisions of the consultants with the junior doctors, PRB was 
able to influence the junior doctor’s approach to prescribing medicines. 
However, the ability of the trainees to influence senior members of the ward 
team (alignment) appeared to be limited. This may have been due to the 
trainee’s ‘pre-registration’ status and this is perhaps appropriate, given their 
position as a trainee and not a registered healthcare professional. Hence, the 
ability of pre-registration pharmacists to fully integrate into hospital ward 
communities of practice may be limited by their ‘pre-registration status’. 
However, the ‘pre-registration’ status is not a barrier to the trainees building 
relationships with the ward team, sharing knowledge and participating in 
useful activities that allows the community to achieve their joint enterprise 
(patient care). Therefore, whilst pre-registration pharmacists may not be able 
to influence the practice of all members of the ward community of practice, 
this study has shown that there are benefits for the trainee and the ward, 
through the pre-registration pharmacists being able to engage and imagine.   
Once the trainees had started to become part of the team and transition into 
membership in the community of practice, they began to experience an 
enriched learning experience. Better social environments that facilitate 
learning are seen in communities of practice (Wenger-Trayner and Wenger-
Trayner, 2018). Hence, becoming part of the team and a member of the ward 
community of practice gave the pre-registration pharmacists access to a 
plethora of learning opportunities. These would have been unavailable to 
them in the rotational training model. Learning opportunities included: board 
rounds, medicines administration rounds, bed managers meetings, 
occupational home visits and most notably, the consultant ward round. The 
doctors included the trainees in their teaching on the ward rounds, were 
approachable, patient and offered learning opportunities to the trainees 
beyond the ward round (outpatient clinics). Acquiring knowledge about the 
consultants’ prescribing habits helped PRB feel more useful to the team and 
gave her a sense of purpose. The pre-registration pharmacists made a direct 
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link between becoming part of the ward team and the enriched learning 
experience. This led the trainees to believe that their learning experience 
during the longitudinal placement was superior to their rotational training 
because of their access to the ward team, which they had earned through 
membership. The placement enabled the trainees to practise applying their 
knowledge in the ‘real-life setting’ and making decisions. The trainees knew 
that their work was still being checked by a pharmacist, which provided a 
safety net, if needed.  
The trainees also believed that they were more prepared for the registration 
assessment as a result of the longitudinal placement. This was because they 
had had more exposure to clinical decision-making and had not spent the 
majority of their time performing medicines reconciliations. This indicates that 
undertaking medicines reconciliations –whilst it may be a useful task- does 
not, on its own, optimise the learning experience. The trainees benefitted 
from being able to attend board and ward rounds, from answering 
medicines-related queries and from spending time learning and working 
alongside other members of the ward team. Over time, the trainees earned 
the trust of the ward team and so were given the opportunity to practise more 
independently on the ward. Securing this trust, leading to increased 
responsibilities and independence, is a repeating theme in the longitudinal 
placement literature (Thistlethwaite et al., 2013).  
The confidence and independence of the pre-registration pharmacists built 
over time. It took at least 7-weeks until they had become established. 
Therefore, these results call into question the justification for short block 
rotations during the pre-registration year and short experiential placements 
as part of the MPharm degree. Social learning theory, the literature 
surrounding longitudinal placements and the results of this study, all indicate 
that there are more benefits to trainees from longer placements, which 
support trainees to become part of a team (Wenger, 1998; Thistlethwaite et 
al., 2013).  
Unexpectedly, the pre-registration pharmacists provided an improved 
pharmacy service to the wards. Patient care was enhanced and patient 
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discharges happened in a timelier manner. The ability of the trainees to 
improve the pharmacy service in this way is a testament to them and the 
ward team. The pre-registration pharmacists’ confidence and ability to 
practise independently on the ward improved during the longitudinal 
placement, as a result of their membership in the team, which gave them 
greater access to the shared repertoire. This led to the trainees being able to 
provide a greater level of patient-centred pharmacy care compared to 
pharmacists carrying out 2-hour ward visits. These results have implications 
for hospital pharmacist working practices. Brief ward visits do not allow 
pharmacists to become members of the ward team, thus preventing 
pharmacists from accessing all the relevant information to provide a 
patient-centred pharmacy service to patients.  
7.5.5 Institutionalisation 
Beta testing an intervention involves exploring the concept of tolerance. 
Tolerance describes how precisely specific elements of the intervention need 
to be implemented so that, when replicated, the intervention meets its 
outcomes. Interventions with a high tolerance mean that when replicated, 
they do need to be implemented with a high degree of accuracy. 
Interventions with a low tolerance need to be implemented very precisely and 
with a high degree of accuracy to meet the outcomes.  
In order to determine whether/how the longitudinal 13-week ward placement 
could become institutionalised, a part of standard practice, it is important to 
consider the design of the placement in the context of its tolerance. 
The participants in this study advocated for the longitudinal 13-week ward 
placement to become part of hospital pre-registration pharmacist training at 
both hospitals. Recommendations were given on different aspects of the 
placement’s design as to how it could be improved to support its ability to 
become a part of standard practice.  
The length of the placement (13-weeks) was optimal to enable the trainees 
to first become part of the ward team, learn and develop as a professional 
prior to improving the ward pharmacy service. Whilst the final few weeks of 
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the placement were less beneficial for the trainees’ learning from their 
perspective, this was when they were the most useful to the ward team. It is 
possible that the trainees failed to acknowledge that whilst they were not 
learning as much ‘clinical knowledge’ towards the end of their placement, 
they were developing other skills, namely learning how to practise 
autonomously.  
Shortening the placement length may have reduced the benefits of the 
placement to the ward. This could have resulted in less investment from staff 
earlier in the placement. It is a natural expectation that ward staff would like 
to have trainees based on the ward long enough for them to see a ‘return on 
their investment’. Therefore, the length of the longitudinal placement is likely 
to be a design feature that has a low tolerance and should remain at 
13-weeks. 
The placements were implemented at different times in the pre-registration 
year (week 14, 23 and 27). All trainees advocated that the placement should 
occur in the middle of the training year, to allow time to settle into the 
pre-registration pharmacist role within the pharmacy department and also 
avoid proximity to the registration assessment. The placement may be 
implemented flexibly within the middle of the training year, indicating that the 
exact timing of the placement is likely to have a medium degree of tolerance.  
The main desirable qualities of the ward hosting the placement were 
described as: being ‘pro pharmacy’ and ‘generalist’ with a ‘low patient 
turnover’ and ‘low staff turnover’. However, there was some disagreement 
amongst participants in this study about the importance of the ward having 
low patient turnover. On the one hand, pre-registration pharmacists and 
nurses emphasised the value of establishing patient-staff relationships and 
being able to understand the whole patient journey from admission to 
discharge. On the other hand, one of the ward pharmacists (BWP) believed 
that it would not matter if the patient turnover was high, because there would 
be other associated benefits, such as a wider variety of patient conditions. 
Study participants considered the other ward qualities, namely ‘pro 
pharmacy’, ‘generalist’ and ‘low staff turnover’ to be essential for successful 
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outcomes of a longitudinal placement. However, it is not possible to establish 
the level of tolerance of the ward environment data from this study. These 
characteristics will need testing in subsequent iterations of the longitudinal 
placement in order to determine their respective tolerance levels. 
The supervision and support trainees receive from each member of the ward 
team should be clear, realistic and consistent during the placement. The 
placement design and development discussions need to place greater 
emphasis on the role of the ward pharmacist, particularly at the start of the 
placement. Support and supervision provided by a pharmacist, nurse and 
doctor throughout the placement, appears to be the optimal model for 
implementation. Based on the results of this study, it is not possible to 
estimate the tolerance level of the support and supervision requirements 
during the longitudinal placement. Further research in this area will need 
conducting to determine this. 
The qualities and characteristics of the pre-registration pharmacists 
undertaking the longitudinal ward placement were important to the ward 
team. They believed that the placement would not work well with trainees 
who were not motivated to become part of the team and become involved 
with the activities on the ward. Since the pre-registration pharmacists in this 
study volunteered, they were highly motivated to participate. It is likely that 
only through repeating the placement with other pre-registration pharmacists, 
who did not volunteer, will it be possible to determine whether the trainees’ 
motivation to participate had any bearing on the outcome. Hence, the 
tolerance with respect to the qualities of the pre-registration pharmacists 
undertaking the placement remains unknown. 
7.5.6 Summary  
This study identified that the 13-week longitudinal ward placement held 
benefits for the: 
 Pre-registration pharmacist’s learning and development. 




 Patients, who received a more proactive and timely discharge service.  
The concept of tolerance was explored which identified that there are some 
design features of the longitudinal placement which were reported to have a:  
 Low tolerance - placement length. 
 Medium tolerance - timing of the placement. 
 Unknown tolerance – ward environment, supervision requirements, 
qualities of the pre-registration pharmacists undertaking the 
placement.  
In order to establish which features of the placement design are ‘essential’ 
and which are ‘desirable’ for ensuring successful implementation of 
longitudinal 13-week ward placements, more placements should be 
implemented and additional data gathered in order to inform this process.  
The next chapter discusses the contribution to knowledge this research has 



















This is one of the first pharmacy education studies to have used the DBR 
approach in pharmacy education globally and the very first in the UK. The 
DBR approach informed the design of the research undertaken in this thesis:  
 Chapter 1: analysis and exploration of the literature. 
 Chapter 2: explanation of the DBR approach. 
 Chapter 3: explanation of learning theories to inform DBR approach. 
 Chapter 4: analysis and exploration of stakeholder views. 
 Chapter 5: design and construction of the ward placement. 
 Chapter 6: prototype placement implementation and evaluation. 
 Chapter 7: longitudinal placement implementation and evaluation. 
The aim of this thesis was to develop an alternative model for hospital 
pre-registration pharmacist training, which usually consists of a series of 
short block rotations through different areas. An alternative model to short 
block rotations in medical education is the longitudinal placement. 
Longitudinal placements afford trainees more time in the same environment, 
allowing them to build relationships with staff members. Learning theories 
emphasise the importance of giving trainees time in a community of practice 
so that they can become members and access learning opportunities.   
Barriers to developing an alternative training model, a ward placement, for 
pre-registration pharmacists includes the registration assessment. Enablers 
for introducing a ward placement included the potential for the 
pre-registration pharmacist to become part of the ward team. In collaboration 
with the researcher, key stakeholders designed and constructed a ward 
placement. Novel methods facilitated this process, thus contributing new 
knowledge to the design and construction phase of the DBR approach.  
Alpha testing a 4-week prototype placement established the placement’s 
soundness; the design was appropriate for pre-registration pharmacist 
training. Beta testing the 13-week longitudinal ward placement revealed that 
the placement’s viability was connected to the pre-registration pharmacists 
becoming members of the ward team. Innovative methods of data analysis 
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were used, thus contributing knowledge to longitudinal qualitative research. 
Pre-registration pharmacists struggled to influence senior members of the 
ward team (alignment), suggesting their status as an unregistered healthcare 
professional may affect their ability to fully integrate into communities of 
practice. 
This thesis has illuminated the shortcomings of short rotational hospital 
pre-registration training programmes and provided evidence to support the 
further development of longitudinal models of training for pharmacists. In the 
process, this research has contributed new knowledge to the DBR approach, 
qualitative longitudinal research and landscapes of practice. 
8.2 Main discussion  
8.2.1 Strengths and limitations of the research 
The strengths of this research were: the involvement of stakeholders, the use 
of learning theories, the iterative nature of the studies and the innovative 
approaches to data analysis. However, the data generated may have been 
influenced by researcher bias, social desirability bias and selection bias, all 
of which are limitations. In addition, it is not possible to know at this stage, 
whether these findings can be considered generalisable.   
Designing the ward placement was a lengthy and detailed process involving 
multiple stakeholders at both hospitals over a period of several months 
(chapter 5). The involvement of stakeholders in DBR indicates a practical 
and authentic response to the research aims and reflects the pragmatic 
philosophical underpinning of this research (Kelly, 2006; McKenney and 
Reeves, 2012f; Morgan, 2014). 
Several learning theories were applied to the research, which enabled the 
research findings to be better understood in a wider context. Each study built 
upon the findings from the previous one, allowing a measured and detailed 
approach towards designing, implementing and evaluating the longitudinal 
placement. A range of methods and approaches to data analysis were used. 
These were tailored according to the research aim and objectives of each 
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study. This strengthened the trustworthiness of the data generated and is 
indicative of research which is underpinned by the DBR approach (Barab 
and Squire, 2004; McKenney and Reeves, 2012e; Creswell and Poth, 
2017c).  
To account for researcher bias, the researcher practised reflexivity during 
each study; highlighting the presence of her own ideas and assumptions 
regarding the research. This allowed additional measures to be put in place, 
to ensure these did not affect the overall study findings. Large quantities of 
qualitative data were collected and analysed thoroughly, with another 
member of the research team (JS) checking coding accuracy. Therefore, 
readers should have confidence that the analysis and interpretation of the 
data presented in this thesis is accurate. 
The researcher was heavily involved in the design process, which is 
expected as part of the DBR approach. However, the involvement and 
influence of the researcher on the placement design, may be viewed as a 
limitation of the research. This may have affected the willingness of 
participants to express any criticism of the placement design to the 
researcher; social desirability bias. The researcher was aware of this and 
encouraged participants to provide honest accounts, but it is possible 
participants may have chosen not to disclose this information. 
The pre-registration pharmacists volunteered to undertake the longitudinal 
ward placement, which potentially increased the likelihood of a positive 
outcome. Hence, selection bias may have affected the results generated. 
Consequently, these findings may not be transferable to other settings where 
pre-registration pharmacists are assigned to complete a longitudinal ward 
placement. However, the context of both placement wards has been 
extensively described, as have the characteristics of the trainees, 
pharmacists and staff working on these wards. This should enable readers to 
interpret these results in the context of their own practice setting, to 
determine whether these results are transferable. Additionally, the 
application of learning theories to the results generated also gives readers a 
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better understanding of the research context, supporting the transferability of 
these findings.  
The reader determines the generalisability of findings in design-based 
research. In order for a reader to determine whether the results from a study 
are generalisable to their setting, there must be sufficient descriptions of the 
theoretical constructs, the intervention and the research context (McKenney 
and Reeves, 2012a).  
This research has provided a comprehensive descriptive account of each of 
these factors to enable the reader to determine whether similar findings 
would be identified, if they implemented the longitudinal 13-week ward 
placement in their setting(s). Only once this research has been widely 
disseminated, will it be possible to determine whether these findings can be 
considered generalisable.  
8.2.2 Design-based research 
Chapter 4 identified possible features of the ward placement design, such as 
a clear structure. However, the thematic analysis of this data did not provide 
enough detail to inform the design requirements or propositions needed to 
construct the placement design. Currently, there is a lack of DBR literature 
describing how interventions are constructed, specifically, how researchers 
use data to construct an intervention. 
In order to construct the placement design, detailed data was needed to 
inform the design requirements and propositions. Consequently, the 
framework method was applied to the ‘design’ data generated by the 
thematic analysis (Gale et al., 2013). This allowed the relevant data 
pertaining to the placement’s design to be extracted (chapter 5). The 
application of the framework method to a qualitative dataset to determine 
design requirements and propositions contributes to the DBR literature.  
During framework analysis, whilst the design requirements and propositions 
were identified, a series of concerns relating to the placement design were 
also detected. This led to the creation of a third element to the framework, 
called ‘design concerns’. These design concerns described design features 
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that the ward placement should not incorporate. Identifying these design 
concerns strengthened the placement design, leading to the accreditation of 
the placement by the GPhC. Thus, increasing the likelihood of its successful 
implementation. The identification of ‘design concerns’ as part of the design 
and construction process presents a novel contribution to the DBR literature 
and further research into their use is merited.  
The DBR approach is time-consuming and complex since it involves 
research in the real-life context, which makes for a fragile research setting. 
These drawbacks may have prevented the DBR approach from being used 
by pharmacy education researchers to date. However, the findings from this 
thesis show that the DBR approach can be used effectively to design, 
implement and evaluate a pharmacy education intervention. DBR warrants 
further investigation as a possible approach for informing education research 
within pharmacy and other healthcare disciplines.  
8.2.3 Hospital pre-registration training 
Short rotational models in medical education foster a ‘trainee as a tourist’ 
phenomena, whereby students struggle to build relationships with the 
medical team and patients, apply their knowledge and acquire 
responsibilities (O’Brien, Cooke and Irby, 2007; Holmboe, Ginsburg and 
Bernabeo, 2011). Newly qualified pharmacists identified similar outcomes 
from their experiences of the short block rotational pre-registration 
pharmacist training programme in chapter 4. They described how short 
rotations fostered a culture of shadowing, which inhibited their ability to 
develop autonomy and contributed to them ‘feeling like a burden to the 
pharmacists’.  
During the 13-week longitudinal placement, the pre-registration pharmacists 
described how it took them at least 3-4 weeks to settle onto the ward before 
they could begin to apply their knowledge and contribute meaningfully to the 
practice of the ward (chapter 7). Therefore, if it can take up to four weeks 
before the pre-registration pharmacist’s experience on the ward becomes 
meaningful; this calls into question the suitability of short ward rotations 
within pre-registration pharmacist training.  
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Pre-registration managers and chief pharmacists do not appear to be aware 
of some of the difficulties pre-registration pharmacists face through 
undertaking short rotations. Instead, they hailed the short block rotational 
model as a success, since pre-registration pharmacists were passing the 
registration assessment. Hence, they perceived no rationale for adopting an 
alternative training model. This is concerning as it suggests the pharmacists 
responsible for the education and training of the postgraduate workforce do 
not realise that; passing the registration assessment is not an indicator of an 
efficacious pre-registration training programme.  
It appears the pre-registration training year is trying to serve two purposes: 
the first, to equip trainees to pass the registration assessment and the 
second, to prepare trainees for practice. Passing the registration assessment 
is not synonymous with being equipped to practise safely as a pharmacist.  
Some pre-registration pharmacists were only interested in learning 
information that would help them pass the registration assessment (chapter 
4). In medical education, it is widely accepted that assessment drives 
learning (Cooke et al., 2006; Wormald et al., 2009). Hence, positioning the 
registration assessment at the end of the pre-registration year may not 
support trainees to pursue learning opportunities that will help them prepare 
for practice. This is due to trainees focusing their efforts on revising for the 
exam, rather than seeking to acquire the experiences and develop the skills 
they will need for their future practice (Kinsey, 2020).    
8.2.4 Barriers and enablers to introducing a ward placement 
In chapter 4, pharmacists expressed concerns that a ward placement would 
reduce the quantity of rotations a pre-registration pharmacist could 
undertake. This could potentially limit their exposure to certain disease states 
and medicine groups, thereby affecting the trainee’s ability to pass the 
registration assessment. The underlying assumption that frequent rotations 
provide more learning opportunities in medical education, applies to 




Reassuringly, longitudinal placements in medical education are not 
associated with poorer academic performance. Student’s marks in 
knowledge-based assessments are equivalent or better than those 
completing short block rotations (Walters et al., 2012). Hence, whilst it is not 
possible to predict what effect the longitudinal placement might have on the 
ability of pre-registration pharmacists to pass the registration assessment; 
evidence from medical education suggests longitudinal placements are 
unlikely to affect academic performance. A possible reason for this, is that 
the knowledge gained and skills developed during a longitudinal placement 
cannot be effectively measured by a knowledge-based assessment (Walters 
et al., 2012).  
Other barriers to introducing a ward placement included whether 
pre-registration pharmacists could achieve performance standards during a 
ward placement. The accreditation of the placement by the GPhC overcame 
this. However, there may be cause for concern if chief pharmacists and 
pre-registration managers do not believe that performance standards are 
achievable during ward placements. This is important given that, in chapter 
7, PRA described how she had been able to achieve more of the GPhC 
performance standards during her longitudinal placement than she had prior 
to commencing it.  
In chapter 4, pharmacists were concerned that the supervision of 
pre-registration pharmacists by non-pharmacy staff during a ward placement 
would be inadequate. This concern did not materialise during the course of 
the longitudinal placement. It is possible that in chapter 4, the pharmacist 
participants failed to recognise that non-pharmacy staff are very familiar with 
the concept of ‘pre-registration’ students on wards.  
The supervision of pre-registration pharmacists worked most effectively 
during the prototype placement at hospital 1 (chapter 6) and during the 
longitudinal placement at hospital 2 (chapter 7). In both instances, the ward 
pharmacists maintained overall oversight and accountability for the 
medicines-related work, the ward sister managed the day-to-day learning 
activities and involved the pre-registration pharmacist in the multi-disciplinary 
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meetings and the ward consultants assumed responsibility for teaching, 
questioning and involving trainees in decision-making. It appears that only 
the ward pharmacists can take responsibility for providing opportunities for 
legitimate peripheral participation during ward placements. This is due to 
pre-registration pharmacists needing to learn the skills and knowledge 
necessary for their future practice from registered pharmacists. This 
highlights that a multi-disciplinary approach, which includes the ward sister, 
pharmacist and consultant, reflects the best model for supervision and 
training    
Chief pharmacists and pre-registration managers struggled to identify 
activities that pre-registration pharmacists could undertake during a ward 
placement (chapter 4). Instead, their concerns ranged from trainees having 
no activities to do, to being asked carry out personal care for patients, to 
having too much responsibility. Whereas the newly qualified pharmacists, 
nurses, doctors and ward pharmacist had a plethora of suggested activities 
for pre-registration pharmacists to undertake. These were fully realised 
during stakeholder discussions in chapter 5.  
These barriers and others were not observed when the longitudinal 
placement was implemented. Nonetheless, these concerns about the 
redesign of hospital pre-registration training programmes to incorporate 
patient-facing activities, represents a challenge for changing hospital 
pre-registration training.  
The barrier not addressed by the prototype or longitudinal placement was 
pharmacist accountability. The question of whether ward pharmacists are 
accountable for the mistakes a pre-registration pharmacist makes when the 
pharmacist is not present on the ward at the time of the mistake is yet to be 
resolved. Given the culture of fear that exists around giving pre-registration 
pharmacists autonomy, which may have its roots in the peppermint water 
case, pharmacist accountability in longitudinal placements will need to be 
established in the near future.  
Possible enablers for introducing a ward placement into the hospital 
pre-registration year included: the placement wards being supportive 
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learning environments and the opportunity for trainees to become part of the 
team. The prototype and longitudinal placements identified that the         
‘right wards’ at both hospitals had been selected to host the placement 
(chapter 6 and 7). This was due to each ward having an already existing 
positive learning culture and a stable ward team. Each of the pre-registration 
pharmacists became a member of the ward team during their longitudinal 
placement, which led to further learning opportunities and unexpectedly, 
benefits for the ward team and patients. Thus, the enablers predicted for 
introducing a ward placement into the pre-registration year were accurate.   
However, chief pharmacists, pre-registration managers and diploma tutors 
did not identify becoming part of the ward team as an enabling feature of a 
ward placement. It is not clear why this was the case, but a possible 
explanation is that these pharmacists did not work as part of ward teams 
themselves, due to their senior positions within the pharmacy department. In 
addition, pre-registration pharmacist training sits outside of the hospital 
education infrastructure in most Trusts. Hence, pharmacists have no 
experience of undertaking joint learning and teaching sessions with 
healthcare professionals from other disciplines.  
8.2.5 Ward placement development  
Nursing staff at both hospitals were heavily involved in stakeholder 
discussions regarding the placement design (chapter 5). It is possible this 
gave the nurses a sense of ownership over the placement. Hence, when the 
placements were implemented, the nurses, particularly the ward sisters, 
invested heavily in supporting the trainees to develop.  
There was little involvement from doctors during stakeholder discussions 
regarding the placement design and no doctors attended the advisory panel 
at either hospital (chapter 5). The absence of the doctors from the design 
discussions held repercussions when the longitudinal placement was 
implemented. In chapter 7, the consultants described how they were not fully 
aware of their responsibilities towards the pre-registration pharmacists. 
Similarly, the junior doctors were also unaware of the pre-registration 
pharmacists’ training programme and were unsure of how to interact with the 
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trainees. This demonstrates the importance of involving doctors in the 
discussions regarding the placement design. In the future, creative ways to 
engage with doctors in the early stages of designing longitudinal placements 
will need to be developed.  
During the stakeholder meetings and advisory panels, there were no 
discussions about the role, responsibilities and characteristics of the ward 
pharmacist in the longitudinal placement. It is possible that the lack of this 
discussion was a result of the researcher and stakeholder participants 
assuming the role of the ward pharmacist would not differ to the block 
rotational model of supervision. Consequently, when the longitudinal 
placement was implemented, the model of ward pharmacist supervision was 
distinctly different for each trainee. If the ward pharmacist was unable or 
unavailable to supervise the pre-registration pharmacist appropriately (as 
was the case for PRA and PRC respectively), it affected the ability of the 
pre-registration pharmacist to practise autonomously. Hence, the supervisory 
responsibilities of the ward pharmacist during the longitudinal placement 
appear to differ to rotational training. In longitudinal placements, the ward 
pharmacist has greater responsibility for ensuring pre-registration 
pharmacists undergo legitimate peripheral participation.  
8.2.6 Longitudinal placement design  
The longitudinal ward placement design reflected the qualities of a 
longitudinal placement, it:  
 Provided opportunities for the pre-registration pharmacists to care for 
patients. 
 Sought to encourage the pre-registration pharmacists to build good 
working relationships with the ward team. 
 Aligned to the GPhC performance standards. 
 Was 13-weeks in length. 
 (Thistlethwaite et al., 2013; Poncelet and Hirsh, 2016).  
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Studies exploring longitudinal placements as part of medical education 
identified many of the same benefits for medical students as the longitudinal 
placement for the pre-registration pharmacists did. These included:  
 Assuming greater responsibility for patients as trust developed 
(Walters et al., 2011). 
 Improved confidence (Bell et al., 2008; Zink et al., 2008; Wamsley et 
al., 2009; O’Donoghue, McGrath and Cullen, 2015). 
 Feeling ‘useful’ (Walters et al., 2011; O’Donoghue, McGrath and 
Cullen, 2015). 
This demonstrates these benefits are not synonymous only with medical 
students. Therefore, the longitudinal placement model may hold benefits for 
other professions as well.  
8.2.7 Longitudinal placement implementation 
The longitudinal placement was implemented in the middle of the hospital 
pre-registration year. It is likely that the timing of the placement had 
considerable bearing on the outcomes observed. The pre-registration 
pharmacists had completed their degree and had worked in their respective 
hospitals for a number of months before the placement began.  
It was clear that the pre-registration pharmacists needed sufficient time to 
embed themselves into the culture and practices of the pharmacy 
department prior to commencing their longitudinal placement. The trainees 
needed the skills and knowledge of the pharmacy operating systems. They 
also needed good working relationships with members of the pharmacy team 
to be able to undertake their role on the ward effectively. Therefore, if 
longitudinal ward placements are to be implemented by other hospitals in the 
future, pre-registration pharmacists must have the opportunity to embed 
themselves into the pharmacy team before commencing a longitudinal 
placement. 
The hospital wards hosting the longitudinal placement displayed the 
characteristics indicative of a community of practice. There was evidence 
that the nurses and doctors had a joint enterprise, shared repertoire and 
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mutual engagement with one another. All the pre-registration pharmacists 
became members of the ward community of practice, which improved their 
access to learning and developmental opportunities. The positive learning 
culture, support of the ward sisters, board rounds, consultant ward rounds, 
length of time the trainees spent on the ward, their willingness become part 
of the team, the staff members understanding the trainee’s role and the 
placement’s design, all supported the pre-registration pharmacists to cross 
the boundary into the ward community of practice and transition from the 
periphery to the centre of membership.  
The trainees continued membership within the pharmacy team and their 
transition into the ward community of practice, enabled them to practice 
across their landscape of practice; the pharmacy team and the ward 
community of practice. 
Practising across their landscape of practice gave the pre-registration 
pharmacists access to more learning opportunities. The trainees learnt from 
their experiences and were able to apply their learning more readily during 
the longitudinal placement. The ability of the longitudinal placement to 
facilitate learning across the landscape is important, given that an estimated 
80% of practitioners’ knowledge is acquired from learning in the workplace 
(Yardley, Teunissen and Dornan, 2012; Dornan et al., 2019).  
8.2.8 Identity 
The creation of an identity within a community of practice is an indicator of 
the extent to which a person can be considered a full member. The 
pre-registration pharmacists demonstrated that they engaged with the 
practice of the ward (engagement) and were able to understand what their 
role was on the ward (imagination). However, the ability of pre-registration 
pharmacists to influence (alignment) the practice of the ward staff was 
variable. The pre-registration pharmacists appeared to be able to influence 
the practice of the junior members of the ward team, but not the senior. Due 
to their limited practice experience and role as a ‘pre-registration’ pharmacist, 
their ability to influence the practice of registered healthcare professionals, 
particular those who are senior, appears limited. This may be appropriate, 
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given their status as an unregistered healthcare professional. Therefore, the 
creation of one’s identity within a community of practice may only be fully 
realised upon acquiring professional registration and/or sufficient experience 
to be identified by others as competent and trustworthy.   
This highlights the importance of the ward pharmacist during the longitudinal 
placement. As a registered healthcare professional, they may have more 
power to influence change (alignment) within the ward community of 
practice. However, pharmacists cannot begin to influence change within 
ward communities of practice if they are not seeking to acquire membership 
in the first instance. It appears that not all pharmacists are engaging with 
ward communities of practice; the most common form of communication 
between doctors and the ward pharmacist was via the green pen (chapter 4). 
The pre-registration pharmacists recounted how, often, nurses and doctors 
would not even know the name of the ward pharmacist (chapter 7). It would 
appear that pharmacists are not generally considered members of the ward 
community of practice and are not seeking membership. This could be due to 
the many responsibilities hospital pharmacists have. In chapter 7, a newly 
registered pharmacist had to cover two to three wards each morning, a 
1-hour checking slot in pharmacy and covered patient discharges for up to 
four wards each afternoon. Therefore, the pharmacist’s peripheral ward 
membership may have arisen out of necessity for the pharmacist to be able 
to work in all of these communities on any given day. If the ability of 
pharmacists to acquire membership within ward communities of practice is 
hampered by the working conditions of pharmacists in hospitals, then these 
practices need addressing. The Carter agenda will never be realised until 
issues surrounding pre-registration training and workforce development are 
solved.  
Further possible evidence for pharmacists’ non-membership in ward 
communities of practice can be found from the Francis report and the 
Gosport Independent Panel report (Francis, 2013; Gosport Independent 
Panel, 2018). In the Francis report, the omission of the pharmacists’ 
presence and role on the ward may imply their non-membership in the ward 
community of practice. The Gosport Independent Panel reported the 
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pharmacists’ role was as a supplier of medicines - rather than a member of 
the ward team who was involved in decisions about a patient’s care. This 
infers that the ward pharmacist was not practising as a member of the ward 
community of practice. This lack of membership may hold consequences for 
patient care, particularly when medicines are involved. For this reason, it is 
vital that pre-registration training equips the future pharmacist workforce to 
be able to acquire membership in ward communities of practice. This is so 
that, upon registration, these pharmacists can engage, imagine and align 
across their landscape of practice to help prevent instances where medicines 
misuse is responsible for the harm or death of patients. 
8.2.9 Placement viability 
Unexpectedly, the pre-registration pharmacists enhanced the pharmacy 
service the longitudinal placement wards received. The trainees provided a 
more patient-centred proactive pharmacy service, which benefitted both staff 
and patients. Thus highlighting, how pharmacy support on hospital wards is 
not currently meeting the demands of the staff or the needs of patients. The 
2-hour visit to the ward by the pharmacist to fulfil the medicines supply 
requests is not appropriate and pharmacists must undertake more 
patient-facing roles. The longitudinal placements have demonstrated the 
value-added to the pre-registration pharmacists, ward team and patients 
from the consistent presence of a member of the pharmacy team. The 
viability of the longitudinal placement is linked to the pre-registration 
pharmacists becoming part of the ward team, enabling them to better 
contribute to providing a safer and more efficient pharmacy service to the 
ward.  
It must also be acknowledged that the placement’s viability may be due to 
the way it was designed and who it was implemented by. The extensive 
stakeholder involvement in the design helped create a placement that was 
more likely to succeed in the ward settings it was developed for. There was 
also a long lead-in time between designing and implementing the longitudinal 
placement. Hence, if longitudinal placements are implemented in other 
settings that do not involve an extensive design process, the ability of the 
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placement to be viable in that setting may be affected. Therefore, other 
hospitals, which seek to introduce longitudinal ward placements as part of 
pre-registration pharmacist training will need to go through their own process 
of design and construction.  
The viability of the longitudinal placement was also influenced by the 
willingness of the ward team to accept the trainees and their ‘pro pharmacy’ 
attitude. Communities of practice have the potential to be welcoming, 
supportive and accepting of trainees, as well as the potential to alienate, 
marginalise and frustrate trainees (Terry et al., 2020). Hence, whilst the 
wards hosting the longitudinal placement in this study were accepting of the 
pre-registration pharmacists, other ward settings may not be so welcoming.  
8.2.10 COVID-19 
During March 2020, the COVID-19 pandemic caused the UK to go into 
lockdown and the GPhC announced that the June and September 2020 
registration assessments would be postponed and a form of provisional 
registration would be introduced (General Pharmaceutical Council, 2020c). In 
May 2020, the GPhC made it known the registration assessment would be 
held online, in late 2020 or early 2021. At the time of writing (July 2020), the 
actual date of the postponed assessment had not been announced (General 
Pharmaceutical Council, 2020b). 
By comparison, many universities cancelled final-year medical student 
exams and these students were invited by the GMC in early April to apply for 
provisional registration and join the medical register to work as interim 
foundation doctors (FiY1) (General Medical Council, 2020). In a similar vein, 
the NMC announced in early April that final year nursing students could 
move into clinical practice and be placed on the NMC temporary register 
(May, 2020). This highlights the differences in approach to the education and 
training of doctors and nurses compared to pharmacists. The pharmacy 
degree involves little patient-facing experience in the first four years and 
therefore it would be unsafe to allow pharmacy graduates to practice as an 
interim pharmacist without the year of practical experience provided by 
pre-registration pharmacist training. 
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8.2.11 Reforms to initial education and training 
In July 2020, the NHS People Plan announced that the pre-registration 
pharmacist training year would be replaced by a foundation year, in order to 
enhance trainee’s clinical experience (NHS, 2020). This forms part of the 
GPhC’s reforms to the initial education and training of pharmacists, following 
a consultation in 2019 with the profession (General Pharmaceutical Council, 
2019a; Chief Pharmaceutical Officers and UK Pharmacy Regulators, 2020). 
It appears that trainees completing the new foundation programme, will 
qualify as both a pharmacist and prescriber at the end of this year. The 
foundation training will be implemented in phases, which will begin as early 
as July 2021 (Chief Pharmaceutical Officers and UK Pharmacy Regulators, 
2020; Pharmacy Schools Council, 2020).  
The Pharmacy Schools Council have expressed their support for developing 
a curriculum that will enhance the skills of pharmacists from their degree to 
their pre-registration/foundation training. The Council acknowledges that 
pharmacists are moving away from medicines-supply into roles that involve 
the management of complex patients. Therefore, pharmacists will need the 
relevant knowledge and skills to prepare them for this role, such as, scientific 
reasoning, communication and decision-making. However, the Pharmacy 
Schools Council makes it clear that they consider pharmacists to be 
‘Science-Based Therapeutic Practitioners’ – there is no mention of 
pharmacists as healthcare professionals. This, along with the proposal to 
keep the 4+1 model, may indicate that the misconception that the scientist 
must come first and the professional second, permeates the educational 
leadership of the profession (Taylor and Harding, 2007; Chief 
Pharmaceutical Officers and UK Pharmacy Regulators, 2020; Pharmacy 
Schools Council, 2020).  
8.3 Conclusion  
The DBR approach underpinned this research, providing a structure to a 
series of iterative studies that involved the design, implementation and 
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evaluation of a longitudinal 13-week ward placement for hospital 
pre-registration pharmacists.  
The comprehensive descriptions of learning theories in this research is 
distinctive in the field of pharmacy education research. The application of 
learning theories has provided an explanation for the findings generated in 
each study, enabling the interpretation of results to have wider applicability 
beyond this research.  
This is the first study to have introduced longitudinal placements into 
pre-registration pharmacist training and indicates that this training model is 
feasible and viable for training future pharmacists.  
In summary, this research has contributed the following knowledge: 
Theoretical and methodological 
 Situated learning – legitimate peripheral participation is best provided 
by a ‘master’ from the same profession as the ‘apprentice’. 
 Landscapes of practice – alignment as a part of developing a person’s 
identity in a community may be inhibited if the person is an 
unregistered or trainee professional.  
 Design-based research – design concerns are a useful additional 
stage in the design and construction phase. 
 Longitudinal qualitative analysis – using abductive analysis to code 
the data, framework analysis to organise the data, and trajectory 
analysis to interpret the data in the context of a change over time, 
presents a strategy for analysing qualitative longitudinal data.  
Hospital pharmacists 
 Hospital pharmacists may not work as part of ward teams. Therefore, 
are not considered members of a ward community of practice. Their 
membership and working practices on wards appears peripheral. 
Current hospital pre-registration pharmacist training  
 Short block rotational models of pre-registration training: 
o Foster a culture of ‘tourism’ amongst trainees.  
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o Do not provide sufficient time for trainees to acquire 
membership within teams. 
 The pre-registration pharmacist registration assessment acts as a 
barrier to the adoption of ward placements.  
Longitudinal placements 
 Longitudinal placements in hospital pre-registration pharmacist 
training have similar outcomes to those observed in medical 
education. Namely, an improved learning experience for trainees, their 
development as healthcare professionals and the opportunity to make 
a positive contribution to patient care.  
 The apparent success of longitudinal placements may be attributable 
to their ability to support trainee healthcare professionals to acquire 
membership within a team.  
A full-time 13-week longitudinal ward placement presents a viable model for 
informing the future foundation pharmacist training.  
8.4 Recommendations for longitudinal ward placements 
The findings from this research indicate that further studies exploring 
longitudinal ward placements as an alternative to short block rotations as 
part of hospital pre-registration pharmacist training are warranted. A number 
of recommendations for how longitudinal ward placements could become a 
part of standard practice, therefore becoming institutionalised, have been 
identified.  
The first 13-weeks of the pre-registration year 
Pre-registration pharmacists will require a minimum of 13-weeks at the 
beginning of their pre-registration year based in the pharmacy team. This will 
enable them to build relationships with members of the pharmacy team, 
become familiar with the pharmacy culture and enable them to develop 
competence with respect to technical activities, such as dispensing. 
Therefore, the first quarter of the pre-registration year should: 
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 Make every effort to incorporate the pre-registration pharmacists into 
the pharmacy team.  
 Support pre-registration pharmacists to complete all the necessary 
pharmacy logs/competencies.  
 Be seeking to prepare pre-registration pharmacists for their 
longitudinal ward placement. 
 Incorporate a ‘Medicines Information’ rotation, where possible.  
Choosing a ward to host the longitudinal placement 
In order to determine an appropriate ward to host a 13-week longitudinal 
placement for pre-registration pharmacists, the following considerations 
should be made regarding the ward team: 
 There is a good learning culture already established.  
 They are considered ‘pro pharmacy’ and have an already recognised 
positive relationship with the pharmacy team.  
 The leadership team on the ward are prepared to champion the 
longitudinal placement to staff.  
 The ward team are stable i.e. there is not a high staff turnover.  
 The ward sister, consultant(s) and pharmacist are willing and enabled 
to support the pre-registration pharmacist.  
The following considerations regarding the ward type should be made:  
 Highly specialised wards should be avoided. 
 Generalist wards are favoured (due to the generalist nature of the 
registration assessment).  
Selecting the pharmacist 
To allocate a suitable pharmacist(s) to the longitudinal placement, the 
following considerations should be made: 
 Where possible, consistency of pharmacy supervision/support should 
be maintained. 
 The pharmacist(s) should be sufficiently available to support the 
trainee, particularly at the start of the longitudinal placement.  
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 The pharmacist is properly briefed about the longitudinal placement 
and understands that their supervisory responsibilities will be different 
to the rotational model. 
Ideally, pharmacist(s) should have:  
 Sufficient experience to support a pre-registration pharmacist during a 
longitudinal ward placement.  
 An interest in developing others.  
 An already positive pre-existing relationship with the ward 
sister/consultant. 
Designing the 13-week longitudinal ward placement 
In order to develop and design the longitudinal placement, there will need to 
be at least one individual who is responsible for directing this process. This 
will most likely be the education and training lead/pre-registration manager or 
pre-registration tutor. So that the longitudinal ward placement can be 
developed for the relevant context, the following should be considered: 
 Chief pharmacists/deputy chief pharmacists should be supportive of 
the longitudinal placement initiative and communicate their support to 
the wider pharmacy team and hospital wards participating.  
 Every effort should be made to involve the ward sister and 
consultants/registrars in the design of the placement. The placement 
is more likely to be implemented successfully if these individuals are 
involved in the development of the placement. 
 Discussions regarding the role of the trainee, the pharmacist, the 
sister and the consultant should be included as part of the discussion 
surrounding the placement design.  
 The workbook used to communicate the placement design in this 
thesis (appendix 25) may be used as a blueprint and adapted for the 
relevant hospital/ward setting. 
 Discussions surrounding the supervision and support of the 
pre-registration pharmacist by different individuals should take place.  
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 A non-pharmacy member of the ward team (e.g. ward sister) should 
be responsible for developing a 1-week induction programme for the 
pre-registration pharmacist. The purpose of the induction week is for 
the trainee to learn about the roles and responsibilities of 
non-pharmacy healthcare professionals based on the ward. 
 The longitudinal placement should be a minimum of 13-weeks in 
length. This time may include up to 1-week of annual leave and time 
allocated for specific study sessions.  
Pre-registration pharmacist 
The main qualities and attributes that pre-registration pharmacists will need 
in order to make the most of the longitudinal placement include: 
 Self-motivated to become part of the ward team.  
 Willing to get ‘stuck in’.  
 Friendly and approachable. 
 Aware of the limitations of their role.  
 Aware that learning occurs as a result of becoming part of the team.  
Implementing the placement 
When a longitudinal placement is due to be implemented, the following 
considerations should be made:  
 Learning objectives for the pre-registration pharmacist should be 
defined.  
 The pharmacist and pre-registration pharmacist should have an 
awareness of any workplace assessment tools that might be used as 
part of pre-registration training.  
 Pharmacist support should be withdrawn gradually, in line with the 
pre-registration pharmacist’s development. 
Evaluation 
The pre-registration tutor should seek feedback from the pre-registration 
pharmacist, ward pharmacist and nursing/medical team throughout the 
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longitudinal placement. The use of 360° feedback may be used to facilitate 
this process.  
8.5 Recommendations for future research 
The findings from this research indicate a number of different avenues that 
should be explored in future research studies.  
Design-based research 
More research using the DBR approach should be undertaken in pharmacy 
and other healthcare disciplines such as medicine and nursing, to determine 
its value as an approach to researching educational interventions within 
healthcare.  
Utilising the ‘framework method’ to identify the ‘design requirements’ and 
‘design propositions’ warrants further investigation as useful method for 
designing an intervention.  
The concept of ‘design concerns’ as a supplement to ‘design requirements’ 
and ‘design propositions’ to aid the design and construction of an 
intervention should also be investigated further.  
Learning theory 
Additional research into the application of learning theories, particularly 
communities of practice and landscapes of practice to pharmacy is needed. 
Specifically, research into whether hospital pharmacy departments and 
community pharmacies operate as communities of practice.  
Further research into the concept of ‘alignment’ as part of identity building in 
a community of practice amongst trainee professionals is merited. This 
should seek to ascertain whether trainees are able to influence the 
community of practice they are placed within and if not, determine if this is as 
a result of their status as a ‘trainee’.  
The process of legitimate peripheral participation of pre-registration 
pharmacists and pharmacy students during training and/or experiential 




Future research should seek to conduct beta testing on 13-week longitudinal 
ward placements at other hospitals. This research should focus on 
determining the local viability, tolerance and institutionalisation of the 
placement. 
Following further iterations of beta testing the 13-week longitudinal ward 
placement, gamma testing may be carried out on a large enough sample, to 
determine the effectiveness and impact of the placement. 
Research may then explore the feasibility of a pre-registration training model 
that involves up to four 13-week longitudinal placements. There is the 
possibility for these placements occurring in different sectors of practice to 
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Appendix 7 Placement requirements - chapter 5 
NB: * indicates opposing opinions.  
Requirement 
subclass 
Requirement Who said so? 
Placement 
length 
Half a day shadowing specialists PM5 
      
 
1-2 weeks CP1 CP4 
     
 
2 weeks maximum (after the exam) PM1 
      
 
1 month CP3 
      
 
1 - 2 months NQ4 CP2 DR5 
    
 
2-3 months DT3 DR5 
     
 
3 months NS2 NS3 DR3 
    
 
4 months maximum PM2 




4-6 months NQ1 
      
 
6 months* NQ3 WP1 NS1 
    
 
Not 6 months* CP4 CP1 
     
 
Enough time to meet other competencies a 
pre-reg needs to do in their year 
DT1 
      
 
Two at the same time, could alternate  WP1        
Timing of 
placement 
Beginning of pre-reg NQ12 
      
 
Middle of pre-reg NQ3 PM2 PM4 
    
 
Near end of pre-reg NQ4 
      
 
Induction period first PM4 
      
 
Pre-Reg needs to have grounding in 
pharmacy activities before ward based* 
PM1 PM5 CP4 CP3 
   
 
Pre-Reg to go to the ward before pharmacy* DT1 




Ward type   Older Persons Medicine  NQ1 NQ14 NQ3 NS2 NS3 WP1 NS1  DR3 
Surgical as simpler* NQ2 
      
 
AMU/EAU**   NQ13 DT2 DT3 DT2 Dr5 
  
 
Cardiology  as learnt a lot about cardiac 
medicines 
NQ4 
      
 
Medical over surgical DT1 
      
 
Not surgical as only doing TTOs and not 
learning* 
NQ1 NQ5 DT1 
    
 
Not AMU** NQ3 
      
 
Not a specialist ward NQ11 NQ17 




Which GPhC competencies do pre-reg’s have 
difficulty obtaining now? E.g. patient 
experience and confrontational situations 
CP2 CP4 CP3 CP1 




Ward staff should know what performance 
standards the pre-reg is expected to meet 
DT3 DT1 DT2 
    
 
Pre-Reg must meet all competencies in their 
pre-reg year 
DT1 
      
 
Activities must be mapped to the GPhC 
performance standards 
CP3 DT3 DT2 




Careful selection required  PM2 PM5 
     
 
Selection of pre-reg's for placement should be 
random* 
PF3 
      
 
Researchers/hospital to select the appropriate 
candidates for placement* 
CP2 
      
 
Pre-Reg to sit a test prior to doing placement NQ5 




Nurses clear about their responsibilities when 
supervising; need for training nurses 
CP3 
      
 
Supervisor on the wards understand about the 
performance standards 
DT3 




Pre-reg should not be unsupervised  PM5 
      
 
Someone from pharmacy available on the 
ward the whole time pre-reg was there 
NQ5 PM1 PM2 PM4 CP1 CP4 
 
 
Should be someone closer to the pre-reg in 
qualification time 
NQ11 NQ15 NQ16 NQ13 
   
 
Should come from a specialist pharmacist 
(better learning opportunities) 
NQ16 NQ17 NQ18 
    
 
Should come from an educational person NQ15 
      
 
Should be clear who is responsible for 
supervising 
PF1 PF4 
     
 
Supervision should be robust and include 
providing feedback  
DR5        
Support Working hours need to be the same as 
pharmacists; Monday - Friday 9am-5pm 
WP1 NS1 
     
 
Support network needs to be well structured DT3 




Near peer support for pre-reg to be explored  DT3 
      
 
Pre-Reg needs to feel supported DT3 
      
 
Pre-reg needs to be supported by more than 
just pharmacy  
DR2        
Pharmacist available on the end of a bleep to 
help pre-reg 
NQ4 NQ2 




Avoid having multiple student types on the 
ward at the same time 
PF3 NS1 
     
 
Desire an immersive ward based experience 
with consistency 
CP2 
      
 
Determine who is accountable (when pre-reg 
makes mistake) 
NQ12 
      
 
Be ready to pull the plug on the placement if it 
isn't working 
CP2 
      
 
Consider liability and memorandums of 
understanding for each hospital 
PF4 




Consider utilising learning contracts for the 
pre-reg pharmacists 
PF1 
      
 
Defined objectives are outlined for the 
placement 
CP1 CP2 CP3 PF4 DT3 DT2 DT1 WP1 
Good training needed for the placement to be 
successful 
NQ1 DR5 
     
 
Clear guidance in place CP3 WP1 
     
 
Ensure the pre-reg’s gain clinical and not just 
administrative experience 
DR5        
Clear role Patients need to be aware the pre-reg is a 
student 
PF1 
      
 
Pre-Reg needs to make it clear to staff that 
they are a trainee 
NQ15 
      
 
The role of the pre-reg needs to be clearly 
defined 
DT3 




Pre-reg needs to know where their boundaries 
are 
WP1        
Pre-Reg needs to have different uniform so 
they can be recognised as a trainee 
NQ12 
      
 
Advice giving Pre-Reg should not give advice to staff PM3 
      
 
Pre-Reg cannot give pharmaceutical advice in 
absence of pharmacist 
NQ17 NQ12 NQ14 
    
 
Ward staff need to know legally that pre-reg 
cannot give advice 
PM5 
      
 
Any advice given to a healthcare professional 
must be vetted by a pharmacist  
PM4 
      
 
Pre-Reg needs to be aware of their limitations 
when giving advice 
DT3 




Competency assessments to take place prior 
to independent working 
PF1 PF3 




Must be completed by a pharmacist to meet 
the GPhC requirement 
DT1 
      
 
Assessment will depend on objectives for the 
placement and how long the placement is and 
who is responsible for assessment 
PF4 
      
 
Close monitoring of the progress of the pre-
reg to make sure they're producing adequate 
documentary evidence 
CP2 CP4 
     
 
Mini-PAT NQ4 
      
 
Team need to 
be happy 
Trust management to approve programme NQ17 
      
 
Ensure all of the team are happy to be taking 
the pre-registration pharmacist for placement 
PF4 PF2 
     
 
Make sure the provider organisations are 
100% behind the project - then they will make 
it work 
PF1 




Appendix 8 Placement propositions - chapter 5 
Proposition 
subclass 
Proposition Who said so? 
Pharmacy 
assistant 
Stock ordering NS1 
          
Cleaning the drug cupboard  NQ1 
          
Fetching blister packs for 
TTOs 
NS1 
          
Picking up discharge 
medicines from pharmacy 
which are ready and taking 
them to the ward 
NQ17 




          
Fetching drugs from the 
emergency cupboard 
NS3 
          
Datix reporting NQ3 





POD checks NQ17 CP4 PM5 PM4 
       
Ordering medication  NQ3 NQ11 WP1 
        
Medication history taking  NQ3 CP2 CP4 CP3 PM5 DT3 NS1 
    
Medicines reconciliation NQ5 CP4 PM4 PM5 DT3 NS1 WP1 DR3 DR5 
  
Dispense medicines for 
patients on the ward 
NQ16 CP4 PM5 NQ17 
       
Prepare NOMAD trays on 
the ward 
CP3 CP4 
         
Transcription of medicines to 
fresh drug charts 
CP4 DR3 
         
Carrying out ward audits WP1 
          
CD audits NQ4 
          
Clinical pre-screening CP3 
          
339 
 
Preparing discharges for the 
following day 
NS1 WP1 
         
Support the discharge letter 
process (ensure sufficient 
information available) 
DT3 
          
Checking discharge letters WP1 DR3 DR1 DR3 




          
Any activity which a 
technician does, a pre-reg 
should do 
NQ17 
          
Clinical Screening 
(ambiguity) 
NQ4 CP2 WP1 




          
Antibiotic stewardship NQ12 NQ15 NS1 WP1 DR5 





Medicines management  NQ11 NQ17 
         
Therapeutic drug monitoring NQ12 NQ15 NQ16 DR5 
       
On-call practice  NQ12 
          
Medicines review on patients 
who have been admitted 
following a fall 
NS1 WP1 
         
Answering questions from 
junior doctors* 
DR3 
          
Prompting consultants to 
consider medicines 
DR5 DR1 
         
Supporting deprescribing of 
medicines by highlighting 
possible patients to the ward 
staff 
WP1 NS1 DR1 DR5 
       
Challenge consultant 
decisions 
NS1 WP1 DR1 DR5 
       
341 
 
Educating staff about 
medicines 
NS1           
Be familiar with prescribing  DR2           
Information sharing DR5           




         
Giving advice; confusion 
over what advice allowed to 
give therefore guidance and 
training needed* 
NQ2 NQ18 NQ1 
        
Cannot work as the ward 
pharmacist 
PM4 
          
Giving advice; no advice 
should be given* 
NQ3 NQ4 NQ5 DT3 






Assess whether patients can 
take medicines out of the 
packets 
NS1 WP1 
         
Assessing if patients need 
large print labels or other 
devices 
WP1 NS1 
         
Talking to patients about how 
they manage their medicines 
NS1 WP1 DR2 DR5 
       
Talk to patients about their 
adherence to their medicines 
NS1 WP1 
         
Assess patient’s ability to 
self-administer medication* 
NQ12 NQ15 NQ16 NS1 WP1 
      
Support more frail patients to 
manage their medicines  
WP1           
Counselling patients e.g. at 
discharge or on a drug round 
NS1 WP1 NQ18 PF4 NQ14 NS2 NS3 




(ambiguity – some need for 
structure here or crib sheet) 
NQ3 NQ12 WP1 
        
Counselling patients on 
specific medicines e.g. 
anticoagulation (need to go 
through a competency first) 
CP1 PM5 
         
Some counselling of patients 
could take place 
CP3 PM3 PF4 WP1 
       
Work with 
Doctors 
Attend formal teaching with 
medical students and 
foundation doctors 
DR1 
          
Spend time with the 
foundation doctors 
NQ12 
          
Board Rounds CP2 NS1 WP1 DR5 DR1 
      
Attending the Multi-
disciplinary Team meetings*  




Working on the frailty/older 
persons acute admission unit 
NS1 DR5 
         
Attending a consultant ward 
round 
NQ11 CP4 PM3 DT3 DT2 NS1 WP1 DR5 DR1 WP1 NS1 
Attend consultant ward 
rounds in A & E 
DR1 DR5 
         
Attend family meetings DR5           
Support consultants to 
manage Parkinson’s therapy 
NS1 WP1 
         
Shadow specialist nurses or 
specialist teams on the ward 
e.g. Parkinson’s, AKI, anti-
microbial (but teams need to 
know that they aren't 
qualified, and they can't give 
advice PM5) 
PM4 
          
Understanding patient flow 
and complex discharges 
CP2  CP4 DT2 DT1 





(spend time with bed 
managers) 
Weigh patients DT1 
          
Carry out patient 
observations 
DT1 
          
Observing a drug round 
should do*  
NQ11 NQ14 NQ16 NQ11 CP2 PM3  DT2 DT1 DT3 NS2 
 
Clerking in patients to the 
ward* 
CP2 CP4 
         
Personal care e.g. wash 
patients 
NS2 




          
Taking blood (dependent on 
the individual pre-registration 
pharmacist[NQ12])* 
NQ12 NQ15 
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Shouldn’t make beds CP2 CP4 
         
Shouldn’t wash patients CP2 CP4 DT1 
        
Should not take blood* CP1 
          
Medicines administration 
shouldn't do on their own 
(must observe nurse)* 
DT1 DT2 
         
Medicines administration 
shouldn’t do (for CPs 
shouldn't do as won't be 
doing that as pharmacists)* 
NQ3 NQ4 CP1 CP2 CP3 CP4 PM5 NS3 
   
Patient assessments alone 
(shadowing is ok)* 
DT3 DT1 DT3 




Low pharmacy presence NQ5           
Consider using just one 
clinical area in the hospital 
for the placement 




Low turnover and simple 
patients 





Need for induction to the 
ward prior to commencing 
placement 
PF4           
Consideration for training 
requirements - manual 
handling patient contact may 
be needed 
PF4           
Clinical areas need to be 
prepared prior to the 
placement 




Pre-reg will need to be 
innovative and flexible, nice 
people and good team 
players 
PF3           
Forthright, clearly spoken, 
self-motivated and who will 
speak up 











Ward housekeeper PF4           
Ward clerks NQ3 NQ5          
Healthcare assistants  PF4           
Assistant practitioner PF4           
Ward co-ordinator (person in 
charge) 
NQ1 NQ3          
Nurses  NQ3 NQ2          




Not a newly qualified 
pharmacist 
NQ12 NQ11 NQ17 NQ15 NQ16       
Anyone other than a 
pharmacist 
NQ5 NQ3          
Pre-reg 
Guidance 
Contribute to patient care 
whilst on placement 












Integrated into the ward team DT2           
Pre-reg should be aware of 
their own responsibilities 
NQ11           
Guidance for what pre-reg do 
in certain situations e.g. 
screening 
NQ4           
Well-defined for what the 
pre-reg can do 
NQ2 NQ15 NQ14 PF1 DT3       
Rules for what pre-reg can 
do 
NQ11 NQ13 PM5 PF1 DT2       
Pre-reg's need to have 
awareness of the hospitals 
raising and escalating 
concerns procedure 
PF1           
Pre-reg should know what 
they are doing day-to-day 
DT3           
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Pre-reg should always be 
working within their level of 
competency 
PF1           
Pre-reg should be aware of 
own limitations 




Staff should be aware of 
what is expected of the pre-
reg 
DT1 DT3          
Ward staff to be aware of 
pre-reg limitations 
PM5           
Knowing the 





When attending pre-reg 
attending MDT, staff need to 
understand their role 
NQ11           
Pre-reg should have a full 
understanding of the plan for 
the patient 
DT3 DT1          
Pre-reg should understand 
the discharge process 




Pre-Reg to understand the 
pressures doctors are under 




Appendix 9 Placement concerns - chapter 5 
Concern 
subclass 




Pre-reg year is already very busy DT1 
     
Pre-reg feels detached from pharmacy team DT2 
     
Pre-reg will lose identity as a pharmacist PM5 
     
Placement won't meet training needs of pre-reg PM4 
     
Reputation of pharmacy damaged if pre-reg makes mistake PM2 PM5 PM4 CP3 CP4 WP1 
No benefits for pre-reg with the placement PM4      
Students may get upset by witnessing death on the ward PF3      
Holistic patient focus doesn't require the pre-reg to be on a 
ward - rather ethos of pharmacy needs to change 









Do the benefits of the placement outweigh the risks for what 
will be removed from the programme 
CP3      
What is the pre-reg year not currently fulfilling? How to assess 
and monitor that? 
CP1 CP3 CP2    
Why is this placement being done? Not clear what it is trying 
to achieve 
CP3 CP4     
Patient care Unconscious incompetence of the pre-reg dangerous  PM4 PM2 
    
 
Pharmacy giving medicines risky for patients as pharmacy not 
aware of all that is going on with patients 
DT2 
     





Tutor uncomfortable leaving pre-reg supervision to nurse or 
medical team 
PM4 
     
Tutor signing off pre-reg based on another healthcare 
professionals' opinion who doesn't understand the GPhC 
competencies 
PM5 CP3 CP4 
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Tutor not prepared to sign pre-reg off at the end as can't be 
confident the pre-reg has demonstrated the competencies 
CP4 
     
Tutor is expected to pick up the evidence produced from the 
placement 
PM5 
     
Pre-reg tutor uncomfortable with signing pre-reg off for ward 
placement  
PM5 
     
If pre-reg is writing care plans on the ward someone has to 
review that work with them 
PM3      
Learning 
outcomes 
Outcomes for this placement aren't clear CP3 CP1 
    
Who will be responsible for making sure learning outcomes 
are met 
PM5 
     
Uncertain of outcomes for the pre-reg PM5 
     
Pre-reg distracted from achieving their learning outcomes by 
staff 
PM5 
     
GPhC Liability with the placement, particularly medicines 
administration - how will it work? 
CP2 
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Placement will turn into a shadowing exercise where they can't 
demonstrate competencies 
CP3 CP2 
    
No guarantees pre-reg will be able to achieve all their 
competencies 
CP1 DT3 DT2 
   
Lack of supervision runs legal risk with the GPhC PM5 
     
Pre-reg not able to meet the performance standards on the 
ward 
PM4 CP3 
    
Legal risk of what the pre-reg is allowed to do PM5 
     
On a ward the pre-reg might not be able to receive the training 
that the GPhC feels they should  
PM5 
     
Would the placement achieve what the GPhC wants it to 
achieve 
PM5 
     
Other healthcare professionals don't understand pharmacy 
professional competencies 
PM5 
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Could other healthcare professionals assess a pre-reg against 
the performance standards to the same quality a pharmacist 
would? 
PM1 
     
Supervision  No pharmacist supervision will result in pre-reg not learning 
the right information or how to do the right thing 
PM3      
 
Pre-reg can't do anything which isn't checked by a pharmacist CP3 
     
Ward pharmacist would play a pivotal role in this placement - 
concern too many fingers in the pot 
CP4 
     
Ward manager is going to be responsible for what the pre-reg 
does and how they're supervised 
CP3 CP2 
    
Daily oversight of pre-reg is difficult to achieve when they 
aren't in pharmacy department 
CP3 
     
Pre-reg unsupervised on the ward is uncomfortable PM2 PM4 PM5 NQ12 
  
Pre-reg model of supervision should not mirror FY1 
supervision - not acceptable for them to be abandoned 
PM5 CP4 CP3 
   
357 
 
How would personality of the pre-reg cope being unsupervised 
- some would not cope 
PM5 
     
Worry that other professions would want pharmacists to 
supervise their pre-registration students 
PM2  
     
Additional work for nurses to supervise CP3 CP2 CP4 CP1 PF1 
 
Cannot guarantee correct level of supervision CP2 
     
Nurses have to supervise their own students CP2 CP4 
    
Nurses don't have enough time to supervise the pre-reg PM2  
     
No pharmacist supervision will result in pre-reg not learning 
the right information or how to do the right thing 
PM2  
     
No pharmacist supervision will result in pre-reg doing menial 
roles 
PM2  
     
Healthcare professionals supervising need to have a basic 
knowledge of medicines and some do not  
PM4 
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Pharmacy staff too busy to supervise pre-reg on placement PM5 
     
Non-pharmacist supervision is not appropriate – don’t know 
enough about medicines 
NQ5      
Ward team Volume of pre-registration students on wards (could be 
saturated learning environments) 
PF1 PF2 PF3 
   
Would the nursing staff support this DT1 DT3 
    
Risk of abuse of pre-reg so they do things they shouldn't really 
do 
NQ13 
     
Ward staff are transient so may not get the 'team' feeling PM4 CP2 CP4 
   
How would a pre-reg be able to fit into the ward routine when 
a lot of it isn't drug based 
CP1 CP4 
    
If on a ward which has a pharmacist all day, might as well just 
be with the pharmacist 
CP3 
     
How the pre-reg would manage fitting into a team when the 
team is busy 
PM2  PM4 
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Advice giving Pre-reg not confident or lacks knowledge to provide correct 
advice 
DT3 
     
Unqualified therefore legally not covered to give advice to 
healthcare professional (shouldn't open BNF to give dosage 
advice) 
PM5 
     
Any advice given would have to be vetted by a pharmacist and 
that may not be achievable on placement 
PM4 
     
Exam Fewer rotations leave pre-reg feeling more nervous about 
sitting exam 
NQ13 
     
No guarantee pre-reg will be able to pass exam   CP4 
     
Overall pre-
reg year 
Clinical knowledge will come at the expense of 
stores/procurement knowledge 
DT2 
     
Exposure to different types of patients on different wards is 
reduced 
PM4 PM5 
    
What will be removed from the pre-reg year to accommodate 
the placement 
CP2 CP3 





Discrepancy between ward staff expectations for the pre-reg 
and pharmacy expectations 
DT3 
     
Ward staff think the pre-reg is already qualified and expect 
them to deal with specific queries 
DT3 
     
One uniform for all pharmacy staff doesn't help staff to 
understand the different roles 
DT1 DT3 
    
Novelty of the pre-reg placement, people don't know who they 
are or what they do 
PF3 
     
Healthcare professionals don't understand the role of the pre-
reg 




Physician assistants and other unregistered roles, concerns 
over how they operate 
CP2 CP4 
    
Role overlap pre-reg and other professionals; potential for 
conflict 
DT3 
     
Run out of things to do on the ward NQ11 NQ18 
    
Pre-reg will be a sitting lemon on the ward CP2 CP1 CP4 
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Pre-reg overconfident on the ward (could lead to patient harm 
if wrong advice given) 
CP1 CP4 NQ16 NQ4 NQ1 NQ5 
If pre-reg has to do research and look everything up then they 
won't be useful to the ward 
PM4      
Not enough for the pre-reg to do on the ward PM1      
Registration Wreck the pre-reg year for the trainee CP4 
     
Professional registration is on the line CP4 
     
Recruitment No control over who is recruited for the pre-reg CP4 
     
Personality of 
the pre-reg 
Success of placement will depend upon the individuals 
themselves 
PF3 PF1 NS2 
   
 
Some pre-reg's thrive in stressful environment whereas others 
crumble 
DT3   
   
Pre-Reg would feel nervous being on a ward without a 
pharmacist 
NQ11   
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Pre-Reg overwhelmed by placement if on AMU DT3   
   
Lack of knowledge the pre-reg has NQ5 NQ4  
   
Nursing fears Nursing job is already being eroded NS3 NS2 
    
 
Nursing job is becoming more task-orientated NS3 NS2 
    
Pre-Reg not to take over nursing role NS3 NS2 
    
Nurse needs to know what medicines patient is taking 
therefore medicines administration shouldn't be taken away 
NS3 NS2 
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Appendix 10 Placement design 7-weeks at hospital 2 – chapter 5 
Prior to 
Placement 
Week 1 Week 2 Week 3 Week 4 Week 5 Week 6/7 
Introduce self to 
ward staff prior 
to commencing 
placement 
Ward Induction - 
ward staff to have 
input into this; 
bay of patients 













processes to the 
ward 
Clerk in 
patients to the 
ward with 
junior doctors 
Pre-reg to work 
long day(s) if 
wishes to 
Work with pre-





























Opportunity to observe patient 
journey from admittance to theatre 
to ward to rehab. Opportunity for 







Desirable - attend 
consultant ward 







patients on their 
medicines 
(consider whether 
to be assessed 
by pre-reg tutor, 
ward pharmacist 
or both) 






Board Rounds (to 
attend first few 
with pharmacist 
to introduce pre-
reg to the ward 
team) 
Work with ward 
staff to identify 
opportunities to 
undertake audit 
for the ward 
Attendance at consultant ward 
round 
  
MI training prior 
to placement 
Patient Observations shadowing/training (work 
with HCA or nursing mentor to attain competence 
in this) 
   




Observe drug rounds (attend drug rounds with nursing mentor - If 






Assessments and Opportunities 































































consultant round in 
bay of patients - 
Case Based 
Discussion on 


































 Opportunity: To liaise with ward 
pharmacist after attendance at 
the board round to discuss 
relevant specific patients 
Opportunity: Reflective evidence 
on where boundaries lie 
 Opportunity: 
Reflective 





Appendix 11 Placement design 13-weeks at hospital 1 – chapter 5 
Prior to 
placement 











to have input into 
what induction 














































































letters to the 
GP, 
particularly 
























round initially with 
pre-reg to 
introduce them to 
team Or nurse 
who is working 
with the pre-reg 












Long day shifts 


































training (from a 
HCA or nurse? 
Person to do this 














































Audit analysis     
Spend time 















HCA and nursing 
mentor to care for 
patients in their 
bay) 
All staff clear 
of their role 
and 
responsibility 
to care of the 
pre-reg during 
placement 







(just for their bay 
of patients?) 
            
Assessments and Opportunities 









5 CBD and 5 
Assessments: 
Reflective 
evidence on new 















































the end of 
placement? 




target for each 
student? 
learning plan 
set at start of 
placement 
  Opportunity: To 
conduct a 
medicine review 
on a patient 
whose 
observations 






























long day(s) on 
















  Opportunity: To 



















































and what they 
are 
uncomfortable 






Appendix 12 Placement design prior to advisory panel (both hospitals) – 
chapter 5 
General Placement Guidance 
The pre-registration pharmacist will be under the day-to-day supervision of 
their ward supervisor; (staff member to be confirmed). The ward supervisor 
will oversee the activities of the pre-registration pharmacist on the ward, 
ensuring they are supported and appropriately supervised over the course of 
the placement. 
The role of the pre-registration tutor will be to support the pre-registration 
pharmacist throughout their placement, liaising with staff and monitoring the 
pre-registration pharmacists’ progress during their placement. The pre-
registration tutor will be expected to conduct (at the minimum) two weekly 
meetings with their trainee throughout their placement and also conduct 
workplace assessments (as listed below) with the pre-registration pharmacist 
during their placement. 
The ward pharmacist and Older People’s Medicine pharmacy team will be 
expected to support the pre-registration pharmacist by responding to queries 
regarding clinical advice. The pre-registration pharmacist will also be 
expected to liaise with the ward pharmacy team regarding patient discharge 
and clinical information pertaining to patients which is relevant in the context 
of their medicines management.  
All paperwork/entries made into medical notes/drug charts etc. will be 
countersigned by a registered healthcare professional. There will be 
consistent and ongoing dialogue between ward supervisor, pre-registration 
tutor and pre-registration trainee throughout placement. 
Introductions to ward staff and development of learning plan 
The pre-registration pharmacist should seek out their ward supervisor and 
ward staff prior to attendance at the placement so there is the opportunity to 
familiarise themselves with their supervisor and the ward environment (this 
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may include attending the ward as a pre-registration pharmacist in their usual 
capacity prior to beginning the placement). A learning plan should be 
developed between the trainee, tutor and ward supervisor prior to 
commencement of the placement in order to enable each individual to be 
aware of the learning needs and objectives of the trainee during their 
placement.  
Learning objectives 
By the end of the placement, the trainee will be able to: 
 Perform usual pharmacist ward based activities under supervision 
(Mini-CEX, CBD, COT, care plans) 
 Demonstrate effective time-management, prioritisation and 
organisational skills (Performance Standards) 
 Demonstrate effective inter-professional working (Mini-Pat) 
 Evaluate their learning experience during placement (Reflective 
evidence) 
 
Preparation prior to placement 
Pre-registration pharmacists prior to undertaking their placement should 
have completed and/or received; 
- POD competency assessment 
- Drug history competency assessment 
- Medicines Reconciliation competency assessment 
- Discharge planning training and assessment 
- Stock ordering and acquisition procedures 
- Clinical monitoring training 
- Pharmaceutical care plan training 
- Medicines Information training 
- Patient observations training 




- Discussed and agreed working practices with ward pharmacist, pre-
registration tutor and ward mentor in a personalised learning plan 
- Assessment training; Mini-CEX assessments, Consultation 
Observation Tool, Case Based Discussion, Intervention Recording, 
Pharmaceutical Care Plans, Reflective Evidence and Mini-PAT 
 
Staff training that needs to have been received and completed; 
- Ward staff have clear understanding of role of pre-registration 
pharmacist 
- Ward staff have received training in how to complete some of the 
relevant competency assessments e.g. mini-CEX and Consultation 
Observation Tool 
 
Ward Induction – to be confirmed with nursing and medical staff 
The ward induction should be designed and managed by ward supervisor 
(staff member TBC at hospital 2, ward sister at hospital 1) who will liaise and 
work with members of the multi-disciplinary team to facilitate introducing pre-
registration pharmacist to different members of the ward team. This could 
include; spending time with FY1, allied healthcare professionals etc. The 
ward induction should aim to ground the pre-registration pharmacist in the 


















learning plan  
Pharmacy Activities;  
POD, MR, Ordering 
Achieved 
competency 




Utilises Medicines Management skills to support staff with 
patient discharges 




Ward Induction  Induction  
Patient Observations  Training Conduct observations independently 
Pharmaceutical care 
planning 
 Training and practice Implementation to support ward pharmacist 
Board rounds  Attendance and Observation Contributes if appropriate 
Medicines administration  








 Observation and practice 
Competency 
assessment 
Conducts assessments independently; liaising with 
primary care providers on discharge 
Patient Counselling  
Orientation from ward pharmacist where pre-
reg will receive training and opportunity to 
practice 
Competency assessment for patient counselling; conduct 
independently 
Consultant ward round  Attendance and Observation; supporting medical team and communicating with pharmacist 
Responding to staff and 
patient MI queries 




Familiarisation with relevant 
guidelines 




Work in the day 
assessment unit 
 Observation and Training 
Practice under 
supervision 
Work under supervision of healthcare professional to 
assist with clerk-in patients 
Audit  
Identification of audit topic and completion of audit data 


























The pre-registration pharmacist should receive training on conducting patient 
observations prior to commencing their placement so that they may assist 
with this aspect of patient care. Patient observations need not be a 
routine/daily activity for the pre-registration pharmacist if this not perceived to 
be appropriate by the ward supervisor and pre-registration pharmacist.  
Pharmaceutical care planning 
The pre-registration pharmacist should receive training and the opportunity to 
practise undertaking pharmaceutical care plans for patients under their care. 
The pre-registration pharmacist to work with their ward supervisor to identify 
appropriate patients to undertake pharmaceutical care plans for. The pre-
registration tutor should support the pre-registration pharmacist in developing 
of care plans. 
Board rounds 
The pre-registration pharmacist should attend the board rounds under the 
supervision of a qualified healthcare professional. As the placement 
continues, the pre-registration pharmacist may be given more autonomy by 
their ward supervisor to attend the board round on their own and feedback 
information to ward supervisor/ward pharmacist as appropriate. 
Attendance at board round should also provide pre-registration pharmacist 
opportunities to learn of discharge information relating to specific patients, 
the pre-registration pharmacist should then apply this knowledge to manage 
their medicines appropriately and prepare for discharge. 
Medicines administration 
The pre-registration pharmacist may utilise opportunities to observe the 
lunchtime medication round with a qualified nurse. When appropriate, at a 
time considered between the ward supervisor and pre-registration tutor, the 
pre-registration pharmacist may attend the morning/evening medication 
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round with a nominated member of ward staff. The pre-registration 
pharmacist should attend this in a primarily observational role.  
Patient counselling 
The pre-registration pharmacist should undertake a competency assessment 
during their placement on counselling patients on their medication. The pre-
registration pharmacist should observe, receive training, practice and then 
complete a competency assessment to perform this activity independently on 
the ward. Once this competency assessment has been completed, the pre-
registration pharmacist should prepare to counsel patients/relatives on their 
medicines. The pre-registration pharmacist should work within their own 
professional competence and be aware of their own limitations when 
counselling patients. When appropriate, the pre-registration pharmacist 
should seek support from a qualified pharmacist prior to conducting a 
consultation to affirm that they are giving the relevant and appropriate advice 
to the relevant patient.  
During these consultations with patients about their medicines, the patients 
will have had opportunities to ask the pre-registration pharmacist questions. 
However, it is likely that questions asked to the pre-registration pharmacist 
may differ patient to patient. The pre-registration pharmacist should have an 
awareness of their own limitations and use the judgement of their own 
competence to determine whether it is appropriate to answer a patient’s 
question about a medication. If the pre-registration pharmacist is unsure of 
an answer to give to a patient regarding a medication, they should use the 
resources available to identify the answer and run their answer past a 
qualified pharmacist before informing the patient. 
Consultant ward round 
Pre-registration pharmacists should attend the consultant ward round in an 
observation/learner capacity during their placement. If asked for clinical 
advice during the consultant ward round, the pre-registration pharmacist 
should not answer questions regarding clinical advice unless they have run 
this advice past a qualified pharmacist first. Exceptions may be considered in 
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the case of simple questions – pre-registration pharmacist will be expected to 
use their own clinical judgement to determine whether the advice they are 
being asked to give is within their competency or not. 
The pre-registration pharmacist may highlight any prescription discrepancies 
highlighted during the drug history process to the medical team in order to 
reconcile the patients’ medicines during the consultant ward round.  
If the pre-registration pharmacist wishes to make a recommendation to alter 
a patient’s therapy, they should first run their recommendation past a 
qualified pharmacist before discussing it with the medical team and the 
patient e.g. in the cases of deprescribing/switching therapies. 
Medicines information queries 
The pre-registration pharmacist should have completed some training in 
Medicines Information prior to their placement. When asked questions from 
ward staff and patients alike, the pre-registration pharmacist should use the 
resources they have learnt about to help them answer the query. The pre-
registration pharmacist should talk through their answer with a qualified 
pharmacist prior to informing the enquirer of the information. 
Guidelines implementation 
The ward pharmacist, pre-registration tutor and ward supervisor should direct 
pre-registration pharmacist to most appropriate guidance the trainee needs 
to familiarise themselves with at the start of their placement.  
Self-administration of Medicines Assessment 
The pre-registration pharmacist should receive training from a qualified 
pharmacist prior to undertaking a self-administration of medicines 
assessment on a patient. The pre-registration pharmacist should also 
undertake some self-administration of medicines assessments whilst being 
observed by a qualified pharmacist who can provide feedback on their 
assessment and assess their competency to assess patients thereafter. 
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The pre-registration pharmacist should support ward staff and patients with 
respect to patient self-administration. Part of this process will include being 
present to have open and clear dialogue between patients and prescribers to 
ensure effective communication regarding medication from one to the other.  
Pre-registration pharmacists through this work, may identify patients who 
need large print labels, or other devices to enable patients to access their 
medicines safely. The pre-registration pharmacist should support patients 
seeking to manage their medicines independently in hospital. 
Day assessment unit 
The pre-registration pharmacist may have the opportunity to work in the day 
assessment unit as part of their placement and will have opportunities to 








1 2 3 4 5 6 7 




   As needed thereafter 
Case Based 
Discussion 
       
Intervention 
Recording 
       
Pharmaceutical 
Care Plans 
       
Reflective 
Evidence 
       





Appendix 13 GPhC Application and mapping of performance standards – 
chapter 5 
Placement on Hospital Ward – 13 weeks 
NB: The trainee will be meeting with their Pre-reg tutor at least once every two 
weeks. 
Week 1 
Induction to the ward placement 
 Meet the team 
 Roles of healthcare professionals 
within the team 
 Overview of working hours and 
range of activities 
 Supervision and mentoring 
arrangements 
 Overview of how ward operates 
 Orientation of the ward; location 
of ward items e.g. equipment, 
medicines 
 Understand transfer of care issues 
 
Specific skills training 
 Patient Observations training 
 Use of any ward computer 
software pre-reg not already 
familiar with 
 Orientation of medical notes 
 Answering the ward telephone 
 Training on accessing patients' 
records and; 
o viewing pathology 
results 
o viewing medical history 
o admitting a patient to 
the ward on the 
computer system 
o discharging a patient from the ward 




A1.1   A1.4   A1.5  
A2.3   A5.1 – A5.5 
B1.1 – B1.11 









A1.1 – A1.8   A2.1–
A2.4 
A3.1   A4.1   A4.5 
A5.1 – A5.7  B1.1-
B1.12 
B2.1 – B2.3    C1.11 






























Placement on Hospital Ward - Weeks 2 & 3 
Attendance at Board Rounds (Red to 
Green meetings) 
 Attend board round, making 
relevant notes regarding patient 
care 
 Communicate relevant 
information regarding patients’ 
medicines and discharge 
information to ward pharmacist 
and ward staff via handover 
sheets and whiteboard magnets 
 Lead Board Round with support 
from staff 
Attendance at medication 
administration rounds  
 Attend administration rounds, 
making relevant notes regarding 
administering medication to 
patient group  
 Support ward staff to crush and 
disperse medicines to administer 
to patient 
 Support ward staff to prepare and 
administer IV medication to 
patients 
Medicines management at ward level 
 Assist ward staff with stock 
control 
 Review of medication stocked on 
ward 
 Take responsibility for updating 
patient whiteboard with: 
o discharge information 
o  TTO status 
 Assist ward and pharmacy staff in 
proactive discharge medication 
preparation  
 Support clinical team in 
monitoring therapeutic drug 




A1.1-A1.8    A2.1-2.4 
A3.1-A3.5    A4.6-A4.7 
A5.1-A5.7    B1.1-
B1.12 
B2.1-B2.3    B2.5-B2.7 





A1.1-A1.8    A2.1-A2.4 
A3.1-A3.5    A4.1-A4.2 
A4.4-A4.7    A5.1-A5.7 
B1.1-B1.12    B2.1-
B2.6 
B2.9    C1.2-C1.11 




A1.1-A1.8    A2.1-2.4 
A3.1-A3.5    A4.1-A4.8 
A5.1-A5.7    B1.1-
B1.12 
B2.1-B2.9    C1.9 
C1.11-C1.12    C2.1-






































Placement on Hospital Ward - Weeks 4 & 5 
Attendance at clinical ward rounds  
 Attend ward round, making 
relevant notes regarding patient 
care 
 Communicate relevant 
information on specific patients to 
ward pharmacist 
 Observe healthcare professional-
led patient consultations  
 Witness history-taking sessions by 
other healthcare professionals 
 Witness multi-disciplinary team 
decision-making process 
 Consider the role of the 
pharmacist as a member of the 
multi-disciplinary team 
 Patient Counselling and Treatment 
 Be observed conducting 
patient-centered consultations 
o with patients 
o with patients' relatives 
 Use the correct terminology 
and processes when contacting 
patients’ relatives or care 
providers to ensure 
confidentiality is maintained 
 Conduct supervised history-
taking from patients 
 Assist the team in counselling 
patients, if applicable 
 Respond to patient medicine 
queries using an evidence-
based approach 
 Gather feedback from patients 
and staff on own counselling 
technique 
 Identify areas for improvement 
when counselling patients 
 Help to create a holistic clinical 
management plan for a patient 
which takes into consideration 





A1.1-A1.8    A2.1-2.4 
A3.1-A3.5    A4.1-A4.8 
A5.1-A5.7    B1.1-
B1.12 
B2.1-B2.6    C1.3-C1.5 







A1.1-A1.8    A2.1-2.4 
A3.1-A3.5    A4.1-A4.8 
A5.1-A5.7    B1.1-
B1.12 
C1.2-C1.5    C1.8    
C1.11 





   
 


































Placement on Hospital Ward - Weeks 6 & 7 
Audit 
 Agree an audit topic and undertake 
literature search 
 Define audit standards  
 
Medicines Information 
 Answer medicines information 
queries from ward staff using a 
variety of different resources 
 Implement responses to queries 
under pharmacist supervision 
 Contribute to improving patient 
care through accessing 
Medicines Information resources 
 Communicate answers to 
Medicines Information queries 




 Use current guidelines and 
reference sources to assess the 
suitability of current treatment 
regimes 
 Review patients’ clinical notes, 
referring to current treatment 
guidelines  
 Work with team to implement 
safe use of trust guidelines in 
patients’ treatment plans where 
appropriate 
 Identify guidance which is not 
widely implemented and 
communicate this to ward team 
GPhC Performance 
Standards: 
A1.1-A1.2    A1.6-A1.8 




A1.1-A1.8    A2.1-2.4 
A3.1-A3.5    A4.6-A4.8 
A5.1-A5.7    B1.1-B1.12 







A1.1-A1.8    A2.1-2.4 
A3.1-A3.5    A4.1-A4.2 
A4.4     A4.6-A4.7 
A5.1-A5.7    B1.1-B1.12 
B2.1-B2.3    B2.5-B2.6 
B2.9    C1.3-C1.5 
C1.11    C2.1-C2.4 
C2.7    C2.11 
 
   
 





































Placement on Hospital Ward - Weeks 8 & 9 
Audit (continued) 
 Pilot data collection tool 





Patient-centred care on discharge 
 Review clinical discharge 
summaries 
 Discuss medicine discharge 
summaries with patients and 
carers 
o Clarify questions 




 Assist ward and pharmacy staff 
to facilitate discharges in a 
proactive manner 
 Attend Care Home visits and/or 
home visits with a healthcare 
professional e.g. Occupational 
Therapist 
 Support patients to manage their 
medicines at home 












A1.1-A1.2    A1.6     
A2.1-A2.4    A4.1     




A1.1-A1.8    A2.1-2.4 
A3.1-A3.5    A4.1-A4.2 
A4.4-A4.8    A5.1-A5.7     
B1.1-B1.12    B2.5-B2.6 
B2.9    C1.4    C1.8 


































Placement on Hospital Ward - Weeks 10 & 11 
Teaching session 
 Agree topic and audience 
 Devise an evaluation form for 







 Analyse data 
 Agree recommendations 
 Write audit report 
 Prepare a summary 




Patient-centred care on discharge 
(continued) 
 Communicate with the relevant 
primary care providers 
regarding patients’ discharge 
medicines e.g. community 
pharmacy 
 Support patients to manage 
their medicines at home 
 Have an awareness of 
safeguarding issues and learn 
how to initiate appropriate 
actions 
 Support patients to use aid 
devices to manage their 







A1.1-A1.8    A2.1-2.4 
A3.1-A3.5    A5.1-A5.7     
B1.1-B1.12    B2.1-B2.3 




A1.1-A1.2    A1.6     
A2.1-A2.4    A4.1     






A1.1-A1.8    A2.1-2.4 
A3.1-A3.5    A4.1-A4.2 
A4.4-A4.8    A5.1-A5.7     
B1.1-B1.12    B2.1-B2.9 
C1.2-C1.5    C2.1-C2.9 
C2.11 

































Placement on Hospital Ward - Weeks 12 & 13 
Audit (continued) 
 Presentation of audit findings 






Teaching session (continued) 
 Deliver teaching session to 
ward staff 
 Deliver teaching session to 
pharmacy staff 
 Gather feedback on teaching 
sessions 
 
Work shift hours 
 Agree working hours 
 Observe patient handover from 
night to day shift and vice versa 
 Conduct supervised patient 
hand over from day to night 
shift 
 Observe morning activities of 
ward staff 
 Observe writing of late 
discharge prescriptions 
 Evaluate strategies which the 
pharmacy department could 






A1.1-A1.2    A1.6     
A2.1-A2.4    A4.1     




A1.1-A1.8    A2.1-2.4 
A3.1-A3.5    A5.1-A5.7     
B1.1-B1.12    B2.1-B2.3 





A1.1-A1.8    A2.1-2.4 
A3.1-A3.5    A4.1-A4.2 
A4.4-A4.8    A5.1-A5.7     
B1.1-B1.12    B2.1-B2.9 
C1.2-C1.5    C2.1-C2.9 
C2.11 






































Appendix 15 Key activities within the ward placement design – chapter 5 
The key activities which were discussed at the advisory panel are described 











Assist ward staff with 
individual patient ordering 
of medicines 
Yes Yes 
A1.1-A1.8    
A2.1-2.4    
A3.1-A3.5    
A4.1-A4.8   
A5.1-A5.7    
B1.1-B1.12   
B2.1-B2.9    
C1.9    
C1.11-C1.12    
C2.1-C2.9    
C2.11 
 
Completing Patient Own 




Dealing with medication 
supply queries 
Yes Yes 





Support ward staff to 
monitor therapeutic drug 
levels for specified patients 
and drugs 
Yes Yes 
Update the patient 

















Assist ward staff with 
conducting patient 
observations  
Yes Yes A1.1 – A1.8   
A2.1–A2.4   
A3.1   A4.1   
A4.5     
A5.1 – A5.7  
B1.1-B1.12    
B2.1 – B2.3    
C1.11    C2.4    
C2.11 
 
Take responsibility for 
ensuring observations are 
taken at the appropriate 
intervals for a bay of 
patients 
No No 
Respond accordingly if a 
patient’s observations 
result in them scoring a 
high NEWS score 
No No 
 








Attend board round, 
making relevant notes 
regarding patient care 
Yes Yes A1.1-A1.8    
A2.1-2.4 
A3.1-A3.5    
A4.6-A4.7 
A5.1-A5.7    
B1.1-B1.12 
B2.1-B2.3    
B2.5-B2.7 




patients’ medicines and 

















rounds, making relevant 
notes regarding 
administering medication 
to patient group  
Yes Yes A1.1-A1.8    
A2.1-A2.4 
A3.1-A3.5    
A4.1-A4.2 




B2.9             
C1.2-C1.11 
C2.1-C2.9    
C2.11 
Support crushing and 
dispersing of medicines 
to administer to patient 
Yes Yes 
Support preparation and 
administration of IV 
medication to patients 
Yes Yes 
Observe administration of 
















Attend ward round, 
making relevant notes 
regarding patient care 
Yes Yes A1.1-A1.8    
A2.1-2.4 
A3.1-A3.5    
A4.1-A4.8 
A5.1-A5.7    
B1.1-B1.12 
B2.1-B2.6    
C1.3-C1.5 
















medication queries with 
















Use current guidelines 
and reference sources to 
assess the suitability of 
current treatment regimes 
Yes Yes A1.1-A1.8     
A2.1-2.4 
A3.1-A3.5     
A4.1-A4.2 
A4.4               
A4.6-A4.7 
A5.1-A5.7     
B1.1-B1.12 
B2.1-B2.3     
B2.5-B2.6 
B2.9              
C1.3-C1.5 
C1.11            
C2.1-C2.4 
C2.7              
C2.11 
Review patients’ clinical 
notes and refer to current 
treatment guidelines  
Yes Yes 
Work with team to 
implement safe use of 
trust guidelines in 
patient’s treatment plan 
where appropriate 
Yes Yes 
Identify guidance which is 
not widely implemented 
















Review clinical discharge 
summaries 
Yes (but not 
amending 
independently) 
Yes A1.1-A1.8    
A2.1-2.4 
A3.1-A3.5    
A4.1-A4.2 
A4.4-A4.8    
A5.1-A5.7     
B1.1-B1.12    
B2.1-B2.9 





with patients  
Yes Yes 
Communicate with the 
relevant primary care 
providers regarding 
patient’s discharge e.g. 
community pharmacy 
Yes Yes 
Assist ward and 




Attend Care Home visits 
and/or home visits with a 
healthcare professional 
Yes Yes 
Witness and support 
patients to manage their 
medicines at home 
Yes Yes 
Identify safeguarding 








During the advisory panel, participants suggested groups of key activities 
that were missing from this list which included:  
 Working in the day assessment unit.  
 Patient counselling 
 Patient’s self-administration of medicines 
 Responding to medicines information queries 
 ‘Other’ category of opportunistic activities that did not fit into one of the 
above activity groups.   
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Not a routine expectation, but trainees could assist healthcare 
assistants if the ward is busy. 
Yes Yes 
Washing patients 
Trainees should be aware of how patients are washed but should 
not be actively involved in washing patients. 
Yes Yes 
Walk patients to the toilet 
Trainees should not escort patients to the toilet independently but 
should find a relevant member of staff to assist. 
Yes Yes 
Talk to patients about 
medicines 
Trainees should have holistic discussions with patients about their 
medicines that go beyond the medication history and discharge 
counselling. 
Yes Yes 
Dispense urgent medicines 
Trainees should assist the ward to facilitate urgent discharges 
which may include dispensing items in main pharmacy. These 
items should still be checked by a pharmacist. 
Yes Yes 
Discharge planning 
Trainees should assist with managing discharges, ensuring 
patients have enough medicines and liaising with the ward 
pharmacist. 
Yes Yes 
Ensure patients have 
enough to drink/are eating 
Trainees should not assist patients with food but can provide 
patients with drinks.  
Yes Yes 
Mobilising patients and 
role if patients fall 
Trainees should have an awareness of and should know who to 
call for in the event of a patient falling.   
Yes Yes 
Take patient’s blood 
Trainees should be aware of how blood is ordered, taken, sent 




used, their colours and what these mean. Trainees should not be 
taking blood themselves 
Ordering controlled drugs 
for the ward 
Ordering controlled drugs should remain the responsibility of 
qualified nursing staff.  
Yes Yes 
Complete a final check on 
medicines dispensed  
Final check of medicines dispensed should remain the 
responsibility of a qualified pharmacist. 
Yes Yes 
Complete the final Clinical 
Screen of medication 
Final clinical screen of medication should remain the 
responsibility of the qualified pharmacist. 
Yes Yes 
Counsel patients on 
discharge about their 
medicines 
Trainees should provide patients with information and an 
opportunity to ask questions about their medicines prior to their 
discharge. This is particularly important if changes have been 
made to the patient’s regular medicines. 
Yes Yes 
Managing the discharge 
updates on the patient 
board 
Trainees should have an awareness of the planned discharges 
for patients on the ward and communicate this to ward staff via 





Manage Patient’s own 
Controlled Drug Book  
Trainees should monitor and assist ward staff in ensuring the 
Patient’s own Controlled Drug book is kept up to date and entries 
in there tracked and recording is undertaken thoroughly.  
Yes Yes 
Relabel medicines when 
doses have been changed 
Trainees can relabel medicines where doses have been changed, 
the relabel should be final checked by a qualified pharmacist. 
Yes Yes 
Second check TTO 
medicines 
Trainees should assist the nurses with checking TTO medicines 
by acting as a second checker, only when they have not been 
involved in the dispensing of the items. 
Yes Yes 
Answering patients’ bell 
calls  
Trainees should answer patient’s bell calls. They should go to 




escalate patient’s needs safely and hand over responsibility to the 
next member of staff. 
Working with patients in 
isolation rooms 
Trainees should continue to work with patients in isolation rooms, 




Trainees may administer medicines under the supervision of a 
registered nurse (as student nurses do) but they should not be 
administering medicines independently. 
Yes Yes 
Act as a third checker 
when checking giving IV 
medication 
Trainees may act as a third checker for the administration for 



























Appendix 19 Prototype placement workbook – chapter 6  
Pre-registration pharmacist integrated 
ward-based placement 
 
Developed in collaboration between [hospital 1] and the                    




 1.1 Learning Outcomes  
 1.2 Role and Responsibilities 
 1.3 Role Boundaries 
 1.4 Personal Development Plan  
 1.5 Technical Competency Assessments 
2. Activity Timeline 
 Week 1 
 Week 2 
 Week 3 
 Week 4 
 Other opportunities 
3. Evidence Tools 
 3.1 Evidence Information 
 3.2 Mini-CEX 
 3.3 Intervention Recording 
 3.4 Consultation Observation Tool 
 3.5.1 Case Based Discussion Preparation 
 3.5.2 Case Based Discussion 
 
Pre-registration Pharmacist  
Education Supervisor  




1.1 Learning Outcomes 
This placement has a set of Learning Outcomes designed to complement the 
76 Performance Standards pre-registration pharmacists need to achieve as 
part of their pre-registration year. The learning outcomes are as follows: 
 Apply and synthesise knowledge in the context of clinical decision-
making 
 Critically appraise prescriptions and develop personalised 
management plans for patients 
 Demonstrate effective time-management, prioritisation and 
organisational skills 
 Demonstrate effective interprofessional working 
 Demonstrate effective communication and consultation skills with 
patients, carers and healthcare professionals 
 Evaluate their placement experience  
 
1.2 Role and Responsibilities  
Role of the pre-registration pharmacist: 
 Work as a member of the ward team to provide patient care 
 Engage in the activities on the ward to provide care to patients 
 Use learning opportunities on the ward to enhance your knowledge 
and develop your skills 
Responsibilities of the pre-registration pharmacist: 
 Adhere to the GPhC Professional Standards  
 Follow guidance and instruction from your Practice Supervisor 
 Maintain regular contact with your Education Supervisor 
 Effectively communicate with your supervisors  
 Be responsible for your own learning 
 Seek out opportunities to gather feedback on your performance using 
the tools provided in this handbook 
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How the pre-registration pharmacist will be supported  
The pre-registration pharmacist will be supported by their Education 
Supervisor, Practice Supervisor and ward staff throughout this placement.  
The Education Supervisor (pre-registration tutor) will remain responsible for 
overseeing the education and development of the pre-registration pharmacist 
throughout their placement. The Education Supervisor will have regular 
meetings with the pre-registration pharmacist, reviewing evidence collected 
and reviewing and updating the learning outcomes in accordance with the 
pre-registration pharmacists’ progress. 
The Practice Supervisor (ward sister) is responsible for overseeing day-to-
day activities of the pre-registration pharmacist on the ward. The Practice 
Supervisor will facilitate opportunities on the ward for the pre-registration 
pharmacist to achieve their learning objectives and integrate into the ward 
team.   
Ward staff will support the pre-registration pharmacist throughout their 
placement, enabling them to achieve their learning objectives and including 
them in different aspects of ward-based work, providing direct supervision 
where necessary. 
1.3 Role Boundaries 
This section provides a more comprehensive overview of the role 
expectations for the pre-registration pharmacist. This list is not prescriptive, if 
there are activities which arise during the course of the placement which are 
not listed here, the pre-registration pharmacist should consult with their 











The table below includes activities which the pre-registration pharmacist 
should not undertake: 
Activity Further information 
Make beds This activity should not be a routine expectation 
from the role, but pre-reg could help Healthcare 
Assistants with this when the ward is very busy. 
Wash patients   The pre-reg should be aware of how patients are 
washed but they should not be actively involved 
and should not be washing patients. 
Take patients’ blood  The pre-reg should be aware of how blood is 
ordered, taken, sent off, but they should not be 
taking blood themselves. This should include 
acquiring knowledge of the different vials used, 
their colours and what these mean. 
Ensure patients have 
enough to drink/are 
eating 
Pre-reg should not assist with food. Pre-reg can 
assist with drinks and provide patients with drinks, 
but it is nursing responsibility to deal with patients 
who may have modified diets. 
Walk patients to the 
toilet 
The pre-reg should not escort or assist patients to 
the toilet. The pre-reg should find the relevant 
member of staff to assist with this activity.  
Mobilising patients and 
role if patients fall 
Pre-reg should have an awareness of and should 
know how to help in an assisted fall, but should 
not be attempting to move the patient in any way.  
Order controlled drugs 
for the ward 
Ordering controlled drugs should remain the 
responsibility of qualified nursing staff.  
Complete a final check 
on 
medicines dispensed  
Final check of medicines dispensed should 
remain the responsibility of a qualified 
pharmacist.  
Complete the final 
Clinical Screen of 
medication 
Final clinical screen of medication should remain 
the responsibility of the qualified pharmacist. 
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The table below includes information which the pre-registration pharmacist 
could undertake during their placement: 
Activity Further information 
Talk to patients 
about their 
medicines 
Pre-reg should have more holistic discussions with 
patients about their medicines that goes beyond the 
medication history and the discharge counselling. 
Counsel patients on 
discharge about 
their medicines 
Pre-reg should provide patients with information 
and an opportunity to ask questions about their 
medicines prior to their discharge. This is 
particularly important if changes have been made to 
the patient’s regular medicines. 
Manage the 
discharge (TTO) 
stickers on the 
patient board  
The pre-reg should have an awareness of the 
planned discharges for patients on the ward and 
communicate this to ward staff via the patient 
board, taking care to keep it up to date and 
relevant.  
Manage Patient’s 
own Controlled Drug 
Book (SAM book) 
Pre-reg to monitor and assist ward staff in ensuring 
the Patient’s own Controlled Drug book is kept up to 
date and entries in there tracked and recording is 
undertaken thoroughly. The ward sister checks this 
every Wednesday – pre-reg to conduct this activity 
and ward sister to maintain overall responsibility for 
this being filled out correctly. 
Dispense urgent 
medicines in 
pharmacy (still need 
to be checked by 
pharmacist) 
Pre-reg should assist the ward to facilitate urgent 
discharges and this may include dispensing 
medicines in Main Pharmacy. These items 
dispensed should still be checked by a pharmacist. 
Note: If the pre-reg is working a long day (outside of 
pharmacy hours), it may be difficult to dispense and 
so pre-reg could assist by locating where an item 
may be stocked. But if urgent and not available 
elsewhere, the on-call pharmacist should be 
contacted.  
Relabel medicines 
when doses have 
been changed  
Pre-reg should relabel medicines where doses have 
been changed, the relabel should be final checked 
by a qualified pharmacist. 
Second check TTO 
medicines 
Pre-reg should assist the nurses with checking TTO 
medicines by acting as a second checker, only 
when they have not been involved in the dispensing 
of the items.  
Answering patients’ 
bell calls  
Pre-reg should answer patient’s bell calls. They 
should go to patient and ask what they need. The 
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pre-reg should recognise what they can and cannot 
do. 
Pre-reg needs to be clear about how to escalate 
patient’s needs safely and hand over responsibility 
to the next member of staff. 
Working with 
patients in isolation 
rooms 
Pre-reg should continue to work with patients in 
isolation rooms, taking the normal precautions and 
procedures when working with these patients. 
Medicines 
Administration 
Pre-reg may administer medicines under the 
supervision of a registered nurse. The pre-reg 
should not be administering medicines 
independently.  
Act as a third check 
when checking 
giving IV medication 
Currently nursing students act as a 3rd check for IV 
medication. Pre-reg to act as 3rd checker for 
preparing IV medication. 
Act as a second 
check for Controlled 
Drugs checks 
Pre-reg can act as a 2nd check for Controlled Drugs 
checks (pharmacy technicians can currently 
perform this role). 
 
1.4 Personal Development Plan 
Prior to the placement commencing, a personal development plan should be 
filled out to identify, prioritise and design ways in which the pre-registration 
pharmacists’ educational needs may be met during their placement. This 
plan should reflect the commitment from the pre-registration pharmacist, 
Practice and Education Supervisors to meeting the learning needs of the 
trainee. 
To help identify some of the learning objectives for this placement, please 





Personal Development Plan 
Pre-registration pharmacist: …………………… Education Supervisor: …………………… Practice Supervisor:………………… 
Date: 
What do you want to 
learn? 
(Objectives) 




How are you going to 
show that you have 
learnt it? 
(Evidence) 
How are you going 

































1.5 Technical Competency Assessments  
Below is a list of technical competencies which once the pre-registration 
pharmacist has demonstrated proficiency in, may be able to perform 
independently. This list should be kept up to date by the pre-registration 
pharmacist to enable clear communication between ward and pharmacy staff 



























The information below provides more information on the activities the pre-
registration pharmacist could be undertaking during their placement.  
Please be aware that the order, arrangement and specifics of the activities 
are not prescriptive and have been written and designed to provide guidance 
and structure to the placement. The activities are not compulsory and may 











Week 1 Week 2 Week 3 Week 4 
Introductions to ward staff and 




Pharmacy Activities;  
POD, MR, Ordering 
Achieved 
competency 




Utilises Medicines Management skills to support ward pharmacist and nursing staff with patient 
discharges.  
Ward Induction  Induction  
Patient Observations  Training Conduct observations independently 
Board rounds  Attendance and reporting to ward pharmacist 
Medicines administration  Observation at lunchtime rounds Observe OM/PM round 
Self-administration of 
Medicines Assessment 
 Observation and practice  
Patient Counselling  Practice patient counselling using evidence tools to support development 
Consultant ward round  
Attendance and Observation; supporting medical team and communicating with ward 
pharmacist 
Responding to staff and patient 
Medicines information queries 
 
Practice and implement responses under ward pharmacist supervision where 
applicable 




Training and practice with ward pharmacist Implementation 
Work in the day assessment 
unit 
 Training from staff in day assessment unit 
Perform pharmacist 








Work in ED 
Patient handovers e.g. General all-purpose 
handover with medical and nursing staff 




Week 1  
Meet the team 
Name Role Responsibilities  
   
   
   
   
   
   
   
   
   
   
   
   
   















Overview of how ward operates   
Orientation of the ward; location of ward 
items e.g. equipment, medicines 
  
Time spent with FY1; learning about their 
job roles 
  





Conduct observations with HCAs   
Time spent in day assessment unit; 
learning how the unit operates 
  
Time spent with infection control   

















Assist ward staff with stock control; 
ordering medicines for patients and ward 
  
Assist ward and pharmacy staff in 
proactive discharge medication 
preparation 
  
Support clinical team in monitoring 
therapeutic drug levels for specified 







Week 2  





Attend board round, making relevant notes 
regarding patient care 
  
Communicate relevant information 
regarding patients’ medicines and 
discharge information to: 
1. Ward pharmacist 














Attend administration rounds, observing 
nursing staff administering medication to 
patients 
  
Support ward staff to administer medicines 
to patients with an NG tube 
  
Support ward staff to manage medicines 
administration of medicines to patients 
having Total Parenteral Nutrition  
  
Observe ward staff preparing and 





















Attend ward round, making relevant notes 
regarding patient care 
  
Communicate relevant information on 
specific patients to ward pharmacist 
  
Observe healthcare professional-led 
patient consultations 
  
Witness history-taking sessions by other 
healthcare professionals 
  
Witness multi-disciplinary team decision-
making process 
  
Consider the role of the pharmacist as a 








During week 2 please try to complete the evidence tools: 
- Mini-CEX 
- Intervention Recording  





Conduct assessments to determine if 
patients suitable to self-administer 
medicines 
  
Support patients in self-managing their 











Be observed conducting patient-centred 
consultations: 
1. With patients 
2. With patients’ relatives/carers 
  
Use the correct terminology and 
processes when contacting patients’ 
relatives or care providers to ensure 
confidentiality is maintained 
  
Conduct supervised history-taking from 
patients 
  
Respond to patient medicine queries using 
an evidence-based approach 
  
Gather feedback from patients and staff on 
own counselling technique 
  
Identify areas for improvement when 
counselling patients 
  
Help to create a holistic clinical 
management plan for a patient which 
takes into consideration their physical, 























During week 3 please try to complete a Consultation Observation Tool  





Review clinical discharge summaries   
Discuss medicine discharge summaries 
with patients 
  
Clarify questions patients may have 
regarding their individual discharge 
summary 
  
Communicate with the relevant primary 
care providers regarding patients’ 
discharge medicines e.g. community 
pharmacy 
  
Support patients to manage their 
medicines at home e.g. checking they can 
remove their tablets from the packets 
  
Have an awareness of safeguarding 
issues and learn how to initiate 
appropriate actions 
  
Support patients to use aid devices to 










Answer medicines information queries 
from ward staff using a variety of different 
resources 
  
Implement responses to queries under 
pharmacist supervision 
  
Contribute to improving patient care 
through accessing Medicines Information 
resources 
  
Communicate answers to Medicines 













Use current guidelines and reference 
sources to assess the suitability of current 
treatment regimes 
  
Review patients’ clinical notes, referring to 
current treatment guidelines 
  
Work with team to implement safe use of 
trust guidelines in patients’ treatment plans 
where appropriate  
  
Identify guidance which is not widely 

































During week 4 please try to complete a Case Based Discussion and 
distribute the mini-PAT





Observe patient history-taking and 
decision-making with diagnosis  
  
Complete medication reconciliation for 
patients in the unit 
  
Liaise with clinical team to review patients’ 
medicines 
  
Counsel patients on any medication 
changes 
  
Liaise with primary care providers 
regarding patient discharge 
  
Liaise with ward pharmacist regarding 
care plans for patients 
  
Under supervision, recommend 
interventions to patients’ medicines 
  
















Observe patient handover from night to 
day shift and vice versa 
  
Conduct supervised patient hand over 
from day to night shift 
  
Observe morning activities of ward staff   
Observe writing of late discharge 
prescriptions 
  
Evaluate ways in which the pharmacy 















Attend a ‘no harm’ panel with Practice 
Supervisor 
  












Spend time with FY1 and/or nursing 
student teaching them about medicines 
  
Take part in a micro ward round    
Observe an iron infusion being calculated 
and subsequently administered 
  
Take advantage of opportunities on the 
ward to obtain knowledge and/or skills 
  
Conduct a teaching session/presentation 
with ward staff 
  
Attend training/teaching sessions with 
junior doctors 
  
Conduct a patient handover with    
Observe elderly care consultant ward 




















































3. Evidence Tools  
3.1 Evidence Information 
Please see the below suggested minimum timetable for collecting each of 
the following pieces of evidence. If time allows, please consider completing a 
Mini-CEX, intervention recording and Consultation tool weekly. 
Evidence Tool 
Week 
1 2 3 4 
Mini-Cex     
Intervention 
Recording 
    
Consultation 
Observation Tool 
    
Case Based 
Discussion 
    
Mini-PAT     
 
The Tools are designed to be used with another member of staff who can 
provide feedback on the pre-registration pharmacists’ performance which 
can be used to improve practice.  
The tools have been designed with the GPhC Performance Standards in 
mind, to enable the pre-registration pharmacist to gather as much evidence 
in support of their activities during the placement. This will also allow the pre-
registration pharmacist to demonstrate that they have met the minimum safe 
standard of practice by collecting evidence in support of meeting these 
standards.  






































reasoning in a range 







Depth and breadth of 
knowledge on a clinical 
area inspired by the 





with the team 
When to use? Real-time Real-time Retrospectively Retrospectively Retrospectively 
Preparation 
required? 
No No Yes – 45 mins Yes – 2 hours No 



















could be used 
Conducting 
medication history 
taking or discharge 
counselling with a 
patient 
Discuss decision-
making process and 
clinical reasoning in 
scenarios 
When a clinical  
intervention has been 
made (or is being 
considered)  by the  
pre-reg 
To explore a complex 
patient and their care in 




At end of placement to 
gather feedback from 





Feedback should be 




completed for range 
of activities, better it is 
for informing further 
development 
Snapshot recording of 
interventions made to 
improve patient care 
Discussion that can be 
presented as a case 
study on a chosen 




submitted to colleagues 




















































Appendix 25 Longitudinal placement workbook – chapter 7 
 
 
Pre-registration pharmacist integrated ward-based placement 
 






 1.1 Role and Responsibilities 
 1.2 Role Boundaries 
 1.3 Personal Development Plan  
 1.4 Learning Outcomes 
 1.5 Technical Competency Assessments 
 1.6 Typical working day 
 1.7 Top tips on integration 
2. Activity Timeline 
 Week 1 Induction 
 Week 2 – 3 
 Week 4 – 5 
 Week 6 – 7 
 Week 8 – 9 
 Week 10 – 11 
 Week 12 – 13 
 Other Activities 
 
Pre-registration Pharmacist  
Education Supervisor  
Practice Supervisor  
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3. Evidence Tools 
 3.1 Evidence Information 
 3.2 Mini-CEX 
 3.3 Intervention Recording 
 3.4 Consultation Observation Tool 
 3.5.1 Case Based Discussion Preparation 
 3.5.2 Case Based Discussion 
 
 
Useful contact details 
Person/Team Useful for Number 
Ward Pharmacist Patient-specific enquiries 
on and general medicines 
advice 
 
Pharmacy team Additional pharmacy 






related enquiries that 






management of patients 





Additional source of 
clinical information and 






This workbook has been designed to be used by pre-registration pharmacists 
and staff members who are involved in the 13-week longitudinal placement. 
The workbook contains an overview of the roles and responsibilities of the 
pre-registration pharmacists during their placement. Information has been 
included to support the development of personal learning objectives for the 
pre-registration pharmacist, which includes suggested learning outcomes for 
the placement.  
Suggested activities have been included, please be aware that the order, 
arrangement and specifics of the activities are not prescriptive and have 
been written and designed to provide guidance and structure to the 
placement. The activities are not compulsory and may be tailored to suit the 
learning needs of the pre-registration pharmacist. 
To support learning, a variety of ‘Evidence Tools’ (or workplace assessment 
tools)have been developed that could be used by the pre-registration 
pharmacists to gather evidence in support of them achieving the GPhC 
Performance Standards and also obtain feedback from a range of healthcare 
professionals that can be used to inform their further development. Use of 
these tools is not a compulsory. 
Please be aware that any feedback on improvements to the 13-week 
placement and accompanying workbook would be important to inform further 
developments to this programme. 
 
1.1 Role and Responsibilities  
Role of the pre-registration pharmacist on this ward-based placement: 
 Work as a member of the ward team to provide patient care 
 Engage in the activities on the ward to provide care to patients 
 Use learning opportunities on the ward to enhance your knowledge 
and develop your skills 
 
Responsibilities of the pre-registration pharmacist on this ward-based 
placement: 
 Adhere to the GPhC Professional Standards  
 Follow guidance and instruction from your Practice Supervisor 
 Maintain regular contact with your Education Supervisor 
 Effectively communicate with your supervisors and ward staff 
throughout the placement 
 Be responsible for your own learning 
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 Seek out opportunities to gather feedback on your performance using 
the tools provided in this handbook 
 
How the pre-registration pharmacist will be supported on this ward-based 
placement: 
The pre-registration pharmacist will be supported by their Education 
Supervisor, Practice Supervisor and ward staff throughout this placement.  
The Education Supervisor will remain responsible for overseeing the 
education and development of the pre-registration pharmacist throughout 
their placement. The Education Supervisor will have regular meetings with 
the pre-registration pharmacist, reviewing evidence collected and reviewing 
and updating the learning objectives in accordance with the pre-registration 
pharmacists’ progress. 
The Practice Supervisor is responsible for overseeing day-to-day activities of 
the pre-registration pharmacist on the ward. The Practice Supervisor will 
facilitate opportunities on the ward for the pre-registration pharmacist to 
achieve their learning objectives and integrate into the ward team.   
Ward staff will support the pre-registration pharmacist throughout their 
placement, enabling them to achieve their learning objectives and including 














1.2 Role Boundaries 
This section provides a more comprehensive overview of the role 
expectations for the pre-registration pharmacist. This list is not prescriptive, if 
there are activities which arise during the course of the placement which are 
not listed here, the pre-registration pharmacist should consult with their 
Practice and Education supervisors to determine what is most appropriate. 
The table below includes information which the pre-registration pharmacist 
should not undertake: 
Activity Further information 
Make beds This activity should not be a routine expectation 
from the role, but pre-reg could help Healthcare 
Assistants with this when the ward is very busy. 
Wash patients   The pre-reg should be aware of how patients are 
washed but they should not be actively involved 
and should not be washing patients. 
Take patients’ blood  The pre-reg should be aware of how blood is 
ordered, taken, sent off, but they should not be 
taking blood themselves. This should include 
acquiring knowledge of the different vials used, 
their colours and what these mean. 
Ensure patients have 
enough to drink/are 
eating 
Pre-reg should not assist with food. Pre-reg can 
assist with drinks and provide patients with drinks, 
but it is nursing responsibility to deal with patients 
who may have modified diets. 
Walk patients to the 
toilet 
The pre-reg should not escort or assist patients to 
the toilet. The pre-reg should find the relevant 
member of staff to assist with this activity.  
Mobilising patients and 
role if patients fall 
Pre-reg should have an awareness of and should 
know how to help in an assisted fall, but should 
not be attempting to move the patient in any way.  
Order medicines for 
patients on the ward 
All medication orders must still be screened and 
checked by a qualified pharmacist. 
Order controlled drugs 
for the ward 
Ordering controlled drugs should remain the 
responsibility of qualified nursing staff.  
Complete a final check 
on 
medicines dispensed  
Final check of medicines dispensed should 
remain the responsibility of a qualified 
pharmacist.  
Complete the final 
Clinical Screen of 
medication 
Final clinical screen of medication should remain 
the responsibility of the qualified pharmacist. 
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The table below includes activities which are not compulsory, but which the 
pre-registration pharmacist should undertake during their placement: 
Activity Further information 
Talk to patients 
about their 
medicines 
Pre-reg should have more holistic discussions with 
patients about their medicines that goes beyond the 
medication history and the discharge counselling. 
Counsel patients on 
discharge about 
their medicines 
Pre-reg should provide patients with information 
and an opportunity to ask questions about their 
medicines prior to their discharge. This is 
particularly important if changes have been made to 
the patient’s regular medicines. 
Manage the 
discharge (TTO) 
stickers on the 
patient board  
The pre-reg should have an awareness of the 
planned discharges for patients on the ward and 
communicate this to ward staff via the patient 
board, taking care to keep it up to date and 
relevant.  
Manage Patient’s 
own Controlled Drug 
Book  
Pre-reg to monitor and assist ward staff in ensuring 
the Patient’s own Controlled Drug book is kept up to 
date and entries in there tracked and recording is 
undertaken thoroughly.  
Dispense urgent 
medicines in 
pharmacy (still need 
to be checked by 
pharmacist) 
Pre-reg should assist the ward to facilitate urgent 
discharges and this may include dispensing 
medicines in Main Pharmacy. These items 
dispensed should still be checked by a pharmacist. 
Note: If the pre-reg is working a long day (outside of 
pharmacy hours), it may be difficult to dispense and 
so pre-reg could assist by using the electronic 
system to find where an item may be stocked. But if 
urgent and not available elsewhere, the on call 
pharmacist should be contacted.  
Relabel medicines 
when doses have 
been changed  
Pre-reg should relabel medicines where doses have 
been changed, the relabel should be final checked 
by a qualified pharmacist. 
Second check TTO 
medicines 
Pre-reg should assist the nurses with checking TTO 
medicines by acting as a second checker. However, 
if the pre-reg has dispensed or created the letter for 
the TTO check, they should not be involved in this 
checking process as they should not be checking 
their own work. 
Answering patients’ 
bell calls  
Pre-reg should answer patient’s bell calls. They 
should go to patient and ask what they need. The 
pre-reg should recognise what they can and cannot 
do. 
Pre-reg needs to be clear about how to escalate 
patient’s needs safely and hand over responsibility 
to the next member of staff. 
Working with 
patients in isolation 
rooms 
Pre-reg should continue to work with patients in 
isolation rooms, taking the normal precautions and 




Pre-reg may administer medicines under the 
supervision of a registered nurse. The pre-reg 
should not be administering medicines 
independently.  
Act as a third check 
when checking 
giving IV medication 
Currently nursing students act as a 3rd check for IV 
medication. Pre-reg to act as 3rd checker for 
preparing IV medication at a point determined 
suitable by the Supervisory team. 
Act as a second 
check for Controlled 
Drugs checks 
Pre-reg can act as a 2nd check for Controlled Drugs 
checks (pharmacy technicians can currently 
perform this role) at a point determined suitable by 
the Supervisory team. 
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1.3 Personal Development Plan 
Prior to the placement commencing, a personal development plan should be 
agreed to identify, prioritise and design ways in which the pre-registration 
pharmacists’ educational needs may be met during their placement. This 
plan should reflect the commitment from the pre-registration pharmacist, 
Practice and Education Supervisors to meeting the learning needs of the 
trainee. 
To help identify some of the learning objectives for this placement, please 
reflect on the learning outcomes listed below. 
 
 
1.4 Learning Outcomes 
This ward-based placement has a set of Learning Outcomes designed to 
complement the 76 Performance Standards pre-registration pharmacists 
need to achieve as part of their pre-registration year. At the end of this 
placement, you will be able to: 
 Apply and synthesise knowledge in the context of clinical decision-
making 
 Critically appraise prescriptions and develop personalised 
management plans for patients 
 Demonstrate effective time-management, prioritisation and 
organisational skills 
 Demonstrate effective interprofessional working 
 Demonstrate effective communication and consultation skills with 
patients, carers and healthcare professionals 
 Reflect on the experience and identify future learning needs 
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Personal Development Plan 
Pre-registration pharmacist: ……………………… Education Supervisor ………………… Practice Supervisor………………… 
Date: 
What do you want to 
learn? 
(Objectives) 




How are you going to 
show that you have 
learnt it? 
(Evidence) 
How are you going 
































1.5 Technical Competency Assessments  
Below is a list of technical competencies which once the pre-registration 
pharmacist has demonstrated proficiency in, may be able to perform 
independently. This list should be kept up to date by the pre-registration 
pharmacist to enable clear communication between ward and pharmacy staff 





















1.6 Suggested typical working day 
Below is an example of what a typical working day for a pre-registration 
pharmacist during the longitudinal placement could look like.  
9am   Attend Board Round 
9:30am  Attend Consultant ward round 
11am*  Complete any outstanding Medicines Reconciliations if possible 
Respond to requests for medication orders (ready to be 
screened by pharmacist) 
Have queries ready for discussion with the ward pharmacist 
1pm Lunch 
2pm  Support any discharges that may be taking place 
Respond to requests for medication orders 
Liaise with pharmacy team for updates and tasks and current 
ward status 
Check in with Practice Supervisor for tasks and help with 
prioritising tasks 
Review medicine charts, identifying patients which may be 
interesting to discuss 
Complete Audit activities 
Complete any Evidence Tools 
Seek out other learning opportunities which may be available 
5pm  Finish work 
 
Please be aware that this placement will see a gradual progression in terms 
of complexity and responsibility, so the pre-registration pharmacist may not 
be able to complete all tasks assigned at the start of the placement, it is 






*Don’t worry about finishing everything before going to lunch 
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1.7 Top tips on integrating into the ward team 
1)  Get to know the ward team and discharge coordinator. 
2)  Understand the roles of each staff member (this allows you to know 
who to approach when you have a question). 
3)  Present information about your working activities to your Practice 
Supervisor at all times so that they know that you are working on. 
4) Make good use of time, be practical and seek Practice Supervisor out 
and ask if there is anything you should/could be doing. 
5)  Communicate with Practice and Education Supervisors about 
activities. 
6) Try and stay on top of the ward list, who is on the ward and who is 
likely to be going home soon. 
7) Keep a list of patients with queries or extra complications that you can 
forward to the ward pharmacist. Write things down that might be 
relevant to the ward pharmacist. 
8)  If you suspect a patient may not be managing their medicines, speak 
to staff nurse and Practice Supervisor first, liaising between the ward 
staff and the ward pharmacist. 
9) When healthcare professionals visit the ward to review specific 
patients, introduce yourself as a pharmacy student and ask to 
observe/learn from them and ask them to explain what they are doing. 
 
448 







Week 4-5 Week 6-7 Week 8-9 Week 10-11 Week 12-13 
Learning agreement Develop plan  Review plan  Review plan  
Pharmacy Activities;  
POD, MR, Ordering 
 Work towards achieving competencies 
Conducts independently referring to ward pharmacist when 
necessary 
Discharge Planning  
Utilises Medicines Management skills and 
works with pharmacist to support staff with 
patient discharges 
Practice discharge letter proofing 
Competency for 
discharge letters 
Patient Observations  Observe observations by ward staff 
Pharmaceutical care 
planning 
 Training and practice Implementation to support ward pharmacist 
Board rounds  
Attendance and Observation, updates 
patient list 
Contributes if appropriate 
Medicines administration  
Observation of oral 
medicines administration 
Observation of IV medicines 
administration 
Support administration & 




 Observation and practice with pharmacist 
Conducts assessments independently; liaising with 
primary care providers on discharge 
Patient Counselling  
Orientation from ward pharmacist where 
pre-reg will receive training and 
opportunity to practise 
Completion of evidence tools to support development 
of consultation skills 
Consultant ward round  Attendance and Observation; supporting medical team and communicating with pharmacist 
Responding to staff and 
patient MI queries 
 
Practice and implement responses under ward pharmacist supervision; completing Evidence Tools 





Familiarisation with relevant 
guidelines  
Training and practice 
Implementation with support from 
ward pharmacist 
Work in the day 
assessment unit 
 Observation and Training 
Work under supervision of healthcare professional to 
assist with caring for patients 
Audit  Identification of audit topic Audit data collection  Write-up Presentation 
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Week 1 Induction 
The pre-registration pharmacist should complete the table below when they 
meet staff on the ward. 
Meet the team 
Name Role Responsibilities  
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Notes/Link to Evidence 
Overview of how ward 
operates 
  
Orientation of the ward; 




Time spent with FY1; 
learning about their job 
roles 
  
Understand transfer of 
care issues  
  
Time spent with 
infection control 
  
Time spent with 
physiotherapy 
  
Attend board round 
meetings 
  
Orientation of medical 
notes 
  
Training on answering 
the ward telephone  
  
Training on accessing 










Week 2 - 3 
 
Attendance at Board Rounds 
Activity Undertaken 
(Date) 
Notes/Link to Evidence 
Attend board round, 
making relevant notes 




patients’ medicines and 
discharge information 
to: 
 Ward pharmacist 




Support ward staff to 
keep the patient 




 TTO status 






Attendance at medication administration rounds 
Activity Undertaken 
(Date) 












Notes/Link to Evidence 
Liaise with Practice 
and Education 
supervisors to identify 







Notes/Link to Evidence 






















Attendance at clinical ward rounds 
Activity Undertaken 
(Date) 
Notes/Link to Evidence 
Attend ward round, 
making relevant notes 
regarding patient care 
  
Communicate relevant 
information on specific 






Notes/Link to Evidence 
Agree audit topic   






Notes/Link to Evidence 
Collect Medicines 
Information queries 
from ward staff 
  
Draft responses to 





Go through responses 






Medicines management at ward level 
Activity Undertaken 
(Date) 
Notes/Link to Evidence 
Assist ward staff with 
stock control 
  
Take a proactive role in 
helping facilitate the 
ordering of medicines 
for the ward and for 
patients 
  
Review of medication 




Patient Counselling and Treatment 
Activity Undertaken 
(Date) 
Notes/Link to Evidence 
Work with ward 
pharmacist to identify 
patients appropriate for 
counselling 
  




Counsel patients on 
their discharge 
medicines under 
















Attendance at clinical ward rounds 
Activity Undertaken 
(Date) 















Attendance at medication administration rounds 
Activity Undertaken 
(Date) 
Notes/Link to Evidence 
Support ward staff to 
administer medicines to 
patients with an NG 
tube 
  
Support ward staff to 
manage medicines 
administration of 
medicines to patients 






Notes/Link to Evidence 
Define audit standards   
Pilot data collection 
tool 
  







Patient Counselling and Treatment 
Activity Undertaken 
(Date) 
Notes/Link to Evidence 
Be observed conducting 
patient-centred 
consultations: 
3. With patients 
4. With patients’ 
relatives/carers 
  
Gather feedback from 
staff on own counselling 
technique 
  












Medicines management at ward level 
Activity Undertaken 
(Date) 
Notes/Link to Evidence 
Support clinical team in 
monitoring therapeutic 
drug levels for 




Week 8 -9 
 
Attendance at medication administration rounds 
Activity Undertaken 
(Date) 
Notes/Link to Evidence 
Observe ward staff 
preparing and 
administering IV 






Notes/Link to Evidence 
Use current guidelines 
and reference sources 
to assess the suitability 




clinical notes, referring 









Notes/Link to Evidence 









Notes/Link to Evidence 
Answer medicines 
information queries 
from ward staff using a 















Self-administration of medicines 
Activity Undertaken 
(Date) 
Notes/Link to Evidence 
Conduct assessments 
to determine if patients 
suitable to self-
administer medicines  
  
Support patients in self-
managing their 
medicines during ward 
stay 
  
Patient-centred care on discharge 
Activity Undertaken 
(Date) 















Patient Counselling and Treatment 
Activity Undertaken 
(Date) 
Notes/Link to Evidence 




relatives or care 




Respond to patient 




Help to create a holistic 
clinical management 
plan for a patient which 
takes into consideration 
their physical, social 













Notes/Link to Evidence 
Work with team to 
implement safe use of 





Identify guidance which 
is not widely 
implemented and 





Attendance at clinical ward rounds 
Activity Undertaken 
(Date) 
Notes/Link to Evidence 
Consider the role of the 
pharmacist as a 






Notes/Link to Evidence 
Prepare a summary 






Notes/Link to Evidence 
Contribute to improving 





















Patient-centred care on discharge 
Activity Undertaken 
(Date) 
Notes/Link to Evidence 
Communicate with the 






Support patients to 
manage their 
medicines at home e.g. 
checking they can 
remove their tablets 
from the packets 
  
Have an awareness of 
safeguarding issues 
and learn how to initiate 
appropriate actions 
  
Support patients to use 
aid devices to manage 






Notes/Link to Evidence 
Agree a topic and 
audience 
  
Devise an evaluation 
form for attendees and 









Working in day assessment unit 
Activity Undertaken 
(Date) 








patients in frailty unit 
  
Liaise with clinical team 
to review patients’ 
medicines 
  

















Notes/Link to Evidence 







Patient-centred care on discharge 
Activity Undertaken 
(Date) 
Notes/Link to Evidence 
Undertake competency 
assessment in EDS 






Notes/Link to Evidence 
Deliver teaching 
session to ward 
staff/pharmacy staff 
  










Working in day assessment unit 
Activity Undertaken 
(Date) 
Notes/Link to Evidence 




Liaise with ward 
pharmacist regarding 








from patients under 
supervision  
  
Work shift hours 
Activity Undertaken 
(Date) 
Notes/Link to Evidence 
Agree working hours   
Observe patient 
handover from night to 
day shift and vice versa 
  
Observe morning 
activities of ward staff 
  
Observe writing of late 
discharge prescriptions 
  
Evaluate ways which 
the pharmacy 
department could 









Notes/Link to Evidence 
Attend a ‘no harm’ 
panel with Practice 
Supervisor 
  














Spend time with FY1 
and/or nursing student 
teaching them about 
medicines 
  
Take part in a micro 
ward round  
  






Take advantage of 
opportunities on the 
ward to obtain 
knowledge and/or skills 
  
Attend training/teaching 
sessions with junior 
doctors 
  
Conduct a patient 
handover with  
  
Observe consultant 






















































3. Evidence Tools  
3.1 Evidence Information 
Please see the below suggested minimum timetable for collecting each of 
the following pieces of evidence. The Tools are designed to be used with 
another member of staff who can provide feedback on the pre-registration 
pharmacists’ performance which can be used to improve practice.  
The tools have been designed with the GPhC Performance Standards in 
mind, to enable the pre-registration pharmacist to gather as much evidence 
in support of their activities during the placement. This will also allow the pre-
registration pharmacist to demonstrate that they have met the minimum safe 
standard of practice by collecting evidence in support of meeting these 
standards.  










1 2 3 4 5 6 7 8 9 10 11 12 13 
Mini-CEX              
Intervention 
Recording 




             
Case Based 
Discussion 
             




































reasoning in a range 
of clinical scenarios 
Consultation skills 





Recommending, justifying and 
communicating interventions 
In-depth discussion 
Depth and breadth of knowledge on 
a clinical area inspired by the 






with the team 
When to use? Real-time Real-time Retrospectively Retrospectively Retrospectively 
Preparation 
required? 
No No Yes – 45 mins Yes – 2 hours No 








Any healthcare professional 
with knowledge in clinical area 
Any healthcare professional 







Discussion of clinical 
reasoning decisions 
in real-life scenarios  





Any opportunity where 






• Responding to MI 
queries 
When a clinical intervention is 
being considered by the pre-reg 
• Medicines reconciliation - 
intervention picked up as a 
result 
• Attendance at consultant ward 
round – discussions with ward 
pharmacist afterwards may 
involve suggesting 
intervention 
To explore a complex patient and 
their care in greater depth in order to 
deepen understanding of 
disease/medicine 
• Complex medication regime 
reduced (deprescribing) 
• Complex medicines reconciliation 
process 
• Complex medical condition with 
specific medication regime 











completed for range 
of activities, better it 
is for informing 
further development 
Feedback should be 
used to develop 
consultation skills 
further 
Snapshot recording of 
interventions made to improve 
patient care 
Discussion that can be presented as 
a case study on a chosen patient to 









Name ………………………        Observer name ………………………… 
                                            
Date   ………………..                 Observer job role….……………………                                                        
 






















Anything especially good?  












Suggestions for development  

















Please mark in the box whether the trainee pharmacist has 
met each of the below standards. Please leave the box 





A1.1 Behave in a manner consistent with membership of the 
profession 
 
B1.8 Behave in a manner which instills confidence  
B1.9 Behave assertively  
A1.4 Respond with willingness and flexibility to new situations 
and to change  
 
Problem Solving 
A3.1 Recognise and define actual or potential problems  
C2.7 Recognise possible adverse drug reactions, evaluate risks 
and take action accordingly 
 
A1.6 Make decisions which demonstrate clear and logical 
thought 
 
A3.2 Identify workable options to resolve the problem  
A3.3 Select the best solution, based on sound analysis and 
appropriate evidence 
 




B1.11 Provide information and advice appropriate to the needs 
of the recipient(s)  
 
B2.2 Present your own ideas and opinions appropriately when 
speaking and in writing 
 


















3.3 Intervention Recording 
Name ………………………           Reviewer name………………………… 
                                            
Date   ………………..                    Reviewer job role……………………… 
                                                    
Intervention summary (context of intervention, pre-registration pharmacist 























Anything especially good?  










Suggestions for development  
(to be filled out by observer) 
 




Please mark in the box whether the trainee pharmacist has 
met each of the below standards. Please leave the box blank 





A3.1 Recognise and define actual or potential problems   
C2.7 Recognise possible adverse drug reactions, evaluate risks 
and take action accordingly 
 
A3.2 Identify workable options to resolve the problem  
A1.6 Make decisions which demonstrate clear and logical 
thought 
 
A3.3 Select the best solution, based on sound analysis and 
appropriate evidence 
 
A3.4 Suggest and, if appropriate, implement solutions to 
problems 
 
A3.5 Evaluate the outcome of the solution after implementation, 
and if necessary re-define the problem  
 
Behaviour  
B1.11 Provide information and advice appropriate to the needs 
of the recipient(s)  
 
B2.1 Acknowledge the ideas and opinions of others and act on 
them when appropriate  
 
C2.4 Actively provide information and advice to healthcare 
professionals 
 
C2.2 Pro-actively assist patients to obtain maximum benefit 
from their treatment  
 
C2.3 Identify and take action to minimise risk to patients from 
their treatment  
 













3.4 Consultation Observation Tool 
Name ……………………………      Observer name………………………. 
                                            
Date   ………………..                      Observer job role…………………….                                   
 






















Anything especially good?  












Suggestions for development  




Agreed action (to be filled out by pre-registration pharmacist as SMART objectives): 
 
475 
Please mark in the box whether the trainee pharmacist has 
met each of the below standards. Please leave the box 




Empathy and negotiation 
B1.5 Listen effectively to the whole message  
B1.4 Elicit all relevant information by the use of appropriate 
questions 
 
A1.5 Remain composed and personally effective in all situations  
B1.10 Use appropriate body language  
B1.7 Act appropriately in response to spoken and unspoken 
needs of others  
 
B2.1 Acknowledge the ideas and opinions of others and act on 
them when appropriate 
 
B1.2 Behave in a polite and helpful manner  
Influencing 
B1.11 Provide information and advice appropriate to the needs 
of the recipient(s) 
 
C2.1 Provide considered and correct answers to queries, 
founded on research-based evidence 
 




C2.2 Pro-actively assist patients to obtain maximum benefit from 
their treatment  
 
C2.3 Identify and take action to minimise risk to patients from 
their treatment  
 
A1.3 Recognise your personal and professional limitations and 
refer appropriately 
 













3.5.1 Case Based Discussion Preparation 
Name ……………………………… Observer name…...……………………… 
                                           
Date   ………………..                     Observer job role   ……………………… 
Case Summary (explanation of patient’s journey through from their diagnosis and 





















Other relevant patient 






























































































3.5.2 Case Based Discussion 
Name …………………………….   Reviewer name………..…………………… 
                                            
Date   ………………..                          Reviewer job role…………………………… 
 
 
Anything especially good?  










Suggestions for development  
(to be filled out by reviewer): 
 










                                                 
Please mark in the box whether the trainee pharmacist 
has met each of the below standards. Please leave the box 





Use of resources and problem solving  
A2.4 Use resources effectively  
A3.1 Recognise and define actual or potential problems   
A3.5 Evaluate the outcome of the solution after 
implementation  
 
A4.6 Base your actions, advice and decisions on evidence  
Learning opportunities 
A5.3 Make full use of learning and development opportunities  
A5.6 Record your own learning and development process 
and outcomes 
 
A5.7 Apply learning to practice   
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Please mark in the box whether the trainee pharmacist 
has met each of the below standards. Please leave the box 





B2.2 Present your own ideas and opinions appropriately 
when speaking and in writing  
 
Patient care 
C2.5 Construct medication histories using a range of sources  
C2.6 Use medication histories correctly  
C2.3 Identify and take action to minimise risk to patients from 
their treatment  
 
C2.2 Pro-actively assist patients to obtain maximum benefit 
from their treatment  
 


















































Appendix 27 Participant information sheet for pre-registration tutors and ward 










































Appendix 33 Additional quotes – chapter 7 
Background 
Pre-registration pharmacists  
Pre-registration pharmacist A (PRA) 
“what to give, how to give them [medicines]” A0 
“feel bad sometimes…should know this” A0 
“didn’t even hesitate” A0 
“just standing there with nothing to do” A0 
Pre-registration pharmacist B (PRB) 
“the environment…just wasn’t friendly” B0 
“there’s a team around you…more opportunities to interact with patients” B0 
“more relevant for actually practising” B0 
“learn better from doing…just reading stuff” B0 
“be able to be part of a team properly” B0 
“turn into the ward skivvy and…be the nurses slave” B0 
“see that happening cos there’s too many people that have a vested interest 
in” B0 
Pre-registration pharmacist C (PRC)  
“not an easy job” C0 
“you really need to be passionate about wanting to help people” C0 
“you actually see in practice…how medicines…affect…life of people and how 
pharmacists help manage that…” C0 
“… learn more about…other healthcare professionals that work on the 
ward…and how we as the pharmacy department can work together with 
these members to deliver…good patient care” C0 
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Ward experience prior to placement 
“…pharmacists just came on the wards, picked up the drug charts, ordered 
what needed to be ordered, did the MRs and just left…” A3  
“…I think it’s quite easy…for a lot of pharmacists to be like ‘ok you [PRB] just 
see the new patients and do their meds rec’…they [pharmacists] 
don’t…really go through the problems with you…or explain any cases to 
you…cos obviously they don’t have much time…” B4 
Placement wards 
Hospital 1 
“…everyone respects each other…they were all really welcoming…I think 
that’s the first ward that I’ve seen that…openly values the pharmacists and 
appreciates the job that we have to do…” A0 
“…I was concerned that with [prototype placement]…the nurses…[would 
think] she [PRA] could do what [prototype pre-reg] did straight away…I think 
over the first week…they’ve learnt that her skill set…was…different…and I 
think…now they’re able to recognise what her limitations are…” APT1 
Hospital 2 
“for us [ward staff] I think it was nice…to be a big part of this new trial 
because it’s something that’s completely different, so I’ve kind of felt…almost 
humbled that [BWP] had said [placement ward] could do that…” BWS 
Hospitals 1 and 2 
“…we’re used to having…students and pre reg’s and all sorts with us on drug 






“…the workbook has been…a good guide as to what you should be doing 
[during the placement]…it wasn’t a robust thing, we could amend it as and 
when we went along, which was good…” A14 
“…not looked at it [workbook] for a while…because of the nature of the ward 
[placement]…certain things…I was doing in the first week…and then I ended 
up building that relationship [with the staff]…so I feel like [I don’t need the 
structure] …” A7  
“…I think we missed a lot of opportunities, to use them [workplace 
assessment tools], to formally record things that she did…so whether that is 
because of bad planning or because of the nature of the tool [I’m not sure].” 
BWP 
Induction 
“…the first week was…induction so [ward sister] showed me round the ward, 
introduced me to the staff, I was with the [specialist nurse] for a day…[they] 
teach me about hand hygiene…[another day] I was with the discharge 
coordinator… I went with her [to]… meetings, she showed me…what steps 
goes…in place before a patient gets discharged…[another day] I was with 
[consultant]…I done the morning ward rounds with him…and then he 
was…doing a…teaching session [for doctors] which was quite interesting…” 
C5 
Tutor meetings 
“… because I’m on [placement ward] he [pre-reg tutor CPT] likes to come on 
[the ward] …and ‘hope you’re putting him to use’ that’s what he told the 
nurses [jokingly] …yeah [CPT] is cool… we’ve got a meeting coming up 
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soon…he’s asked me to prepare a case based discussion and then we’ll go 
over it…” C8 
Relationship with pharmacy 
“…sometimes if it’s a late [patient] discharge I’ll just come down [to 
pharmacy], apologise and wait…or give them a hand with dispensing it…and 
then I’ll take it back up [to the ward]…and I think they’re [dispensary staff] 
appreciating it a lot more…I think it’s building a relationship with everyone” 
A7 
Adaptations 
“…there’s not really much to do [on the ward] cos nobody’s really around in 
terms of pharmacy…So I’ll ring the [pharmacy] phone and sometimes I’ll end 
up on [other wards]…helping out with anything that they’ve got to do…” A3 
Board round 
“…in the board rounds, sometimes they’d [ward staff] flag up things that they 
wanted us to have a look at…so it was quite useful cos it gives you a heads 
up…you can prioritise the patients rather than…just bumbling along…” B14 
Ward round 
“…she [PRB] would normally come along on the ward round in the morning 
…[BCONS] is very good at discussing medications and it’s quite medication 
heavy on the ward round so…we’d always review all the medication… and 
then in the afternoon if we had…any queries about…different medications… 
then [we’d] probably discuss with [PRB]…it was really good…because it’s 
just another source of information…” BFY1 
Activity summary 
“…I watched a doctor do cannulation…she put the cannula in…[then] she 
was like ‘oh will you apply pressure to this bit of the cotton swab and I’ll be 
back’…I kept pressing down…then I told the doctor…‘she’s still bleeding’ and 
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she was like ‘yeah she’s on Apixaban’ [blood thinning medication] and…I 
didn’t think of all of these things. It all makes sense now...” A3 
Personal care 
“…we talked about…her [PRB] observing personal care and…I actually 
thought ‘I’m not sure if you really need to do that’. So in the end…I think she 
probably did …observe personal care in terms of seeing a patient being 
washed…but there was no need for that [to be repeated]…” BWS  
Routine 
“…I like the routine…I come in [to pharmacy] at half eight…and then 9am’s 
like board round and ward round afterwards, I like the set structure…I think 
it’s gearing me up towards the end when I have to do independent working 
on my own…cos I’ll be used to working in an MDT where it’s not just 
pharmacy…I’ll be confident enough to speak to other people” A7 
Knowledge sharing 
“…sometimes the doctors will come to me and they’ll ask me a question, so I 
always have the printed guidelines in case there’s not a computer 
available…” A7 
“…I went to morning drug round and…noticed…Amoxicillin [antibiotic] 
suspension in the patient [locker]…[and] that needs to be in the fridge…I told 
the nurse..[it] needed to be in the fridge…cos otherwise you have to throw it 
out…and now they [nurses] do [keep it in the fridge]…” A3 
The ward pharmacist 
PRA 
“I know at the beginning of [PRA]’s placement…the ward sister wasn’t 
happy…she felt there wasn’t enough senior clinical pharmacist…presence 
there on the wards with [PRA] and so she felt…[PRA] was left all by 
herself…so she highlighted that to the department…” APT2 
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PRB 
“…he’s [BWP] just like ‘ok you write the TTO and then I’ll do it separately and 
see whether we agree’…it’s helping me with that next step…and if there’s 
anything that he thinks I’ve missed he’ll be like ‘so why didn’t you do that?’ or 
‘is there a reason that you did this?’…so he goes through it a lot more [than 
other pharmacists]” B4 
“My approach, is…it depends on your student… probably the old-fashioned 
way…see one, do one, teach one… I would get her to look into things and 
report back...” BWP 
“…especially when there are complex patients…quite often [BWP] would be 
like ‘no you go on [the ward round]’…so then he’d be like ‘so tell me what’s 
going on ‘I…really enjoyed it, I felt like I learnt a lot…’” B14 
PRC 
“… [there] was always someone [pharmacist] I could get hold of if I needed 
to…I’ve never found myself on the ward where I need help that I’ve not been 
able to reach anyone so…that’s good” C5 
“…[CWP] she shadowed me for the first couple of weeks [ordering 
medicines] but now…I go on the ward I do them [medication orders] and then 
when she comes she checks them…” C8 
“…I just don’t think he was supervised enough…I don’t know that he knew all 
he needed to [from a pharmacy perspective]…I don’t know where he was at 
with that sort of stuff…” CWS 
“…he knew that he wasn’t being supported, but we turned it into a positive, 
how well he was doing…I just think he knew in his heart he wasn’t getting the 
training he should be, the education part of it…” CWS 
“…most times I have to cover additional wards in addition to [placement 
ward]…I would go to the other wards…knowing that PRC has done the 
medicines reconciliations and he would always cascade or refer problems to 
me. On the very rare occasions when I just had [placement ward] to cover I 
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would probably attend the ward rounds for an hour or so with the doctors 
and…then I would just clinically screen whatever he has done…” CWP 
“…he did get a bit more support…I definitely saw more of a presence of 
other pharmacists around than I have done previously with the pre reg’s…it 
gave him more time to learn...” CDS  
The ward team 
Hospital 1 
“…the…senior nurses…have really…taken him [PRC] under their wing. He’s 
always had someone he can go to if he’s in trouble or he’s got any issues. 
They’ve [nurses] always given him enough time…to write up his evidences 
and do the…case based discussions…” CPT 
Hospital 1 and 2 
The pre-registration pharmacists 
“…[PRC] got on with everyone, he is very quiet…but he interacted really 
well…he would always come in and join in the conversation…he wouldn’t 
hide away…he’d always be in the hub of everyone…cos a lot of pharmacists 
come down here [secluded place on the ward] where it is a bit quieter, but he 
always stayed up with us…[he was] very involved…” CWS  
“…[PRB] was so competent and always wanted to go the extra mile and be 
helpful, really good knowledge base…very keen to be proactive and 
learn…she was…aware of her boundaries… she grasped every opportunity 
to do the very best she could…” BWS 
“if they [pre-registration pharmacists] are interested… keen…and eager to 
um make use of the resources…take advantage of the environment… being 
on the wards has positively impacted on her development as well but there 
might be other factors which have contributed to that and some of them 
might be her as a person maybe her eagerness as a trainee or you know or 
her personality” APT2 
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Local viability  
Part of the team  
“…so I think it was…teething issues at first…we [ward team] were not 
entirely sure what her [PRB] role could be, but she adapted to it quite quickly 
and…when she started getting embedded in the team and coming to 
things…she learnt our names and…I know that sounds trite, but just knowing 
people’s names…is quite important to enable her to get involved a bit 
more…” BCONS 
 “…[I] look at their [patient’s] antibiotics…if it’s…overdue the review date…I 
just annotate it for it to get reviewed…” C5 
“…sometimes they [nurses] don’t take into account…the pharmacy…time 
before a medication comes up [to the ward]…they [nurses]…order 
transport…in an hour…but…we [pharmacy] should have 4 hours [to do the 
discharge medicines (TTOs)] cos the pharmacy might be busy…I think this is 
a matter for the pharmacists to keep educating the nurses about…” C5 
“…I think…when you go into any new area where…you haven’t met these 
people … there’s a certain level of professional conduct that you need to 
[show]…but as she got to know us and become part of that team…those 
professional boundaries…are dropped a little bit…” BWS 
“…I think when you build up more of a working relationship with them 
[doctors], I feel more comfortable to ask more questions and I think that’s 
what I was almost missing on previous rotations…I felt very supported 
[during the longitudinal placement] but equally very independent in what I 
was doing…” B14 
“…when they [nurses] have discharges, before it would be ‘oh this persons 
going at 2pm, will you be able to make sure pharmacy [is ready]?’…but now 
they’re coming up to me…‘what time do you think you’ll be ready from 
pharmacy?’… [AWS]’s like ‘the decision’s down to you, I don’t want to stress 
you out’” A7 
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“…I’ve had a really good relationship with pretty much everyone on the 
ward…in the mornings when I come in, before the board round, we just have 
a chat really about pretty much everything from football…[to] 
Neighbours…so it was good and I think that’s one way that kind of helped 
me immerse in the team…when I attended the rounds…they don’t see me 
like an outsider, they see me as part and parcel of the team…” C14 
“…I like to think that I’ve kind of built…a good relationship with most of the 
members of the staff…I’m pretty much a member of the team, when I’m sat 
there patient’s buzzer is going off, I go and you answer, find out what they 
need and they come and say thank you so…I think gradually I’m merging 
into the team which makes it you know very easy for them to come to me 
with anything they need which I think all works together to make sure that 
you know we giving the best possible care to patients which is what they 
deserve” C8 
 “ … I had a [health and social care] student shadowing me, watching what 
I’m doing …I bring them round here [pharmacy department]…it really helps 
with general communication and interpersonal skills…” C8 
“…I think as time goes on you become more integrated so I feel like I kind of 
have a place within the ward team…we’re…forming a…basis for a ward 
pharmacist… role…becoming more established” B7 
Enriched learning experience 
“…I felt like my learning on [placement ward] I learnt a lot more than I did on 
any of my [other ward] placements…” B14 
“…the placement has definitely helped because it gives you that 
context…that opportunity to go and see…how a ward works…talking with 
patients…much more than the current [rotational training] pre-regs get…” 
BWP 
“…we had a ward round and he [consultant] thought of a condition…I’d never 
heard of it before… and they [patient] were …on the other side of the 
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hospital so…he took me and all the FY1s down there and had this massive 
talk through all the medications …’” A3 
“…knowing how the clinic works…I think she quite enjoyed mine and was 
quite helpful for her because it’s knowing how people…[are] followed 
up…your thought process is completely different in terms of the decisions 
you’re making. They’re not a five minute consultation with the patient…[so] 
I’ve got a decent chance of making a sensible decision…” BCONS  
“…when they [ward staff] see things that they think might be beneficial for me 
to learn, from they’ll like call me over…‘oh I’m having a drugs round now if 
you wanna come watch’…they actively look for me to learn” A7 
“… so we [junior doctors and myself] built more of a…friendship as opposed 
to a working relationship so that also helps me learn because…I’d be sitting 
on the ward reading something, they come over and kind of ask ‘oh what are 
you reading?’ and I’d be able to understand it from their view as well…so it 
helps build up a really good learning environment…” A14 
“…every time I went to look and find out [something] I learnt from it…I think 
you learn more by finding out yourself…so then…when it came up next time I 
felt completely happy and competent to give a valid answer because I knew I 
knew the answer…” B14  
“…with [ward sister] on [placement ward] she gives you the option to…go 
away and process it [learning]…Whereas when I’ve done other rotations…I 
kind of get home and…I can’t…[identify] one single thing I learnt cos it was 
just ‘go go go’ non-stop. I wasn’t really reflecting on what I had done...” A14 
“…I think it’s [consultant ward round]...good opportunity [for learning] but 
then it goes on till about 12pm…so… when there are…orders for 
medication…new patients that need to be seen, it makes it quite hard for me 
to attend it everyday…” C5 
“…I had [APT1] with me the whole time…I can see how much of an impact 
that’s made on my learning. I’ve learnt a lot more…and then I’ve had a lot 
more to write for my competencies…” A7 
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“…every time I went to look and find out [something] I learnt from it…I think 
you learn more by finding out yourself…so then…when it came up next time I 
felt completely happy and competent to give a valid answer…” B14  
“…it’s [placement] been quite enlightening…it’s interesting to see how it’s 
adapted as the period has gone on…we [pre-registration managers/tutors] 
try and do our best to try and come up with a programme that’s um best for 
them [pre-registration pharmacists] but having seen that there’s more that we 
could contribute in…greater depth in a prolonged period I think it’s something 
that we can definitely do in the future. What I liked about it the most, it 
has…certainly improved…their learning…” APT1  
“…she [AWS] gives you the option to…go away and process it 
[learning]…Whereas when I’ve done other rotations…I kind of get home 
and…I can’t…[identify] one single thing I learnt cos it was just ‘go go go’ non-
stop. I wasn’t really reflecting on what I had done...” A14 
Development as a professional  
Trust and responsibility 
“…there was a bit more trust...between me, [ward sister] and…the other 
pharmacists …I knew my limitations as well…gradually, over the progression 
of the 13 weeks, just working alongside different members of staff…building 
that relationship…with them…that’s when they saw more of my 
capabilities…” A14  
 “…they [nurses] trust me with queries…they also know that even if I cannot 
answer it they trust me to…find out the answer and get back to them…I like 
to think that I’ve…built like a decent relationship…with…most…members of 
staff…” C8 
“…I knew what I was doing, so there was a bit more trust…between me, 
[AWS]…and the other pharmacists …” A14  
“…it gives an opportunity to…work and make mistakes get it rectified or just 
learn about just pick up as you go really I think that’s what this project was 
about” C14 
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“…[having more responsibilities] slowly builds my confidence…I think it’s 
needed sometimes…[to] know that you’re going in the right direction so 
it…motivates me to work hard knowing that I’m not making a lot of mistakes, 
I’m at least doing something right and also knowing I’ve also got like a safety 
net at the end it kind of improves my confidence and erm motivation to work 
harder…positive feedback makes me feel like a valued member of the 
team…” C8 
“…[having more responsibilities] slowly builds my confidence…[to] know that 
you’re going in the right direction…and also knowing I’ve got a safety net at 
the end it kind of improves my confidence…” C8 
Establishing an identity 
“…the nurses…[are] not expecting me to be a nurse…an HCA [healthcare 
assistant], they’re treating me more like a pharmacist but they understand 
that obviously…there’s certain things that I can’t do…they all know that I’ve 
finished my degree but they also know that I’m not a qualified pharmacist…” 
B4 
 “…My main erm concern is that some of the staff on the ward… I’m not sure 
they’ve actually got the understanding of what I can do and what I cannot 
do……” C5 
“…I’ve done a couple of ward rounds with the nurses…they’ve all been very 
good in the sense that they’re not expecting me to be a nurse, they’re not 
expecting me to be an HCA [healthcare assistant], they’re treating me more 
like a pharmacist but they understand that obviously…there’s certain things 
that I can’t do…they all know that I’ve finished my degree but they also know 
that I’m not a qualified pharmacist. So they’re very aware when I have to say 
‘oh I need to get this checked’…[and] they’re happy with that” B4 
“…I think initially no [I didn’t know what my role was]…I was…a bit like a 
sitting duck, I just didn’t know where I fitted in. But now…I definitely do, 
because I…know where to go to help…from pharmacy…[and] I feel like the 
ward pretty much considers me to be their pharmacist but they know I’m not 
a pharmacist yet [giggles]” A7 
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“…[I am] ‘establishing’ [an identity on the ward]…if you…ask me in 2 weeks’ 
time, it’ll probably be a different answer…it’s still ongoing…not everyone is 
crystal clear as to my limitations…you still get the odd nurse 
that…shrugs…when you tell them ‘no I can’t do this’…I think I’m 
establishing…it’s loading [draws circle in the air], identity loading…” C8 
“…I had to remind people all the time that he is the pre-reg, give him 
time…people see him as a pharmacist, he was always on his own.” CWS 
“…I think towards the last four weeks of the placement everyone was pretty 
clued up as to my role and what I’m meant to do and what the placement is 
about…slowly but surely we got there” C14 
Confidence and independence 
“…I’m a lot more confident…with the patients on [placement ward]…the 
initial encounter is very formal…[then becomes more relaxed]… it’s building 
more of an interaction between us …before I never used to build that 
relationship it was always …you do the MR, you walk back out…I wasn’t as 
confident because…it was a two-minute interaction…” A7 
 “…prior to my ward placement…I knew the names of medications but…[not] 
how to apply them. Whereas now…I feel like I know…because I’ve been on 
the wards…I feel a lot more confident …because I have that experience to 
back up what I say…I feel like it’s…triggered me…not to just sit there and 
read things out of a book, which I think the other pre-reg’s are doing because 
they haven’t had that clinical face-to-face.” A7 
“…I was a lot more independent in the last few weeks cos…I know what to 
do, I know what my routine is, I know who to call…it made me feel like an 
actual pharmacist…it made me think beyond the exam …” A14 
 “[ward pharmacist]…wasn’t always…on the ward towards the end [of the 
placement], because he knew that if I needed something I’d just call him… 
that worked quite nicely cos I could…do as much as I could, but then I had 
that support behind me if I needed it … I felt like that gave me that more 
independence…more of a transition from a pre-reg to a pharmacist…” B14  
515 
“…I’m being prepared to be a pharmacist more…but I think there’s positives 
and negatives because they’re…gonna see more wards and…specialities 
but…because there’s medical patients on the ward so I do still see a large 
number of drugs…” B7 
“…it [having independence on the ward] made me feel more of like more as 
part of the team …. made me feel almost…like of the FY1’s doctors 
cos…they’re (FY1 doctors) still trusted to…be given tasks 
and…responsibilities and they can get on with it and if they do have a 
problem they can go to someone…” A14 
Improved pharmacy service 
The pre-registration pharmacist service 
“…it went very well…being part of the MDT, went on the board rounds and 
she [PRB] knew a lot more about patients than I did because I only have a 
limited time to spend, so it’s…what we [pharmacy] should be doing anyway.” 
BWP 
“…I’ve seen at first hand when we’re [the ward] trying to get hold of a 
pharmacist to come…I’ve got the personal numbers for some of these 
pharmacists so I can get hold of them like much more easily than they 
[nurses] can…then obviously it means that they will not have to go round 
looking for a pharmacist…” C14 
“…there’s lots of questions that we might need to ask her [PRA] um its’ nice 
to see a familiar face every day that you now that the jobs will get done; 
you’re not having to chase around” ADS  
 “…this [placement] was unique because…every day was an MDT…it 
benefitted the patient… the pharmacist in the board round was invaluable…it 
provides a better level of care… and also on ward rounds, it’s useful to know 
what they’re [doctors] thinking is behind decisions and they can…ask you 
questions…so it works both ways…” B14 
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Patient care 
“…I’ve had a really good relationship with pretty much everyone on the 
ward…I realised if you if you help them in one way or another they…really 
appreciate it and…whenever you need something… they’re more than willing 
to help you…they don’t see me like an outsider, they see me as part and 
parcel of the team…” C14  
 “…since I’ve been to [placement ward] I’ve…got into the habit of actually 
looking at the patient and… every aspect…the blood [tests]…the red notes 
[blood pressure]…the blue notes [previous admissions]… whereas before 
[the placement] it was just the drugs…” C5 
 “…it was a brilliant programme…it really gives…an opportunity to actually 
get to understand what working in a multidisciplinary team means… [it’s an] 
opportunity to……know how…we can all work together to ensure that 
patients get the best possible care” C14  
“…I know that I’m on the ward all day so I can sit with a patient and…when 
I’m doing history for a patient, I don’t feel rushed so I…just engage in a 
conversation with a patient…which…allows you to provide a…holistic 




“…they [ward staff] don’t have to ask…[PRA] she’s got the drive to be able to 
do it [prepare TTO medicines] in advance…it’s almost…intuitive and the 
response time is quicker…so patients are able to be discharged quicker…” 
APT1 
“…to have someone on the ward…that you know…makes a big difference, 
so it’s a bit more cohesive with things like the discharges…it all flows a bit 
better because they know the patients…you [nurses] don’t have to kind of 
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keep ringing somebody and chasing somebody for various different bits…” 
CDS 
“…she…was forward thinking…[she] came…[to] board rounds…and was 
very keen to think about discharge…for the next day…she was very aware of 
what’s going on with all of the patients both medically and socially and that… 
awareness…made it so much more easier for us…” BWS 
Institutionalisation  
Continuation of the placement 
“…to integrate this [ward placement] or some form of ward-based placement 
into the pre-registration year next year…where you’re there all day…by 
yourself with a…senior pharmacist there if you need the help. I think kind of 
being thrown in the deep end with things is the best way to learn. You learn 
as you go along, as opposed to being told it or always shadowing someone 
around because then you become familiar to that routine ‘oh yeah I’m just 
following this person or I’m just doing this’ and you don’t really learn the 
responsibility of working independently. Whereas now I think of things where 
I’m like ‘ok I’m gonna have to feed this back to the pharmacist who comes on 
the ward’ so I make sure that I do my research properly beforehand [and] I’ve 
fully communicated with the other members of staff ‘ok what do you need? 
What’s the problem?’ things like that, how to go around it. Whereas before 
when I was just shadowing someone…I was just waiting for them to tell me 
something that I need to know for the exam, that was it. I wasn’t really 
proactively asking questions or wanting to be involved as much.” A7 
“it’s [placement] got to make a better pharmacist at the end. To have an 
understanding of… the entire team on the ward, the patient journey…the 
valuable input the pharmacy element is…cos so many of our patients are on 
so many medicines, so if we do the pharmacy bit well…that makes a big 
impact…” BDS 
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“…I think a lot of doctors, their first experience of a pharmacist is on a ward 
being like ‘you’ve prescribed this wrong’ so it’s [placement] kind of about 
trying to build bridges…” B14  
Preparation for the placement 
“…in terms of preparation…it will be good…if the person [pre-registration 
pharmacist] can do it [placement] after they’ve done certain accreditations 
such as medicines reconciliation…ordering medication… rewriting a 
chart…they can…be a bit more useful and help out [during the longitudinal 
placement]” C14 
Length of the placement 
“…very often [the benefit] it’s in those last…4 weeks [of the placement] that 
they say ‘oh I feel like I’m there, I’m getting this now’ so if you…cut it 
shorter…you might miss that…” BDS  
“…in practice …pharmacists…don’t spend all the time on the wards…it’s 
kind of mixed services that we provide… to make it [training] more 
realistic…spread it [placement] out…over the training year…not just have it 
as a block programme…” APT2 
Timing of the placement 
“…[starting after Christmas] means you can actually help out on the 
ward…which makes things…easier and cos you’re there to learn… [and] to 
help as well, so it’s a two way street …” C14 
“…if you’d [pre-registration pharmacist] have been spending every afternoon  
revising for the exam he [PRC] would have missed out on a lot of the stuff 
that’s going on in [placement] ward…” CPT 
Qualities of the ward and ward staff 
“…I think it [placement] requires a ward that’s quite diverse…not just [one 
condition] all the time so you see other [conditions]…” B7 
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“…I would like to test it [placement] out in a probably more rapid turnover [of 
patients ward]…I have no reason to believe that it wouldn’t work…and 
actually it would be a good thing to do…” BWP 
“…somewhere that has a good contact for education, is willing to do it…and 
has … the resources to …help them [pre-registration pharmacist]. 
So…some…wards have education facilitators… who can help … put 
together a plan…” CPT 
Qualities of the ward pharmacist 
“…if they see someone that is a pharmacist, they won’t necessarily 
think…‘she’s not qualified yet’… which is [why], the whole thing then about 
having…support…from someone senior to help her [is important]…” ADS   
Qualities of the pre-registration pharmacist 
“…it’s got to be people [pre-registration pharmacists] who are 
interested…with a lot of the teaching being ad hoc and ward round based 
you’ve got to be quite self-motivated and…have quite a decent concentration 
span…learning on a ward round is different to sitting down to a lecture or 
reading a text book…so you’ve got to have someone who…has quite a high 
verbal way of learning…” BCONS 
“…people have got to want to do it with it being a new thing. People are 
scared of change…and deviating from their peers. I think as long as people 
understand what it’s about…you’ve got to have had enough people that have 
done it and enjoyed it so…it’s got to be people who are interested in it…” 
BCONS 
“…it [placement results/outcomes]…might boil down to…[the] 
individual…and if they are interested…being on the wards has probably 
helped…her [PRA] development … but there might be other factors which 
have contributed to that…her as a person …her eagerness…or her 
personality” APT2 
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Support and supervision 
“…just to know…that she’s [PRA] been supervised enough. I do question 
sometimes if she has been… supervised…I don’t think she was [supervised] 
at the beginning… …which I raised…I didn’t want to let her down as her 
supervisor [and] I didn’t want her to be let down by anyone [else]…” AWS 
“…it’s [placement] good. I think it’s intensive …in terms of how much …work 
we have to put in to mentor them and have them on every ward round…I 
think in the future, we perhaps couldn’t keep up that level of intensity…it was 
easy with [PRB] because she was keen … if you’ve got someone who is like 
trying to get blood out of a stone…keeping up that enthusiasm in…[this] 
model might not be as easy” BCONS 
 
 
 
